Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3003458	fp-pi	mmol/l (mmol/l)	30378	168929	0.10%
3003458	p-pi	mmol/l (mmol/l)	26108	177452	0.00%
3003458	fp-pi	— (—)	5412	10230	100.00%	Distribution not available
3003458	p-pi	— (—)	3929	9359	100.00%	Distribution not available
3003458	fs-pi	mmol/l (mmol/l)	1412	1919	0.00%
3003458	fp-pi	mmol/l____ (mmol/l)	868	4971	0.00%
3003458	fs-pi	— (—)	719	804	100.00%	Distribution not available
3003458	p-pi	MMOL/L (mmol/l)	346	960	0.00%
3003458	fp-pi	mmol/L (mmol/l)	328	1294	0.00%
3003458	p-pi	mmol/l____ (mmol/l)	279	1202	0.00%
3003458	s-pi	mmol/l (mmol/l)	58	80	0.00%
3003458	s-pi	— (—)	7	7	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Gastroduodenal ulcer

3191

16068

2.28

323.31

8.3

5.6

1.07

1.04

mmol/l

6.97

3015

14828

Peripheral arterial reconstruction

2314

10448

2.72

323.01

12.2

5.6

1.16

1.03

mmol/l

58.74

2173

9644

Retention of urine

4099

17988

2.08

322.46

6.9

5.9

1.05

1.03

mmol/l

2.38

3845

16732

All anxiety disorders

6058

28230

1.79

320.96

5.9

6.4

1.05

1.04

mmol/l

0.33

5696

26461

Other anxiety disorders

4546

21517

1.95

320.13

5.8

6.3

1.05

mmol/l

0.77

4279

20145

Alcohol dependence

3085

15436

2.29

319.61

5.5

7.3

1.01

1.03

mmol/l

3.02

2908

14525

Fungal Sepsis

782

1951

6.38

319.34

16.1

4.5

1.09

1.02

mmol/l

6.87

749

1786

Other or unspecified ileus, impaction or obstruction

2363

10710

2.60

317.98

7.3

5.5

1.03

1.04

mmol/l

0.93

2247

9892

Other eating disorders

729

1669

5.84

315.52

6.9

6.7

1.12

1.10

mmol/l

0.89

672

1569

Other neurological diseases

7803

39077

1.67

315.14

6.0

6.1

1.04

mmol/l

0.23

7326

36256

Conduction disorders

3241

13052

2.24

313.61

7.4

5.0

1.09

1.01

mmol/l

34.69

3023

12062

Abnormal findings on examination of urine, without diagnosis

828

2219

6.07

310.72

15.0

6.3

1.11

1.05

mmol/l

8.75

812

2071

Early onset COPD, excluding more controls

2183

9580

2.62

309.58

7.5

5.3

1.07

1.02

mmol/l

11.89

2067

8939

Polyneuropathies and other disorders of the peripheral nervous system

2767

13589

2.42

309.24

11.2

6.1

1.09

1.04

mmol/l

14.62

2622

12659

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1866

7675

2.86

309.03

5.3

6.7

1.04

mmol/l

0.27

1768

7190

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

2961

14667

2.26

307.72

5.1

6.5

1.04

mmol/l

0.57

2789

13769

Glomerulonephritis

2137

5220

7.23

307.65

23.7

6.3

1.15

1.05

mmol/l

35.93

2101

4893

Cystic kidney disease, including avohilmo

926

1736

14.29

307.65

28.1

6.2

1.14

1.06

mmol/l

11.12

918

1620

Cystic kidney disease

897

1597

17.03

307.65

28.8

6.3

1.14

1.06

mmol/l

10.62

892

1492

Congenital malformations of the urinary system

1209

2999

7.04

307.65

25.8

6.9

1.15

1.09

mmol/l

7.39

1191

2812

Unspecified kidney failure

2834

4676

13.16

307.65

16.6

2.9

1.17

0.99

mmol/l

129.71

2720

4241

Nephrotic syndrome

842

1565

15.14

307.65

29.3

6.1

1.20

1.08

mmol/l

16.27

834

1458

Other bacterial intestinal infections, including avohilmo

2857

13564

2.44

307.65

11.8

5.1

1.07

1.04

mmol/l

6.38

2680

12570

Renal failure

15193

22159

12.75

307.65

15.1

3.1

1.16

0.98

mmol/l

307.65

14601

20237

Hypoparathyroidism

731

1681

7.88

307.65

7.5

4.6

1.14

1.06

mmol/l

10.87

688

1544

Asthma-related infections

6695

38705

1.84

307.65

6.6

6.2

1.07

1.05

mmol/l

6.82

6303

35935

Unspecified human immunodeficiency virus [HIV] disease, including avohilmo

382

463

171.17

307.65

17.3

7.7

0.92

1.01

mmol/l

8.78

382

444

Hyperlipidaemia, other/unspecified

4971

20421

2.56

307.65

9.7

5.0

1.06

1.02

mmol/l

21.18

4703

18841

Condition for Implicit Sepsis (Organ dysfunction codes)

13816

33967

3.45

307.65

9.5

4.6

1.09

1.02

mmol/l

120.68

13137

31353

Bacterial Sepsis

9492

22976

4.73

307.65

11.5

4.5

1.11

1.01

mmol/l

129.85

9028

21130

Certain infectious and parasitic diseases

10985

27355

2.21

307.65

8.6

3.8

1.06

1.03

mmol/l

18.43

10408

25212

Anaemia in chronic diseases classified elsewhere

666

1221

15.76

307.65

35.9

5.6

1.28

1.04

mmol/l

52.30

652

1134

Anaemias

3991

2530

13.76

307.65

14.1

3.6

1.11

1.07

mmol/l

5.74

3855

2262

Erysipelas

7424

28575

2.60

307.65

8.9

4.6

1.08

1.01

mmol/l

56.51

7000

26376

Septicaemia

8039

22991

4.31

307.65

13.6

4.6

1.11

1.03

mmol/l

70.57

7693

21141

Obesity

8716

35561

2.71

307.65

6.5

6.3

1.08

1.03

mmol/l

40.45

8311

33137

Explicit bacterial Sepsis

1563

5075

4.00

307.65

12.8

4.7

1.09

1.02

mmol/l

13.24

1489

4670

11745

39601

1.59

307.65

7.6

5.4

1.05

1.04

mmol/l

8.61

10946

36763

Explicit Sepsis, including avohilmo

8397

23542

4.32

307.65

13.3

4.5

1.10

1.02

mmol/l

92.55

8037

21656

Enterocolitis due to Clostridium difficile

1631

5981

3.57

307.65

15.2

5.4

1.10

1.04

mmol/l

10.68

1539

5508

Metabolic disorders

13839

33061

2.96

307.65

9.1

5.1

1.06

1.03

mmol/l

18.77

13146

30599

Viral Sepsis

3922

11099

4.98

307.65

14.4

4.4

1.11

1.02

mmol/l

50.32

3744

10197

Implicit viral Sepsis, including avohilmo

5285

16817

4.16

307.65

12.2

4.4

1.10

1.02

mmol/l

52.50

5030

15417

Asthma, hospital admissions 3, pneumonia

4515

24075

2.12

307.65

7.3

6.0

1.07

1.05

mmol/l

4.06

4252

22231

Any event in cancer register

9748

32315

1.92

307.65

7.3

6.2

1.04

mmol/l

0.55

9282

30000

Implicit fungal Sepsis, including avohilmo

1185

3307

5.14

307.65

13.0

4.3

1.08

1.02

mmol/l

7.49

1123

3034

Biguanides

10083

38083

1.72

307.65

5.7

5.9

1.07

1.02

mmol/l

48.52

9475

35349

Excluding asthma or asthma-COPD overlap

7921

21611

1.98

307.65

7.3

4.9

1.05

1.03

mmol/l

6.71

7452

20063

Multiple myeloma, including Hilmo

947

2166

7.98

307.65

11.3

5.3

1.08

1.03

mmol/l

4.69

922

1986

Malignant neoplasm, including Hilmo

9693

30308

2.05

307.65

7.4

6.2

1.04

mmol/l

0.12

9251

28102

Mental and behavioural disorders due to alcohol, excluding acute intoxication

5505

27222

2.30

307.65

5.6

7.1

1.02

1.03

mmol/l

2.49

5212

25636

Asthma, hospital admission 2, infections

6695

38705

1.84

307.65

6.6

6.2

1.07

1.05

mmol/l

6.82

6303

35935

Gastro-oesophageal reflux disease

7127

37798

1.71

307.65

6.7

5.9

1.04

mmol/l

0.79

6631

35189

Amputation

1586

5686

3.74

307.65

18.1

5.5

1.21

1.02

mmol/l

67.52

1497

5251

Autoimmune diseases excluding thyroid diseases, strict definition

11688

35083

1.98

307.65

9.0

5.5

1.06

1.04

mmol/l

11.38

11097

32629

Abnormal findings on examination of blood, without diagnosis

5558

29181

1.93

307.65

7.8

6.4

1.06

1.04

mmol/l

5.91

5297

27292

Malignant neoplasm of digestive organs, including Hilmo

5185

18827

2.32

307.65

5.4

5.9

1.00

1.04

mmol/l

11.14

4938

17337

Any reimbursement code in KELA

5731

10396

3.05

307.65

8.1

3.1

1.06

1.02

mmol/l

19.56

5440

9364

Osteoporosis with pathological fracture (FG)

1196

3813

4.44

307.65

5.0

4.3

1.02

1.04

mmol/l

2.47

1076

3415

First line medication for Crohn's disease

14019

36248

2.33

307.65

10.3

4.5

1.06

1.04

mmol/l

8.15

13330

33470

Solid cancers

8710

29313

1.89

307.65

6.8

6.1

1.04

mmol/l

0.48

8298

27149

Ischaemic heart disease, wide definition

8112

31066

1.75

307.65

8.9

5.5

1.07

1.02

mmol/l

50.96

7691

28839

Neoplasms

7368

21749

1.90

307.65

8.4

5.9

1.06

mmol/l

0.36

6996

20237

Depression or dysthymia

6766

22181

1.79

307.65

6.2

6.9

1.03

1.04

mmol/l

1.89

6323

20767

Implicit Sepsis, including avohilmo

13849

34006

3.62

307.65

9.6

4.6

1.09

1.02

mmol/l

121.94

13163

31403

Asthma-related pneumonia or sepsis

4515

24075

2.12

307.65

7.3

6.0

1.07

1.05

mmol/l

4.06

4252

22231

Iron deficiency anaemia

6245

27179

2.70

307.65

8.3

5.5

1.07

1.04

mmol/l

12.31

5864

25055

Other and unspecified anaemias

7300

26252

3.34

307.65

9.9

5.1

1.09

1.03

mmol/l

50.27

6937

24149

Hypertensive Heart Disease

3008

8523

3.20

307.65

10.0

3.6

1.11

0.99

mmol/l

62.68

2791

7793

Bleeding

10951

38789

2.26

307.65

9.1

5.7

1.06

1.04

mmol/l

9.06

10371

36010

Streptococcal septicaemia

1369

4443

4.12

307.65

12.9

4.8

1.09

1.04

mmol/l

7.85

1304

4092

COPD/asthma related infections

10882

30815

1.92

307.65

7.7

4.9

1.05

1.03

mmol/l

9.06

10220

28568

Congenital malformations of the urinary system, including avohilmo

1250

3203

6.58

307.65

25.2

6.8

1.14

1.08

mmol/l

7.89

1226

2998

Malignant neoplasm

9492

29860

2.05

307.65

7.4

6.1

1.04

mmol/l

0.20

9064

27672

Gout, strict definition

3186

11273

3.96

307.65

12.4

5.8

1.11

1.02

mmol/l

47.15

3035

10506

COPD (mode)

3711

12883

2.60

307.65

6.6

4.8

1.07

1.02

mmol/l

16.99

3464

11946

Sleep apnoea

10152

40657

1.70

307.65

6.3

1.05

1.03

mmol/l

10.81

9505

37987

COPD differential diagnosis

7869

21619

1.97

307.65

7.3

4.9

1.05

1.03

mmol/l

6.81

7399

20076

12282

30815

2.69

307.65

9.2

4.9

1.06

1.03

mmol/l

20.96

11669

28568

Any death

8952

28518

2.64

307.65

8.1

5.8

1.08

1.01

mmol/l

61.62

8539

26519

Chronic pancreatitis

1900

6809

3.72

307.65

8.1

6.6

1.02

1.03

mmol/l

0.58

1843

6383

Alcoholic liver disease

1497

5488

3.63

307.65

6.5

6.9

1.02

1.03

mmol/l

0.81

1424

5159

Type 1 diabetes

3431

12523

3.33

307.65

15.7

6.0

1.14

1.04

mmol/l

52.91

3281

11710

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

822

1448

16.63

307.65

26.0

7.7

1.13

1.06

mmol/l

7.02

809

1360

Dialysis, with operation codes

4478

5624

36.86

307.65

37.6

3.5

1.27

1.00

mmol/l

307.65

4431

5210

Aplastic and other anaemias

8055

27719

3.43

307.65

11.5

5.1

1.10

1.03

mmol/l

71.09

7662

25529

Diabetes medication

12063

39012

1.98

307.65

8.0

5.5

1.08

1.02

mmol/l

66.32

11399

36202

All influenza

3266

14508

2.63

307.65

11.4

5.4

1.08

1.04

mmol/l

10.44

3055

13501

Dipeptidyl peptidase 4 (DPP-4) inhibitors

7661

28415

2.50

307.65

8.2

5.8

1.09

1.02

mmol/l

92.34

7186

26331

Diabetes, varying definitions

12319

35963

2.21

307.65

8.2

5.4

1.08

1.02

mmol/l

68.02

11660

33366

Other nutritional deficiencies

9398

36843

2.74

307.65

6.5

6.3

1.07

1.03

mmol/l

33.98

8956

34318

Venous thromboembolism

6066

35058

1.84

307.65

8.0

5.6

1.04

mmol/l

0.32

5726

32407

Other anaemias

7337

26404

3.33

307.65

9.9

5.1

1.09

1.03

mmol/l

50.73

6972

24291

Other (not insulin) diabetes medications

10600

36721

1.84

307.65

6.5

5.3

1.07

1.02

mmol/l

61.92

9980

34034

Disorders of calcium metabolism

1748

2914

14.11

307.65

11.4

5.1

1.04

1.03

mmol/l

0.28

1674

2700

Paroxysmal tachycardia

2130

6584

3.04

307.65

8.0

3.7

1.07

1.02

mmol/l

10.70

2000

6043

Endocrine, nutritional and metabolic diseases

9183

17085

3.05

307.65

8.0

4.7

1.06

1.04

mmol/l

11.92

8683

15781

Volume depletion

1689

4749

5.01

307.65

10.0

5.1

1.07

1.04

mmol/l

2.41

1601

4349

Other disorders of kidney and ureter

2384

7469

4.74

307.65

26.6

5.6

1.18

1.04

mmol/l

77.22

2313

6962

Hypokalaemia

2042

5891

4.81

307.65

7.7

4.9

1.01

1.03

mmol/l

2.79

1938

5410

IgA nephropathy (IgA glomerulonephritis)

710

1089

25.01

307.65

26.4

6.7

1.14

1.02

mmol/l

14.74

699

1022

Hydronephrosis

1596

4895

4.21

307.65

11.3

3.3

1.09

0.99

mmol/l

23.92

1535

4476

Hyperkalaemia

1317

2748

8.58

307.65

17.4

5.2

1.20

1.03

mmol/l

49.76

1277

2541

Any gastric operation

9179

16469

3.14

307.65

8.1

3.4

1.06

1.04

mmol/l

4.18

8666

15003

Gout, idiopatic and unspecified

4075

15980

3.36

307.65

11.9

5.7

1.11

1.03

mmol/l

50.34

3879

14868

Glomerular diseases

4905

9894

10.62

307.65

24.6

5.0

1.19

1.03

mmol/l

184.26

4792

9235

Neurological diseases

8236

25881

1.69

307.65

6.5

1.06

1.05

mmol/l

0.65

7728

24119

Chronic kidney disease

10968

16020

17.44

307.65

19.0

3.0

1.17

0.98

mmol/l

307.65

10593

14583

Obesity and other hyperalimentation

8751

35722

2.70

307.65

6.4

6.3

1.08

1.03

mmol/l

40.84

8344

33284

Gout, FINNGEN

4918

18596

3.44

307.65

12.2

5.4

1.11

1.02

mmol/l

63.08

4691

17247

Alcohol abuse, main dg, excluding more controls

1778

6967

3.04

307.65

5.4

7.2

1.02

1.04

mmol/l

2.27

1688

6591

Used for control exclusion in common control thyroid runs

11759

33589

1.91

307.65

8.2

5.5

1.06

1.04

mmol/l

8.42

11106

31245

Psychiatric diseases

9807

31688

1.65

307.65

6.4

6.5

1.04

1.05

mmol/l

1.48

9178

29597

Other diseases of the digestive system

4233

20984

2.36

307.65

9.0

5.8

1.07

1.04

mmol/l

5.91

4007

19393

Mental and behavioural disorders due to psychoactive substance use

7279

34639

2.17

307.65

5.9

6.9

1.03

1.04

mmol/l

1.47

6889

32499

Hyperparathyroidism

4231

10076

7.13

307.65

13.6

4.7

0.99

1.05

mmol/l

25.33

3976

9229

Diabetic nephropathy

3435

11392

5.06

307.65

21.4

5.3

1.21

1.05

mmol/l

139.29

3316

10638

Acute tubulo-interstitial nephritis

8558

28079

3.04

307.65

9.8

3.1

1.07

1.00

mmol/l

68.07

8078

25713

All chronic kidney diseases

15312

22143

9.71

307.65

14.9

3.2

1.13

1.00

mmol/l

307.65

14732

20267

Viral pneumonia

1842

6483

3.59

307.65

11.8

5.4

1.07

1.04

mmol/l

3.87

1752

6027

GASTRO-related operations

9179

16469

3.14

307.65

8.1

3.4

1.06

1.04

mmol/l

4.18

8666

15003

Stroke, including SAH

7604

30563

2.00

307.65

6.8

6.0

1.03

1.04

mmol/l

1.04

7134

28332

Stroke, excluding SAH

7157

29350

1.97

307.65

6.8

6.0

1.04

mmol/l

0.27

6716

27189

Coronary revascularization (ANGIO or CABG)

8752

30904

1.89

307.65

9.7

5.5

1.08

1.02

mmol/l

56.67

8280

28702

Other arrhythmias

6064

26997

1.80

307.65

6.1

5.2

1.05

1.02

mmol/l

13.56

5620

25126

Ulcer of lower limb, not elsewhere classified

2479

8649

3.95

307.65

15.0

5.5

1.15

1.03

mmol/l

51.81

2337

8004

KRA_PSY_EATING, excluding more controls

1145

2206

6.65

307.65

6.3

5.5

1.11

1.08

mmol/l

3.92

1066

2047

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

2961

11706

2.84

307.65

5.1

6.4

1.04

mmol/l

0.50

2789

10993

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

11318

34338

2.18

307.65

8.5

5.4

1.08

1.02

mmol/l

80.43

10729

31837

Pulmonary heart disease, diseases of pulmonary circulation

3839

20573

2.13

307.65

7.1

5.7

1.05

1.04

mmol/l

0.91

3613

18997

Insulin, fast-acting or short human

5434

22757

2.92

307.65

13.1

5.9

1.13

1.04

mmol/l

77.39

5171

21250

Insulin, intermediate and long-acting

8072

34423

2.72

307.65

10.7

5.6

1.12

1.03

mmol/l

119.13

7667

32041

Hypothyroidism (congenital or acquired)

2438

2470

6.29

307.65

7.6

3.4

1.06

1.04

mmol/l

3.00

2298

2199

Diseases of liver

4792

21323

2.70

307.65

7.6

6.3

1.05

1.04

mmol/l

2.80

4547

19917

Paralytic ileus and intestinal obstruction

3351

15579

2.52

307.65

7.4

5.4

1.03

1.04

mmol/l

0.13

3184

14396

Substance abuse, excluding more controls

7086

27420

2.46

307.65

5.8

6.7

1.03

1.04

mmol/l

1.50

6706

25759

Hypertensive Renal Disease

1020

1393

17.61

307.65

22.3

3.4

1.21

0.99

mmol/l

61.63

988

1259

Hypertension

10077

21417

3.08

307.65

10.5

3.9

1.07

1.01

mmol/l

71.56

9632

19779

Coronary atherosclerosis

7009

25872

1.88

307.65

9.3

5.2

1.08

1.01

mmol/l

63.35

6652

23958

Type 2 diabetes, definitions combined

10540

33381

2.01

307.65

6.4

5.1

1.06

1.01

mmol/l

58.42

9937

30918

Personality disorders, excluding more controls

2681

10618

2.87

307.65

5.3

6.6

1.05

1.04

mmol/l

0.72

2499

9995

Covid-19 confirmed case

5379

24130

2.68

307.65

11.2

5.5

1.07

1.04

mmol/l

7.25

5159

22321

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

2270

8740

3.15

307.65

17.9

7.0

1.15

1.08

mmol/l

15.84

2217

8205

Hypothyroidism, levothyroxine purchases

2394

2456

6.21

307.65

7.2

3.4

1.06

1.04

mmol/l

2.76

2252

2186

Emergency coronary revascularization (for ACS)

9596

34536

1.83

307.65

9.3

5.6

1.08

1.03

mmol/l

56.14

9048

32063

ILD medications: immunosuppressive drugs

8972

34284

2.78

307.65

16.2

4.4

1.07

1.04

mmol/l

29.03

8659

31819

Infections, IBD-co-morbidities

2463

3435

6.52

307.65

16.8

5.1

1.08

1.02

mmol/l

12.85

2357

3187

ILD medications: azathioprine

2036

6878

3.72

307.65

17.8

4.3

1.08

1.05

mmol/l

5.21

1969

6395

Cardiovascular diseases

6185

12396

2.94

307.65

10.1

4.0

1.08

1.05

mmol/l

9.58

5900

11450

All-cause Heart Failure

9092

25533

3.09

307.65

9.4

5.4

1.11

1.01

mmol/l

147.78

8589

23638

Insulin, combination of fast acting with intermediate-acting or long-acting

8839

36626

2.58

307.65

11.0

5.5

1.12

1.03

mmol/l

123.85

8397

34038

Disorders of choroid and retina

8728

39680

1.66

307.65

10.1

5.5

1.08

1.03

mmol/l

49.34

8121

36948

Inflammatory bowel disease treatment related agents

13581

41480

1.99

307.65

8.1

5.8

1.05

1.04

mmol/l

2.85

12845

38500

Heart failure and antihypertensive medication

4254

5828

6.54

307.65

12.3

3.9

1.12

1.00

mmol/l

86.37

4066

5336

ILD medications: prednisolone, methylprednisolone, prednisone

14041

37494

2.34

307.65

11.0

4.3

1.06

1.04

mmol/l

19.80

13308

34695

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

1328

2410

4.74

307.65

8.6

4.9

1.05

1.01

mmol/l

4.35

1254

2241

Invasive ventilation

1221

3994

4.39

307.65

10.2

6.5

1.07

1.06

mmol/l

0.33

1160

3736

Pneumonia, organism unspecified

12853

38429

2.66

307.65

9.4

5.2

1.06

1.04

mmol/l

17.02

12194

35717

Bacterial intestinal infections, IBD co-morbidities

2400

10846

2.65

307.65

13.1

5.5

1.08

1.04

mmol/l

7.55

2261

10042

Autoimmune diseases related-to ILD

8970

47671

1.69

307.65

7.2

6.0

1.05

1.04

mmol/l

1.83

8476

44339

Gout, unspecified

3391

12666

3.60

307.65

12.2

5.6

1.11

1.03

mmol/l

42.45

3227

11782

GI-bleeding

4222

21004

2.34

307.65

9.1

5.8

1.07

1.04

mmol/l

5.86

4001

19410

Dental caries

4456

13222

4.20

307.65

17.6

5.2

1.10

1.04

mmol/l

28.64

4299

12284

Insulin, fast-acting

5410

21515

3.11

307.65

13.2

5.8

1.13

1.03

mmol/l

84.95

5149

20082

Insulin medication

8826

31254

2.79

307.65

11.0

5.7

1.12

1.02

mmol/l

131.85

8390

29019

Acute peritonitis

1143

3367

5.16

307.65

28.0

5.8

1.18

1.04

mmol/l

29.83

1124

3127

Diabetic nephropathy, excluding more controls

3406

7752

6.32

307.65

21.5

4.9

1.21

1.03

mmol/l

164.10

3289

7201

Caries of dentine

4017

11845

4.39

307.65

17.2

5.2

1.10

1.04

mmol/l

25.09

3877

11015

Certain disorders involving the immune mechanism

2474

10563

2.87

307.65

14.9

6.2

1.09

1.05

mmol/l

9.23

2384

9878

Coagulation defects, purpura and other haemorrhagic conditions

2469

11124

2.65

307.65

9.8

6.2

1.06

1.05

mmol/l

1.31

2353

10370

ILD medications

14306

38081

2.26

307.65

10.9

4.4

1.06

1.04

mmol/l

16.37

13567

35247

Other diseases of blood and blood-forming organs, wide

2908

12992

2.72

307.65

9.8

6.1

1.05

1.04

mmol/l

0.24

2795

12096

Bacterial pneumonia, not elsewhere classified

4720

20198

2.34

307.65

9.2

5.1

1.07

1.03

mmol/l

14.99

4452

18721

Other and unspecified iron deficiency

4976

21319

2.82

307.65

7.7

5.5

1.07

1.04

mmol/l

7.88

4669

19649

Constipation

9818

42535

1.68

307.65

6.5

6.2

1.04

1.05

mmol/l

0.11

9114

39699

Mood disorders

11211

43623

1.77

307.65

6.3

1.04

mmol/l

0.54

10493

40658

Depression

10368

41689

1.80

307.65

6.4

6.3

1.04

mmol/l

0.38

9703

38893

Intestinal stricture

4001

19907

2.36

307.65

7.6

5.9

1.04

mmol/l

0.20

3813

18414

Diabetes, insulin treatment (Kela reimbursement)

12066

39223

2.02

307.65

8.5

5.5

1.08

1.02

mmol/l

79.47

11420

36365

Gastrointestinal diseases

5583

14385

2.09

307.65

7.7

3.9

1.06

1.05

mmol/l

1.93

5257

13252

Disorders of parathyroid gland

4846

11512

7.16

307.65

12.7

4.7

1.01

1.05

mmol/l

15.18

4550

10542

Obesity, other/unspecified

5096

17435

3.66

307.65

5.4

6.2

1.07

1.03

mmol/l

20.00

4900

16238

Primary hyperparathyroidism

2783

5936

10.10

307.65

5.2

5.4

0.89

1.05

mmol/l

153.63

2580

5460

Obesity due to excess calories

6807

26927

3.05

307.65

6.7

6.4

1.08

1.03

mmol/l

37.24

6493

25148

Disorders of mineral metabolism

2111

3917

10.70

307.65

11.5

5.4

1.03

mmol/l

0.42

2019

3636

Disorders of lipoprotein metabolism and other lipidaemias

10138

29617

2.35

307.65

8.6

5.0

1.06

1.02

mmol/l

26.52

9570

27405

Hypo-osmolality and hyponatraemia

2880

9301

4.09

307.65

7.8

4.7

1.04

1.03

mmol/l

0.90

2726

8511

Solid cancers, including Hilmo

8955

29856

1.90

307.65

6.9

6.1

1.04

mmol/l

0.56

8533

27670

Primary_lymphoid and hematopoietic malignant neoplasms

4160

14839

3.83

307.65

9.7

6.0

1.06

1.04

mmol/l

4.26

4026

13732

Kidney transplant status

2008

2547

139.53

307.65

45.3

5.4

1.19

1.06

mmol/l

44.96

2003

2383

Substance abuse

7086

34086

2.18

307.65

5.8

6.9

1.03

1.04

mmol/l

1.80

6706

31987

Vocal cord dysfunction

1420

3596

4.03

307.65

6.3

4.6

1.04

1.02

mmol/l

1.63

1318

3285

Type 2 diabetes, wide definition

10761

29992

2.63

307.65

9.0

5.3

1.09

1.01

mmol/l

133.43

10200

27768

Type 1 diabetes, wide definition

2854

10727

3.20

307.65

15.6

6.1

1.14

1.04

mmol/l

46.06

2729

10033

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

2364

9391

3.02

307.65

17.4

6.9

1.14

1.08

mmol/l

16.53

2302

8810

Gout

4918

15048

3.71

307.65

12.2

5.8

1.11

1.02

mmol/l

61.21

4691

13975

Other disorders of skin and subcutaneous tissue

8706

41939

1.94

307.65

10.2

5.4

1.08

1.03

mmol/l

39.59

8188

38922

Diseases of the skin and subcutaneous tissue

9971

32327

1.64

307.65

8.0

5.1

1.06

1.04

mmol/l

11.44

9349

30045

Genitourinary diseases

6095

14100

2.38

307.65

10.2

3.8

1.08

1.02

mmol/l

28.87

5800

13176

Diseases of arteries, arterioles and capillaries (FINNGEN)

3544

5711

5.51

307.65

13.0

3.6

1.11

0.99

mmol/l

78.93

3413

5232

Alcohol use disorder, ICD-based

5066

25384

2.29

307.65

5.6

7.1

1.02

1.03

mmol/l

2.62

4800

23906

Asthma-related pneumonia

4511

24027

2.12

307.65

7.4

6.0

1.07

1.05

mmol/l

4.12

4248

22185

Asthma, unspecified (mode)

6125

20530

2.40

307.65

6.0

4.8

1.05

1.03

mmol/l

7.82

5747

19042

Obesity related asthma

4116

21232

2.21

307.65

6.0

6.3

1.06

1.03

mmol/l

9.21

3905

19839

Alcohol use disorder, Swedish definition

6937

31443

2.29

307.65

6.1

6.9

1.03

1.04

mmol/l

1.29

6580

29530

Hernia of abdominal wall, postoperative

2568

6982

4.56

307.65

10.0

3.5

1.05

1.02

mmol/l

5.92

2449

6408

Streptococcal septicaemia, including avohilmo

1403

4545

4.13

307.65

12.8

4.8

1.09

1.04

mmol/l

7.71

1337

4188

Explicit bacterial Sepsis, including avohilmo

1602

5181

4.02

307.65

12.7

4.7

1.09

1.02

mmol/l

13.52

1527

4762

Other septicaemia

7286

21132

4.45

307.65

13.9

4.5

1.11

1.03

mmol/l

70.94

6978

19408

Non-Hodgkin lymphoma, all, including Hilmo

1864

6762

3.56

307.65

7.3

5.9

1.04

mmol/l

0.04

1802

6203

Multiple myeloma and malignant plasma cell neoplasms

971

2685

6.36

307.65

11.4

5.4

1.08

1.03

mmol/l

4.45

943

2486

Liquid cancers, including Hilmo

5829

18269

3.62

307.65

8.4

5.9

1.06

1.04

mmol/l

2.14

5611

16816

Malignant neoplasm

9515

29915

2.05

307.65

7.4

6.1

1.04

mmol/l

0.22

9089

27723

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

2332

8661

3.62

307.65

7.9

6.9

1.05

1.03

mmol/l

0.95

2225

8126

Sleep apnoea, including avohilmo

10298

41314

1.61

307.65

6.1

6.3

1.05

1.03

mmol/l

8.36

9621

38584

Depression medications

2503

2603

5.38

307.65

6.2

3.5

1.05

1.03

mmol/l

1.38

2351

2322

Other bacterial intestinal infections

2415

10348

2.82

307.65

13.0

5.1

1.08

1.04

mmol/l

7.72

2269

9561

Other functional intestinal disorders

5320

26558

2.02

307.65

7.0

5.6

1.06

1.05

mmol/l

1.23

4947

24599

Chronic nephritic syndrome

975

1787

13.28

307.65

26.1

4.9

1.14

1.02

mmol/l

23.71

965

1662

Glomerular disorders in diseases classified elsewhere

3560

6095

16.93

307.65

26.1

5.0

1.21

1.03

mmol/l

170.50

3474

5679

Other retinal disorders

7189

34111

1.75

307.65

10.6

5.5

1.09

1.03

mmol/l

55.72

6678

31688

Other septicaemia, including avohilmo

7406

21491

4.41

307.65

13.9

4.5

1.11

1.03

mmol/l

71.99

7095

19745

Nephropathy related operations

4215

6622

28.34

307.65

39.1

4.2

1.28

1.03

mmol/l

279.74

4171

6200

Other diseases of urinary system

10358

37373

1.66

307.65

7.4

6.0

1.05

1.04

mmol/l

0.49

9687

34878

Osteoporosis

4248

15013

3.36

307.65

6.6

5.0

1.01

1.05

mmol/l

13.91

3938

13710

Intestinal infectious diseases

11208

47458

1.92

307.65

10.2

5.4

1.07

1.04

mmol/l

17.02

10562

44140

Bacterial pneumonia (organism specified)

5393

26636

2.06

307.65

9.4

5.8

1.07

1.04

mmol/l

10.57

5086

24664

Diseases of the digestive system

6046

30443

2.27

307.65

8.7

5.8

1.06

1.04

mmol/l

5.38

5739

28195

Opioids

10833

28359

2.16

307.65

7.1

5.5

1.05

1.03

mmol/l

8.40

10241

26248

Peripheral artery disease

5731

22822

2.31

307.65

11.6

5.1

1.13

1.02

mmol/l

110.50

5395

21042

Neurological diseases, wide definition

2719

5070

2.95

307.65

7.1

5.6

1.07

mmol/l

0.06

2547

4705

Anxiety disorders, excluding more controls

8527

31810

1.85

307.65

6.6

6.4

1.04

mmol/l

0.42

7995

29690

Asthma, excluding more controls

7465

19026

2.19

307.65

6.1

4.7

1.05

1.02

mmol/l

16.79

7045

17646

Asthma (only as main-diagnosis), excluding more controls

6737

19026

2.12

307.65

6.1

4.7

1.05

1.02

mmol/l

15.61

6345

17646

Osteopathies and chondropathies

7782

33264

2.50

307.65

8.2

5.8

1.05

1.04

mmol/l

0.18

7285

30851

Cardiovascular diseases (excluding rheumatic etc)

7154

14185

3.27

307.65

10.4

3.9

1.07

1.04

mmol/l

13.24

6843

13074

Diseases of oesophagus, stomach and duodenum

12390

41518

1.93

307.65

7.4

5.9

1.05

1.04

mmol/l

2.43

11651

38649

Bacterial infection, other or unspecified

9550

26975

3.88

307.65

11.9

4.5

1.08

1.02

mmol/l

50.84

9078

24832

Autoimmune diseases excluding thyroid diseases

12174

36480

1.98

307.65

8.9

5.5

1.06

1.04

mmol/l

12.56

11550

33918

Other antidepressants

11188

34119

1.81

307.65

5.6

6.7

1.03

1.04

mmol/l

3.34

10424

31867

Malignant neoplasm, wide definition

9693

30387

2.04

307.65

7.5

6.2

1.04

mmol/l

0.16

9255

28171

Autoimmune diseases

12373

36744

1.85

307.65

8.3

5.5

1.06

1.04

mmol/l

8.98

11675

34169

Influenza and pneumonia

14350

39880

2.54

307.65

9.4

5.2

1.06

1.04

mmol/l

17.21

13630

37057

Other diseases of intestines

11445

38122

1.80

307.65

7.7

6.0

1.05

mmol/l

1.78

10776

35545

Other bacterial diseases

15240

37419

3.29

307.65

10.8

4.7

1.08

1.03

mmol/l

58.06

14531

34594

COPD/asthma/ILD related infections

10882

30815

1.92

307.65

7.7

4.9

1.05

1.03

mmol/l

9.06

10220

28568

Intestinal infectious diseases, including avohilmo, including avohilmo

12753

44345

1.72

307.65

8.7

5.4

1.06

1.04

mmol/l

5.92

11959

41244

Infections of the skin and subcutaneous tissue

6741

37663

1.94

307.65

10.4

6.1

1.08

1.04

mmol/l

23.69

6412

35246

Hard cardiovascular diseases

9620

30376

2.08

307.65

9.3

5.6

1.07

1.03

mmol/l

35.18

9117

28234

Cardiac arrhythmias

6176

17300

2.54

307.65

7.8

4.9

1.06

1.02

mmol/l

20.78

5814

16023

Other heart diseases

5763

11614

3.78

307.65

10.9

3.9

1.09

1.03

mmol/l

34.63

5509

10697

Episodal and paroxysmal disorders

11176

36663

1.64

307.65

6.0

6.5

1.05

mmol/l

0.01

10469

34079

Renal tubulo-interstitial diseases

18031

34247

5.30

307.65

12.6

3.3

1.11

1.00

mmol/l

307.65

17278

31517

Pacemaker

4544

23088

2.10

307.65

7.2

5.8

1.08

1.03

mmol/l

22.80

4257

21265

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

12282

30815

2.69

307.65

9.2

4.9

1.06

1.03

mmol/l

20.96

11669

28568

Heart failure and bmi 25plus

5212

13961

3.13

307.65

9.1

5.4

1.11

1.01

mmol/l

88.43

4885

12912

Other soft tissue disorders, not elsewhere classified

10363

35225

1.81

307.65

7.1

6.2

1.05

mmol/l

2.13

9746

32807

Other bacterial diseases, including avohilmo

15248

37458

3.01

307.65

10.4

4.6

1.07

1.03

mmol/l

44.12

14526

34642

Bacterial pneumoniae

4996

21360

2.34

307.65

9.2

5.1

1.07

1.03

mmol/l

14.45

4713

19827

Bronchitis

11316

45809

1.57

307.65

8.2

5.5

1.06

1.04

mmol/l

15.47

10600

42584

Lower back pain or/and sciatica

11003

46595

1.55

307.65

5.7

6.3

1.04

mmol/l

0.37

10262

43422

Disorders of other endocrine glands

7717

25645

3.85

307.65

10.8

5.5

1.03

1.06

mmol/l

11.16

7290

23789

Polyarthropathies

8498

27006

2.27

307.65

9.8

6.0

1.08

1.03

mmol/l

29.24

8079

25145

Other diseases of pleura

5806

26702

2.17

307.65

8.8

5.9

1.07

1.03

mmol/l

16.93

5470

24756

Other pulmonary diagnosis

7948

21611

1.99

307.65

7.3

4.9

1.05

1.03

mmol/l

7.24

7472

20063

Valvular heart disease excluding rheumatic fever

5632

19053

2.42

307.65

9.1

5.3

1.09

1.01

mmol/l

58.32

5297

17694

Non-ischemic cardiomyopathy

4407

14492

2.96

307.65

8.2

5.1

1.09

1.01

mmol/l

51.16

4123

13326

Anxiety (asthma-related co-morbidities)

5945

25354

1.93

307.65

5.9

6.6

1.05

1.04

mmol/l

0.18

5592

23751

All pneumoniae

14068

40750

2.58

307.65

9.5

5.3

1.06

1.04

mmol/l

15.81

13371

37884

Pure hypercholesterolaemia

8822

28266

2.22

307.65

7.8

5.0

1.06

1.02

mmol/l

21.63

8312

26139

Other disorders of fluid, electrolyte and acid-base balance

6035

16677

4.75

307.65

9.8

4.8

1.07

1.03

mmol/l

15.91

5738

15303

Benzodiazepine use

11294

46185

1.79

307.65

5.6

6.3

1.03

1.04

mmol/l

3.83

10460

43113

Codeine or tramadol medication

12507

40343

1.82

307.65

6.1

1.04

1.03

mmol/l

2.34

11730

37520

All kidney diseases

18713

34169

4.80

307.65

11.8

3.2

1.10

1.01

mmol/l

240.31

17932

31396

Convulsions, not elsewhere classified

2930

11322

2.99

307.65

7.0

5.5

1.05

mmol/l

0.46

2783

10506

Oedema, not elsewhere classified

4418

17319

2.97

307.65

8.4

5.0

1.07

1.04

mmol/l

12.09

4168

15947

Malaise and fatigue

7708

23064

3.14

307.65

7.0

5.0

1.05

1.04

mmol/l

1.06

7206

21270

Pain in limb

9418

34604

1.88

307.65

7.4

6.1

1.06

1.04

mmol/l

5.40

8860

32230

Low back pain

8306

34146

1.77

307.65

5.8

6.4

1.04

mmol/l

0.35

7744

31862

Oral corticosteroids

12925

40416

2.07

307.65

6.9

5.7

1.05

1.04

mmol/l

3.79

12199

37493

Other disorders of urethra and urinary system

7896

31459

1.91

307.65

7.8

5.5

1.05

1.04

mmol/l

1.20

7370

29192

Codeine

10302

27929

2.19

307.65

6.1

5.5

1.04

1.03

mmol/l

3.51

9670

25856

Tramadol

10438

26420

2.73

307.65

8.0

5.6

1.06

1.03

mmol/l

16.89

9835

24454

Statin medication

6303

20441

1.86

307.65

9.3

4.5

1.06

1.01

mmol/l

27.94

5931

18981

Parasetamol

7491

18816

2.18

307.65

7.2

5.9

1.05

1.04

mmol/l

0.97

7057

17413

Azathioprine

2036

7278

3.49

307.65

17.8

6.0

1.08

1.05

mmol/l

3.71

1969

6809

Postprocedural endocrine and metabolic disorders, not elsewhere classified

1536

5267

3.58

307.65

7.8

4.7

1.09

1.03

mmol/l

10.47

1443

4837

Use of hypnotics and sedatives

11432

41368

1.70

307.65

6.8

6.2

1.04

mmol/l

0.71

10726

38620

Other reaction to severe stress, and adjustment disorders

3721

18622

2.21

307.65

9.0

6.2

1.05

1.04

mmol/l

1.25

3528

17436

Diverticular disease of intestine

7623

29264

1.75

307.65

7.4

5.6

1.04

1.03

mmol/l

2.87

7088

27207

Cardiac arrest

916

1759

5.74

307.65

9.2

3.6

1.08

0.98

mmol/l

12.51

870

1610

L04AA Selective immunosuppressants

4032

12211

4.68

307.65

26.1

5.1

1.11

1.04

mmol/l

44.67

3957

11408

Concussion

5018

20950

2.01

307.65

5.4

6.5

1.04

1.05

mmol/l

3.64

4692

19517

Hypothyroidism, drug reimbursement

1416

1584

7.33

307.65

6.8

3.1

1.08

1.01

mmol/l

11.80

1331

1378

Heart failure and coronary heart disease

6514

19138

2.97

307.65

10.0

5.3

1.12

1.01

mmol/l

128.06

6137

17660

Oxycodone

6193

19685

3.33

307.65

7.9

5.4

1.05

1.03

mmol/l

5.54

5853

18193

L04AD Calcineurin inhibitors

3224

5531

16.26

307.65

34.8

5.4

1.14

1.07

mmol/l

35.17

3201

5195

Abdominal and pelvic pain

10263

32213

1.71

307.65

7.2

5.9

1.04

1.05

mmol/l

1.22

9648

29962

Nausea and vomiting

4016

15284

3.11

307.65

11.1

5.5

1.07

1.06

mmol/l

0.73

3788

14092

Enlarged lymph nodes

1886

7486

2.98

307.65

7.5

5.4

1.05

1.04

mmol/l

1.44

1808

6928

Pain, not elsewhere classified

3372

14108

2.76

307.65

6.8

5.0

1.05

1.04

mmol/l

1.10

3179

13002

Symptoms and signs involving cognition, perception, emotional state and behaviour

10497

44043

1.71

307.65

5.9

6.4

1.03

1.04

mmol/l

2.21

9788

41151

Non-invasive ventilation

3407

7333

4.94

307.65

7.9

5.0

1.08

1.01

mmol/l

24.81

3220

6728

Haemorrhage from respiratory passages

4172

18914

2.21

307.65

8.3

5.7

1.07

1.03

mmol/l

13.80

3912

17509

Symptoms and signs involving the circulatory and respiratory systems

10031

30919

1.73

307.65

7.3

5.9

1.06

1.04

mmol/l

13.12

9465

28750

Finngen Rheumatological endpoints

9620

34668

1.68

307.65

7.2

6.0

1.06

1.03

mmol/l

9.59

9072

32304

Acute renal failure

6314

11050

12.13

307.65

13.3

3.0

1.19

0.98

mmol/l

294.59

6093

10111

Isolated proteinuria

656

1339

10.50

307.65

16.9

6.4

1.13

1.04

mmol/l

11.37

648

1249

Headache

6678

27575

2.03

307.65

6.2

5.1

1.05

1.04

mmol/l

1.57

6254

25476

Mood [affective] disorders

11195

43584

1.78

307.65

6.3

1.04

mmol/l

0.54

10478

40628

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

3300

6410

2.80

307.65

7.2

4.6

1.05

1.04

mmol/l

1.53

3083

5891

Pain in throat and chest

8953

30319

1.89

307.65

6.7

5.9

1.05

1.03

mmol/l

6.54

8408

28186

Any mental disorder

11589

35617

1.75

307.65

6.2

6.4

1.04

mmol/l

1.04

10827

33247

Syncope and collapse

5223

21155

2.31

307.65

6.6

5.1

1.05

1.04

mmol/l

2.72

4896

19494

Symptoms and signs concerning food and fluid intake

1497

5296

3.54

307.65

7.5

5.2

1.07

1.06

mmol/l

0.08

1396

4893

Unspecified haematuria

5185

22739

2.10

307.65

9.1

6.0

1.06

1.03

mmol/l

5.43

4912

21190

Hypertension, essential

9889

20694

3.14

307.65

8.8

3.8

1.07

1.00

mmol/l

75.01

9428

19094

Secondary hypertension

2263

2409

21.53

307.65

29.9

3.7

1.17

1.02

mmol/l

56.50

2221

2223

Heart failure, strict

9296

25915

3.12

307.65

9.5

5.5

1.11

1.01

mmol/l

150.21

8776

23997

Hypercalcemia

1053

2366

9.80

307.65

9.7

5.5

0.98

1.04

mmol/l

8.72

1009

2176

Hypocalcemia

624

1140

15.37

307.65

15.5

5.9

1.18

1.04

mmol/l

13.80

603

1054

Atherosclerosis, excluding cerebral and coronary sclerosis

5293

21459

2.24

307.65

11.2

5.0

1.13

1.02

mmol/l

106.81

4978

19758

Atrial fibrillation and flutter with reimbursement

3082

5659

4.13

307.65

6.9

3.6

1.06

0.98

mmol/l

29.45

2926

5151

Major coronary heart disease event

9247

33114

1.82

307.65

9.6

5.5

1.08

1.02

mmol/l

56.25

8750

30766

Percutaneous Coronary Intervention

8812

30888

1.91

307.65

9.6

5.5

1.08

1.02

mmol/l

57.98

8330

28687

Erysipelas, including avohilmo

9418

32030

2.49

307.65

8.5

4.5

1.07

1.02

mmol/l

55.80

8879

29588

Diarrhoea and gastroenteritis of presumed infectious origin

8545

40860

2.07

307.65

10.5

5.4

1.07

1.04

mmol/l

14.06

8064

37984

Atrial fibrillation and flutter

3720

7050

4.05

307.65

8.7

3.6

1.06

0.99

mmol/l

36.74

3547

6460

Bacterial infection, other or unspecified, including avohilmo

10196

28639

3.73

307.65

11.6

4.5

1.08

1.02

mmol/l

49.97

9695

26372

Cardiomyopathy

2192

8669

3.06

307.65

8.9

5.5

1.10

1.01

mmol/l

39.26

2077

8073

Injuries to the head

11715

46353

1.59

307.65

6.2

6.4

1.04

1.05

mmol/l

2.93

10952

43213

Complications of procedures, not elsewhere classified

10301

42328

2.21

307.65

8.5

5.3

1.06

1.03

mmol/l

25.12

9764

39258

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

10939

44706

1.68

307.65

8.7

5.4

1.06

1.04

mmol/l

6.83

10269

41574

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

13717

34281

3.24

307.65

9.4

4.6

1.09

1.02

mmol/l

97.95

13066

31641

Eating disorder

1156

3128

4.68

307.65

6.4

6.1

1.12

1.08

mmol/l

5.88

1077

2918

Explicit Sepsis

8262

23153

4.35

307.65

13.3

4.4

1.11

1.02

mmol/l

92.43

7907

21286

Nutritional anaemias

7194

31153

2.61

307.65

8.0

5.5

1.07

1.04

mmol/l

11.50

6761

28751

Complications of surgical and medical care, not elsewhere classified

12968

43584

2.24

307.65

9.2

5.4

1.07

1.03

mmol/l

29.70

12275

40430

Pneumonias (Asthma/COPD co-morbidities)

14027

40608

2.60

307.65

9.5

5.2

1.06

1.04

mmol/l

16.12

13336

37738

Diabetic maculopathy, excluding more controls

1544

4927

4.07

307.65

18.9

5.5

1.19

1.01

mmol/l

73.26

1490

4587

Asthma, unspecified (mode), excluding more controls

5933

18213

2.62

307.65

6.1

4.6

1.05

1.02

mmol/l

15.57

5578

16876

Implicit viral Sepsis

3919

11082

4.99

307.65

14.4

4.4

1.11

1.02

mmol/l

50.24

3741

10180

Disorders of lens

7074

26956

1.77

307.65

11.0

5.6

1.07

1.03

mmol/l

24.26

6643

25267

Intracranial trauma

6123

21122

2.14

307.65

5.8

6.5

1.03

1.06

mmol/l

7.01

5758

19676

Major coronary heart disease event excluding revascularizations

6501

25753

1.83

307.65

8.6

5.3

1.09

1.01

mmol/l

66.63

6123

23854

Type 1 diabetes, wide definition, subgroup 1

2793

9823

3.48

307.65

15.5

6.2

1.14

1.04

mmol/l

42.81

2668

9207

Asthma (mode)

7546

21615

1.98

307.65

5.8

4.9

1.05

1.03

mmol/l

7.18

7112

20072

Sub-endpoint used in defining T1D endpoints

3590

16646

2.45

307.65

15.4

6.1

1.14

1.05

mmol/l

46.58

3425

15508

Type 2 diabetes, definitions combined, including avohilmo

10422

33300

1.98

307.65

6.3

5.2

1.06

1.01

mmol/l

54.29

9829

30860

Type 2 diabetes, strict (exclude DM1)

10592

33679

2.00

307.65

6.4

5.2

1.06

1.01

mmol/l

58.01

9986

31195

Poisoning by medicine

2549

10773

2.78

307.65

5.3

6.6

1.04

mmol/l

0.36

2411

10099

Disorders of thyroid, IBD co-morbidities

1787

3642

3.81

307.65

5.8

4.7

1.05

1.02

mmol/l

3.23

1677

3363

Implicit bacterial Sepsis, including avohilmo

9261

22348

4.81

307.65

11.3

4.4

1.11

1.01

mmol/l

138.61

8805

20541

Other disorders involving the immune mechanism, not elsewhere classified

859

1551

15.24

307.65

25.3

7.4

1.13

1.06

mmol/l

7.41

845

1455

Transplanted organ and tissue status

3315

4776

27.49

307.65

35.8

4.8

1.15

1.05

mmol/l

49.52

3281

4480

Codes for special purposes

6710

34196

2.21

307.65

10.4

5.6

1.06

1.04

mmol/l

7.51

6410

31706

Provisional assignment of new diseases of uncertain etiology

6700

34162

2.21

307.65

10.4

5.6

1.06

1.04

mmol/l

7.49

6401

31676

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

15951

40019

3.27

307.65

10.0

4.9

1.07

1.03

mmol/l

49.43

15168

37036

Hypertensive diseases (excluding secondary)

6886

11046

4.35

307.65

11.7

3.7

1.08

1.02

mmol/l

47.19

6608

10163

Implicit Sepsis

13336

32614

3.84

307.65

9.9

4.5

1.10

1.02

mmol/l

129.80

12676

30094

Symptoms and signs involving the urinary system

9221

38984

1.98

307.65

8.0

5.9

1.05

1.04

mmol/l

1.96

8631

36256

Fall on same level

11910

41336

1.63

307.65

7.0

6.3

1.05

mmol/l

0.48

11180

38613

Medical observation and evaluation for suspected diseases and conditions

7168

18302

2.19

307.65

7.8

4.9

1.06

1.03

mmol/l

8.63

6688

16972

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

6947

37715

2.07

307.65

9.1

5.6

1.07

1.03

mmol/l

21.47

6557

35029

Ischaemic Stroke, excluding all haemorrhages

6550

28269

1.90

307.65

6.8

6.0

1.04

mmol/l

0.19

6132

26176

Malignant neoplasm of digestive organs

4599

17835

2.24

307.65

5.3

5.9

1.00

1.04

mmol/l

10.02

4372

16402

Liquid cancers

4983

15864

3.95

307.65

8.9

5.9

1.06

1.05

mmol/l

2.68

4800

14581

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

13694

41125

2.55

307.65

9.4

5.4

1.06

1.04

mmol/l

15.61

13002

38256

Fever of other and unknown origin

8697

26683

3.41

307.65

11.0

5.1

1.06

1.04

mmol/l

11.35

8348

24660

7218

32814

2.23

307.65

6.1

6.9

1.03

1.04

mmol/l

1.34

6844

30794

Other heart diseases, wide

10546

31983

2.21

307.65

9.1

5.5

1.08

1.03

mmol/l

51.78

9978

29840

Certain infectious and parasitic diseases, including avohilmo

7230

19873

1.96

307.65

7.6

3.9

1.06

1.03

mmol/l

10.95

6798

18309

Exposure to unspecified factor

10942

48256

1.65

307.65

7.2

6.2

1.05

mmol/l

1.92

10259

44965

Antihypertensive medication - note that there are other indications

6030

12717

2.73

307.65

9.9

3.9

1.07

1.04

mmol/l

10.10

5713

11725

Diseases of arteries, arterioles and capillaries

8764

32745

2.26

307.65

10.7

5.3

1.10

1.02

mmol/l

93.28

8294

30306

Neurotic, stress-related and somatoform disorders

9027

39683

1.67

307.65

6.7

6.3

1.05

1.04

mmol/l

0.77

8465

37050

Hypertensive heart and/or renal disease

3903

9052

3.98

307.65

12.4

3.6

1.13

0.99

mmol/l

113.60

3668

8276

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

7901

39912

1.91

307.65

7.3

5.9

1.05

1.04

mmol/l

4.10

7435

37050

Implicit bacterial Sepsis

8638

20914

5.04

307.65

11.7

4.4

1.11

1.01

mmol/l

133.40

8217

19186

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

7709

38937

2.21

307.65

9.5

5.4

1.07

1.03

mmol/l

24.92

7291

36093

Cerebrovascular diseases

9042

34692

2.03

307.65

7.1

6.0

1.03

1.04

mmol/l

0.31

8490

32237

Care involving dialysis

2996

3758

58.92

307.65

46.9

4.4

1.32

1.03

mmol/l

282.72

2985

3495

Persons encountering health services for specific procedures and health care

15004

37957

2.69

307.65

11.5

4.0

1.08

1.03

mmol/l

68.02

14312

35044

ILD differential diagnosis

7862

21615

1.96

307.65

7.3

4.9

1.05

1.03

mmol/l

6.77

7393

20072

Factors influencing health status and contact with health services

2815

6003

2.56

307.65

7.3

3.2

1.05

1.01

mmol/l

6.85

2631

5521

Symptoms and signs involving the digestive system and abdomen

10718

32225

1.79

307.65

7.6

5.9

1.05

mmol/l

0.45

10093

29974

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

4275

10049

3.00

307.65

8.9

3.6

1.05

1.00

mmol/l

22.49

4054

9205

Complications of medical and surgical care

9642

43426

2.28

307.65

9.2

5.5

1.07

1.03

mmol/l

26.10

9124

40287

Asthma (only as main-diagnosis)

6988

21418

1.97

307.65

6.1

4.9

1.05

1.03

mmol/l

8.49

6571

19886

Extracorporeal dialysis

2083

3204

39.62

307.65

52.9

5.1

1.36

1.03

mmol/l

234.66

2075

3012

7490

33517

2.19

307.65

6.1

6.8

1.03

1.04

mmol/l

1.09

7107

31448

Other medical care

7026

24798

2.85

307.65

6.7

3.8

1.05

1.02

mmol/l

9.06

6692

22726

Other special examinations and investigations of persons without complaint or reported diagnosis

6525

18307

1.94

307.65

8.0

4.9

1.06

1.03

mmol/l

9.99

6135

16977

Eating disorders

1287

4117

3.82

307.65

6.7

6.1

1.11

1.06

mmol/l

9.54

1202

3844

Asthma

7832

21418

2.04

307.65

6.0

4.9

1.05

1.03

mmol/l

8.78

7381

19886

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

12729

38758

2.34

307.65

12.7

4.3

1.09

1.03

mmol/l

78.73

12084

36018

Care involving use of rehabilitation procedures

7444

34146

2.19

307.65

8.5

4.0

1.07

1.03

mmol/l

24.90

7071

31486

1676

6386

3.12

307.65

10.6

5.2

1.06

1.03

mmol/l

3.25

1585

5911

Examination and observation for other reasons

6856

18117

2.38

307.65

7.8

4.9

1.05

1.03

mmol/l

4.11

6489

16817

Persons encountering health services in other circumstances

4492

23895

2.06

307.65

7.1

5.3

1.05

1.04

mmol/l

1.31

4242

22143

Anxiety disorders

9112

40067

1.67

307.65

6.6

6.3

1.05

1.04

mmol/l

0.72

8548

37386

Heart failure, not strict

13169

27581

4.23

307.65

12.9

4.0

1.11

1.00

mmol/l

242.51

12585

25534

Mental and behavioural disorders due to alcohol

6188

30470

2.18

307.65

5.7

7.0

1.02

1.04

mmol/l

2.39

5863

28604

Diabetes mellitus

12380

35938

2.21

307.65

8.3

5.3

1.08

1.02

mmol/l

68.92

11719

33342

Persons encountering health services in other circumstances, wide

13098

39500

1.85

307.65

8.2

5.4

1.06

1.04

mmol/l

7.03

12416

36543

Persons encountering health services for other counselling and medical advice, not elsewhere classified

12521

39274

1.84

307.65

8.7

5.5

1.06

1.04

mmol/l

9.96

11903

36363

Presence of cardiac and vascular implants and grafts

5562

20864

2.25

307.65

7.8

4.6

1.09

1.02

mmol/l

50.57

5203

19332

Mood disorders, excluding more controls

10440

34607

1.93

307.65

6.3

1.04

mmol/l

0.32

9762

32306

Heart failure,strict

8561

20113

3.84

307.65

9.9

3.9

1.11

0.99

mmol/l

194.75

8107

18564

Disorders of gallbladder, biliary tract and pancreas

11362

41508

1.86

307.65

7.0

5.9

1.04

mmol/l

1.74

10737

38530

Dyspnoea

11248

43393

2.09

307.65

7.3

5.9

1.07

1.03

mmol/l

30.94

10535

40399

Non-rheumatic valve diseases

5562

18866

2.40

307.65

8.9

5.2

1.09

1.01

mmol/l

58.09

5227

17512

Peripheral artery operations in Hilmo

1792

7093

3.16

307.65

16.1

5.2

1.18

1.02

mmol/l

61.53

1691

6526

Viral hepatitis, IBD co-morbidity

678

1302

6.56

307.65

8.2

5.3

1.03

1.01

mmol/l

0.98

655

1219

Cerebrovascular diseases (FINNGEN)

4257

7648

4.82

307.65

8.1

3.6

1.04

1.00

mmol/l

12.34

4045

7003

Ischemic heart diseases

9066

31699

1.86

307.65

9.8

5.5

1.08

1.02

mmol/l

56.24

8607

29446

Type 2 diabetes

11741

34270

2.21

307.65

8.1

5.2

1.08

1.01

mmol/l

88.45

11107

31754

Unspecified human immunodeficiency virus [HIV] disease

359

435

170.99

307.65

17.3

7.7

0.92

1.01

mmol/l

7.45

359

418

Myocardial infarction

5391

21481

1.95

307.65

9.2

5.3

1.09

1.01

mmol/l

64.83

5090

19887

Other CVD (FINNGEN)

1746

2915

6.12

307.65

8.9

3.4

1.05

0.98

mmol/l

16.33

1648

2656

Poisoning by drugs, medicaments and biological substances

2770

12009

2.69

307.65

5.4

6.6

1.04

1.05

mmol/l

0.91

2616

11252

Continuous positive airway pressure

2588

5810

4.66

307.65

8.9

5.6

1.08

1.03

mmol/l

9.58

2413

5373

Other metabolic disorders

1684

5808

3.56

307.65

8.1

4.8

1.09

1.04

mmol/l

9.57

1583

5346

Hypothyroidism and >3 levothyroxin purchases

2394

2456

6.21

307.65

7.2

3.4

1.06

1.04

mmol/l

2.76

2252

2186

General symptoms and signs

13054

30075

2.43

307.65

7.7

5.2

1.05

1.04

mmol/l

4.75

12371

27815

STROKE

6873

19556

2.74

307.65

7.1

4.8

1.03

1.01

mmol/l

11.29

6500

18071

Disorders resulting from impaired renal tubular function

1231

1893

40.89

307.65

41.2

6.1

1.26

1.05

mmol/l

71.66

1222

1761

Hypertensive diseases

10082

21432

3.08

307.65

10.5

3.9

1.07

1.01

mmol/l

70.97

9637

19794

General examination and investigation of persons without complaint and reported diagnosis

6973

18260

2.17

307.65

8.1

4.9

1.05

1.03

mmol/l

5.51

6581

16938

Abnormalities of breathing

10319

30868

2.10

307.65

7.3

5.9

1.07

1.04

mmol/l

20.13

9690

28703

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

2790

13247

2.37

306.25

5.1

5.9

1.01

1.04

mmol/l

3.80

2665

12223

Adjustment and management of implanted device

2264

10266

2.62

305.93

7.6

3.7

1.09

1.02

mmol/l

20.28

2142

9330

DVT of lower extremities and pulmonary embolism

4743

27500

1.91

304.75

7.4

5.7

1.04

mmol/l

0.20

4455

25398

Cytomegalovirus infection, IBD co-morbidity

537

1057

11.38

303.93

33.1

6.3

1.13

1.05

mmol/l

6.09

527

988

Persons encountering health services for examination and investigation

6137

18307

1.79

303.78

7.1

4.9

1.05

1.03

mmol/l

4.88

5717

16977

Cutaneous abscess, furuncle and carbuncle

2966

14908

2.26

301.06

11.3

6.2

1.09

1.04

mmol/l

14.30

2845

13981

Failure and rejection of transplanted organs and tissues

395

590

24.00

300.75

43.2

6.5

1.18

1.05

mmol/l

9.54

388

550

Diseases of peritoneum

1452

5470

3.45

300.44

23.1

5.8

1.15

1.04

mmol/l

28.45

1419

5074

Second line medication for Crohn's disease

5992

37064

1.75

299.42

9.6

6.0

1.05

1.04

mmol/l

0.16

5718

34571

Suicide or other Intentional self-harm

2626

12639

2.36

298.27

5.3

6.6

1.04

mmol/l

0.21

2473

11872

Cholelithiasis, broad definition with cholecystitis

8761

38741

1.60

298.17

6.4

5.8

1.05

1.03

mmol/l

3.72

8222

35866

Cardiomyopathy (excluding other)

1554

6001

3.17

297.71

9.3

5.7

1.10

1.01

mmol/l

27.80

1472

5603

Dysphagia

2935

14780

2.26

297.38

6.3

5.5

1.02

1.04

mmol/l

3.63

2740

13672

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

837

2319

5.55

296.23

9.2

5.3

1.07

1.03

mmol/l

3.41

791

2131

Cytomegaloviral disease, including avohilmo

546

1112

10.34

295.86

32.8

6.3

1.12

1.04

mmol/l

7.05

536

1040

Cytomegaloviral disease

542

1099

10.51

295.55

32.9

6.4

1.12

1.04

mmol/l

7.07

532

1027

Other/unspecified cytomegaloviral diseases

482

889

13.37

294.37

35.2

6.4

1.13

1.04

mmol/l

6.88

475

834

Cardiomyopathies, Primary/intrinsic

1506

5761

3.20

294.08

9.4

5.7

1.11

1.01

mmol/l

27.52

1428

5381

Selective serotonin reuptake inhibitors

9831

34451

1.57

293.68

5.4

6.8

1.03

1.04

mmol/l

3.53

9112

32192

Fibrosis and cirrhosis of liver

1216

4258

3.96

293.51

9.0

6.2

1.09

1.04

mmol/l

5.85

1158

3952

Substance use, excluding alcohol

2183

9837

2.55

292.69

6.2

7.0

1.04

mmol/l

0.10

2058

9235

Malignant neoplasm of urinary organs, including Hilmo

1522

5909

3.23

292.61

9.3

6.0

1.08

1.04

mmol/l

3.84

1444

5433

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

1891

8098

2.82

292.48

6.6

6.0

1.03

1.04

mmol/l

0.53

1834

7461

Sleep disorders (combined)

10959

39531

1.53

291.58

5.8

6.4

1.05

1.04

mmol/l

1.02

10184

36823

Dorsalgia

9773

34961

1.56

290.99

5.8

6.4

1.04

mmol/l

1.51

9132

32614

Iron deficiency anaemia secondary to blood loss (chronic)

2057

9195

2.68

288.87

10.0

5.6

1.08

1.04

mmol/l

6.00

1945

8470

Presence of other functional implants

6207

26380

1.74

288.53

8.1

4.4

1.06

1.02

mmol/l

21.09

5729

24400

L04AX Other immunosuppressants

5818

36085

1.75

288.50

9.8

6.0

1.05

1.04

mmol/l

0.13

5551

33648

Other CVD

2641

13080

2.39

288.30

7.9

5.5

1.06

1.04

mmol/l

1.80

2465

12052

Diseases of the respiratory system

6034

18176

1.77

288.12

6.8

4.9

1.05

1.03

mmol/l

6.99

5628

16864

Abnormal findings on diagnostic imaging of lung

5420

31385

1.80

287.83

7.5

5.8

1.05

1.03

mmol/l

3.68

5097

29107

Multiple myeloma

594

1324

8.40

286.55

11.5

4.9

1.10

1.03

mmol/l

4.19

577

1216

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

594

1324

8.40

286.55

11.5

4.9

1.10

1.03

mmol/l

4.19

577

1216

Chronic lower respiratory diseases

11982

44489

1.49

285.64

6.3

6.4

1.06

1.04

mmol/l

3.66

11247

41470

Implicit fungal Sepsis

714

1811

6.25

285.44

16.5

4.3

1.09

1.01

mmol/l

6.70

684

1655

Other acute lower respiratory infections

5814

34360

1.74

285.10

9.1

6.0

1.08

1.05

mmol/l

11.59

5456

31920

Falls/tendency to fall

10378

35575

1.54

284.87

6.7

6.3

1.05

mmol/l

0.41

9743

33222

AV-block

2134

8148

2.59

284.42

7.8

4.9

1.09

1.00

mmol/l

33.20

1994

7500

Other and unspecified polyneuropathies, also in other diseases

2436

11795

2.47

283.53

11.5

6.1

1.09

1.03

mmol/l

16.60

2315

10988

Need for immunization against other single viral diseases

467

871

13.05

281.75

31.5

6.5

1.11

1.04

mmol/l

3.85

461

813

Persons encountering health services for specific procedures, not carried out

1135

3809

3.73

281.43

7.9

4.1

1.02

mmol/l

0.33

1072

3537

Purpura and other haemorrhagic conditions

1777

7575

2.89

280.92

9.7

6.4

1.07

1.05

mmol/l

1.57

1694

7073

Acute pancreatitis

2343

11142

2.46

280.09

8.0

6.2

1.04

mmol/l

0.02

2224

10372

Pulmonary embolism

3434

18677

2.09

279.84

6.9

5.8

1.04

mmol/l

0.00

3228

17257

Benign neoplasm of colon, rectum, anus and anal canal

6898

37812

1.67

279.76

7.6

5.8

1.05

1.03

mmol/l

7.71

6465

35084

Disorders of adult personality and behaviour

2810

14170

2.21

277.62

5.2

6.6

1.05

1.04

mmol/l

0.53

2624

13332

Diabetic retinopathy, excluding more controls

3300

9671

2.25

277.32

14.7

4.9

1.13

1.03

mmol/l

60.25

3130

9002

Bipolar affective disorders

1916

8316

2.62

277.28

5.1

6.5

1.04

1.03

mmol/l

0.13

1802

7814

Ascites

1124

3851

3.89

276.91

9.6

5.5

1.09

1.04

mmol/l

4.94

1081

3565

Personality disorders

2681

13316

2.25

276.75

5.3

6.5

1.05

1.04

mmol/l

0.88

2499

12528

Pulmonary heart disease

3434

18751

2.08

276.43

6.9

5.8

1.04

mmol/l

0.08

3228

17338

Asthma (diagnoses ohter than nonallergic)

8895

48961

1.56

275.59

5.9

6.3

1.06

1.05

mmol/l

2.82

8346

45560

Spondylopathies

7990

31149

1.62

275.44

5.6

6.3

1.04

mmol/l

0.22

7435

29043

Insulin, fast-acting (human)

1590

6422

2.91

273.04

18.7

5.7

1.14

1.03

mmol/l

37.95

1529

6006

Other respiratory disorders and diseases

2557

12747

2.35

272.38

8.8

6.0

1.07

1.05

mmol/l

4.28

2399

11785

Other diseases of the respiratory system

2557

12747

2.35

272.38

8.8

6.0

1.07

1.05

mmol/l

4.28

2399

11785

Recurrent or chronic depression

3722

14004

1.99

272.10

5.7

7.1

1.04

mmol/l

0.11

3492

13151

Cholelithiasis

8336

38170

1.58

271.99

6.2

5.7

1.04

1.03

mmol/l

3.02

7811

35312

Hypothyroidism, strict autoimmune

6913

29157

1.65

269.29

6.2

5.1

1.05

1.03

mmol/l

4.62

6402

26988

Nerve, nerve root and plexus disorders

10626

44747

1.50

269.07

6.9

6.0

1.05

1.03

mmol/l

12.58

9959

41653

Hypotension

2328

11304

2.46

268.85

7.8

5.4

1.05

1.04

mmol/l

0.62

2168

10398

Disorders of the thyroid gland

9345

41698

1.54

265.56

6.2

6.1

1.05

1.04

mmol/l

1.67

8674

38926

Cystitis

8321

33141

1.58

265.55

6.4

5.7

1.04

mmol/l

0.05

7776

30801

Malignant neoplasm of urinary organs

1309

4955

3.34

265.07

9.4

6.0

1.08

1.04

mmol/l

4.44

1242

4551

Schizophrenia or delusion, excluding more controls

2855

14482

2.14

264.69

5.1

6.6

1.04

mmol/l

0.05

2671

13588

Idiopathic gout

1357

5309

3.35

263.16

11.5

6.0

1.10

1.03

mmol/l

16.05

1286

4959

4684

27888

1.81

263.04

6.8

6.4

1.07

1.05

mmol/l

4.52

4406

25962

Pain in joint

5666

21372

1.74

262.85

6.1

1.04

mmol/l

0.00

5297

19951

Sequelae of external causes of morbidity and mortality

2974

15772

2.15

262.07

9.6

6.0

1.06

1.04

mmol/l

4.34

2847

14679

Congenital malformations, deformations and chromosomal abnormalities

5609

33288

1.71

261.51

10.8

6.0

1.07

1.05

mmol/l

10.19

5312

31143

Chronic apical periodontitis

10947

43383

1.49

261.32

7.3

5.8

1.04

mmol/l

0.45

10307

40345

Cellulitis

2588

13102

2.26

259.91

11.2

6.2

1.09

1.04

mmol/l

11.44

2457

12259

Amputation of toe

1116

3992

3.86

259.65

18.7

5.9

1.21

1.03

mmol/l

49.61

1058

3719

Pain (limb, back, neck, head abdominally)

6979

22391

1.65

259.58

7.1

6.1

1.05

mmol/l

0.07

6552

20860

Myocardial infarction, without ST-elevation

4600

25021

1.84

258.35

9.0

5.7

1.11

1.03

mmol/l

48.32

4315

23145

Dizziness and giddiness

7610

39590

1.59

257.91

5.7

6.2

1.04

mmol/l

0.47

7061

36902

Other cataract

4727

21049

1.83

257.79

10.6

5.4

1.07

1.03

mmol/l

20.06

4409

19668

Hypothyroidism, other/unspecified

8672

38899

1.55

257.68

6.1

6.0

1.05

1.04

mmol/l

3.60

8028

36245

Senile cataract

6332

24568

1.69

257.22

9.9

5.5

1.06

1.02

mmol/l

17.67

5921

22995

Myocardial infarction, strict

4795

20452

1.82

254.99

8.9

5.3

1.09

1.01

mmol/l

52.58

4519

18938

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

3598

20338

1.97

254.94

6.2

6.1

1.06

1.05

mmol/l

3.02

3348

18963

Specific personality disorders

2324

11294

2.31

254.65

5.1

6.5

1.05

1.04

mmol/l

1.05

2168

10604

Systemic connective tissue disorders

3781

21727

1.94

254.00

7.4

5.4

1.06

1.04

mmol/l

3.79

3557

20052

Dermatitis

6484

41511

1.64

253.18

8.3

5.8

1.06

1.04

mmol/l

8.68

6104

38655

Gastric ulcer

2163

10390

2.43

252.40

7.9

5.6

1.06

1.04

mmol/l

3.31

2058

9568

Hypothyreosis and Thyroxine purchase for inclusion criteria

8989

40623

1.53

252.23

6.1

6.0

1.05

1.04

mmol/l

4.36

8315

37831

Cirrhosis of liver, NAS

912

2990

4.51

250.61

9.2

6.4

1.10

1.03

mmol/l

6.42

864

2788

Periodontitis

9853

44164

1.50

249.22

8.6

5.7

1.04

1.03

mmol/l

3.29

9240

41177

Other disorders of glucose regulation and pancreatic internal secretion

1184

4405

3.45

249.10

12.6

6.5

1.11

1.06

mmol/l

6.16

1136

4101

Chronic periodontitis, including avohilmo

9841

44162

1.50

248.95

8.6

5.7

1.04

1.03

mmol/l

3.16

9226

41180

Secondary and unspecified malignant neoplasm of lymph nodes

1117

4045

3.52

245.85

7.3

6.0

1.04

mmol/l

0.10

1084

3718

Non-follicular lymphoma

1349

5463

3.22

244.52

7.2

6.2

1.04

mmol/l

0.30

1307

5078

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

1292

5056

3.19

244.32

9.7

6.0

1.08

1.04

mmol/l

4.17

1224

4651

COPD

4950

24903

1.77

244.04

6.5

6.2

1.06

1.03

mmol/l

10.78

4609

23186

Problems related to lifestyle

1230

4631

3.17

243.92

6.5

5.8

1.04

1.03

mmol/l

0.79

1176

4327

Sequelae of cerebrovascular disease

4078

20592

1.88

242.81

7.0

5.8

1.03

1.04

mmol/l

0.98

3779

18977

Artificial opening status

865

2776

4.42

242.06

10.3

4.7

1.04

mmol/l

0.03

836

2578

Intracranial injury

6090

36922

1.65

241.94

5.6

6.4

1.03

1.05

mmol/l

4.25

5683

34381

Acute pancreatitis (for exclusion)

2343

11794

2.30

241.44

8.0

6.2

1.04

mmol/l

0.06

2224

11021

Abnormalities of heart beat

3621

20061

1.91

240.54

5.9

5.4

1.05

1.03

mmol/l

5.38

3353

18529

Missing teeth due to accident, extraction or parodontitis

6512

38547

1.63

240.50

7.0

6.0

1.03

mmol/l

1.15

6030

35962

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

3180

17621

2.01

240.00

6.7

6.4

1.09

1.01

mmol/l

38.92

3020

16548

Glucagon-like peptide-1 (GLP-1) analogues

3180

17621

2.01

240.00

6.7

6.4

1.09

1.01

mmol/l

38.92

3020

16548

Diseases of the myoneural junction and muscle

1614

7090

2.80

239.67

6.3

1.06

1.04

mmol/l

1.37

1501

6606

Noninfective enteritis and colitis

4770

29451

1.75

239.59

7.6

6.3

1.04

1.05

mmol/l

1.04

4520

27472

Acidosis

443

902

9.28

236.07

10.6

5.8

1.09

1.03

mmol/l

2.38

426

841

Injuries to the abdomen, lower back, lumbar spine and pelvis

4384

26304

1.79

235.23

6.9

5.9

1.04

1.05

mmol/l

0.42

4086

24381

Later onset COPD, excluding more controls

2343

8882

2.30

234.90

5.7

4.7

1.06

1.02

mmol/l

7.54

2168

8191

Hernia

9159

42760

1.50

233.79

7.3

6.1

1.04

mmol/l

0.40

8612

39742

Symptoms and signs involving the nervous and musculoskeletal systems

6011

39463

1.64

233.74

6.2

1.04

1.05

mmol/l

0.51

5674

36690

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

6076

36163

1.63

233.72

10.3

6.0

1.07

1.04

mmol/l

9.41

5739

33834

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

9490

42381

1.49

233.11

7.4

6.0

1.05

1.03

mmol/l

5.18

8896

39494

Valvular operations

1613

7127

2.66

229.41

7.3

5.7

1.10

1.02

mmol/l

17.14

1511

6628

Benign neoplasm: Colon

5805

35688

1.66

229.31

7.9

5.8

1.05

1.03

mmol/l

8.10

5445

33127

Other chronic obstructive pulmonary disease

4733

24145

1.76

227.90

6.4

6.1

1.06

1.03

mmol/l

10.87

4406

22479

Malignant neoplasm of kidney, except renal pelvis

1162

4472

3.27

227.61

9.8

6.1

1.08

1.04

mmol/l

4.27

1102

4117

Acute bronchitis

4378

26321

1.77

227.45

8.9

5.8

1.07

1.05

mmol/l

4.97

4084

24375

Renal tubulo-interstitial disorders in diseases classified elsewhere

268

349

26.52

226.72

22.9

3.0

1.12

0.97

mmol/l

9.95

263

317

Exclusions for E4_PCOS_BROAD

1986

9601

2.40

226.52

7.9

7.1

1.06

1.07

mmol/l

0.90

1901

8999

Other diseases of intestine

1855

8772

2.48

225.25

9.7

5.8

1.06

1.03

mmol/l

3.36

1775

8168

Benign neoplasms

9346

35804

1.49

224.83

7.8

6.0

1.05

mmol/l

0.00

8792

33475

Lung transplantation

263

361

94.29

224.79

22.7

8.7

1.09

1.06

mmol/l

0.71

263

341

Other diseases of liver

2046

10042

2.35

224.38

7.5

6.2

1.05

1.04

mmol/l

1.12

1935

9376

Epilepsy

3226

18269

1.94

221.93

6.0

6.7

1.04

1.06

mmol/l

2.48

3023

17023

Lung transplant status

261

361

92.81

221.79

22.6

8.7

1.09

1.06

mmol/l

0.76

261

341

Alcohol abuse, main dg

1778

8316

2.49

221.00

5.4

7.2

1.02

1.04

mmol/l

2.42

1688

7877

Malignant neoplasm of head and neck, including Hilmo

1219

4853

3.08

220.90

6.0

6.3

0.99

1.03

mmol/l

8.20

1164

4476

Secondary uncertain malignant neoplasm

1565

6959

2.66

220.60

6.5

5.8

1.03

1.04

mmol/l

0.35

1504

6378

Other symptoms and signs involving cognitive functions and awareness

5053

28607

1.70

219.89

5.3

6.1

1.03

1.04

mmol/l

2.48

4635

26581

Acute alcohol intoxication, ICD10

2218

11275

2.24

219.47

5.5

7.3

1.02

1.04

mmol/l

3.09

2097

10664

Exclusions for E4_PCOS_CONSORTIUM

6560

27192

1.59

219.28

5.8

1.05

mmol/l

0.37

6091

25186

Other and unspecified myopathies

1225

4970

3.15

218.84

6.2

6.1

1.06

1.04

mmol/l

1.31

1134

4628

Symptoms and signs involving the skin and subcutaneous tissue

7172

46604

1.54

217.48

7.8

6.0

1.05

1.04

mmol/l

1.94

6738

43384

Other dorsopathies, not elsewhere classified

9514

35057

1.48

217.19

5.8

6.5

1.04

mmol/l

2.27

8877

32705

Other chronic obstructive pulmonary disease, including avohilmo

5693

30775

1.65

215.62

6.0

6.2

1.06

1.03

mmol/l

8.43

5298

28675

Other and unspecified dermatitis

5334

34692

1.65

215.61

8.5

5.8

1.06

1.04

mmol/l

7.88

5026

32293

Hypoglycaemia, other or unspecified

971

3530

3.59

214.49

12.3

6.7

1.11

1.06

mmol/l

3.97

934

3282

Spinal stenosis

5350

25489

1.67

213.96

5.4

6.1

1.04

1.03

mmol/l

0.95

4929

23702

Elevated blood glucose level

1134

4459

3.21

213.91

9.2

6.4

1.07

1.05

mmol/l

1.98

1087

4153

Chronic tubulo-interstitial nephritis

551

1400

5.51

212.74

22.1

3.0

1.14

0.98

mmol/l

24.62

531

1264

Respiratory insufficiency

1025

3781

3.31

212.72

7.8

4.8

1.09

1.04

mmol/l

5.46

949

3490

COPD related to multimorbidity

4362

22986

1.77

212.56

6.5

6.0

1.07

1.03

mmol/l

11.23

4048

21373

Follow-up examination after treatment for conditions other than malignant neoplasms

3952

15596

1.80

212.24

6.1

4.8

1.04

1.03

mmol/l

1.50

3693

14445

Urinary track infection

5017

15609

1.71

211.38

6.8

4.4

1.06

1.05

mmol/l

0.36

4689

14312

Viral infections characterized by skin and mucous membrane lesions

4355

27174

1.74

211.19

11.3

6.1

1.07

1.05

mmol/l

4.99

4136

25371

Alcohol withdrawal state with delirium

969

3578

3.60

210.29

5.1

7.5

0.99

1.03

mmol/l

4.87

916

3388

Other specific joint derangements/joint disorders

6823

28709

1.56

209.43

6.2

6.1

1.04

mmol/l

0.66

6411

26791

Emotionally unstable personality disorder

1223

4919

2.86

209.42

4.8

6.2

1.05

1.04

mmol/l

0.56

1153

4602

Other disorders of skin and subcutaneous tissue, not elsewhere classified

1696

7994

2.50

208.54

11.8

5.4

1.11

1.04

mmol/l

14.82

1588

7414

Angina pectoris

5492

23718

1.65

208.29

8.0

5.2

1.07

1.01

mmol/l

40.71

5175

21937

Malignant neoplasm of head and neck

1041

3955

3.29

208.19

6.1

6.3

0.98

1.03

mmol/l

8.37

993

3649

Dermatitis and eczema

10920

47548

1.42

207.98

7.6

6.0

1.06

1.04

mmol/l

7.61

10216

44305

Injuries to the thorax

4858

31261

1.68

207.23

7.0

6.2

1.04

mmol/l

0.21

4563

29089

Gout due to impairment of renal function

311

549

20.78

205.69

29.4

5.5

1.21

1.02

mmol/l

16.62

302

510

Sequelae with surgical and medical care as external cause

2313

12278

2.16

204.63

10.0

5.9

1.07

1.04

mmol/l

4.13

2222

11419

Myeloid leukaemia

518

1352

6.58

203.99

13.5

6.1

1.04

1.03

mmol/l

0.54

511

1244

COPD-related respiratory insufficiency

1519

6971

2.66

203.74

9.0

6.0

1.10

1.04

mmol/l

9.98

1412

6460

ILD, hospital admission 2, with pulmonary infections

1204

4961

2.95

202.86

8.9

5.0

1.05

1.03

mmol/l

2.10

1131

4586

Postmenopausal osteoporosis with pathological fracture

937

3480

3.62

202.35

4.3

4.2

1.01

1.05

mmol/l

4.21

836

3146

Persons with potential health hazards related to communicable diseases

3381

19714

1.83

201.91

12.3

6.4

1.07

mmol/l

0.42

3250

18509

Agranulocytosis

1384

6123

2.77

201.81

11.3

6.1

1.04

1.05

mmol/l

0.35

1344

5690

Other noninfective gastroenteritis and colitis

2656

14695

2.02

201.69

8.8

6.3

1.06

1.07

mmol/l

0.40

2509

13661

Misadventures to patients during surgical and medical care

1655

7819

2.48

201.52

9.9

5.4

1.07

1.03

mmol/l

5.68

1568

7245

Calcific aortic valvular stenosis

3393

19491

1.88

201.35

8.5

5.5

1.11

1.03

mmol/l

35.00

3180

17886

Calcific aortic valvular stenosis, operated

3393

19491

1.88

201.35

8.5

5.5

1.11

1.03

mmol/l

35.00

3180

17886

Soft tissue disorders

9641

35557

1.45

201.26

6.8

6.2

1.06

1.05

mmol/l

2.05

9008

33109

Acute alcohol intoxication

2670

14803

2.00

201.04

5.8

7.1

1.02

1.04

mmol/l

1.79

2529

13906

Acute upper respiratory infections of multiple and unspecified sites

7378

37446

1.51

200.72

8.8

5.7

1.06

1.04

mmol/l

8.40

6939

34841

External causes of morbidity and mortality

5907

19333

1.61

200.69

6.8

5.7

1.05

1.04

mmol/l

1.44

5540

17905

Charcot foot

353

672

9.55

200.34

24.4

4.7

1.18

0.99

mmol/l

19.07

340

618

Any operation in hilmo

312

146

11.94

200.14

6.4

1.5

1.03

1.08

mmol/l

0.93

283

118

Calcific aortic valvular stenosis, diagnosis (helper)

3382

19446

1.87

199.91

8.4

5.5

1.11

1.03

mmol/l

35.12

3169

17843

Operations 2 for CAVS

3382

19446

1.87

199.91

8.4

5.5

1.11

1.03

mmol/l

35.12

3169

17843

Calcific aortic valvular stenosis, including rheumatic fever

3390

19491

1.87

199.51

8.4

5.5

1.11

1.03

mmol/l

35.15

3176

17886

Other external causes of accidental injury

7456

25682

1.52

199.02

6.5

6.1

1.05

1.04

mmol/l

0.88

6989

23916

Diaphragmatic hernia

3776

23203

1.79

198.31

6.3

5.5

1.03

1.04

mmol/l

1.23

3534

21444

Diffuse large B-cell lymphoma, including Hilmo

730

2384

4.28

198.02

8.2

5.5

1.03

mmol/l

0.01

706

2194

Diffuse large B-cell lymphoma, helper endpoint

730

2384

4.28

198.02

8.2

5.5

1.03

mmol/l

0.01

706

2194

Diffuse large B-cell lymphoma

730

2384

4.28

198.02

8.2

5.5

1.03

mmol/l

0.01

706

2194

Delirium, not induced by alcohol and other psychoactive substances

1641

7830

2.51

197.54

6.6

5.9

1.03

1.05

mmol/l

1.61

1533

7222

Pleural effusion

1858

9284

2.35

197.17

9.5

5.8

1.09

1.03

mmol/l

13.65

1757

8575

Decubitus ulcer and pressure area

921

3420

3.54

196.97

13.2

5.1

1.10

1.03

mmol/l

7.66

871

3150

Non-Hodgkin lymphoma, all

685

2159

4.42

195.99

7.8

5.4

1.06

1.03

mmol/l

1.81

665

1976

Unspecified mental disorder

3745

22869

1.77

195.90

5.0

6.6

1.04

mmol/l

0.90

3495

21440

Malignant neoplasm of oesophagus, including Hilmo

587

1689

5.13

195.29

6.0

6.1

0.94

1.02

mmol/l

11.08

575

1561

Anorexia (incl.atypical)

705

2199

3.95

195.28

7.6

6.2

1.13

1.05

mmol/l

10.96

665

2063

Hernia of abdominal wall

4660

30253

1.67

192.58

8.4

6.2

1.05

1.03

mmol/l

4.64

4406

28285

Transient ischemic attack

5307

28032

1.62

191.97

5.7

5.9

1.04

mmol/l

0.10

4965

25915

Diagnoses used for exclusion with ILD

2744

15617

1.96

191.52

7.3

6.0

1.03

1.04

mmol/l

0.37

2576

14504

Hyperkinetic disorders, excluding more controls

1023

3593

2.93

191.36

6.6

7.3

1.10

1.11

mmol/l

0.17

957

3387

Open wound of head

5606

35423

1.59

191.24

6.7

6.6

1.04

1.05

mmol/l

1.44

5230

33048

Other gastritis (incl. Duodenitis)

2381

12985

2.06

190.68

8.8

5.6

1.06

1.04

mmol/l

3.80

2264

12029

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

1993

10270

2.22

190.58

4.9

5.8

1.01

1.04

mmol/l

4.41

1912

9421

Unspecified fall

5289

34614

1.61

190.52

6.7

6.2

1.05

mmol/l

0.20

4915

32171

Accidents

7400

25682

1.51

189.91

6.5

6.1

1.05

1.04

mmol/l

1.00

6935

23916

Osteomyelitis

911

3429

3.48

189.75

18.0

6.2

1.18

1.05

mmol/l

22.37

874

3210

Diseases of the eye and adnexa

7041

24186

1.53

189.74

8.3

5.6

1.06

1.04

mmol/l

4.28

6628

22750

Oesophageal varices

673

2173

4.55

189.11

9.1

6.3

1.06

1.04

mmol/l

0.61

648

2023

Other diseases of pancreas

1096

4521

3.05

187.98

8.0

6.2

1.04

1.03

mmol/l

0.39

1053

4197

Chronic periodontitis, complicated

5638

37356

1.58

185.64

9.2

5.9

1.05

1.03

mmol/l

8.26

5299

34973

Cardiomyopathy, other and unspecified

918

3454

3.27

185.61

8.8

5.4

1.09

1.01

mmol/l

13.52

874

3211

Diseases of the musculoskeletal system and connective tissue

4800

15249

1.66

184.99

7.2

6.1

1.06

1.05

mmol/l

1.33

4495

14242

Fentanyl

1216

5200

2.74

184.90

7.9

5.3

1.05

1.04

mmol/l

0.88

1139

4740

Fracture of lumbar spine and pelvis

2535

14236

2.00

184.53

6.8

5.5

1.04

mmol/l

0.39

2349

13092

COPD, early/later onset

4779

26347

1.66

184.40

6.4

6.1

1.06

1.03

mmol/l

10.18

4445

24532

Hepatic failure, not elsewhere classified

616

1912

4.77

184.09

10.5

6.0

1.08

1.04

mmol/l

2.00

593

1776

Fracture of rib(s), sternum and thoracic spine

3327

20185

1.82

183.88

6.7

6.2

1.03

1.04

mmol/l

0.44

3108

18781

Endocarditis

541

1515

5.00

183.86

15.3

5.5

1.17

1.00

mmol/l

17.98

519

1409

Cough

3934

22995

1.71

183.39

7.5

5.7

1.05

1.04

mmol/l

2.82

3682

21317

Nonorganic sleeping disorders, excluding more controls

1847

9268

2.19

183.08

6.0

6.3

1.05

mmol/l

0.38

1702

8684

COPD, hospital admissions

4728

26172

1.65

182.21

6.4

6.1

1.06

1.03

mmol/l

9.90

4391

24370

COPD, hospital admission 2, with asthma infections

3520

18623

1.80

181.90

6.6

6.1

1.06

1.04

mmol/l

6.50

3259

17276

Chronic gastritis

2830

16554

1.90

178.80

6.4

5.3

1.04

1.03

mmol/l

0.71

2623

15235

Chronic ulcer of skin, not elsewhere classified

940

3695

3.26

178.76

14.2

5.2

1.13

1.03

mmol/l

14.11

892

3423

Other arthritis (FG)

3023

17942

1.83

177.74

8.1

5.8

1.06

1.03

mmol/l

6.00

2860

16675

Other diseases of pericardium

621

1936

4.26

177.62

13.2

5.2

1.11

1.01

mmol/l

9.83

594

1798

Isolated proteinuria with specified morphological lesion

278

494

14.15

176.45

20.1

4.3

1.14

1.02

mmol/l

9.11

272

456

Other/unspecified dorsalgia

3645

22422

1.73

175.96

6.0

6.2

1.04

mmol/l

0.03

3407

20829

Ventral hernia

2549

14575

1.95

175.08

8.1

5.8

1.05

1.04

mmol/l

1.80

2414

13553

Sulfonylureas

3540

17382

1.77

175.05

8.9

5.5

1.14

1.02

mmol/l

89.58

3281

15991

Other necrotizing vasculopathies (FG)

812

2992

3.52

174.99

12.7

5.6

1.08

1.03

mmol/l

4.06

781

2757

Mycoses

2869

16935

1.87

174.68

10.0

6.1

1.05

1.04

mmol/l

1.17

2695

15826

Thrombocytopenia, unspecified

974

3945

3.15

174.67

9.8

6.3

1.06

1.05

mmol/l

0.75

930

3682

Malignant neoplasm of oral cavity, including Hilmo

635

2045

4.22

174.26

6.1

5.4

0.97

1.02

mmol/l

6.75

619

1882

Other necrotizing vasculopathies

962

3901

3.17

172.82

14.0

5.8

1.09

1.04

mmol/l

5.92

928

3612

Kela-code for severe mental illness

3333

20428

1.76

172.41

4.7

6.6

1.04

mmol/l

0.33

3102

19154

Non-selective monoamine reuptake inhibitors

3546

21169

1.74

172.20

5.0

6.1

1.04

mmol/l

0.23

3296

19649

COPD, hospital admissions 3, with asthma pneumonia sepsis

3020

15542

1.85

170.97

6.6

6.0

1.06

1.04

mmol/l

4.54

2784

14400

Disorder of lipoprotein metabolism, unspecified

1410

6658

2.46

170.83

9.3

5.0

1.09

1.02

mmol/l

13.38

1316

6133

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

1060

4459

2.86

170.34

8.3

5.7

1.07

1.04

mmol/l

1.84

1017

4138

Diabetic retinopathy, strict definition

2196

10942

2.14

169.57

19.0

6.3

1.18

1.06

mmol/l

55.15

2090

10287

Other systemic involvement of connective tissue (FG)

2512

14101

1.92

168.53

5.0

5.3

1.04

1.03

mmol/l

0.90

2336

12943

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1200

5394

2.70

168.28

13.3

6.1

1.08

1.04

mmol/l

4.89

1154

5031

Intestinal adhesions without obstruction

1054

4468

2.86

167.66

7.8

5.8

1.04

1.03

mmol/l

0.38

997

4137

ILD, hospital admissions 3, with pneumonia sepsis

1046

4431

2.88

167.09

9.2

5.2

1.05

1.03

mmol/l

1.42

982

4091

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

508

1444

4.72

166.88

25.2

6.3

1.17

1.02

mmol/l

21.02

493

1355

Acute upper respiratory infections

9922

44585

1.39

166.74

7.5

5.6

1.05

1.04

mmol/l

2.74

9252

41426

Visual disturbances and blindness

5189

35439

1.56

165.81

6.9

5.9

1.05

mmol/l

0.55

4835

32916

All influenza (not pneumonia)

1488

7213

2.33

165.35

11.3

5.6

1.09

1.05

mmol/l

5.05

1392

6751

Diseases of pulp and periapical tissues, including avohilmo

9812

37884

1.40

164.89

6.5

6.0

1.04

1.05

mmol/l

3.49

9216

35142

Other disorders of adrenal gland

641

2147

4.00

164.51

8.7

6.1

1.05

1.08

mmol/l

1.15

624

2002

Vascular disorders of the intestines

904

3619

3.11

163.65

10.0

5.2

1.08

1.04

mmol/l

2.92

862

3323

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

8611

49730

1.41

162.70

8.3

6.0

1.05

mmol/l

0.78

8086

46363

Malignant neoplasm of oral cavity

520

1552

4.78

162.49

6.4

5.3

0.96

1.02

mmol/l

7.74

510

1427

Vitreous haemorrhage

1229

5668

2.61

161.90

18.9

6.3

1.17

1.04

mmol/l

32.94

1173

5288

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

1000

4238

2.93

161.42

7.7

5.5

1.08

1.04

mmol/l

4.62

943

3895

Viral pneumonia (unknown virus, not influenza)

858

3378

3.15

160.24

12.0

6.5

1.07

1.04

mmol/l

1.89

836

3152

Dorsopathies

9392

35365

1.40

160.22

6.0

6.5

1.04

1.05

mmol/l

0.42

8781

33004

Traumatic subdural haemorrhage

1516

7009

2.31

160.13

6.5

5.8

1.00

1.05

mmol/l

6.91

1439

6475

Alcohol-induced chronic pancreatitis

832

3259

3.29

160.00

7.9

7.4

1.01

1.03

mmol/l

1.04

802

3081

Undetermined asthma, excluding more controls

1221

5511

2.48

159.93

6.2

4.4

1.04

1.02

mmol/l

1.77

1141

5106

Pneumonitis due to solids and liquids

1070

4678

2.79

159.90

6.3

6.0

1.00

1.04

mmol/l

4.75

1002

4331

Viral and other specified intestinal infections, including avohilmo

2522

14017

1.86

159.38

11.6

5.4

1.09

1.07

mmol/l

3.76

2405

13069

Acute sinusitis

4717

28791

1.57

158.97

8.1

5.8

1.05

1.04

mmol/l

2.59

4428

26900

Adrenocortical insufficiency

536

1652

4.52

158.75

8.9

5.7

1.05

1.06

mmol/l

0.38

522

1540

Cholecystectomy

6727

41041

1.47

158.64

6.2

5.8

1.04

mmol/l

0.42

6302

38005

Extreme obesity with alveolar hypoventilation

591

1946

4.19

157.64

6.0

5.8

1.08

1.02

mmol/l

4.72

549

1801

Other viral diseases

2723

16166

1.82

157.20

15.5

6.4

1.10

1.06

mmol/l

7.94

2582

15179

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1781

8024

2.09

156.99

8.0

7.4

1.12

1.10

mmol/l

1.42

1670

7583

Other intervertebral disc disorders

7546

32624

1.44

156.51

5.3

6.3

1.03

1.04

mmol/l

0.67

7018

30441

Tubulo-interstitial nephritis, not specified as acute or chronic

739

2692

3.28

156.23

11.4

3.0

1.08

0.99

mmol/l

12.50

695

2438

Sciatica+with lumbago

4844

29099

1.56

155.70

5.4

6.4

1.04

1.03

mmol/l

0.14

4548

27172

Hypothyroidism, strict autoimmune, 3 medication purchases required

7611

37347

1.43

154.95

6.0

5.8

1.05

1.04

mmol/l

1.82

7023

34713

Vitamin deficiency

651

2268

3.71

154.41

7.0

6.0

1.04

mmol/l

0.21

616

2091

Vitamin deficiency, wide

651

2268

3.71

154.41

7.0

6.0

1.04

mmol/l

0.21

616

2091

Candidiasis, including avohilmo

2904

17736

1.78

153.62

7.7

5.7

1.04

mmol/l

0.08

2702

16512

Colectomy operation

1858

10100

2.11

153.62

7.2

6.0

1.03

1.04

mmol/l

0.50

1768

9388

Disorders of eyelid, lacrimal system and orbit

8301

45251

1.41

153.19

6.4

6.1

1.04

mmol/l

0.33

7702

42172

Other respiratory diseases principally affecting the interstitium

2021

11291

2.04

152.97

9.7

5.8

1.07

1.04

mmol/l

3.91

1911

10457

Other pleural conditions

1248

5926

2.52

152.72

10.1

5.8

1.10

1.04

mmol/l

10.44

1179

5467

Schizophrenia or delusion

2855

17360

1.78

152.42

5.1

6.6

1.04

mmol/l

0.08

2671

16308

Coronary artery bypass grafting

2641

11607

1.87

152.01

8.0

5.3

1.09

1.01

mmol/l

35.27

2480

10739

Disorders of magnesium metabolism

207

318

19.04

151.74

11.7

5.5

1.00

1.02

mmol/l

0.33

202

292

Malignant neoplasm of oesophagus

442

1252

5.31

151.23

6.0

5.9

0.94

1.02

mmol/l

7.65

432

1160

Acute myeloid leukaemia and myelodysplastic syndromes

407

1090

5.72

150.85

12.2

4.8

1.10

1.03

mmol/l

5.09

392

990

Other complications of surgical and medical care, not elsewhere classified

1076

4800

2.63

150.13

7.6

5.3

1.06

1.04

mmol/l

1.34

1029

4426

Schizophrenia, schizotypal and delusional disorders

2857

17453

1.77

149.76

5.1

6.6

1.04

mmol/l

0.15

2673

16392

Asthma/COPD (KELA code 203)

8851

44417

1.38

149.47

5.6

6.4

1.05

1.04

mmol/l

2.76

8282

41401

Spondylosis

5229

28317

1.53

149.22

4.9

6.2

1.03

mmol/l

0.25

4868

26393

Chronic lymphocytic leukaemia, helper endpoint

472

1408

4.92

149.16

8.5

5.3

1.09

1.02

mmol/l

7.25

458

1294

Chronic lymphocytic leukaemia

472

1408

4.92

149.16

8.5

5.3

1.09

1.02

mmol/l

7.25

458

1294

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

472

1408

4.92

149.16

8.5

5.3

1.09

1.02

mmol/l

7.25

458

1294

Bulimia nervosa (incl. atypical)

382

939

5.09

149.01

5.4

5.6

1.08

1.04

mmol/l

2.04

354

880

Calculus of kidney and ureter

3032

18965

1.75

148.39

6.4

6.5

1.00

1.04

mmol/l

12.38

2885

17739

Viral and other specified intestinal infections

1916

10183

1.99

148.21

13.5

5.6

1.10

1.08

mmol/l

2.83

1827

9481

Other diseases of anus and rectum

2985

18467

1.74

147.52

7.3

5.4

1.04

mmol/l

0.63

2787

17074

Other and unspecified nonorganic psychotic disorders

1750

9319

2.07

147.46

5.0

6.8

1.04

mmol/l

0.06

1639

8748

Other specified/unspecified arthritis

2614

15713

1.81

146.77

8.3

5.9

1.06

1.03

mmol/l

5.23

2471

14609

Urolithiasis

3259

20792

1.71

146.60

6.5

1.00

1.04

mmol/l

12.72

3101

19433

Diabetic retinopathy

4115

17093

1.67

146.58

13.6

6.2

1.13

1.06

mmol/l

38.22

3875

16046

Injury, poisoning and certain other consequences of external causes

4684

15616

1.57

146.22

6.7

5.5

1.06

1.04

mmol/l

1.62

4377

14424

Asthma, including avohilmo

11060

47127

1.34

145.81

5.7

6.5

1.05

mmol/l

1.08

10380

43885

Arthropathies

8014

29814

1.41

145.13

6.9

6.1

1.06

1.04

mmol/l

3.55

7542

27781

Cholangitis (primary sclerosing, PSC)

812

3279

3.10

145.07

9.3

6.1

1.05

mmol/l

0.03

778

3041

Other diseases of biliary tract

1049

4733

2.66

145.04

8.0

5.7

1.02

1.04

mmol/l

1.10

1012

4359

Nonischemic cardiomyopathy

1131

5250

2.54

144.46

8.9

5.7

1.08

1.02

mmol/l

9.76

1074

4877

Lymphoid leukaemia

788

3193

3.27

144.13

11.2

6.5

1.09

1.06

mmol/l

2.56

758

2974

Arthropathies in other diseases classified elsewhere

527

1707

4.23

143.92

20.2

6.0

1.15

1.02

mmol/l

14.56

507

1590

Malignant neoplasm of skin, including Hilmo

4684

21295

1.56

143.90

7.8

5.8

1.04

mmol/l

0.90

4347

19594

Visual disturbances

4704

32478

1.54

142.94

6.6

6.0

1.04

mmol/l

0.04

4402

30218

Other and unspecified drugs and medicaments

1001

4456

2.70

142.77

8.5

6.1

1.06

1.05

mmol/l

0.94

960

4145

Other symptoms and signs involving the digestive system and abdomen

1665

8854

2.09

142.12

7.2

5.1

1.04

1.05

mmol/l

0.62

1529

8162

Colorectal cancer, including Hilmo

2558

14370

1.81

141.59

5.0

5.7

1.01

1.04

mmol/l

3.75

2409

13168

Weight loss

1217

5895

2.46

141.55

6.3

6.4

1.05

1.06

mmol/l

0.09

1124

5498

Other headache syndromes

3613

23507

1.62

141.05

4.9

6.1

1.04

mmol/l

0.28

3361

21812

Asthma, hospital admissions , main diagnosis only

7574

49098

1.40

140.82

6.1

6.3

1.06

1.05

mmol/l

2.24

7102

45677

Rare circulating lymphoid malignancy, including Hilmo

465

1427

4.73

140.59

12.4

6.5

1.11

1.09

mmol/l

0.55

450

1323

Dilated cardiomyopathy

1361

6902

2.34

140.49

8.9

6.7

1.11

1.04

mmol/l

14.58

1290

6481

Disorders of phosphorus metabolism and phosphatases

156

192

40.82

140.48

17.9

7.0

0.87

1.06

mmol/l

8.08

151

180

Lung diseases due to external agents

1563

8253

2.17

140.31

6.5

6.1

1.02

1.05

mmol/l

2.87

1457

7629

Intestinal malabsorption

625

2253

3.61

140.26

10.7

5.8

1.06

1.03

mmol/l

1.38

611

2080

Injuries to the hip and thigh

4895

30597

1.53

139.08

6.8

5.9

1.05

1.04

mmol/l

1.77

4531

28335

Unspecified nephritic syndrome

365

964

5.86

138.19

23.6

4.9

1.13

1.01

mmol/l

10.55

357

892

Gingivitis and periodontal diseases

9298

36545

1.37

137.42

7.4

5.5

1.04

mmol/l

0.30

8694

33936

Other viral diseases, including avohilmo

3357

21516

1.65

136.76

13.4

6.3

1.09

1.06

mmol/l

7.14

3174

20229

Other postsurgical states

788

3217

3.01

136.41

8.1

4.5

1.07

1.04

mmol/l

1.61

747

2987

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

719

2767

3.05

136.24

5.4

7.4

1.06

1.04

mmol/l

0.92

688

2612

Noninfectious colitis NAS

1443

7463

2.20

136.21

9.4

6.2

1.06

mmol/l

0.23

1367

6950

Panic disorder

1269

6193

2.25

135.76

5.5

6.0

1.04

mmol/l

0.17

1197

5782

Malignant neoplasm of skin

4442

20453

1.56

135.36

7.5

5.7

1.04

mmol/l

0.75

4107

18801

Undetermined asthma

1221

5898

2.30

135.19

6.2

4.6

1.04

1.03

mmol/l

0.43

1141

5466

Other diseases of arteries and capillaries

1021

4673

2.58

135.18

18.8

5.3

1.14

1.03

mmol/l

23.29

976

4325

Candidiasis

1471

7677

2.17

135.12

10.3

5.8

1.04

mmol/l

0.24

1379

7147

Pneumocystosis

359

978

6.47

134.98

15.0

6.0

1.07

1.03

mmol/l

1.36

353

909

Pneumocystosis, including avohilmo

359

978

6.47

134.98

15.0

6.0

1.07

1.03

mmol/l

1.36

353

909

Benign neoplasm of other and ill-defined parts of digestive system

1860

10531

2.00

133.88

7.3

5.9

1.03

1.04

mmol/l

0.29

1746

9762

Post-traumatic stress disorder

758

2986

2.86

133.84

5.4

5.7

1.04

1.05

mmol/l

0.26

722

2800

Malignant neoplasm of stomach, including Hilmo

722

2844

3.10

133.73

5.2

5.5

0.98

1.03

mmol/l

5.56

697

2594

Other joint disorders

7673

29666

1.40

133.66

5.8

6.1

1.04

mmol/l

0.01

7162

27639

Gonarthrosis [arthrosis of knee](FG)

6752

28389

1.43

133.28

5.2

5.8

1.04

1.02

mmol/l

5.59

6309

26392

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

769

3120

2.96

133.23

5.2

6.4

1.04

1.06

mmol/l

0.71

730

2914

Speech and linguistic disorders, excluding more controls

778

2915

2.85

132.67

10.4

7.4

1.14

mmol/l

0.06

740

2746

Supplementary factors related to causes of morbidity and mortality classified elsewhere

3018

19316

1.69

131.94

8.1

6.3

1.05

mmol/l

0.83

2848

18055

Persistent mood disorders

1774

9854

1.98

131.49

6.0

1.04

1.03

mmol/l

0.34

1641

9165

Unspecified privation

1164

5669

2.39

131.23

9.1

6.2

1.07

1.05

mmol/l

2.07

1099

5292

Fracture of femur

2891

16549

1.71

130.16

7.1

5.4

1.05

1.04

mmol/l

0.74

2671

15156

Postprocedural disorders of digestive system, not elsewhere classified

489

1622

4.18

129.35

8.8

5.7

1.05

mmol/l

0.19

471

1496

Other blood glucose lowering drugs, excl. Insulins

1630

8950

2.06

129.17

6.9

5.8

1.10

1.02

mmol/l

23.43

1525

8253

Mental and behavioural disorders due to sedatives or hypnotics

749

3042

2.95

129.17

5.4

6.6

1.02

1.03

mmol/l

0.33

707

2850

Fracture of lower leg, including ankle

5141

35992

1.48

128.92

7.2

6.2

1.05

1.04

mmol/l

0.64

4837

33506

Familial hypercholesterolemia

1487

7907

2.12

128.83

8.3

5.0

1.08

1.02

mmol/l

8.17

1393

7271

Haemorrhage, not elsewhere classified

527

1808

3.78

128.50

14.0

4.9

1.12

1.04

mmol/l

6.58

499

1667

Need for other prophylactic measures

735

3011

3.07

128.26

11.7

6.5

1.08

1.06

mmol/l

0.81

720

2815

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

4213

19403

1.55

126.46

7.6

5.7

1.04

mmol/l

0.86

3893

17813

Other viral hepatitis, including avohilmo

693

2737

3.01

125.77

8.1

7.2

1.04

1.03

mmol/l

0.09

669

2579

Early onset COPD

2183

13121

1.84

125.70

7.5

6.7

1.07

1.03

mmol/l

6.43

2067

12307

Phobic anxiety disorders

1125

5388

2.29

125.34

7.6

6.4

1.07

1.05

mmol/l

1.29

1069

5047

Other malignant neoplasms of skin (=non-melanoma skin cancer)

4075

18807

1.56

124.95

7.3

5.7

1.04

mmol/l

0.35

3751

17259

Amputation of foot

434

1395

4.71

124.33

22.1

5.8

1.23

1.02

mmol/l

25.95

417

1296

Other viral hepatitis

663

2585

3.07

123.79

8.3

7.1

1.04

1.03

mmol/l

0.24

640

2434

Zoster [herpes zoster]

1931

11285

1.91

123.49

9.4

5.6

1.06

1.04

mmol/l

2.19

1817

10431

Reimbursement for rheumatic diseases

5171

37003

1.46

123.13

6.7

5.9

1.04

mmol/l

0.26

4903

34317

Other obstructive and reflux uropathy

472

1531

3.78

123.09

14.8

3.4

1.10

1.01

mmol/l

9.01

456

1403

Injuries to the knee and lower leg

10940

46702

1.31

122.56

6.6

6.2

1.05

1.04

mmol/l

0.24

10249

43498

Other symptoms and signs involving the nervous and musculoskeletal systems

3861

26425

1.55

122.27

6.1

1.04

mmol/l

0.61

3657

24629

Malignant neoplasm of stomach

639

2481

3.17

122.13

5.0

5.4

0.97

1.03

mmol/l

6.04

617

2268

Caries of dentine, including avohilmo

7329

28015

1.39

122.09

6.6

5.8

1.04

1.05

mmol/l

1.50

6822

25911

Generalized anxiety disorder

1340

6904

2.10

122.02

4.7

6.1

1.04

1.05

mmol/l

0.11

1250

6460

Other problems related to primary support group, including family circumstances

1093

5141

2.34

122.00

14.5

6.1

1.17

1.11

mmol/l

6.55

1049

4813

Arthrosis

6301

25252

1.43

121.99

5.6

5.9

1.04

1.02

mmol/l

5.70

5892

23510

Pneumonia due to other infectious organisms, not elsewhere classified

457

1497

4.08

121.59

13.4

5.3

1.08

1.03

mmol/l

2.38

441

1387

Myalgia

2182

13129

1.79

121.22

5.4

5.7

1.04

1.03

mmol/l

0.93

2018

12225

Nontraumatic intracranial haemmorrhage

2040

12141

1.85

121.12

6.6

5.6

1.00

1.05

mmol/l

8.95

1910

11176

Non-allergic asthma (mode), excluding more controls

1552

8358

1.99

120.71

6.1

4.4

1.06

1.03

mmol/l

3.87

1470

7740

Budesonide

1338

6990

2.13

120.45

6.1

5.7

1.02

1.04

mmol/l

1.73

1261

6505

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

2287

13761

1.76

120.00

10.4

5.9

1.11

1.07

mmol/l

7.00

2165

12886

Amiodarone users

1157

5881

2.34

119.45

7.5

6.5

1.07

1.04

mmol/l

2.85

1109

5494

Aortic aneurysm

2326

14084

1.77

119.41

7.3

5.5

1.05

1.02

mmol/l

4.71

2209

13104

Amyloidosis

351

996

5.12

118.76

11.3

5.0

1.11

1.02

mmol/l

7.15

341

912

Total colectomy operation

539

1966

3.56

118.53

8.9

6.4

1.04

1.03

mmol/l

0.36

519

1832

Total colectomy

539

1966

3.56

118.53

8.9

6.4

1.04

1.03

mmol/l

0.36

519

1832

Malnutrition

382

1172

5.09

118.36

11.4

7.3

1.09

1.11

mmol/l

0.68

368

1080

Neuromuscular dysfunction of bladder

988

4715

2.45

117.59

7.3

6.1

1.06

1.04

mmol/l

0.86

937

4415

Syphilis, including avohilmo

390

1196

4.64

117.41

18.2

6.5

1.06

1.02

mmol/l

1.67

376

1119

Syphilis

390

1196

4.64

117.41

18.2

6.5

1.06

1.02

mmol/l

1.67

376

1119

Diseases of oral cavity, salivary glands and jaws

5325

19603

1.46

117.28

6.8

4.9

1.04

1.05

mmol/l

0.54

4956

18067

Drug-induced osteoporosis with pathological fracture

303

805

6.45

116.92

7.6

5.1

1.03

1.05

mmol/l

0.26

282

731

Colorectal cancer

2244

13202

1.77

116.64

4.9

5.7

1.01

1.04

mmol/l

3.06

2118

12089

Chronic viral hepatitis

560

2071

3.27

116.08

8.3

7.2

1.04

1.02

mmol/l

0.43

541

1956

Emotional disorders starting during childhood or adolecense, excluding more controls

425

1273

3.76

115.99

9.0

7.5

1.15

1.20

mmol/l

3.73

397

1193

Drug-induced neutropenia

835

3784

2.70

115.82

8.8

6.3

1.02

1.04

mmol/l

0.78

818

3514

Clear cell adenocarcinoma of kidney

586

2262

3.32

115.68

8.3

5.8

1.06

1.03

mmol/l

2.01

558

2090

Diseases of pulp and periapical tissues and dental caries

6121

23021

1.42

115.54

6.8

5.4

1.05

mmol/l

0.19

5688

21202

Superficial injury of head

2371

14785

1.74

115.24

5.4

6.3

1.04

1.06

mmol/l

3.26

2198

13704

Abnormal weight loss

1088

5469

2.35

114.70

5.9

6.3

1.05

mmol/l

0.05

1005

5101

Polyuria

2213

13648

1.78

114.67

6.2

5.8

1.02

1.03

mmol/l

1.21

2045

12704

Dental caries, including avohilmo

6782

25919

1.40

114.39

6.7

5.5

1.04

1.05

mmol/l

1.26

6304

23921

Viral hepatitis

743

3175

2.75

114.18

8.0

7.0

1.03

mmol/l

0.15

712

2974

Viral hepatitis, including avohilmo

774

3368

2.68

113.96

7.8

7.0

1.03

1.04

mmol/l

0.31

742

3159

Myocarditis

418

1298

3.73

113.94

8.0

3.5

1.09

0.99

mmol/l

8.50

401

1196

Other embolism and thrombosis

1317

7035

2.12

113.40

10.1

5.8

1.06

1.03

mmol/l

3.01

1238

6534

Coxarthrosis [arthrosis of hip](FG)

5015

24826

1.46

113.22

5.6

5.7

1.05

1.02

mmol/l

7.06

4650

23046

Inflammatory bowel disease

2814

18329

1.64

112.99

6.7

6.6

1.03

1.04

mmol/l

2.57

2680

17205

Viral pneumonia (known virus, not influenza)

442

1507

4.16

112.99

15.4

6.6

1.08

1.07

mmol/l

0.21

425

1407

Acute myeloid leukaemia

247

571

7.46

112.92

15.6

5.1

1.09

1.03

mmol/l

2.96

242

512

Acute myeloid leukaemia, helper endpoint

247

571

7.46

112.92

15.6

5.1

1.09

1.03

mmol/l

2.96

242

512

Acute myeloid leukaemia, including Hilmo

247

571

7.46

112.92

15.6

5.1

1.09

1.03

mmol/l

2.96

242

512

Fracture of shoulder and upper arm

3485

23769

1.56

112.33

6.9

6.1

1.04

1.05

mmol/l

0.55

3247

22026

Cardiodefibrillation

3520

24151

1.57

112.25

6.9

6.2

1.05

1.03

mmol/l

3.18

3296

22508

Malignant neoplasm of bladder, including Hilmo

1206

6184

2.18

112.12

6.6

6.0

1.04

mmol/l

0.34

1140

5681

Mental and behavioural disorders due to opioids

420

1345

3.84

112.04

6.8

7.0

1.08

1.02

mmol/l

2.81

400

1263

Attention to artificial openings

529

1966

3.43

111.71

9.2

4.1

1.07

1.02

mmol/l

2.44

506

1806

Unstable angina pectoris

3427

18235

1.58

111.67

7.4

5.2

1.07

1.01

mmol/l

25.31

3174

16828

Suppurative and necrotic conditions of lower respiratory tract

701

3003

2.91

111.23

9.3

6.5

1.07

1.03

mmol/l

2.01

676

2800

Primary Sclerosing Cholangitis, IBD and UDCA required

327

928

4.99

109.81

12.8

7.2

1.07

1.08

mmol/l

0.21

320

860

Amenorrhoea

614

2411

2.89

109.81

7.4

5.3

1.09

1.06

mmol/l

2.37

579

2244

Vitamin B12 deficiency anaemia

1100

5597

2.25

109.54

6.0

5.4

1.04

mmol/l

0.14

1036

5148

Other specified and unspecified personality disorders

850

3898

2.49

109.52

5.7

6.5

1.04

1.03

mmol/l

0.37

804

3649

Malignant neoplasm of colon, including Hilmo

1766

10327

1.87

109.51

5.1

5.5

1.01

1.04

mmol/l

3.60

1659

9425

Basal cell carcinoma, including Hilmo

4014

18907

1.52

109.29

7.3

5.7

1.04

mmol/l

0.03

3692

17338

Myelodysplastic syndrome, including Hilmo

424

1421

4.02

109.28

7.6

4.9

1.09

1.03

mmol/l

3.87

399

1295

Gonarthrosis

5718

23722

1.42

109.27

5.2

5.8

1.04

1.02

mmol/l

4.62

5341

22056

Status post-ami

2492

12005

1.71

109.17

8.1

5.2

1.09

1.01

mmol/l

29.39

2331

11087

Diabetic maculopathy

1516

8237

2.06

108.48

18.7

6.4

1.19

1.06

mmol/l

41.05

1463

7745

Exposure to other specified factors

7239

47801

1.35

107.67

6.8

6.4

1.05

mmol/l

0.90

6768

44715

Protozoal diseases

438

1528

4.03

107.54

14.0

6.1

1.08

1.03

mmol/l

2.00

429

1422

Assault

1183

6158

2.12

107.06

6.8

7.3

1.04

mmol/l

0.09

1127

5824

Other systemic involvement of connective tissue

2569

16649

1.67

107.02

5.2

5.4

1.04

mmol/l

0.13

2392

15371

Abnormal results of function studies

949

4619

2.38

107.02

8.2

6.5

1.06

1.05

mmol/l

0.48

892

4313

Amyloidosis, other/unspecified

298

817

5.49

106.78

12.1

5.1

1.13

1.01

mmol/l

8.80

290

748

Use of disulfiram, acamprosate or naltrexone

897

4275

2.44

106.74

4.3

7.7

1.01

1.03

mmol/l

1.08

855

4053

Type of accident

2733

17941

1.64

106.73

8.1

6.2

1.06

1.05

mmol/l

1.32

2577

16762

Status epilepticus

482

1753

3.53

106.18

7.4

6.4

1.06

1.05

mmol/l

0.12

452

1631

Vitamin D deficiency

287

763

5.36

105.45

7.7

6.1

1.04

1.05

mmol/l

0.22

267

706

Mycoses, including avohilmo

8307

49567

1.32

104.97

6.5

6.3

1.04

mmol/l

1.82

7720

46305

Protozoal diseases, including avohilmo

445

1584

3.88

104.96

13.8

6.1

1.07

1.04

mmol/l

1.75

436

1475

Dental operations

5614

21214

1.42

104.92

6.7

5.2

1.04

mmol/l

0.50

5229

19536

Vascular diseases of the intestine

517

1970

3.37

104.67

10.1

4.7

1.08

1.02

mmol/l

3.06

496

1804

Abnormal findings on diagnostic imaging of other body structures

1441

8120

1.99

104.51

7.1

5.9

1.06

1.04

mmol/l

2.05

1360

7544

Injuries to the shoulder and upper arm

7918

47668

1.33

104.32

6.4

6.3

1.04

mmol/l

1.01

7422

44421

Wegener granulomatosis

270

712

6.26

104.29

15.7

6.0

1.07

1.04

mmol/l

1.00

264

664

Disorders of skin appendages

4290

30579

1.46

104.14

8.9

6.1

1.06

1.04

mmol/l

4.23

4038

28599

Disorders of psychological development

1105

5243

2.16

103.71

9.5

7.8

1.14

1.13

mmol/l

0.64

1045

4932

Immunodeficiencies

584

2373

3.10

103.67

13.1

6.4

1.08

1.07

mmol/l

0.19

564

2211

Nonalcoholic fatty liver disease

1028

5215

2.26

103.28

6.1

6.6

1.04

mmol/l

0.03

976

4883

Open wound of lower leg

1527

8763

1.93

103.26

9.2

6.3

1.07

1.05

mmol/l

2.08

1436

8160

Basal cell carcinoma

3860

18404

1.51

102.42

7.1

5.7

1.04

mmol/l

0.03

3534

16877

Shoulder lesions

6731

30702

1.37

102.32

6.1

5.9

1.04

1.03

mmol/l

1.93

6307

28590

Focal epilepsy

2033

12616

1.76

102.16

5.8

6.7

1.03

1.06

mmol/l

5.55

1897

11789

Other interstitial pulmonary diseases

1604

9448

1.91

101.15

8.1

6.0

1.05

1.04

mmol/l

0.74

1508

8750

Deforming dorsopathies

2511

16356

1.64

100.62

5.7

6.3

1.05

mmol/l

0.61

2341

15240

Other diseases of stomach and duodenum

723

3248

2.65

100.58

9.5

5.8

1.06

1.04

mmol/l

1.17

690

2999

Other arthrosis

4720

22955

1.44

100.49

5.9

5.8

1.04

1.02

mmol/l

3.13

4412

21382

Other endocrine disorders

635

2591

2.89

100.42

12.1

8.3

1.20

1.19

mmol/l

0.51

603

2451

Arterial embolism and thrombosis

668

2908

2.75

99.98

11.5

4.9

1.12

1.02

mmol/l

9.49

636

2674

Fracture of skull and facial bones

1970

12162

1.75

99.84

6.8

6.9

1.02

1.05

mmol/l

2.75

1839

11418

Haemolytic anaemias

470

1757

3.52

99.81

15.1

6.4

1.12

1.06

mmol/l

3.18

451

1635

Duodenal ulcer

1141

6067

2.13

99.78

8.6

6.0

1.08

1.04

mmol/l

3.12

1071

5605

Other disorders of lacrimal gland

3334

23098

1.54

99.63

7.1

5.6

1.05

1.04

mmol/l

1.02

3094

21431

Drug-induced cataract

353

1135

4.47

99.45

24.5

5.8

1.09

1.04

mmol/l

2.45

339

1055

Interstitial lung disease endpoints

1604

9495

1.90

99.38

8.1

6.0

1.05

1.04

mmol/l

0.69

1508

8796

Interstitial lung disease

1604

9495

1.90

99.38

8.1

6.0

1.05

1.04

mmol/l

0.69

1508

8796

ILD, hospital admissions

1581

9328

1.91

99.25

8.2

6.0

1.05

1.04

mmol/l

0.60

1486

8643

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

713

3197

2.64

99.18

7.0

5.7

1.05

1.04

mmol/l

0.24

678

2924

Other inflammatory liver diseases

724

3281

2.63

98.99

7.6

6.1

1.05

1.04

mmol/l

0.60

692

3050

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

1274

6947

2.03

98.95

8.7

5.2

1.07

1.04

mmol/l

1.77

1187

6303

Malignant neoplasm of tongue, including Hilmo

361

1168

4.22

98.93

6.1

5.3

0.97

1.02

mmol/l

3.57

349

1069

Migraine

3914

21478

1.48

98.66

5.2

6.3

1.04

1.05

mmol/l

1.00

3677

19974

Benign neoplasm of other and unspecified endocrine glands

1321

7397

2.01

98.50

6.3

1.01

1.04

mmol/l

2.93

1249

6889

Coxarthrosis

4575

21402

1.45

97.71

5.6

5.7

1.04

1.02

mmol/l

5.20

4252

19876

Collagenous colitis

966

4903

2.27

97.56

7.6

5.9

1.04

1.05

mmol/l

0.54

916

4550

Other infectious diseases, including avohilmo

970

4933

2.27

97.54

13.8

6.0

1.10

1.04

mmol/l

7.09

932

4590

Aneurysms, operations, SAH

1557

9140

1.88

97.36

6.8

5.8

1.01

1.04

mmol/l

3.47

1458

8473

Unspecified acute lower respiratory infection

1490

8634

1.90

96.98

10.2

6.3

1.07

1.04

mmol/l

3.53

1418

8085

Malignant neoplasm of endocrine gland, including Hilmo

790

3707

2.45

96.87

6.1

5.7

1.08

1.04

mmol/l

2.98

737

3399

Immunodeficiency with predominantly antibody defects

362

1189

4.15

96.85

14.2

6.0

1.08

1.07

mmol/l

0.50

355

1110

Other and unspecified mood [affective] disorders

626

2634

2.68

96.78

5.8

6.3

1.07

1.05

mmol/l

0.91

592

2454

Other diseases of hard tissues of teeth

5096

19353

1.42

96.74

7.0

4.9

1.03

1.05

mmol/l

2.21

4734

17866

L01XE Protein kinase inhibitors

652

2903

2.85

96.43

9.1

6.0

1.03

1.04

mmol/l

0.34

626

2702

Carbimazole or st.post thyroidectomy, condition for graves disease

1844

11314

1.77

96.31

5.1

5.7

1.07

1.04

mmol/l

4.46

1720

10514

Disturbances of skin sensation

2338

15131

1.65

96.20

5.8

5.9

1.04

mmol/l

0.06

2206

14147

Malignant neoplasm of pancreas, including Hilmo

885

4363

2.33

96.16

3.9

5.6

0.98

1.04

mmol/l

7.27

845

3988

L01XX Other antineoplastic agents

711

3276

2.69

96.08

7.9

5.7

1.09

1.03

mmol/l

6.91

686

3026

Irritable bowel syndrome

2274

14624

1.65

95.53

5.2

5.3

1.03

mmol/l

0.19

2091

13570

Polycystic ovarian syndrome, consortium definition

5605

24032

1.39

94.96

5.6

4.8

1.05

mmol/l

0.22

5175

22042

Other infectious diseases

835

4070

2.41

94.88

14.7

5.9

1.10

1.04

mmol/l

6.92

803

3781

Complications of internal orthopaedic prosthetic devices, implants and grafts

2154

13815

1.70

94.84

6.9

5.0

1.06

1.03

mmol/l

3.49

1998

12677

Phlebitis and thrombophlebitis (not including DVT)

2076

13177

1.71

94.73

9.6

5.8

1.04

1.03

mmol/l

0.99

1966

12257

Non-allergic asthma (mode)

1552

8992

1.84

94.70

6.1

4.6

1.06

1.04

mmol/l

1.78

1470

8337

Other disorders of white blood cells

638

2810

2.78

94.58

9.5

6.0

1.05

1.04

mmol/l

0.45

609

2617

Osteonecrosis

707

3248

2.61

94.19

10.4

5.9

1.06

1.04

mmol/l

1.11

674

3027

Amputation of ankle bones

337

1091

4.40

93.74

28.6

5.7

1.29

1.02

mmol/l

26.59

321

1006

severe traumatic brain injury, does not include concussion

2209

14296

1.68

93.61

6.4

6.1

1.01

1.04

mmol/l

4.46

2074

13258

Focal epilepsy, strict definition

1882

11719

1.75

93.56

5.8

6.7

1.03

1.06

mmol/l

5.89

1760

10944

Ulcerative colitis

2132

13619

1.68

93.46

6.8

6.5

1.02

1.04

mmol/l

2.01

2026

12759

Hypopituitarism

764

3607

2.47

93.34

7.7

7.3

1.08

mmol/l

0.12

730

3401

Disorders of lacrimal system

3963

28156

1.46

92.95

6.8

5.6

1.05

1.04

mmol/l

0.75

3684

26092

Allergic asthma (mode), excluding more controls

1634

9445

1.78

92.83

5.3

4.5

1.06

1.04

mmol/l

3.05

1548

8770

Lumbar disc prolapse

5525

30891

1.38

92.05

5.5

6.4

1.03

mmol/l

0.67

5151

28886

Squamous cell neoplasms and carcinomas of the skin

1039

5502

2.14

91.73

8.7

5.2

1.07

1.04

mmol/l

1.98

972

4991

Gingival hyperplasia

500

2022

3.23

91.52

28.7

6.8

1.16

1.09

mmol/l

5.08

488

1884

Nonorganic sleeping disorders

1847

11458

1.73

91.19

6.0

6.5

1.05

mmol/l

0.40

1702

10743

Psychotic depression

578

2423

2.73

91.15

5.1

6.6

1.05

1.04

mmol/l

0.16

536

2262

Thyrotoxicosis, other and/or unspecified

1745

10693

1.76

91.02

5.6

1.04

mmol/l

0.49

1616

9947

Myeloproliferative diseases

894

4550

2.30

90.92

6.2

5.9

1.04

1.03

mmol/l

0.32

852

4219

ILD, hospital admissions 1, main diag only

1413

8293

1.92

90.72

8.3

6.1

1.05

1.04

mmol/l

0.79

1335

7688

Type 1 diabetes, definitions combined

825

3991

2.29

90.65

11.2

7.3

1.09

1.10

mmol/l

0.15

789

3747

Type 1 diabetes, strict (exclude DM2)

822

3977

2.29

90.37

11.2

7.5

1.09

1.10

mmol/l

0.13

786

3738

Other viral diseases, not elsewhere classified

1670

10139

1.78

89.64

13.8

6.6

1.11

1.07

mmol/l

4.87

1570

9503

Late syphilis

238

642

6.04

89.12

20.0

6.1

1.12

1.02

mmol/l

4.97

225

597

Acquired haemolytic anaemia

355

1223

4.05

88.89

15.9

6.0

1.13

1.06

mmol/l

3.90

341

1128

Primary biliary cholangitis, wide definition

318

1016

4.26

88.82

9.5

4.8

1.06

1.05

mmol/l

0.30

307

931

Special screening examination for infectious and parasitic diseases

1670

7235

1.76

88.76

7.1

5.1

1.01

1.03

mmol/l

1.66

1530

6774

Crohn disease

1170

6484

1.99

88.16

7.6

6.7

1.03

1.05

mmol/l

0.90

1122

6074

Cerebral palsy and other paralytic syndromes

1095

5982

2.05

87.70

6.9

6.5

1.06

mmol/l

0.07

1029

5580

Traumatic subarachnoid haemorrhage

445

1702

3.21

87.62

6.3

5.8

1.00

1.04

mmol/l

2.06

415

1576

Zoster [herpes zoster], including avohilmo

4744

34347

1.40

87.37

7.4

5.5

1.04

mmol/l

0.72

4442

31805

Behavioural syndromes associated with physiological disturbances and physical factors

8227

44459

1.29

87.12

5.4

6.5

1.04

mmol/l

0.58

7633

41524

Malignant neoplasm of colon

1426

8424

1.86

86.69

5.1

5.6

1.01

1.04

mmol/l

3.23

1340

7700

Viral warts

962

5053

2.14

86.66

18.2

6.2

1.09

1.06

mmol/l

3.73

936

4720

Injuries to the elbow and forearm

6307

42029

1.33

86.63

6.6

6.1

1.05

mmol/l

0.23

5867

39108

Alcohol-induced acute pancreatitis

448

1751

3.27

86.57

7.7

7.3

1.01

1.03

mmol/l

0.53

428

1655

DVT of lower extremities

1773

11090

1.74

86.57

8.5

5.8

1.03

1.04

mmol/l

0.03

1663

10292

Disturbance of activity and attention

1022

5270

2.04

86.43

6.7

7.5

1.11

mmol/l

0.07

959

4976

Other local infections of skin and subcutaneous tissue

1040

5623

2.09

86.36

12.8

6.2

1.09

1.05

mmol/l

4.12

992

5247

Injuries to the ankle and foot

6156

40745

1.34

86.16

7.7

6.4

1.06

1.05

mmol/l

4.84

5772

38176

Other general symptoms and signs

532

2188

2.79

86.16

5.5

5.2

1.09

1.11

mmol/l

0.78

495

2037

Other and unspecified local infections of skin and subcutaneous tissue

989

5270

2.12

86.01

13.1

6.2

1.09

1.05

mmol/l

4.22

947

4919

Abnormal involuntary movements

1313

7632

1.91

85.50

5.9

6.4

1.04

1.05

mmol/l

0.39

1232

7118

Polyarthrosis

1911

10929

1.70

85.42

4.6

5.3

1.04

1.03

mmol/l

1.31

1759

10020

Malignant neoplasm of endocrine gland

683

3183

2.47

85.31

6.3

5.7

1.08

1.04

mmol/l

2.53

639

2926

Benign neoplasm: Colon, unspecified

2429

16396

1.60

85.18

8.5

5.8

1.06

1.03

mmol/l

4.79

2266

15259

Fibromyalgia

812

4020

2.25

84.98

3.4

5.2

1.04

1.03

mmol/l

0.26

763

3728

Autoimmune hepatitis, wide definition

499

2044

2.93

84.96

7.2

5.1

1.05

1.04

mmol/l

0.33

479

1885

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

297

940

4.39

84.79

6.3

4.8

0.97

1.01

mmol/l

2.62

286

854

Disorders of continuity of bone

942

4945

2.13

84.64

8.3

5.9

1.06

1.05

mmol/l

0.64

892

4606

SLE (Finngen)

386

1394

3.42

84.58

9.7

4.9

1.08

1.04

mmol/l

1.80

364

1286

Late syphilis, including avohilmo

262

778

5.03

84.11

19.2

5.8

1.13

1.01

mmol/l

6.03

248

726

Ulcerative colitis, NAS

1250

7175

1.91

83.78

7.2

6.6

1.02

1.05

mmol/l

2.26

1205

6719

Thyrotoxicosis

2196

14496

1.62

83.66

5.7

5.5

1.05

1.04

mmol/l

0.74

2033

13436

Acute posthaemorrhagic anaemia

428

1656

3.22

83.26

11.9

4.8

1.10

1.03

mmol/l

4.65

399

1520

Transport accidents

3838

23196

1.43

82.87

6.5

6.1

1.05

1.04

mmol/l

0.87

3621

21658

Functional dyspepsia

2284

15202

1.60

82.84

6.3

5.5

1.04

1.03

mmol/l

0.90

2111

14125

COPD, hospital admissions 1, only main diagnosis

3269

20045

1.49

82.68

6.5

6.0

1.07

1.03

mmol/l

7.58

3027

18589

Focal epilepsy, mode (most common among epilepsy diagnosis)

1744

10983

1.73

82.64

5.6

6.7

1.03

1.06

mmol/l

4.88

1630

10271

Thiazolidinediones

1097

6132

2.02

82.62

7.9

6.2

1.09

1.02

mmol/l

13.57

1028

5712

Other skin changes

1914

12341

1.69

82.56

11.2

5.7

1.06

1.04

mmol/l

2.04

1805

11470

Abnormalities of gait and mobility

1263

7380

1.93

82.31

6.3

6.5

1.06

1.05

mmol/l

0.20

1192

6876

Fracture of foot, except ankle

2123

13937

1.62

82.18

8.2

6.4

1.05

1.04

mmol/l

0.92

1999

13066

Other renal tubulo-interstitial diseases

280

852

4.19

82.18

19.4

3.0

1.11

1.01

mmol/l

6.32

271

778

Malignant neoplasm of bladder

707

3392

2.39

82.06

6.2

5.7

1.04

mmol/l

0.09

673

3093

Mixed and other personality disorders

698

3318

2.37

81.90

5.4

6.6

1.04

1.03

mmol/l

0.22

651

3120

Somatoform disorder

1381

8189

1.83

81.62

5.2

5.9

1.04

mmol/l

0.24

1279

7646

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

671

3185

2.45

81.05

6.9

5.8

1.02

1.04

mmol/l

0.92

647

2926

Rheumatoid arthritis

2727

16668

1.53

80.73

5.3

5.4

1.04

1.03

mmol/l

1.72

2555

15395

Acute nephritic syndrome

293

950

4.27

80.56

24.4

5.6

1.14

1.03

mmol/l

6.94

287

884

Fitting and adjustment of other devices

3141

19630

1.48

80.05

6.1

3.6

1.04

1.02

mmol/l

3.02

2924

17908

Unspecified misadventure during surgical and medical care

646

3064

2.53

79.91

8.5

5.9

1.05

1.03

mmol/l

0.51

619

2843

Benign thyroid growths and nodules

2806

18195

1.52

79.73

5.2

1.04

mmol/l

0.02

2570

16787

Cholecystitis

1340

7973

1.85

79.56

6.7

5.7

1.06

1.04

mmol/l

1.39

1265

7312

Other disorders starting during childhood or adolecense, excluding more controls

416

1502

3.00

79.26

14.9

7.8

1.23

mmol/l

0.01

398

1421

Other pulmonary heart/vessel disease

553

2481

2.74

79.07

7.7

5.8

1.11

1.04

mmol/l

5.28

524

2287

Explicit fungal Sepsis, including avohilmo

143

283

9.65

78.97

17.7

4.6

1.12

1.00

mmol/l

3.76

138

259

Lung cancer and mesothelioma

1652

8718

1.73

78.93

5.2

4.9

1.02

mmol/l

0.22

1558

8079

Cerebral cysts

587

2665

2.56

78.73

8.1

6.7

1.07

1.05

mmol/l

0.83

563

2484

Other and unspecified effects of external causes

2273

15278

1.58

78.36

6.9

6.5

1.06

mmol/l

0.01

2167

14301

Hyperkinetic disorders

1071

5785

1.94

78.23

6.7

8.0

1.12

mmol/l

0.15

1003

5456

Allergic asthma (mode)

1635

9915

1.69

77.36

5.3

4.8

1.06

1.04

mmol/l

1.75

1549

9217

Urticaria and erythema

3029

21545

1.48

77.35

7.2

6.1

1.05

mmol/l

0.12

2829

20127

Pyothorax

521

2304

2.79

77.10

9.0

6.5

1.08

1.03

mmol/l

2.50

502

2144

Other and unspecified disorders of white blood cells

476

2023

2.92

76.91

9.6

5.9

1.05

1.03

mmol/l

0.56

456

1877

Other symptoms and signs involving the urinary system

1024

5717

2.01

76.86

7.8

6.0

1.04

mmol/l

0.08

987

5339

Other viral diseases, not elsewhere classified, including avohilmo

2229

14882

1.58

76.82

11.5

6.3

1.10

1.07

mmol/l

5.43

2093

13983

Other specified disorders of kidney and ureter

398

1556

3.26

76.81

19.0

5.4

1.12

1.03

mmol/l

6.56

382

1440

Intracerebral haemorrhage

1252

7398

1.87

76.77

6.6

5.8

1.01

1.05

mmol/l

4.39

1175

6789

Obsessive-compulsive disorder

557

2462

2.51

76.56

5.9

6.5

1.06

mmol/l

0.07

524

2320

Colorectal adenocarcinoma

1790

11379

1.67

76.40

4.8

5.7

1.02

1.04

mmol/l

1.54

1692

10420

Complications of cardiac and vascular prosthetic devices, implants and grafts

300

1022

4.05

76.27

23.6

5.3

1.20

1.03

mmol/l

12.48

293

938

Congenital malformations of the circulatory system

1340

7834

1.83

76.17

9.2

7.6

1.13

1.09

mmol/l

5.05

1285

7372

Diabetic neuropathy

1367

8416

1.88

75.89

15.7

7.4

1.16

1.07

mmol/l

21.18

1300

7895

Benign neoplasm: Parathyroid gland

191

494

6.40

75.83

10.5

5.1

0.93

1.06

mmol/l

5.39

179

461

5-aminosalicylic acid

1692

10730

1.68

75.71

6.2

5.9

1.02

1.04

mmol/l

1.18

1598

10050

Infections with a predominantly sexual mode of transmission

2225

14916

1.56

75.63

9.6

5.9

1.04

mmol/l

0.04

2098

13968

Mixed hyperlipidaemia

431

1744

2.98

75.59

10.7

5.3

1.11

1.01

mmol/l

8.24

410

1610

Malignant neoplasm of thyroid gland, including Hilmo

670

3246

2.35

75.55

5.6

5.4

1.08

1.04

mmol/l

3.25

622

2969

Thoracic aortic aneurysm

1369

8351

1.81

75.17

7.4

5.8

1.03

1.02

mmol/l

0.65

1309

7823

Other and unspecified types of non-Hodgkin lymphoma, hilmo

500

2206

2.83

74.85

7.5

5.9

1.05

1.03

mmol/l

0.62

479

2039

Malignant neoplasm of tongue

274

893

4.21

74.56

6.3

5.2

0.96

1.02

mmol/l

4.38

267

814

Combinations of oral blood glucose lowering drugs

2460

17052

1.54

74.21

5.5

6.3

1.07

1.01

mmol/l

19.86

2351

15979

Mental and behavioural disorders due to tobacco

843

4483

2.13

73.89

7.4

6.7

1.05

1.04

mmol/l

0.97

789

4206

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

4482

32881

1.37

73.88

6.3

6.6

1.03

1.04

mmol/l

1.09

4167

30886

Secondary right heart disease

500

2216

2.79

73.69

8.0

5.5

1.12

1.04

mmol/l

6.02

473

2040

Rheumatism, unspecified

1170

6842

1.87

73.57

4.2

5.2

1.03

mmol/l

0.16

1087

6304

Disorders of ocular muscles, binocular movement, accommodation and refraction

4015

29855

1.39

73.15

7.4

6.3

1.06

1.05

mmol/l

1.42

3726

27937

Mental and behavioural disorders due to use of other stimulants, including caffeine

291

969

3.62

72.50

6.6

7.8

1.05

1.02

mmol/l

0.72

280

912

Mantle cell lymphoma, including Hilmo

218

633

5.14

72.28

6.7

5.1

1.10

1.02

mmol/l

3.09

213

578

Smoking dependency

843

4522

2.11

72.01

7.4

6.7

1.05

1.04

mmol/l

0.86

789

4240

Other disorders of veins

3498

25398

1.42

71.90

5.5

1.04

1.03

mmol/l

1.85

3195

23522

Sequelae of injuries, of poisoning and of other consequences of external causes

2004

13401

1.60

71.70

6.2

6.7

1.03

1.04

mmol/l

1.07

1887

12605

Iron deficiency

305

1046

3.44

71.65

5.0

6.9

1.06

1.08

mmol/l

0.94

288

965

Umbilical hernia

2396

16621

1.53

71.58

9.3

6.6

1.06

1.04

mmol/l

3.19

2269

15629

Left ventricular outflow tract obstruction (LVOTO), broad definition

957

5364

2.01

71.22

12.0

7.7

1.11

1.06

mmol/l

4.90

928

5075

Use of pramipexole

1991

13371

1.61

71.18

8.7

5.7

1.07

1.04

mmol/l

6.76

1823

12412

IBD patients in KELA-register

1863

12262

1.62

71.15

6.6

1.03

1.04

mmol/l

2.01

1773

11525

Diseases of the ear and mastoid process

9889

41011

1.24

70.77

6.8

6.2

1.04

1.05

mmol/l

0.87

9259

38315

Malignant neoplasm of other connective and soft tissue, including Hilmo

449

1915

2.83

70.75

7.2

5.7

1.00

1.03

mmol/l

1.26

435

1760

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

522

2375

2.59

70.36

8.3

5.6

1.06

1.04

mmol/l

0.94

497

2168

Unspecified jaundice

534

2452

2.55

70.22

7.0

5.6

1.04

1.05

mmol/l

0.28

512

2280

Somnolence, stupor and coma

478

2102

2.71

69.98

8.0

6.2

1.06

1.05

mmol/l

0.46

456

1954

Degeneration of macula and posterior pole

4473

26439

1.37

69.87

6.6

5.2

1.06

1.03

mmol/l

8.58

4069

24411

Other diseases of blood and blood-forming organs

712

3666

2.25

69.71

6.9

6.2

1.04

mmol/l

0.27

677

3404

Subjective visual disturbances

2213

15195

1.55

69.59

6.1

5.9

1.04

mmol/l

0.21

2065

14134

Other sleep disorders

1004

5710

1.93

69.38

6.6

6.7

1.04

mmol/l

0.13

935

5341

Congenital malformations of heart and great arteries

1187

6891

1.84

69.15

9.7

7.8

1.15

1.10

mmol/l

5.89

1147

6494

Paralytic ileus

432

1833

2.86

69.06

8.1

5.6

1.03

mmol/l

0.10

411

1690

Other diseases of oesophagus

913

5084

2.01

68.87

7.1

5.8

1.04

mmol/l

0.13

866

4697

Sequelae of other external causes

594

2873

2.40

68.53

10.4

6.0

1.07

1.04

mmol/l

1.70

562

2668

Personal history of other diseases and conditions

902

4940

1.98

68.48

10.2

3.8

1.14

1.09

mmol/l

4.57

847

4604

Migraine with aura

1775

11603

1.61

68.22

4.7

6.1

1.04

1.05

mmol/l

0.50

1667

10788

Diseases of spleen

264

894

4.14

68.20

9.5

6.1

1.07

1.02

mmol/l

1.45

250

824

Pericarditis

370

1457

3.03

68.14

13.1

5.3

1.11

1.01

mmol/l

6.83

352

1349

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

767

4076

2.15

68.01

10.8

5.7

1.09

1.04

mmol/l

4.59

719

3781

Cyst of kidney

753

3997

2.19

67.99

11.4

5.5

1.09

1.03

mmol/l

6.30

708

3722

Speech and linguistic disorders

823

4247

2.06

67.71

10.7

8.1

1.15

mmol/l

0.03

784

3997

Leisure time condition

1622

10521

1.66

67.47

7.2

6.2

1.06

1.05

mmol/l

0.41

1515

9821

Organic, including symptomatic, mental disorders

4859

26579

1.35

67.11

5.2

5.9

1.02

1.04

mmol/l

4.77

4467

24639

Shock, not elsewhere classified

157

376

6.33

67.10

14.8

5.1

1.11

1.06

mmol/l

0.77

152

344

Disorders of sclera, cornea, iris and ciliary body

4680

36339

1.34

67.00

8.0

6.1

1.05

1.04

mmol/l

2.94

4399

33918

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

532

2487

2.50

66.91

7.4

5.4

1.05

1.04

mmol/l

0.46

502

2267

ILD-related respiratory insufficiency

428

1868

2.93

66.66

10.6

5.9

1.09

1.04

mmol/l

2.90

405

1721

Crohn's disease NAS

614

3033

2.31

66.20

7.8

6.7

1.04

1.05

mmol/l

0.66

586

2835

Pruritus

1040

6064

1.88

66.18

10.9

5.3

1.10

1.04

mmol/l

7.61

973

5611

Soft tissue disorders related to use, overuse and pressure

2400

16875

1.50

66.16

6.4

5.8

1.04

1.03

mmol/l

1.28

2226

15722

Subarachnoid haemorrhage

966

5545

1.94

65.90

6.4

5.8

0.99

1.04

mmol/l

7.93

902

5118

Carpal tunnel syndrome

5189

35342

1.32

65.90

6.2

5.8

1.05

1.03

mmol/l

8.43

4877

32833

malignant neoplasm of female genital organs, including Hilmo

1387

8287

1.72

65.68

4.7

4.4

1.03

1.04

mmol/l

1.12

1280

7434

Irregular menses

3413

18915

1.40

65.64

6.5

4.9

1.05

mmol/l

0.56

3191

17469

Malignant neoplasm of other and unspecified parts of tongue

212

642

4.69

65.27

6.2

4.6

0.95

1.01

mmol/l

3.29

206

579

Emotional disorders and disorders of social functioning with onset specific to childhood

478

2090

2.54

65.23

9.0

8.3

1.15

1.19

mmol/l

2.52

446

1980

Thyroiditis, ILD-related definition

979

5635

1.90

64.97

6.7

5.6

1.06

1.05

mmol/l

0.87

922

5212

Malignant neoplasm of pancreas

677

3490

2.20

64.89

3.5

5.5

0.98

1.04

mmol/l

5.42

647

3195

Social phobias

646

3225

2.18

64.86

6.4

1.06

mmol/l

0.36

608

3040

Systemic lupus erythematosus

386

1600

2.93

64.86

9.7

5.3

1.08

1.04

mmol/l

1.65

364

1480

Intentional self-harm by sharp object

276

956

3.51

64.77

5.6

6.7

1.07

1.05

mmol/l

0.52

264

899

Primary biliary cholangitis (PBC)

270

939

3.73

64.75

7.4

4.2

1.04

mmol/l

0.02

260

855

Other diseases of lip and oral mucosa

3571

26895

1.39

64.38

6.3

6.0

1.03

1.04

mmol/l

2.29

3359

25080

Unspecified contracted kidney

122

255

9.59

64.25

21.5

5.3

1.18

1.05

mmol/l

3.89

122

235

Inflammatory bowel disease, strict (require KELA)

1863

12533

1.58

64.25

6.6

6.7

1.03

1.04

mmol/l

1.89

1773

11784

Malignant neoplasm of thyroid gland

593

2918

2.30

64.16

5.8

5.4

1.08

1.04

mmol/l

2.98

551

2677

Hepatocellular carcinoma, including Hilmo

344

1362

3.14

64.16

8.1

5.5

1.07

1.03

mmol/l

1.22

328

1260

Focal brain injury

595

2922

2.28

64.14

6.3

6.5

1.01

1.04

mmol/l

1.37

561

2728

Aortic valve malfunction, age under 60 years

868

4878

2.00

64.01

11.7

7.6

1.10

1.04

mmol/l

4.99

839

4610

Migraine without aura

1390

8722

1.68

63.85

6.0

6.5

1.05

1.06

mmol/l

0.77

1301

8115

Rotator cuff syndrome

5318

28890

1.31

63.39

5.9

6.0

1.03

mmol/l

0.48

4991

26940

Familial hypercholesterolemia, with ischemic heart disease

899

5134

1.97

63.37

8.7

5.3

1.09

1.01

mmol/l

9.69

843

4720

Other disorders of bladder

1109

6684

1.83

63.36

6.6

6.2

1.02

1.04

mmol/l

0.83

1030

6241

Symptoms and signs involving speech and voice

2883

21117

1.44

62.95

5.8

1.02

1.04

mmol/l

3.57

2676

19628

Other diseases of upper respiratory tract

9710

42316

1.22

62.86

6.0

6.4

1.04

1.05

mmol/l

3.00

9016

39434

Cholangitis (primary sclerosing, PSC), with reimbursement 202

248

843

3.92

62.53

12.2

7.3

1.09

1.08

mmol/l

0.13

242

788

In situ neoplasms

3475

26220

1.39

62.24

7.7

5.3

1.04

mmol/l

0.21

3238

24170

Superficial injury of lower leg

2200

15393

1.51

61.91

7.2

6.1

1.06

1.05

mmol/l

0.61

2053

14338

Short stature, not elsewhere classified

328

1214

3.36

61.70

15.6

11.6

1.34

1.33

mmol/l

0.39

310

1167

Other or ill-defined heart diseases

482

2219

2.45

61.24

12.4

5.5

1.10

1.01

mmol/l

7.46

449

2059

Other disorders of ear

8068

43135

1.24

61.21

6.4

6.3

1.03

1.05

mmol/l

3.52

7490

40255

Type 1 diabetes, strict definition, subgroup 1

576

2821

2.24

61.13

10.2

7.8

1.10

1.12

mmol/l

0.58

546

2663

Disorders of synovium and tendon

4408

29023

1.33

61.10

6.6

6.0

1.05

1.03

mmol/l

3.53

4127

27058

Idiopathic hypercalciuria

116

242

9.33

60.93

3.0

7.0

0.90

1.03

mmol/l

5.65

108

228

Abdominal aortic aneurysm (AAA)

945

5452

1.89

60.92

7.9

5.2

1.08

1.03

mmol/l

4.61

890

4999

SLE, ICD10

364

1514

2.93

60.92

10.0

5.2

1.08

1.04

mmol/l

2.54

341

1395

SLE, strict definition

364

1514

2.93

60.92

10.0

5.2

1.08

1.04

mmol/l

2.54

341

1395

Other coagulation defects

696

3700

2.12

60.82

9.1

5.9

1.03

1.05

mmol/l

0.88

661

3441

3838

26509

1.37

60.75

7.8

5.4

1.03

1.04

mmol/l

0.35

3560

24376

Other aneurysm

557

2758

2.34

60.61

10.3

5.5

1.06

1.02

mmol/l

2.24

528

2565

Corns and callosities

656

3439

2.18

60.52

13.8

5.4

1.12

1.03

mmol/l

9.21

622

3192

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

139

336

7.10

60.51

8.9

4.6

1.05

1.02

mmol/l

0.64

133

306

Stomatitis and related lesions

1693

11345

1.59

60.23

7.3

6.2

1.06

1.05

mmol/l

0.81

1580

10588

Discitis, unspecified

243

841

3.96

60.21

10.5

6.3

1.11

1.03

mmol/l

2.70

234

778

Schizoaffective disorder

643

3327

2.15

60.14

4.2

6.5

1.04

mmol/l

0.04

593

3126

Injuries to unspecified part of trunk, limb or body region

967

5699

1.88

60.12

9.5

6.4

1.08

1.05

mmol/l

1.68

907

5317

Henoch-Schönlein purpura nephritis (HSPN)

160

14.49

59.80

19.4

6.5

1.20

1.07

mmol/l

2.60

143

Drug-induced adrenocortical insufficiency

253

899

3.82

59.72

10.7

6.4

1.04

1.06

mmol/l

0.61

245

832

Malignant neoplasm of gum, including Hilmo

154

402

5.89

59.43

6.4

4.5

0.94

1.02

mmol/l

3.38

154

364

Type 1 diabetes, strict definition

605

3050

2.17

59.28

10.3

7.7

1.10

1.11

mmol/l

0.54

574

2879

Dissociative [conversion] disorders

339

1360

2.86

58.86

4.4

5.2

1.04

mmol/l

0.21

317

1267

Acquired absence of organs, not elsewhere classified

182

534

4.88

58.84

19.1

4.8

1.11

1.03

mmol/l

2.12

173

494

Unknown and unspecified causes of morbidity

570

2838

2.22

58.62

8.1

5.1

1.04

mmol/l

0.07

551

2626

Oesophagitis

553

2765

2.31

58.58

8.0

6.1

1.03

1.04

mmol/l

0.13

523

2568

Disorders of oesophagus in diseases classified elsewhere

276

1035

3.49

58.41

11.7

5.6

1.08

1.02

mmol/l

1.93

268

949

Pneumonia derived septicemia

395

1746

2.75

58.09

12.3

6.6

1.08

1.06

mmol/l

0.93

378

1627

Amputation of thigh

364

1555

2.88

58.05

16.0

5.1

1.21

1.03

mmol/l

15.01

336

1429

Special screening examination for other diseases and disorders

962

5652

1.82

58.00

10.2

5.1

1.11

1.03

mmol/l

10.09

925

5259

Colon adenocarcinoma

1075

6563

1.79

57.90

5.0

5.6

1.02

1.04

mmol/l

1.13

1013

5985

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

1980

11276

1.53

57.87

5.4

5.9

1.02

1.04

mmol/l

1.56

1865

10357

Myelodysplastic syndrome

186

560

4.67

57.65

7.6

4.7

1.10

1.02

mmol/l

2.54

176

507

Pyogenic arthritis

640

3373

2.14

57.47

11.7

6.1

1.11

1.03

mmol/l

7.76

599

3146

Skin changes due to chronic exposure to nonionizing radiation

3646

25379

1.37

57.39

7.8

5.4

1.03

1.04

mmol/l

0.38

3378

23312

Drug-induced hypoglycaemia without coma

221

744

3.99

56.82

13.8

5.7

1.15

1.04

mmol/l

4.91

209

681

Right hemicolectomy

609

3202

2.21

56.72

8.0

5.5

1.02

1.03

mmol/l

0.21

583

2953

Assault by bodily force

640

3362

2.09

56.68

6.6

7.2

1.03

1.04

mmol/l

0.44

612

3175

Acute suppurative otitis media

1891

12123

1.52

56.47

10.0

6.7

1.10

1.07

mmol/l

5.54

1793

11396

Other disorders of bone

1527

10127

1.60

56.47

7.1

6.0

1.05

1.04

mmol/l

0.47

1435

9488

Chronic hepatitis, not elsewhere classified

364

1566

2.80

56.45

7.9

5.6

1.05

1.03

mmol/l

0.73

349

1448

Faecal incontinence

822

4702

1.93

56.32

5.6

4.6

1.03

1.04

mmol/l

0.46

746

4290

Benign neoplasm: Sigmoid colon

1734

11896

1.57

56.31

7.9

6.1

1.06

1.03

mmol/l

2.11

1641

11073

Other Crohn's disease

599

3097

2.16

56.24

8.5

6.5

1.04

1.05

mmol/l

0.50

574

2899

Leukaemia of unspecified cell type

160

452

5.60

56.17

15.4

5.9

1.11

1.08

mmol/l

0.59

155

415

Sarcoidosis

1134

7092

1.74

55.78

8.5

6.0

1.05

1.03

mmol/l

1.94

1075

6626

Other and unspecified diseases of blood and blood-forming organs

318

1308

3.07

55.61

8.3

5.8

1.05

1.03

mmol/l

0.40

307

1212

Heart failure and hypertrophic cardiomyopathy

257

968

3.65

55.25

11.5

5.9

1.12

1.03

mmol/l

5.02

238

903

Actinic keratosis

3545

24846

1.37

55.06

7.9

5.4

1.04

mmol/l

0.29

3289

22813

Other extrapyramidal and movement disorders in other diseases

2148

15357

1.48

54.75

5.1

6.0

1.03

1.04

mmol/l

1.47

1986

14294

Open wound of ankle and foot

929

5543

1.83

54.70

12.4

6.5

1.12

1.05

mmol/l

9.77

890

5204

Fall on and from stairs and steps

2244

16144

1.47

54.65

5.9

6.1

1.03

1.04

mmol/l

0.60

2075

15045

Other degenerative diseases of the nervous system

2244

11636

1.47

54.49

4.4

5.8

1.01

1.04

mmol/l

4.51

2026

10787

Other disorders of eyelid

3947

29086

1.34

54.48

5.8

5.6

1.04

mmol/l

0.05

3654

26909

Heartburn

934

5567

1.81

54.29

6.0

5.7

1.03

1.04

mmol/l

0.87

860

5163

Pneumonia due to Streptococcus pneumoniae

400

1806

2.56

54.26

9.5

5.5

1.04

1.03

mmol/l

0.39

380

1682

Infections with a predominantly sexual mode of transmission, including avohilmo

2766

18695

1.40

54.26

8.9

6.0

1.04

1.05

mmol/l

0.59

2603

17533

Malignant immunoproliferative diseases

170

516

5.25

54.20

11.1

6.1

1.05

1.04

mmol/l

0.19

165

481

Adenocarcinoma and papillary adenocarcinoma of stomach

312

1270

2.95

54.14

4.6

5.1

0.97

1.02

mmol/l

2.81

304

1151

Urticaria

2342

16950

1.45

54.10

7.0

6.2

1.06

1.05

mmol/l

0.04

2187

15851

Localized swelling, mass and lump of skin and subcutaneous tissue

2704

20066

1.41

54.08

7.2

6.0

1.05

1.04

mmol/l

0.92

2516

18717

Haemorrhoids and perianal venous thrombosis

2806

20748

1.40

54.07

6.0

5.4

1.03

mmol/l

0.15

2593

19217

Inflammatory diseases of the central nervous system

747

4214

1.97

54.06

7.4

6.5

1.04

1.05

mmol/l

0.45

703

3941

Anosmia

147

350

4.50

54.04

5.6

2.1

1.01

0.98

mmol/l

0.63

135

296

Infection of intervertebral disc (pyogenic)

202

672

4.25

54.02

12.5

6.3

1.12

1.04

mmol/l

2.92

191

623

Benign neoplasm: Transverse colon

1039

6454

1.79

53.88

8.7

6.2

1.04

1.03

mmol/l

0.29

990

6017

Lack of expected normal physiological development

267

872

3.30

53.87

16.1

5.7

1.30

mmol/l

0.09

260

828

Renal cell carcinoma of kidney

346

1485

2.79

53.82

9.4

4.7

1.10

1.02

mmol/l

4.23

323

1342

Ulcer of oesophagus

665

3643

2.07

53.80

7.4

6.0

1.03

mmol/l

0.28

620

3375

Acquired absence of limb

152

421

5.28

53.61

24.6

4.9

1.24

1.00

mmol/l

11.06

139

388

Diplopia

1164

7396

1.71

53.60

6.3

6.1

1.03

1.04

mmol/l

0.91

1094

6901

Pain in thoracic spine

1240

7957

1.66

53.30

5.2

6.3

1.03

1.04

mmol/l

0.33

1156

7419

Mental disorders, not otherwise specified

643

3452

2.04

53.27

6.0

6.3

1.06

1.04

mmol/l

0.70

611

3233

Asthma and allergy, excluding more controls

839

4768

1.83

53.23

5.1

4.4

1.07

1.05

mmol/l

0.90

794

4426

Viral warts, including avohilmo

1760

12156

1.53

53.21

12.4

6.3

1.07

1.06

mmol/l

1.14

1671

11385

Necrosis of pulp, including avohilmo

4664

36762

1.29

52.96

6.4

6.6

1.02

1.04

mmol/l

3.34

4371

34535

Gonarthrosis,primary

7840

39545

1.23

52.96

5.1

6.3

1.04

1.03

mmol/l

1.53

7320

36798

Acute and transient psychotic disorders

925

5543

1.81

52.95

5.2

6.6

1.03

mmol/l

0.36

875

5194

Seropositive rheumatoid arthritis

1968

13816

1.49

52.83

5.0

5.3

1.04

1.03

mmol/l

1.11

1844

12710

Other arterial embolism and thrombosis

314

1304

2.93

52.76

15.4

4.8

1.13

1.02

mmol/l

6.50

303

1204

Arterial embolism and thrombosis of lower extremity artery

377

1696

2.64

52.60

8.1

5.1

1.10

1.03

mmol/l

4.22

354

1557

Cramp and spasm

472

2322

2.36

52.33

4.9

6.4

1.03

1.04

mmol/l

0.13

452

2162

Lichen simplex chronicus and prurigo

602

3224

2.11

51.95

10.6

5.8

1.10

1.04

mmol/l

5.17

569

2986

Fall on same level involving ice and snow

4910

39517

1.28

51.89

6.3

6.1

1.04

mmol/l

0.23

4573

36815

Pulmonary oedema

241

895

3.51

51.85

19.2

5.0

1.19

1.04

mmol/l

7.36

233

826

Benign neoplasm: Stomach

899

5438

1.84

51.52

6.7

5.8

1.04

mmol/l

0.04

843

5039

malignant neoplasm of female genital organs

1196

7514

1.67

51.50

4.8

4.3

1.03

1.04

mmol/l

0.92

1103

6735

Suppurative and unspecified otitis media

2638

17283

1.40

51.42

8.7

6.4

1.08

1.06

mmol/l

4.16

2490

16234

Disorders of muscles

884

5284

1.82

51.31

7.0

6.2

1.07

1.04

mmol/l

2.53

849

4940

Malignant neoplasm of small intestine, including Hilmo

328

1410

2.82

51.29

8.6

5.6

1.03

mmol/l

0.05

316

1295

Other specified/unspecified necrotizing vasculopathies

190

626

4.21

51.23

13.7

5.8

1.09

1.04

mmol/l

1.38

180

581

Childhood asthma (age<16), excluding more controls

771

3377

1.87

50.89

7.8

4.9

1.11

1.08

mmol/l

2.10

733

3169

Adenocarcinoma and ductal carcinoma of pancreas

376

1717

2.59

50.68

2.9

5.2

0.96

1.02

mmol/l

3.73

361

1574

Pneumococcal septicemia

374

1714

2.63

50.67

11.6

7.0

1.08

1.06

mmol/l

0.66

357

1598

Oesophageal obstruction

392

1830

2.57

50.64

6.4

5.7

1.02

1.03

mmol/l

0.22

372

1685

Other symptoms and signs involving the circulatory and respiratory systems

596

3187

2.07

50.64

8.8

5.7

1.07

1.04

mmol/l

1.58

548

2964

Small fibre neuropathy

352

1585

2.75

50.51

11.6

6.0

1.07

1.03

mmol/l

1.73

334

1468

Artrosis, including avohilmo

6931

31422

1.24

50.50

5.3

6.8

1.04

1.03

mmol/l

0.56

6457

29406

Meniscus derangement

4468

23547

1.30

49.99

5.4

5.9

1.03

1.02

mmol/l

1.68

4172

21958

Fracture of forearm

4611

33196

1.29

49.95

6.6

5.9

1.05

mmol/l

0.06

4286

30792

Herpesviral [herpes simplex] infections

985

6106

1.75

49.79

10.0

5.8

1.05

mmol/l

0.45

930

5680

Adenocarcinoma and Papillary adenocarcinoma of kidney

167

520

4.63

49.75

16.6

5.8

1.10

1.02

mmol/l

2.26

159

479

Mental retardation, excluding more controls

375

1650

2.55

49.73

9.2

8.2

1.19

mmol/l

0.10

360

1556

Hyperosmolality and hypernatraemia

177

561

4.15

49.70

6.2

5.1

1.01

mmol/l

0.03

171

505

Spondyloarthritis

1413

9470

1.58

49.68

7.3

6.1

1.06

1.04

mmol/l

1.78

1330

8820

Vasculitis limited to skin, not elsewhere classified

305

1294

2.92

49.66

7.4

5.2

1.08

1.04

mmol/l

1.77

291

1194

Convalescence

461

2280

2.28

49.24

7.5

3.6

1.06

1.01

mmol/l

3.61

433

2086

Abscess of anal and rectal regions

712

4054

1.92

49.08

9.3

6.5

1.05

1.04

mmol/l

0.56

677

3805

Primary adrenocortical insufficiency

155

461

4.73

48.97

6.7

5.9

1.07

1.04

mmol/l

0.58

149

422

Diseases of salivary glands

2645

19852

1.39

48.95

6.1

6.0

1.04

mmol/l

0.02

2454

18513

Strabismus

2118

15312

1.45

48.94

7.3

6.6

1.07

1.06

mmol/l

0.49

1983

14302

Speech disturbances, not elsewhere classified

851

5141

1.83

48.70

5.9

6.0

1.01

1.04

mmol/l

2.65

791

4781

Sleep disorders

7460

43120

1.22

48.69

4.9

6.5

1.03

1.04

mmol/l

3.74

6916

40266

Fissure and fistula of anal and rectal regions

1868

13251

1.48

48.62

6.1

5.8

1.04

1.03

mmol/l

1.36

1735

12369

Nontoxic multinodular goitre

1573

10860

1.54

48.48

5.2

5.0

1.05

1.04

mmol/l

1.35

1434

9994

Thyrotoxicosis with diffuse goitre

1072

6808

1.68

48.31

5.0

5.5

1.07

1.04

mmol/l

2.84

1001

6316

Poisoning by narcotics and psychodysleptics [hallucinogens]

179

575

3.88

48.20

6.1

6.8

1.03

1.06

mmol/l

0.70

170

537

Malignant neoplasm of liver and intrahepatic bile ducts

333

1479

2.68

47.98

9.3

5.5

1.07

1.03

mmol/l

1.27

314

1361

Childhood asthma (age<16)

772

3444

1.83

47.98

8.0

5.2

1.11

1.08

mmol/l

1.98

734

3236

2776

18091

1.39

47.82

5.9

5.1

1.06

1.04

mmol/l

3.63

2500

16560

Congenital malformations of cardiac septa

654

3578

2.00

47.73

9.3

8.5

1.18

1.14

mmol/l

2.59

632

3357

Personal history of risk-factors, not elsewhere classified

168

525

4.10

47.72

6.2

4.6

1.05

1.07

mmol/l

0.58

163

488

Cerebral aneurysm, nonruptured

755

4433

1.88

47.64

7.2

6.0

1.03

1.04

mmol/l

0.32

704

4102

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

516

2664

2.11

47.60

7.9

5.0

1.05

1.03

mmol/l

0.98

490

2488

Later onset COPD

2626

15887

1.40

47.45

5.4

5.7

1.06

1.04

mmol/l

2.83

2400

14661

Cardiomyopathy in other diseases

219

7.45

47.40

7.7

4.3

1.12

0.99

mmol/l

4.30

203

Asthma and allergy

839

4927

1.77

47.33

5.1

4.7

1.07

1.06

mmol/l

0.73

794

4575

Mucosal proctocolitis

1003

6309

1.71

47.27

6.0

6.8

1.02

1.04

mmol/l

1.47

958

5917

Lesion of ulnar nerve

1161

7572

1.65

47.23

6.8

6.4

1.05

1.03

mmol/l

1.43

1101

7116

Ovarian dysfunction

484

2441

2.13

47.10

4.6

4.4

1.07

1.05

mmol/l

0.94

461

2243

Schizophrenia

1221

8047

1.62

46.77

4.4

7.0

1.03

mmol/l

0.02

1139

7587

Excessive, frequent and irregular menstruation

2736

10890

1.39

46.75

5.9

5.0

1.06

mmol/l

0.18

2545

10023

Papillary adenocarcinoma of thyroid gland

442

2198

2.27

46.75

6.4

5.5

1.09

1.04

mmol/l

3.03

414

2012

Other and unspecified coagulation defects

453

2276

2.26

46.75

9.5

5.9

1.03

1.05

mmol/l

0.75

430

2119

Spondylolisthesis/Spondylolysis

1502

10348

1.54

46.58

5.3

6.2

1.04

mmol/l

0.21

1404

9640

Crohn's disease of small intestine

579

3158

2.03

46.31

7.8

6.4

1.03

1.04

mmol/l

0.60

558

2950

Carcinoma in situ of skin of other and unspecified parts of face

855

5270

1.81

46.07

9.6

5.2

1.04

mmol/l

0.08

796

4851

Methotrexate

1091

7042

1.66

46.02

4.9

5.3

1.02

1.04

mmol/l

1.89

1031

6520

Melanocytic naevi

2431

18176

1.40

45.95

10.6

6.0

1.06

1.04

mmol/l

2.68

2297

16993

Emotional disorders starting during childhood or adolescence

432

2117

2.26

45.85

9.0

8.7

1.15

1.20

mmol/l

3.01

404

2004

Congenital malformations of gallbladder, bile ducts and liver

164

542

4.65

45.72

27.0

7.7

1.18

1.16

mmol/l

0.38

157

505

Other congenital malformations

732

4298

1.87

45.67

8.8

7.6

1.10

1.11

mmol/l

0.78

699

4043

Other disorders of nervous system

628

3556

1.99

45.60

8.4

6.3

1.06

1.03

mmol/l

1.39

599

3316

Visual impairment including blindness (binocular or monocular)

673

3886

1.93

45.50

10.6

5.5

1.10

1.06

mmol/l

2.75

605

3580

Papulosquamous disorders

3234

25216

1.33

45.45

6.2

1.03

1.04

mmol/l

0.14

3047

23548

Conductive and sensorineural hearing loss

6863

38235

1.22

45.38

6.2

1.03

1.04

mmol/l

1.54

6349

35633

Other disorders of eye and adnexa

1168

7692

1.63

45.32

7.0

6.3

1.05

mmol/l

0.32

1080

7184

Coeliac disease

993

6322

1.69

44.99

7.4

6.3

1.05

1.06

mmol/l

0.41

939

5886

Myeloproliferative diseases (CML excluded)

704

4143

1.90

44.90

5.1

5.8

1.06

1.04

mmol/l

1.74

664

3836

Internal derangement of knee

2914

22162

1.35

44.88

5.7

6.0

1.03

mmol/l

0.02

2676

20703

Other and unspecified disorders of skin and subcutaneous tissue

577

3196

2.03

44.81

9.8

5.3

1.06

1.04

mmol/l

1.02

525

2954

Scoliosis

701

4081

1.87

44.69

5.9

6.2

1.07

1.08

mmol/l

0.21

654

3793

Other abnormalities of plasma proteins

206

768

3.54

44.41

12.2

5.5

1.06

1.03

mmol/l

0.67

199

709

Adverse effects, not elsewhere classified

1521

10588

1.52

44.29

7.6

6.4

1.06

mmol/l

0.06

1458

9882

Hyperaldosteronism

299

1322

2.74

44.07

9.1

5.6

1.04

1.05

mmol/l

0.05

283

1228

Other and unspecified injuries of head

686

4012

1.89

43.96

5.5

6.2

1.05

1.06

mmol/l

0.43

640

3711

Sequelae of injuries of head

491

2599

2.14

43.89

5.5

6.9

0.99

1.04

mmol/l

3.25

459

2441

Disorders of vitreous body and globe

4417

33901

1.28

43.87

9.0

5.7

1.07

1.03

mmol/l

11.44

4098

31530

Psoriasis

2299

17199

1.40

43.75

6.3

6.5

1.04

mmol/l

0.25

2171

16131

Other and unspecified vasculitis limited to skin

270

1150

2.90

43.59

7.7

5.1

1.08

1.04

mmol/l

1.81

258

1057

Abnormal serum enzyme levels

2683

19854

1.37

43.54

7.2

6.8

1.04

1.03

mmol/l

1.10

2556

18673

Barrett oesophagus

494

2642

2.15

43.52

6.3

6.4

1.02

1.03

mmol/l

0.31

459

2470

Encephalopathy

147

460

4.58

43.47

11.1

5.9

1.08

1.05

mmol/l

0.64

141

427

Malignant neoplasm of small intestine

255

1059

2.98

43.40

9.0

5.1

1.03

mmol/l

0.08

245

972

Malignant neoplasm of respiratory system and intrathoracic organs

1718

10140

1.48

43.35

5.0

5.8

1.02

1.04

mmol/l

1.32

1619

9294

Chronic sinusitis

3345

26266

1.32

43.27

6.1

6.3

1.03

1.04

mmol/l

0.57

3140

24558

Hodgkin lymphoma, hilmo

292

1284

2.72

43.22

8.1

6.6

1.03

mmol/l

0.17

281

1200

Paracetamol or NSAID medication

1350

4511

1.57

43.17

6.3

8.3

1.06

1.09

mmol/l

3.45

1257

4202

Dermatitis due to substances taken internally

496

2644

2.10

43.14

9.0

5.8

1.07

1.05

mmol/l

0.63

464

2453

Intentional self-harm by unspecified means

155

491

4.00

43.01

6.0

6.8

1.04

1.06

mmol/l

0.21

150

459

Malignant neoplasm of tonsil and base of tongue, including Hilmo

258

1081

2.92

42.90

5.9

0.98

1.02

mmol/l

2.03

248

996

Other abnormal findings of blood chemistry

461

2417

2.18

42.76

7.2

6.1

1.06

1.03

mmol/l

1.18

444

2243

Other condition

1178

7871

1.60

42.76

9.3

6.6

1.05

mmol/l

0.41

1127

7362

Other and unspecified tonsillitis

2332

14448

1.39

42.69

8.0

6.6

1.06

1.05

mmol/l

0.83

2218

13656

Sulfasalazine

2100

15513

1.41

42.62

5.0

5.6

1.03

mmol/l

0.50

1988

14427

Hyperfunction of pituitary gland

393

1930

2.27

42.54

7.5

5.8

1.03

1.06

mmol/l

1.23

373

1798

Molar incisor enamel hypoplasia

411

1987

2.30

42.37

30.8

7.6

1.27

1.25

mmol/l

0.58

403

1888

Crohn's disease of large intestine

444

2292

2.18

42.34

9.3

6.5

1.04

mmol/l

0.00

423

2150

Covid-19 suspected case

1569

11056

1.49

42.29

8.6

5.8

1.06

1.05

mmol/l

1.29

1482

10323

Extrapyramidal and movement disorders

3312

26166

1.32

42.26

4.8

5.9

1.02

1.04

mmol/l

3.42

3050

24281

Infective dermatitis

958

6151

1.68

42.08

7.3

6.1

1.05

1.04

mmol/l

0.98

895

5732

Benign neoplasm: Ascending colon

1264

8648

1.58

42.04

8.2

6.0

1.05

1.03

mmol/l

1.76

1193

8052

Open wound of forearm

826

5122

1.75

41.88

6.9

6.3

1.05

1.04

mmol/l

0.71

761

4772

Injuries to the neck

1782

12876

1.45

41.87

5.7

6.5

1.04

mmol/l

0.34

1690

12074

Deficiency of other B group vitamins

233

939

3.03

41.80

5.5

5.1

1.04

1.03

mmol/l

0.32

223

854

Systemic lupus erythematosus, unspecified

293

1308

2.66

41.80

9.3

5.2

1.08

1.04

mmol/l

2.12

275

1202

Manic episode

280

1214

2.67

41.80

4.6

6.4

1.04

1.03

mmol/l

0.20

272

1126

Osteonecrosis due to drugs

201

771

3.54

41.76

10.1

5.4

1.04

1.03

mmol/l

0.15

193

709

Eosinophilic disease (BM)

166

557

3.72

41.76

8.2

4.9

1.08

1.03

mmol/l

1.21

157

524

Keratitis

2869

22256

1.34

41.70

8.1

6.1

1.06

1.04

mmol/l

3.25

2680

20812

Menorrhagia

2402

9987

1.39

41.68

5.0

1.05

mmol/l

0.34

2201

9176

Pain associated with micturition

997

6467

1.66

41.68

6.8

5.7

1.04

1.05

mmol/l

0.39

923

6013

Left bundle-branch block

595

3376

1.93

41.66

5.5

5.0

1.07

1.00

mmol/l

5.78

544

3119

Procreative management

2562

16049

1.36

41.57

8.0

7.2

1.07

mmol/l

0.08

2417

15077

malignant neoplasm of male genital organs, including Hilmo

2291

10239

1.40

41.56

6.5

7.2

1.03

mmol/l

0.25

2154

9637

Dermatophytosis

1183

7981

1.59

41.52

9.0

6.4

1.06

1.04

mmol/l

1.61

1109

7472

Diseases of external ear

2976

23238

1.33

41.51

7.5

6.3

1.05

mmol/l

0.27

2727

21732

Hepatocellular carcinoma

250

1047

2.91

41.49

8.3

5.1

1.09

1.02

mmol/l

1.64

235

960

Acute pharyngitis

1124

7368

1.59

41.42

9.1

6.5

1.07

mmol/l

0.05

1059

6939

Allergic purpura

297

1336

2.61

41.33

10.8

5.9

1.09

1.05

mmol/l

1.25

280

1242

Agoraphobia

251

1030

2.73

41.26

5.3

6.0

1.04

mmol/l

0.13

245

972

Sensorineural hearing loss

6535

36732

1.22

41.13

6.1

6.2

1.03

1.04

mmol/l

1.35

6039

34196

Benign neoplasm: Rectum, anus and anal canal

1740

12633

1.46

41.10

6.8

6.1

1.04

1.03

mmol/l

0.83

1627

11765

Disorders of parathyroid gland, other and/or unspecified

112

306

5.71

41.08

11.9

4.5

1.08

1.05

mmol/l

0.36

104

275

Cervical disc disorders

2878

22386

1.34

41.02

5.4

6.3

1.02

1.03

mmol/l

1.57

2703

20924

Other follicular disorders

609

3501

1.90

40.82

11.1

6.3

1.07

1.04

mmol/l

2.36

573

3287

Herpesviral [herpes simplex] infections, including avohilmo

1896

13884

1.42

40.79

7.3

5.6

1.04

mmol/l

0.50

1768

12941

Other and unspecified abdominal hernia

417

2159

2.24

40.66

6.9

5.3

1.05

1.04

mmol/l

0.16

399

2001

Disorders of vitreous body

4268

33109

1.27

40.61

9.1

5.7

1.06

1.03

mmol/l

10.81

3959

30800

Congenital malformations and deformations of the musculoskeletal system

729

4386

1.80

40.59

8.8

7.9

1.12

1.13

mmol/l

0.30

702

4116

malignant neoplasm of male genital organs

2246

10071

1.40

40.59

6.4

7.2

1.03

mmol/l

0.21

2109

9475

Protein-energy malnutrition of moderate and mild degree

154

526

4.41

40.56

10.1

7.7

1.09

1.13

mmol/l

0.66

145

482

Malignant neoplasm of gum

208

7.35

40.44

6.3

4.9

0.95

1.02

mmol/l

1.54

192

Erosion of teeth , including avohilmo

1995

14750

1.41

40.40

10.7

6.4

1.07

1.05

mmol/l

2.46

1875

13849

Tobacco use

477

2570

2.08

40.26

7.5

6.5

1.08

1.03

mmol/l

3.48

452

2400

Diseases of middle ear and mastoid

4402

29278

1.26

40.25

7.9

6.3

1.06

1.05

mmol/l

2.33

4134

27406

Benign neoplasm: Rectum

1563

11196

1.49

40.19

6.8

6.1

1.04

1.03

mmol/l

0.70

1465

10435

Specific development disorders of speech and language

537

2885

1.99

40.17

10.2

8.4

1.16

mmol/l

0.19

510

2703

Benign neoplasm: Adrenal gland

712

4334

1.83

40.08

5.8

6.2

1.03

mmol/l

0.02

664

4031

Mental and behavioural disorders due to cannabinoids

242

993

2.76

40.03

5.0

7.9

1.08

1.03

mmol/l

1.41

230

938

Otitis externa

1835

13448

1.43

39.94

8.2

6.4

1.05

mmol/l

0.19

1704

12609

Osteopathy in diseases classified elsewhere

115

325

5.31

39.89

17.6

6.0

1.10

1.06

mmol/l

0.75

110

300

Disorders of purine and pyrimidine metabolism

206

6.63

39.89

11.3

5.6

1.13

1.04

mmol/l

1.47

189

Nontoxic goitre/thyroid nodule

2323

17661

1.38

39.85

5.1

5.2

1.04

mmol/l

0.07

2129

16245

Inflammatory diseases of female pelvic organs

4495

25067

1.26

39.81

5.2

4.9

1.04

mmol/l

0.38

4123

23042

Malignant neoplasm of rectum, including Hilmo

964

6272

1.65

39.74

4.8

5.9

1.02

1.04

mmol/l

0.99

914

5762

Malignant neoplasm of bone and articular cartilage, including Hilmo

210

831

3.13

39.41

9.8

6.0

1.05

mmol/l

0.02

200

751

Monoamine oxidase A inhibitors

905

5810

1.67

39.38

4.7

6.5

1.03

1.04

mmol/l

0.54

832

5443

Other symptoms and signs involving general sensations and perceptions

411

2132

2.20

39.34

4.5

6.0

1.04

1.06

mmol/l

0.79

383

1976

Other shoulder lesions

767

4735

1.74

39.23

6.1

1.04

1.03

mmol/l

0.12

725

4424

Volvulus

288

1312

2.59

39.07

8.5

5.6

1.03

mmol/l

0.00

272

1204

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

886

5638

1.68

38.97

8.1

7.6

1.11

1.12

mmol/l

0.25

846

5282

Hypoplasia of dental enamel , including avohilmo

384

1881

2.28

38.87

31.1

7.8

1.27

1.25

mmol/l

0.76

377

1787

Portal vein thrombosis

196

760

3.29

38.82

9.2

6.7

1.02

1.05

mmol/l

0.63

186

704

Pregnancy hypertension

2602

17891

1.34

38.72

6.3

5.0

1.06

1.04

mmol/l

4.20

2470

16547

Wide developmental disorders, excluding more controls

267

1131

2.57

38.69

5.2

8.5

1.17

1.23

mmol/l

2.18

251

1069

Nonsuppurative otitis media

1672

10451

1.44

38.60

9.4

6.4

1.09

1.08

mmol/l

1.55

1572

9775

Chronic rhinitis, nasopharyngitis and pharyngitis

2531

19498

1.35

38.60

6.2

6.4

1.03

1.05

mmol/l

1.82

2328

18273

Ovarian cyst

2399

10353

1.37

38.47

5.6

5.0

1.04

1.05

mmol/l

0.38

2209

9530

Type1 diabetes, definitions combined, early onset

508

2801

1.97

38.43

11.5

9.1

1.13

1.14

mmol/l

0.19

484

2657

Septal defects

601

3461

1.90

38.38

8.4

8.9

1.17

1.15

mmol/l

0.88

580

3254

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

2919

19783

1.32

38.35

6.4

5.0

1.06

1.04

mmol/l

4.92

2767

18260

Iridocyclitis

1785

13125

1.43

38.12

7.9

6.1

1.05

1.04

mmol/l

0.82

1692

12271

Acute gastritis

627

3715

1.85

38.11

7.2

5.7

1.04

mmol/l

0.06

587

3431

Injury of intra-abdominal organs

253

1101

2.72

38.09

9.3

6.6

1.04

mmol/l

0.14

246

1029

Event of undetermined intent

544

3097

1.93

38.04

6.8

7.0

1.06

1.05

mmol/l

0.45

528

2901

Emphysema

675

4098

1.81

37.92

6.5

6.2

1.04

1.03

mmol/l

0.31

632

3801

Seronegative rheumatoid arthritis

909

5898

1.65

37.81

4.3

5.6

1.03

mmol/l

0.17

852

5445

Abscess of lung

191

743

3.28

37.62

10.2

6.6

1.04

mmol/l

0.03

182

697

Retinal vascular disorders

1076

7286

1.59

37.44

9.6

5.5

1.07

1.04

mmol/l

4.02

1008

6720

Prurigo nodularis

265

1195

2.68

37.44

11.1

5.3

1.12

1.03

mmol/l

4.00

250

1091

Corticotropin deficiency

123

378

4.63

37.35

5.4

6.7

1.03

1.05

mmol/l

0.33

117

346

Nail disorders

710

4370

1.77

37.32

12.2

6.4

1.09

1.05

mmol/l

3.39

668

4085

Injury of other and unspecified intrathoracic organs

577

3374

1.90

37.30

6.2

6.5

1.02

1.03

mmol/l

0.33

553

3164

1971

13803

1.41

37.24

5.6

4.9

1.06

1.04

mmol/l

2.29

1752

12577

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

223

6.79

37.22

7.0

5.4

1.04

1.02

mmol/l

0.20

203

Diseases of male genital organs

4250

17404

1.27

37.15

8.9

7.6

1.05

mmol/l

0.14

4058

16546

Other disorders of the musculoskeletal system and connective tissue

1227

8524

1.54

37.10

5.4

6.2

1.04

mmol/l

0.43

1152

7934

Retinal vascular occlusion

1058

7157

1.60

37.07

9.7

5.5

1.07

1.04

mmol/l

4.21

990

6602

Atopic dermatitis, strict definition with reimbursement

2101

15190

1.37

37.06

6.9

6.3

1.08

1.06

mmol/l

2.50

1969

14256

Exclusion endpoint for clefts

239

1039

2.85

37.02

12.3

10.0

1.18

1.19

mmol/l

0.29

232

989

Retinal detachments and breaks

2972

23557

1.31

37.00

8.8

5.4

1.05

1.03

mmol/l

5.82

2770

21896

Periapical abscess

3709

30094

1.27

36.91

6.9

6.6

1.04

mmol/l

0.02

3504

28244

Superficial injury of thorax

1230

8534

1.53

36.90

7.6

6.4

1.04

mmol/l

0.06

1159

7962

Infarction of spleen

105

298

5.53

36.72

7.1

5.6

1.08

1.05

mmol/l

0.40

280

Unspecified urinary incontinence

757

4761

1.73

36.66

5.0

1.03

1.05

mmol/l

0.89

662

4370

Anorexia

168

614

3.41

36.63

8.1

6.4

1.06

mmol/l

0.14

156

566

Open wound of abdomen, lower back and pelvis

301

1431

2.43

36.44

6.9

1.07

1.05

mmol/l

0.60

282

1345

Pre-eclampsia or eclampsia

1370

9686

1.48

36.19

6.9

5.0

1.06

1.04

mmol/l

2.96

1289

8960

Other specified congenital malformation syndromes affecting multiple systems

211

882

3.06

36.18

12.5

10.7

1.19

1.21

mmol/l

0.25

204

842

Hepatomegaly and splenomegaly, not elsewhere classified

126

397

4.26

36.11

12.0

5.6

1.08

mmol/l

0.05

126

376

Other mental disorders due to brain damage and dysfunction and to physical disease

1074

7338

1.58

35.93

5.2

5.9

1.01

1.05

mmol/l

3.78

979

6796

Neovascular glaucoma

401

2132

2.15

35.92

13.7

5.6

1.15

1.03

mmol/l

9.17

375

1965

Paget disease

215

6.66

35.89

4.8

5.7

0.99

1.05

mmol/l

1.16

202

Conjunctivitis (acute, non atopic)

2206

16788

1.36

35.84

8.1

6.6

1.06

mmol/l

0.20

2076

15746

Other congenital malformations, including avohilmo

991

6624

1.59

35.74

7.7

7.0

1.08

1.09

mmol/l

0.38

942

6210

Superficial injury of abdomen, lower back and pelvis

1228

8557

1.51

35.72

6.8

6.3

1.05

mmol/l

0.06

1136

7978

Polymyalgia rheumatica

1176

8181

1.54

35.71

4.8

5.3

1.04

mmol/l

0.48

1086

7512

Lesion of lateral popliteal nerve

447

2460

2.04

35.61

7.7

6.2

1.05

1.03

mmol/l

0.50

425

2291

Specific development disorders of scholastic skills

380

1929

2.15

35.53

11.9

8.6

1.16

1.18

mmol/l

0.91

360

1825

Recurrent aphthous stomatitis , including avohilmo

1170

8109

1.53

35.52

7.5

6.1

1.06

mmol/l

0.36

1086

7544

Other specified/unspecified systemic involvement of connective tissue

478

2682

1.98

35.44

6.1

5.5

1.04

mmol/l

0.07

455

2474

Insomnia

7178

42918

1.19

35.43

4.8

6.5

1.03

1.04

mmol/l

5.13

6654

40055

Malignant neoplasm of oropharynx, including Hilmo

215

908

2.88

35.17

6.3

6.0

0.99

1.03

mmol/l

0.85

206

836

Dissection of aorta

315

1554

2.35

34.99

6.9

5.4

1.04

1.02

mmol/l

0.52

299

1447

Other encephalitis

277

1302

2.50

34.94

8.0

6.5

1.04

1.05

mmol/l

0.39

259

1208

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

1202

8378

1.51

34.89

6.5

6.9

1.02

1.04

mmol/l

1.87

1145

7874

Disorders of optic nerve and visual pathways

755

4792

1.70

34.88

8.1

6.5

1.05

1.06

mmol/l

0.70

710

4475

Pneumothorax

606

3653

1.82

34.88

8.1

6.0

1.04

1.03

mmol/l

0.25

573

3408

Other disorders of optic [2nd] nerve and visual pathways

567

3365

1.87

34.87

9.5

6.6

1.05

1.06

mmol/l

0.57

540

3138

Malignant neoplasm of mesothelium and soft tissue

366

1901

2.19

34.85

6.3

5.5

1.06

1.03

mmol/l

0.88

352

1749

Calcinosis cutis

17.02

34.84

33.7

5.5

1.30

1.11

mmol/l

2.45

Autoimmune hyperthyroidism

468

2609

1.95

34.63

5.2

4.8

1.07

1.04

mmol/l

1.55

429

2401

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1326

9420

1.48

34.62

6.5

6.8

1.02

1.04

mmol/l

1.84

1265

8867

Speech therapy

2099

16061

1.37

34.56

7.2

6.0

1.06

1.04

mmol/l

2.23

2004

14913

Crohn disease (strict definition, require KELA, min 2 HDR)

501

2864

1.91

34.41

7.2

6.5

1.04

1.05

mmol/l

0.25

476

2678

Other (seronegative) rheumatoid arthritis, wide

1505

10969

1.45

34.40

5.1

5.6

1.03

1.04

mmol/l

0.19

1406

10151

Idiopathic thrombocytopenic purpura

300

1465

2.40

34.40

8.5

6.4

1.05

1.06

mmol/l

0.07

282

1371

Secondary parkinsonism, excluding more controls

234

1023

2.64

34.39

4.4

5.2

1.00

1.04

mmol/l

1.13

214

944

Cystic disease of liver

106

315

5.05

34.38

21.2

5.8

1.13

1.04

mmol/l

2.04

289

Ulcerative colitis (strict definition, require KELA)

1237

8692

1.50

34.36

6.5

6.9

1.02

1.04

mmol/l

1.96

1176

8174

Follow-up examination after treatment for malignant neoplasms

820

5317

1.65

34.21

5.6

4.7

1.04

1.03

mmol/l

0.31

771

4908

Restless leg syndrome

1150

8013

1.53

34.07

4.8

6.0

1.03

1.04

mmol/l

0.26

1064

7460

Superficial injury of hip and thigh

1270

9002

1.49

33.93

6.7

5.7

1.05

1.04

mmol/l

0.38

1163

8325

Early complications of trauma

410

2231

2.07

33.92

9.0

6.6

1.09

1.04

mmol/l

3.24

378

2075

!Aliquae complicationes praecoces traumatis

410

2231

2.07

33.92

9.0

6.6

1.09

1.04

mmol/l

3.24

378

2075

Follicular lymphoma, hilmo

416

2295

2.10

33.88

6.1

5.8

1.00

1.04

mmol/l

2.12

398

2123

Cervicalgia

1612

11871

1.42

33.87

5.4

6.1

1.04

mmol/l

0.16

1497

11038

Other and unspecified urticaria

1463

10612

1.45

33.82

7.2

6.3

1.06

mmol/l

0.00

1367

9920

Malignant neoplasm of tonsil and base of tongue

213

914

2.83

33.68

5.7

6.1

0.98

1.02

mmol/l

1.98

203

840

Endocrine disorders, other/unspecified

192

781

2.96

33.68

7.3

5.2

1.02

1.04

mmol/l

0.76

182

729

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

457

2500

1.96

33.68

14.5

8.3

1.21

1.20

mmol/l

0.38

438

2379

Background retinopathy and retinal vascular changes

226

995

2.74

33.67

20.0

5.7

1.15

1.02

mmol/l

7.41

216

913

Melanocytic naevi of trunk

967

6528

1.58

33.58

12.7

6.3

1.06

1.04

mmol/l

1.08

917

6113

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

222

970

2.75

33.56

4.4

4.8

1.01

1.02

mmol/l

0.08

209

883

Toxic effects of substances chiefly nonmedicinal as to source

884

5857

1.61

33.48

6.1

6.9

1.05

mmol/l

0.08

838

5496

Olecranon bursitis

555

3311

1.85

33.41

8.2

6.8

1.04

1.03

mmol/l

0.12

516

3135

Assault by sharp object

170

651

3.12

33.39

6.7

7.4

1.07

1.03

mmol/l

0.76

164

617

Malignant neoplasm of breast, including Hilmo

2786

14050

1.31

33.27

3.7

4.7

1.03

1.04

mmol/l

0.61

2552

12741

Glaucoma secondary to other eye disorders

401

2187

2.09

33.27

13.7

6.0

1.15

1.04

mmol/l

8.46

375

2024

Implicit parasitic Sepsis, including avohilmo

232

5.50

33.21

9.2

3.9

1.10

1.02

mmol/l

1.34

209

Overexertion and strenuous or repetitive movements

783

5069

1.66

33.21

6.0

6.6

1.03

1.04

mmol/l

0.14

737

4759

Malignant neoplasm of breast, HER2-negative, including Hilmo

2785

14050

1.31

33.20

3.7

4.7

1.03

1.04

mmol/l

0.60

2551

12741

Other strabismus

1632

12032

1.41

33.17

7.1

6.6

1.07

mmol/l

0.33

1524

11281

Crohn disease (strict definition, require KELA)

503

2911

1.89

33.10

7.2

6.5

1.04

1.05

mmol/l

0.22

478

2722

Benign neoplasm: Small intestine

397

2177

2.12

33.05

8.1

5.7

1.05

1.03

mmol/l

0.33

370

2006

Other abnormal uterine and vaginal bleeding

1671

8851

1.41

33.03

4.6

5.0

1.05

mmol/l

0.15

1509

8119

Blood alcohol or alcohol intoxication level

224

981

2.66

33.03

5.5

7.0

0.98

1.04

mmol/l

2.20

214

923

Benign neoplasm: Descending colon

654

4101

1.77

33.01

8.2

6.2

1.05

1.03

mmol/l

0.51

629

3833

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

531

3123

1.85

32.95

7.2

6.6

1.04

1.05

mmol/l

0.17

501

2924

Pain and other conditions associated with female genital organs and menstrual cycle

1349

8037

1.46

32.80

5.0

5.1

1.05

mmol/l

0.36

1238

7457

Other congenital malformations of the digestive system

439

2458

2.01

32.80

18.0

8.2

1.16

1.17

mmol/l

0.11

422

2299

Rheumatoid arthritis, including avohilmo

2975

23909

1.29

32.63

5.1

5.7

1.04

mmol/l

0.34

2783

22110

Gonococcal infection, including avohilmo

306

1522

2.27

32.59

9.2

5.8

1.00

1.04

mmol/l

2.40

291

1405

Other epidermal thickening

419

2326

2.03

32.59

11.4

5.5

1.09

1.04

mmol/l

3.18

394

2162

Visual field defects

722

4625

1.70

32.58

7.0

6.1

1.03

1.04

mmol/l

0.54

674

4305

Other noninfective disorders of lymphatic vessels and lymph nodes

333

1714

2.21

32.53

8.5

5.5

1.05

1.03

mmol/l

0.37

314

1575

Other autoimmune haemolytic anaemias

159

613

3.43

32.50

8.0

5.5

1.10

1.05

mmol/l

1.05

152

561

Carrier of infectious disease

229

1021

2.61

32.43

10.8

5.8

1.05

1.04

mmol/l

0.27

220

953

Benign neoplasm: Caecum

947

6459

1.59

32.30

7.2

6.1

1.06

1.04

mmol/l

2.13

887

6008

Hypertrophic cardiomyopathy

405

2245

2.07

32.29

10.7

6.6

1.09

1.04

mmol/l

3.21

378

2092

Pre-eclampsia

1244

8826

1.47

32.23

6.8

4.9

1.06

1.04

mmol/l

3.04

1165

8161

Injury of unspecified body region

665

4188

1.73

32.22

9.5

6.3

1.08

1.05

mmol/l

1.25

623

3900

Encephalitis

285

1397

2.37

32.20

7.9

6.5

1.04

1.05

mmol/l

0.26

266

1298

Disease of hard tissues of teeth, NOS

4295

18574

1.24

32.17

5.9

5.0

1.02

1.04

mmol/l

5.41

4013

17202

Respiratory disorders in diseases classified elsewhere

167

660

3.25

32.15

8.8

5.6

1.07

1.04

mmol/l

0.75

162

610

Presence of other devices

1962

14754

1.36

32.13

6.3

4.4

1.04

1.02

mmol/l

1.08

1846

13519

Diffuse brain injury

288

1400

2.28

31.96

5.3

6.1

1.03

mmol/l

0.09

264

1305

Chronic myeloproliferative disease

171

690

3.24

31.93

5.9

5.6

1.10

1.02

mmol/l

3.03

160

632

Malignant neoplasm of other connective and soft tissue

246

1146

2.52

31.79

6.9

5.4

1.04

mmol/l

0.04

238

1045

Acne

701

4405

1.67

31.78

10.8

6.6

1.09

1.08

mmol/l

0.14

667

4134

Adhesive capsulitis of shoulder

1306

9409

1.46

31.78

7.7

5.9

1.06

1.03

mmol/l

3.10

1223

8776

Nonsuppurative otitis media, including avohilmo

2235

14967

1.33

31.73

8.6

6.3

1.08

1.06

mmol/l

2.12

2104

14012

Psoriasis vulgaris

1455

10690

1.43

31.50

7.2

6.7

1.05

1.04

mmol/l

0.95

1375

10035

6-mercaptopurine

284

1384

2.28

31.45

8.8

6.3

1.07

1.08

mmol/l

0.32

270

1303

Rash and other nonspecific skin eruption

789

5189

1.64

31.36

8.1

6.2

1.06

1.05

mmol/l

0.34

749

4820

Orchitis and epididymitis

784

5148

1.64

31.35

9.5

7.4

1.03

1.04

mmol/l

0.04

740

4859

Chronic laryngitis and laryngotracheitis

1111

7810

1.51

31.26

5.8

6.1

1.04

mmol/l

0.07

994

7282

Certain conditions originating in the perinatal period

640

3529

1.72

31.25

12.2

7.6

1.19

1.17

mmol/l

0.80

610

3302

Cardiac murmurs and other cardiac sounds

743

4745

1.65

31.24

8.2

6.4

1.12

1.09

mmol/l

2.31

709

4404

Primary gonarthrosis, bilateral

4426

31074

1.23

31.21

4.7

6.1

1.05

1.03

mmol/l

2.71

4115

28792

Mature T/NK-cell lymphomas, hilmo

165

661

3.22

31.03

10.9

5.9

1.07

1.03

mmol/l

1.07

160

614

Adult respiratory distress syndrome

153

587

3.32

31.01

14.6

5.9

1.08

1.03

mmol/l

1.07

147

547

Crystal arthropathies, rheuma endpoint

216

972

2.70

30.90

8.9

5.4

1.06

1.03

mmol/l

0.53

200

884

Excessive attrition of teeth

4667

38924

1.21

30.89

8.1

6.3

1.04

mmol/l

0.12

4361

36506

Cardiomyopathy, Hypertrophic obstructive

181

746

2.90

30.86

11.8

5.0

1.10

1.00

mmol/l

3.62

167

694

Right bundle-branch block

313

1597

2.19

30.86

6.6

4.8

1.05

1.00

mmol/l

2.14

292

1487

Disorders of refraction and accommodation

2106

16255

1.34

30.82

8.2

6.5

1.07

mmol/l

0.55

1940

15248

Malignant neoplasm of breast

2724

13928

1.30

30.77

3.7

4.7

1.03

1.04

mmol/l

0.66

2497

12628

Intracranial and intraspinal abscess and granuloma

146

552

3.45

30.73

7.8

6.0

1.06

1.03

mmol/l

0.49

135

516

Acne vulgaris

544

3250

1.77

30.68

10.4

6.6

1.09

1.08

mmol/l

0.49

522

3059

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

181

754

2.94

30.67

14.9

8.1

1.14

1.15

mmol/l

0.15

174

714

Seborrhoeic dermatitis

816

5433

1.61

30.56

9.5

6.3

1.05

1.04

mmol/l

0.59

766

5090

Autism spe, excluding more controls

179

719

2.75

30.56

4.9

7.9

1.13

1.18

mmol/l

1.28

169

677

Gonococcal infection

285

1417

2.28

30.56

9.2

5.6

1.00

1.04

mmol/l

1.89

271

1303

Voice disturbances

2076

16114

1.34

30.56

5.7

5.8

1.02

1.04

mmol/l

2.78

1923

15009

Trochanteric bursitis

1143

8107

1.49

30.44

5.4

5.3

1.05

1.03

mmol/l

1.03

1054

7475

Sicca syndrome [Sjögren]

662

4218

1.70

30.34

4.9

5.2

1.04

mmol/l

0.13

611

3878

Appendectomy

4865

39201

1.21

30.27

6.1

6.3

1.03

1.04

mmol/l

3.43

4572

36668

Malignant neoplasm of breast, HER2-negative

2717

13920

1.29

30.25

3.7

4.7

1.03

1.04

mmol/l

0.65

2491

12620

Disorders of conjunctiva

6723

45141

1.18

30.24

6.6

6.3

1.05

mmol/l

0.08

6260

42100

Fall involving bed

347

1874

2.14

30.16

7.3

5.7

1.05

1.06

mmol/l

0.15

325

1726

Polycythaemia vera

305

1568

2.22

30.13

5.5

5.1

1.07

1.02

mmol/l

2.01

291

1433

Acute and subacute iridocyclitis

1444

10665

1.42

30.12

8.3

6.2

1.05

1.04

mmol/l

0.54

1362

9985

Malignant neoplasm of rectum

764

5027

1.63

30.08

4.6

6.0

1.02

1.03

mmol/l

0.85

727

4612

Mouth breathing

3114

25361

1.27

29.89

6.9

7.1

1.04

1.05

mmol/l

0.29

2946

23910

Other ulcerative colitis

457

2656

1.88

29.80

9.0

6.4

1.03

1.04

mmol/l

0.21

441

2482

Bronchiectasis

674

4345

1.69

29.80

7.0

5.8

1.04

mmol/l

0.04

611

4018

Generalized skin eruption due to drugs and medicaments

352

1904

2.09

29.78

9.6

6.0

1.08

1.05

mmol/l

1.00

329

1768

Polyglandular dysfunction

10.89

29.76

15.7

7.3

1.20

1.10

mmol/l

1.17

Hyperplasia of prostate

3040

13815

1.28

29.75

7.7

7.2

1.02

1.03

mmol/l

0.51

2887

13106

Acute generalized exanthematous pustulosis

395

2214

2.00

29.74

9.1

6.0

1.07

1.05

mmol/l

1.12

369

2055

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

201

886

2.70

29.68

20.3

7.4

1.15

1.13

mmol/l

0.37

193

834

Maltreatment syndromes

376

2054

1.99

29.66

5.3

6.9

1.06

1.05

mmol/l

0.09

357

1931

Malignant melanoma, including Hilmo

1286

9349

1.45

29.59

7.2

5.7

1.04

mmol/l

0.08

1209

8582

Migraine without aura and triptan purchases

1057

7392

1.49

29.54

5.4

6.1

1.04

1.05

mmol/l

0.88

985

6910

Polyarteritis nodosa and related conditions

156

618

3.14

29.44

9.8

6.2

1.06

1.07

mmol/l

0.24

148

570

Gangrene, not elsewhere classified

103

327

4.29

29.44

18.4

4.9

1.23

1.03

mmol/l

6.25

299

Pure hyperglyceridaemia

214

968

2.57

29.43

11.3

5.8

1.14

1.02

mmol/l

6.68

196

899

Xerosis cutis

192

839

2.80

29.42

8.4

4.8

1.11

1.04

mmol/l

2.40

180

771

Varicose veins

4903

31415

1.21

29.35

5.7

5.6

1.05

1.03

mmol/l

2.26

4531

29037

762

5061

1.63

29.33

5.2

6.8

1.02

1.03

mmol/l

0.59

719

4739

Other crystal arthropathies

216

996

2.62

29.22

8.9

5.4

1.06

1.03

mmol/l

0.45

200

911

Psoriatic and enteropathic arthropathies

840

5656

1.57

29.22

5.1

6.2

1.03

1.02

mmol/l

0.30

805

5284

Fracture of neck

542

3336

1.79

29.21

6.4

1.04

mmol/l

0.02

509

3109

Fibroblastic disorders

1862

14344

1.35

28.97

6.1

5.9

1.03

mmol/l

0.12

1725

13351

Other/unspecified rheumatoid arthritis

983

6874

1.53

28.86

6.0

5.4

1.04

mmol/l

0.13

911

6313

Idiopathic pulmonary fibrosis

697

4573

1.67

28.80

7.7

5.8

1.04

mmol/l

0.20

649

4243

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

779

5196

1.60

28.79

4.5

6.0

1.02

1.04

mmol/l

0.58

741

4772

Use of anticholinesterases

2077

20353

0.76

28.69

3.5

5.3

1.00

1.05

mmol/l

11.88

1842

18626

N06DA Anticholinesterases

2077

20353

0.76

28.69

3.5

5.3

1.00

1.05

mmol/l

11.88

1842

18626

Ulcerative ileocolitis

324

1718

2.10

28.68

7.9

6.3

1.00

1.03

mmol/l

1.21

309

1611

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

2708

21504

1.28

28.59

6.4

6.5

1.06

1.05

mmol/l

0.13

2518

20205

Biological medication for rheuma

1251

9091

1.44

28.55

5.1

6.9

1.03

1.05

mmol/l

1.23

1197

8542

Essential (haemorrhagic) thrombocythaemia

324

1731

2.11

28.43

4.1

5.1

1.07

1.03

mmol/l

2.34

306

1579

Alcoholic gastritis

159

648

3.03

28.28

5.9

6.9

0.98

1.03

mmol/l

1.58

153

605

Anterior Iridocyclitis

1523

11451

1.39

28.28

8.1

6.3

1.05

1.04

mmol/l

0.47

1437

10699

Carcinoma in situ of skin of trunk

343

1895

2.11

28.14

11.5

5.3

1.04

mmol/l

0.09

329

1745

Anankastic personality disorder

293

1505

2.15

28.11

4.0

6.3

1.05

1.02

mmol/l

0.94

267

1415

Dental pulpitis, including avohilmo

7101

39693

1.17

28.09

6.1

6.6

1.03

1.04

mmol/l

2.10

6731

37183

Trigger finger

1102

7877

1.47

28.00

8.5

5.9

1.06

1.03

mmol/l

3.06

1031

7359

Otitis media, unspecified

837

5216

1.56

27.99

10.2

6.4

1.13

1.11

mmol/l

1.55

789

4881

Spondylopathies in diseases classified elsewhere

152

616

3.15

27.86

8.9

5.6

1.01

1.05

mmol/l

0.64

139

565

Endovascular or surgical operations to intracerebral aneurysms

495

3007

1.80

27.78

7.6

5.9

1.01

1.04

mmol/l

2.79

470

2778

Other osteochondrodysplasias, including avohilmo

142

556

3.24

27.72

7.0

6.8

1.06

1.09

mmol/l

0.84

135

523

Radiculopathy

1248

9129

1.44

27.71

5.4

6.0

1.04

mmol/l

0.27

1166

8484

Toxic effect of other and unspecified substances

134

503

3.23

27.63

4.7

6.5

1.04

mmol/l

0.00

126

473

Striking against or struck by other objects

2546

20445

1.28

27.45

6.7

7.2

1.06

1.05

mmol/l

0.57

2382

19286

Acute laryngitis and tracheitis

799

5286

1.56

27.41

7.6

6.2

1.10

1.08

mmol/l

0.95

749

4962

Malignant neoplasm of bronchus and lung, including Hilmo

1610

10180

1.38

27.39

5.2

5.8

1.02

1.04

mmol/l

1.21

1515

9323

Hemiplegia

423

2471

1.88

27.36

6.9

6.0

1.05

mmol/l

0.06

394

2288

Malignant melanoma

1141

8252

1.45

27.19

7.3

5.8

1.04

mmol/l

0.12

1068

7568

D07AA Corticosteroids, weak (group I)

1121

8067

1.45

26.97

6.2

7.1

1.07

1.08

mmol/l

0.67

1064

7546

Other predominantly sexually transmitted diseases, not elsewhere classified

1047

7436

1.46

26.94

8.9

6.0

1.04

mmol/l

0.13

996

6949

Motor disorders, excluding more controls

173

700

2.82

26.91

16.5

10.1

1.31

1.36

mmol/l

1.01

165

667

Migraine with aura and triptan purchases

1022

7230

1.47

26.90

4.1

6.1

1.04

1.05

mmol/l

0.74

949

6752

Special screening examination for neoplasms

501

3058

1.76

26.90

9.3

5.2

1.05

1.02

mmol/l

0.98

469

2856

Other congenital malformations of the digestive system, including avohilmo

480

2908

1.82

26.90

17.2

8.1

1.16

mmol/l

0.01

461

2723

Colonic or urogenital fistula

2034

16015

1.32

26.71

6.4

1.04

mmol/l

0.61

1896

14998

Gastrojejunal ulcer

136

526

3.17

26.70

10.9

5.4

1.09

1.04

mmol/l

1.02

122

479

Seborrhoeic keratosis

2008

15809

1.32

26.66

11.0

5.2

1.04

1.03

mmol/l

0.46

1886

14638

Other and unspecified psoriasis

565

3587

1.72

26.61

6.8

6.6

1.04

mmol/l

0.02

535

3356

Other bursopathies

1026

7322

1.48

26.58

6.7

6.0

1.05

1.03

mmol/l

1.57

955

6838

Benign neoplasm: Pancreas

281

1482

2.22

26.56

7.2

5.7

1.00

1.03

mmol/l

1.57

271

1369

Pre-eclampsia or poor fetal growth

1757

13468

1.34

26.52

6.8

5.0

1.06

1.04

mmol/l

2.18

1641

12515

Abnormal findings on diagnostic imaging of central nervous system

412

2411

1.88

26.48

6.5

5.9

1.03

1.04

mmol/l

0.70

395

2239

Myositis

248

1244

2.30

26.47

8.2

5.9

1.06

1.04

mmol/l

0.46

241

1151

Hallux valgus (acquired)

2433

13904

1.29

26.47

4.2

5.3

1.03

mmol/l

0.31

2209

12802

Postprocedural musculoskeletal disorders, not elsewhere classified

616

4007

1.68

26.41

5.4

6.0

1.06

1.04

mmol/l

1.16

582

3708

Disorders of tooth development and eruption

1135

6644

1.44

26.35

8.9

4.8

1.07

1.06

mmol/l

0.49

1071

6158

Other benign neoplasms of skin

2953

24272

1.26

26.34

7.9

5.7

1.04

mmol/l

0.10

2712

22518

Behavioural disorders, excluding more controls

157

640

2.74

26.23

6.8

7.2

1.11

1.16

mmol/l

1.37

142

604

Ocular pain

656

4309

1.63

26.09

6.2

6.1

1.03

1.05

mmol/l

1.05

603

4014

Osteogenesis imperfecta

9.82

26.06

9.2

10.3

1.08

1.22

mmol/l

2.44

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

523

3259

1.73

26.06

5.5

6.0

1.02

1.05

mmol/l

0.98

491

3003

Myocardial infarction, with ST-elevation

1441

10907

1.39

26.01

8.3

6.1

1.08

1.04

mmol/l

5.93

1339

10132

Other disorders starting during childhood or adolescence

424

2481

1.84

25.99

15.0

8.9

1.23

1.22

mmol/l

0.23

405

2359

Adenocarcinoma and papilloma adenocarcinoma of rectum

737

4966

1.58

25.96

4.6

6.0

1.02

1.03

mmol/l

0.49

700

4560

Ingrowing nail

436

2610

1.83

25.76

13.4

6.3

1.10

1.06

mmol/l

2.06

410

2439

Other other unspecified disorders of the circulatory system

336

1883

2.02

25.75

8.9

6.0

1.12

1.05

mmol/l

2.94

316

1739

Complications following infusion, transfusion and therapeutic injection

158

671

2.86

25.70

16.9

5.0

1.10

1.06

mmol/l

0.79

150

614

Paraplegia, diplegia of upper limbs

216

1044

2.43

25.66

6.5

6.3

1.07

1.04

mmol/l

0.51

197

967

Drug-induced obesity

318

3.84

25.64

7.0

7.1

1.03

1.06

mmol/l

0.40

288

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

244

4.80

25.59

7.1

6.2

1.04

1.07

mmol/l

0.37

227

Nummular dermatitis

686

4584

1.61

25.54

7.3

6.3

1.05

1.04

mmol/l

0.59

638

4280

Carcinoma in situ of skin of scalp and neck

298

1630

2.15

25.53

12.5

5.5

1.04

1.03

mmol/l

0.14

280

1514

Malignant neoplasm of oropharynx

166

722

2.77

25.53

5.6

6.1

0.99

1.03

mmol/l

0.91

157

664

Use of donepezil

1071

13934

0.70

25.50

3.5

5.1

1.02

1.05

mmol/l

3.42

940

12674

Thiamine deficiency

271

4.61

25.50

6.4

6.1

0.99

1.02

mmol/l

0.52

253

Eosinophilia

167

731

2.76

25.43

9.3

6.6

1.08

1.05

mmol/l

0.86

158

680

Disorders of vestibular function (Vertigo)

3777

31036

1.22

25.31

5.2

5.8

1.03

1.04

mmol/l

1.35

3476

28748

Polycystic ovarian syndrome

307

1641

1.98

25.30

3.8

4.4

1.06

1.05

mmol/l

0.41

291

1505

Degeneration of the brain due to alcohol

233

1173

2.37

25.29

4.3

7.5

0.99

1.03

mmol/l

1.46

222

1103

Malignant neoplasm, without specification of site, including Hilmo

381

2203

1.89

25.26

5.3

4.7

1.06

1.03

mmol/l

0.66

354

1996

Fracture at wrist and hand level

2636

21409

1.26

25.24

6.7

7.0

1.05

1.04

mmol/l

0.21

2483

20124

Algoneurodystrophy

254

1294

2.19

25.22

5.3

5.4

1.07

1.04

mmol/l

1.06

241

1199

Atopic dermatitis, strict definition

1977

15222

1.31

25.18

7.0

6.8

1.09

1.07

mmol/l

2.31

1858

14286

Cervicobrachial syndrome

1580

12114

1.35

25.18

5.0

6.2

1.03

mmol/l

0.20

1478

11283

Malignant neoplasm of tonsil, including Hilmo

170

752

2.71

25.15

5.8

6.0

0.98

1.03

mmol/l

1.55

161

692

Other specified/unspecified bacterial intestinal infections

544

3472

1.70

25.05

8.7

5.7

1.04

mmol/l

0.09

511

3225

Erythema intertrigo

245

1251

2.26

24.99

8.3

5.5

1.07

1.03

mmol/l

1.01

225

1154

Aspergillosis, including avohilmo

112

412

3.57

24.94

13.8

6.2

1.04

mmol/l

0.12

106

390

Hypertrophy of breast in women and men

1332

9988

1.39

24.92

5.0

5.5

1.04

mmol/l

0.04

1240

9269

Degeneration of nervous system due to alcohol

233

1180

2.35

24.90

4.3

7.4

0.99

1.03

mmol/l

1.40

222

1113

Colon adenocarcinoma, helper endpoint

1075

7858

1.45

24.74

5.0

5.9

1.02

1.04

mmol/l

1.17

1013

7275

Hidradenitis suppurativa

278

1466

2.08

24.73

8.4

6.3

1.08

1.04

mmol/l

1.36

261

1376

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

1231

9102

1.40

24.71

8.4

6.0

1.04

1.05

mmol/l

0.16

1166

8512

Varicella [chickenpox]

371

2150

1.89

24.69

13.1

7.9

1.07

mmol/l

0.11

357

2039

Other peripheral vascular diseases

599

3903

1.64

24.67

5.6

5.2

1.05

1.03

mmol/l

1.26

564

3619

Other enthesopathies

2171

17353

1.29

24.67

5.2

5.9

1.03

mmol/l

0.17

2022

16203

Hypermobility syndrome

347

1957

1.91

24.64

4.1

5.7

1.05

1.06

mmol/l

0.13

324

1814

Enthesopathies of lower limb, excluding foot

1658

12835

1.34

24.62

6.2

6.4

1.03

1.04

mmol/l

0.29

1537

11989

Other and unspecified acquired haemolytic anaemias

116

438

3.43

24.50

15.7

6.0

1.12

1.05

mmol/l

1.03

110

404

Otitis externa, unspecified

862

6053

1.51

24.46

8.8

6.6

1.06

mmol/l

0.16

813

5674

Malignant neoplasm of prostate

2074

9701

1.31

24.39

6.2

7.2

1.03

mmol/l

0.26

1937

9121

Ptosis of eyelid

928

6636

1.49

24.35

6.3

6.0

1.03

1.04

mmol/l

0.32

874

6157

Malignant neoplasm of prostate, including Hilmo

2108

9851

1.31

24.35

6.3

7.2

1.03

mmol/l

0.11

1975

9264

Other and unspecified visual disturbances

827

5779

1.52

24.30

6.0

1.04

mmol/l

0.26

783

5364

Ulcerative enterocolitis

257

1337

2.16

24.28

8.2

6.1

1.04

1.03

mmol/l

0.20

252

1243

Spondylopathies (FG)

913

6463

1.48

24.27

5.7

6.3

1.04

1.03

mmol/l

0.41

853

6040

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

291

1581

2.07

24.23

11.9

9.4

1.20

1.18

mmol/l

0.33

280

1498

Injuries to the wrist and hand

8311

49086

1.14

24.14

6.3

1.05

1.04

mmol/l

0.27

7793

45807

Carcinoma in situ of skin of upper limb, including shoulder

274

1487

2.18

24.12

13.1

5.5

1.04

mmol/l

0.11

261

1375

Single delivery by forceps and vacuum extractor

420

4128

0.58

24.12

3.6

6.7

1.04

1.06

mmol/l

1.10

382

3856

Lactose intolerance

237

1195

2.20

24.11

5.2

5.3

1.04

1.06

mmol/l

0.49

218

1102

Moderate visual impairment, binocular

288

1570

2.07

24.00

11.2

5.0

1.13

1.05

mmol/l

3.00

250

1430

Non-small cell lung cancer, including Hilmo

1130

7802

1.42

23.95

4.8

5.7

1.02

1.04

mmol/l

1.78

1070

7133

Malignant neoplasm of larynx, including Hilmo

188

881

2.48

23.90

5.8

5.4

0.98

1.01

mmol/l

0.68

173

805

Complications of other internal prosthetic devices, implants and grafts

357

2073

1.91

23.85

10.5

4.9

1.07

1.04

mmol/l

1.47

341

1887

Malignant neoplasm of ovary, including Hilmo

448

2752

1.76

23.79

4.8

4.7

1.01

1.04

mmol/l

1.48

419

2464

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

117

454

3.40

23.74

6.9

5.6

1.04

mmol/l

0.04

112

414

Artificial joint operation, meniscal resection

7549

42831

1.15

23.72

5.0

6.4

1.04

1.03

mmol/l

0.68

7031

39918

Hypotension due to drugs

163

732

2.73

23.71

6.5

5.5

1.03

mmol/l

0.01

153

677

Acute bronchiolitis

500

2842

1.71

23.70

12.9

8.2

1.24

1.21

mmol/l

1.55

478

2661

Coxarthrosis, primary

5039

36263

1.18

23.68

5.4

6.0

1.05

1.03

mmol/l

2.63

4669

33615

Aspergillosis

108

401

3.53

23.65

14.2

6.3

1.05

1.04

mmol/l

0.21

102

380

Benign neoplasm of meninges

813

5710

1.52

23.53

5.3

5.5

1.03

1.04

mmol/l

0.41

740

5275

Pediculosis, acariasis and other infestations, including avohilmo

1221

9115

1.39

23.52

6.8

1.07

1.06

mmol/l

0.32

1154

8572

Malignant neoplasm of tonsil

150

649

2.78

23.39

5.5

5.9

0.99

1.02

mmol/l

0.98

141

596

Malignant neoplasm of larynx

156

684

2.70

23.37

6.1

5.5

0.98

1.02

mmol/l

0.82

144

632

Follicular cysts of skin and subcutaneous tissue

1366

10398

1.37

23.35

8.4

6.3

1.05

1.04

mmol/l

0.99

1293

9737

Benign neoplasm: Duodenum

254

1354

2.19

23.31

8.1

5.9

1.05

1.03

mmol/l

0.45

235

1252

Other acute viral hepatitis

132

539

2.97

23.29

8.2

6.7

1.04

1.02

mmol/l

0.49

127

506

Superficial injury of ankle and foot

886

6296

1.47

23.20

8.0

6.8

1.07

1.06

mmol/l

0.34

830

5899

Dermatophytosis, including avohilmo

5181

44147

1.17

23.18

5.6

6.4

1.03

1.04

mmol/l

0.97

4798

41396

Malignant melanoma of skin, including Hilmo

1035

7568

1.43

23.12

7.1

5.8

1.03

1.04

mmol/l

0.16

973

6937

Paralytic strabismus

576

3797

1.64

23.09

7.6

6.2

1.06

1.04

mmol/l

0.89

542

3536

Malignant neoplasm of breast, ER-positive, including Hilmo

2111

12548

1.29

23.06

3.4

4.6

1.04

mmol/l

0.44

1945

11352

Somnolence

130

529

2.96

23.01

8.7

6.4

1.08

1.05

mmol/l

0.67

124

492

Scabies, including avohilmo

1021

7436

1.43

23.00

6.6

6.9

1.06

1.07

mmol/l

0.13

968

6990

Mental retardation

378

2247

1.87

22.93

9.2

10.2

1.19

mmol/l

0.04

363

2129

Disorders of speech understanding and production

395

2343

1.83

22.85

9.6

8.1

1.16

1.18

mmol/l

0.64

375

2188

Benign neoplasm of urinary organs

417

2563

1.80

22.85

8.6

5.5

1.06

1.03

mmol/l

1.11

390

2363

Malignant neoplasm of breast, HER-positive

2104

12537

1.29

22.75

3.4

4.6

1.04

mmol/l

0.44

1938

11341

Autoimmune polyglandular failure

15.04

22.73

18.0

7.5

1.24

1.13

mmol/l

0.88

Redundant prepuce, phimosis and paraphimosis

1568

11996

1.33

22.67

8.3

7.7

1.07

1.04

mmol/l

2.85

1488

11417

Melanocytic naevi, other sites/unspecified

628

4216

1.59

22.64

13.7

6.1

1.08

1.04

mmol/l

2.81

606

3935

Car occupant injured in other and unspecified transport accidents

1291

9773

1.37

22.61

7.2

6.4

1.05

1.04

mmol/l

0.54

1234

9141

Single spontaneous delivery

2015

13293

0.78

22.58

4.2

5.5

1.04

1.05

mmol/l

1.11

1836

12141

Malignant neoplasm of other and unspecified parts of biliary tract

158

711

2.65

22.50

4.7

1.01

1.02

mmol/l

0.05

149

642

Other disorders of amino-acid metabolism

188

4.98

22.46

18.0

5.9

1.13

1.10

mmol/l

0.40

171

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

719

4983

1.55

22.45

6.1

6.2

1.02

1.04

mmol/l

1.29

679

4628

Viral encephalitis, not elsewhere classified/unspecified

191

927

2.40

22.41

8.6

6.4

1.01

1.05

mmol/l

1.31

177

858

Reactive arthropathies

628

4219

1.58

22.34

7.6

6.3

1.05

1.03

mmol/l

0.84

589

3948

L04AC Interleukin inhibitors

474

2996

1.70

22.34

5.3

6.6

1.04

mmol/l

0.19

464

2815

Hydrocele

950

6903

1.45

22.34

11.2

7.0

1.06

1.04

mmol/l

0.78

891

6489

Anxious personality disorder

154

676

2.57

22.33

5.4

5.9

1.06

1.04

mmol/l

0.45

142

630

Assault by blunt object

139

589

2.77

22.33

5.4

7.4

1.05

1.04

mmol/l

0.23

132

558

Adenocarcinoma of pancreas

255

1366

2.10

22.32

2.6

5.1

0.98

1.03

mmol/l

1.61

241

1246

Toxic effect of ethanol

301

1688

1.95

22.29

6.8

7.1

1.05

1.04

mmol/l

0.20

290

1589

Post-traumatic wound infection, not elsewhere classified

249

1328

2.12

22.19

9.4

6.5

1.08

1.03

mmol/l

2.11

228

1240

Brain meningioma

374

2237

1.82

22.18

4.8

5.1

1.01

1.03

mmol/l

1.13

343

2028

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

194

952

2.37

22.10

8.6

6.4

1.01

1.05

mmol/l

1.17

180

883

Corneal ulcer

1335

10209

1.36

21.96

8.8

6.3

1.06

1.04

mmol/l

1.64

1258

9573

Brain meningioma, including Hilmo

383

2311

1.80

21.96

5.0

5.2

1.01

1.03

mmol/l

1.23

352

2098

Other nutritional anaemias

108

411

3.22

21.91

8.9

5.4

1.06

1.04

mmol/l

0.23

103

376

Complications peculiar to reattachment and amputation

282

3.91

21.84

17.2

4.9

1.22

1.01

mmol/l

5.48

256

Pediculosis, acariasis and other infestations

465

2949

1.70

21.83

8.9

6.8

1.09

1.04

mmol/l

1.95

436

2769

Other obstetric conditions, not elsewhere classified

1615

7880

1.32

21.81

4.9

5.2

1.04

1.05

mmol/l

0.81

1524

7343

conjunctival haemorrhage

636

4336

1.58

21.77

8.7

6.1

1.03

1.04

mmol/l

0.32

601

4027

Left ventricular outflow tract obstruction, narrow definition

423

2639

1.76

21.74

10.7

8.3

1.13

1.10

mmol/l

1.09

416

2492

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

548

3605

1.63

21.74

6.5

5.5

1.04

1.05

mmol/l

0.09

515

3327

Alcohol induced polyneuropathy

121

497

3.10

21.73

6.8

1.03

1.02

mmol/l

0.12

112

468

Cluster headache, strict

260

1402

2.02

21.62

4.9

6.5

1.02

1.03

mmol/l

0.15

242

1321

Benign neoplasm of mouth and pharynx

833

5961

1.48

21.62

6.5

6.2

1.02

1.04

mmol/l

1.12

773

5563

Hyperhidrosis

224

1146

2.13

21.61

4.5

4.6

1.06

1.05

mmol/l

0.36

208

1063

Benign neoplasm: Pituitary gland, craniopharyngeal duct

410

2536

1.76

21.52

5.4

6.2

1.00

1.04

mmol/l

2.96

397

2354

Other disorders of bone density and structure

213

1083

2.21

21.51

5.7

5.6

1.06

1.04

mmol/l

0.35

200

1010

Oter anti-inflammatory and antirheumatic agents, non-steroids

1901

8288

1.30

21.48

5.1

8.9

1.03

1.05

mmol/l

1.52

1747

7750

Glaucoma

4681

34526

1.18

21.47

6.7

5.8

1.04

mmol/l

1.04

4327

31942

Burns and corrosions

1002

7379

1.42

21.43

6.8

7.2

1.07

1.05

mmol/l

1.12

953

6946

Other inflammation of eyelid

1101

8242

1.40

21.35

6.4

6.0

1.04

1.05

mmol/l

0.00

1007

7668

Carcinoma in situ of skin of lower limb, including hip

223

1175

2.23

21.34

10.9

4.9

1.02

1.03

mmol/l

0.47

211

1071

Benign neoplasm: Kidney

321

1880

1.92

21.30

8.7

5.5

1.05

1.03

mmol/l

1.14

297

1727

Juvenile arthritis (FINNGEN)

326

1892

1.86

21.23

9.7

7.0

1.08

1.11

mmol/l

1.13

312

1765

Disorders of plasma-protein metabolism, not elsewhere classified

242

4.00

21.21

8.1

5.4

1.01

1.04

mmol/l

0.60

224

Monoarthritis, not elsewhere classified

331

1939

1.86

21.19

7.1

6.2

1.07

1.03

mmol/l

1.45

312

1792

Toxic liver disease

149

670

2.63

21.17

10.4

5.5

1.04

mmol/l

0.03

142

627

Other hammer toe(s) (acquired)

1286

8943

1.36

21.11

4.6

5.2

1.04

1.03

mmol/l

0.74

1173

8166

Mental retardation, wide definition

389

2381

1.80

21.10

9.1

9.9

1.19

1.18

mmol/l

0.28

372

2251

Malignant neoplasm of corpus uteri, including Hilmo

653

4484

1.55

21.09

4.7

4.3

1.04

mmol/l

0.26

597

4012

Secondary polycythaemia

219

1141

2.19

21.07

6.6

6.8

1.03

mmol/l

0.05

207

1058

Marasmic kwashiorkor

134

7.78

21.06

17.0

10.0

1.08

1.19

mmol/l

1.58

126

Sequelae of injuries of neck and trunk

253

1379

2.06

20.99

4.8

6.2

1.02

1.03

mmol/l

0.27

244

1296

Systemic sclerosis (FG)

203

1029

2.24

20.92

5.8

5.2

1.05

1.04

mmol/l

0.16

185

934

Papilloedema, unspecified

202

1026

2.24

20.72

10.9

6.3

1.05

1.06

mmol/l

0.18

192

960

Unspecified event, undetermined intent

213

1100

2.18

20.69

8.1

7.0

1.08

1.05

mmol/l

0.51

207

1031

Superficial injury of wrist and hand

1483

11579

1.32

20.68

6.9

1.07

1.06

mmol/l

0.67

1396

10834

Contact with and exposure to communicable diseases

1896

15139

1.28

20.65

8.1

6.5

1.07

mmol/l

0.19

1793

14219

Bullous disorders

482

3140

1.67

20.59

7.1

5.8

1.06

1.04

mmol/l

0.64

455

2907

Abnormal findings in nipple discharge synovial fluid wound secretions

147

667

2.62

20.54

10.4

5.8

1.06

1.05

mmol/l

0.21

141

620

Acne, including avohilmo

1294

7976

1.35

20.54

8.4

6.4

1.09

1.08

mmol/l

0.47

1205

7490

Calculus of lower urinary tract

454

2923

1.70

20.53

6.5

6.7

1.00

1.04

mmol/l

1.97

430

2738

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

170

5.52

20.48

13.2

8.0

1.15

mmol/l

0.03

159

Conjunctivitis

5817

41305

1.15

20.46

6.4

6.2

1.05

mmol/l

0.36

5403

38520

Other forms of systemic lupus erythematosus

330

3.47

20.44

10.3

5.6

1.10

1.05

mmol/l

1.08

299

Temporomandibular joint disorders, including avohilmo

3037

24756

1.21

20.42

4.9

6.0

1.03

1.05

mmol/l

3.06

2805

23106

Mixed specific developmental disorders

236

1182

2.14

20.32

12.1

11.4

1.28

1.32

mmol/l

1.16

228

1128

Other disorders of conjunctiva

1116

8451

1.39

20.25

8.1

6.1

1.03

1.04

mmol/l

0.56

1050

7864

Symptoms and signs involving emotional state

244

1325

2.03

20.18

7.8

6.6

1.05

1.07

mmol/l

0.56

231

1237

Inflammatory disease of uterus

842

6068

1.44

20.16

4.5

5.1

1.05

1.04

mmol/l

0.52

789

5610

Embolic stroke with flimmer

222

1172

2.11

20.13

6.4

4.7

1.07

1.03

mmol/l

1.26

211

1080

Other maltreatment syndromes

228

1210

2.07

20.12

7.1

7.0

1.03

mmol/l

0.01

212

1143

Benign neoplasm: Cerebral meninges

733

5205

1.50

20.08

5.3

5.4

1.03

1.04

mmol/l

0.52

668

4806

Carcinoma in situ of skin

713

5052

1.51

20.06

10.2

5.5

1.04

mmol/l

0.17

675

4679

Other orthopaedic follow-up care

402

2507

1.72

20.03

6.4

3.8

1.04

1.01

mmol/l

1.03

375

2294

Other and unspecified vascular occlusions

761

5443

1.49

20.02

9.7

5.4

1.07

1.03

mmol/l

3.01

708

5018

Dissocial personality disorder

139

618

2.61

20.00

5.7

8.3

1.02

mmol/l

0.04

134

587

Other enthesopathy of foot (+metatarsalgia)

740

5239

1.48

19.99

5.8

5.9

1.03

1.04

mmol/l

0.20

698

4864

Delayed milestone in childhood

244

1235

2.21

19.92

17.8

12.8

1.37

1.36

mmol/l

0.05

235

1183

Scabies

360

2194

1.78

19.89

8.8

6.9

1.09

1.04

mmol/l

1.84

341

2056

Varicella [chickenpox], including avohilmo

419

2653

1.71

19.88

12.8

8.0

1.08

1.10

mmol/l

0.88

403

2518

Viral infections of the central nervous system, including avohilmo

560

3774

1.58

19.85

7.3

6.2

1.02

1.05

mmol/l

2.09

525

3518

Neuralgia and neuritis, unspecified

393

2449

1.73

19.82

6.7

6.1

1.05

1.03

mmol/l

0.56

367

2271

Primary ovarian failure

136

595

2.56

19.80

5.9

4.8

1.08

1.06

mmol/l

0.38

131

545

Other and unspecified injuries of lower leg

563

3795

1.57

19.78

6.8

6.4

1.07

1.06

mmol/l

0.89

537

3536

Malignant neoplasm of other and unspecified urinary organs, including Hilmo

327

3.50

19.78

7.6

5.3

1.04

1.03

mmol/l

0.17

300

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1554

7631

1.31

19.75

4.9

5.2

1.04

1.05

mmol/l

0.52

1467

7108

Other intracranial haemorrhages

286

1653

1.93

19.75

5.9

5.6

1.02

1.04

mmol/l

0.90

273

1532

Other juvenile arthritis

287

1642

1.89

19.72

9.8

7.4

1.08

1.12

mmol/l

1.62

275

1541

Viral infections of the central nervous system

520

3457

1.60

19.71

7.5

6.1

1.02

1.05

mmol/l

1.49

490

3221

Malignant neoplasm of corpus uteri

599

4102

1.55

19.70

4.5

4.3

1.04

1.05

mmol/l

0.25

545

3670

Drug-induced polyneuropathy

114

482

3.11

19.70

13.8

7.1

1.05

1.11

mmol/l

1.52

105

448

Adalimumab

677

4730

1.51

19.68

5.1

6.9

1.03

1.05

mmol/l

1.09

643

4434

Cluster headache, wide

273

1540

1.92

19.66

4.8

6.3

1.02

1.03

mmol/l

0.16

254

1446

Other ill-defined and unspecified causes of mortality

758

5442

1.48

19.60

7.7

5.7

1.07

1.04

mmol/l

1.55

711

5039

Cachexia

214

4.17

19.59

6.5

5.0

1.00

1.03

mmol/l

0.33

197

Tumor necrosis factor alpha inhibitors

1069

8048

1.38

19.58

5.0

6.9

1.03

1.05

mmol/l

1.61

1024

7562

Other disorders of patella

1110

8393

1.37

19.57

5.1

6.0

1.03

mmol/l

0.25

1018

7881

Bell's palsy

863

6307

1.44

19.53

6.7

6.1

1.05

1.04

mmol/l

0.45

796

5887

Delivery

2065

13344

0.79

19.53

4.4

5.5

1.04

1.05

mmol/l

1.08

1884

12186

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1912

15534

1.27

19.38

5.0

5.6

1.04

mmol/l

0.23

1794

14379

Diseases of inner ear

4320

35984

1.17

19.37

5.3

5.9

1.03

1.04

mmol/l

1.53

3992

33393

Seropositive rheumatoid arthritis, wide

1967

16030

1.27

19.35

5.0

5.6

1.04

mmol/l

0.25

1844

14831

Thyrotoxicosis with toxic multinodular goitre

480

3168

1.64

19.26

5.4

5.3

1.04

mmol/l

0.06

438

2900

Metatarsalgia

690

4860

1.49

19.25

5.8

5.9

1.03

1.04

mmol/l

0.29

653

4517

Testicular dysfunction

313

1861

1.84

19.11

9.1

7.4

1.02

mmol/l

0.04

300

1780

Cauda equina syndrome

126

551

2.71

19.10

4.2

5.6

1.05

1.03

mmol/l

0.55

118

509

Other factor of the environment

127

559

2.71

19.09

13.5

5.9

1.12

1.04

mmol/l

1.89

120

514

Abnormal blood-pressure reading, without diagnosis

352

2153

1.76

19.09

7.0

5.5

1.08

1.05

mmol/l

1.01

335

1989

Left hemicolectomy

213

1143

2.15

19.07

7.0

5.7

1.03

mmol/l

0.06

208

1056

Poisoning by medicine, drug-induced

122

526

2.74

19.06

4.2

6.5

0.99

1.02

mmol/l

0.67

113

489

Non-small cell lung cancer

765

5432

1.46

19.05

4.7

5.7

1.02

1.04

mmol/l

1.56

727

4951

Parkinson's disease, excluding more controls

968

6631

1.40

18.97

3.9

5.9

1.00

1.04

mmol/l

5.52

884

6123

Crohn disease (strict definition, all UC cases excluded)

371

2304

1.73

18.96

5.9

6.5

1.04

mmol/l

0.24

355

2156

Lesion of radial nerve

303

1793

1.86

18.95

6.3

5.9

1.06

1.03

mmol/l

1.07

282

1663

Other misadventures during surgical and medical care

217

1170

2.11

18.94

12.8

6.0

1.06

1.03

mmol/l

0.95

204

1089

Other immunodeficiencies

116

494

2.85

18.91

11.4

7.3

1.08

1.10

mmol/l

0.36

111

458

Embolic stroke

386

2432

1.72

18.81

6.5

5.6

1.05

1.04

mmol/l

0.12

366

2243

Bacterial, viral and other infectious agents, including avohilmo

645

4513

1.51

18.79

11.7

7.3

1.07

1.05

mmol/l

1.42

615

4248

Other localized connective tissue disorders

177

892

2.28

18.77

15.6

4.5

1.12

1.04

mmol/l

2.31

167

821

Diseases of tongue

457

2986

1.63

18.73

7.0

4.9

1.02

1.04

mmol/l

1.34

429

2725

Malignant neoplasm of brain, including Hilmo

356

2195

1.75

18.71

5.2

5.9

1.01

1.04

mmol/l

1.49

339

2029

Systemic sclerosis

203

1072

2.14

18.69

5.8

4.9

1.05

1.04

mmol/l

0.12

185

984

Malignant neoplasm of bronchus and lung

1373

8980

1.33

18.69

4.7

5.7

1.03

1.04

mmol/l

0.77

1292

8211

Testicular hypofunction

281

1633

1.89

18.68

9.6

7.4

1.03

1.02

mmol/l

0.03

269

1566

Other/unspecified seropositive rheumatoid arthritis

1940

15848

1.26

18.67

5.0

5.6

1.04

mmol/l

0.24

1818

14661

Abnormality of white blood cells, not elsewhere classified

395

3.13

18.67

9.7

5.9

1.06

mmol/l

0.05

364

Atopic dermatitis

4205

29073

1.17

18.62

5.8

6.2

1.06

1.05

mmol/l

1.73

3899

27227

Hyposplenism

9.87

18.61

11.8

7.7

1.12

1.05

mmol/l

0.60

Other sexually transmitted chlamydial diseases

351

2139

1.72

18.61

10.2

6.3

0.98

1.03

mmol/l

4.91

325

2003

Other/unspecified synovitis and tenosynovitis

811

5910

1.44

18.53

7.0

5.9

1.05

1.04

mmol/l

0.58

765

5502

Bacterial, viral and other infectious agents

602

4171

1.53

18.53

12.1

7.3

1.07

1.04

mmol/l

1.91

575

3925

Other abnormal findings in urine

164

814

2.38

18.50

8.1

5.3

1.04

mmol/l

0.03

157

750

Graves disease, strict definition

684

4846

1.48

18.48

4.0

5.6

1.07

1.04

mmol/l

2.26

644

4494

Hypothermia

177

900

2.28

18.47

7.1

6.4

1.03

mmol/l

0.02

169

838

Kyphosis

136

626

2.58

18.47

7.5

5.9

1.09

1.05

mmol/l

0.64

129

576

Malignant melanoma of skin

839

6164

1.43

18.35

7.3

5.9

1.04

mmol/l

0.16

784

5660

Other/unspecified enthesopathies of lower limb, excluding foot

509

3413

1.58

18.34

5.4

6.6

1.02

1.04

mmol/l

1.04

467

3185

Other and unspecified follicular disorders

323

1960

1.79

18.31

13.5

6.3

1.07

1.03

mmol/l

1.83

306

1841

Other female pelvic inflammatory diseases

1028

7783

1.37

18.26

5.0

4.9

1.03

1.04

mmol/l

0.08

931

7162

Congenital iodine-deficiency syndrome/hypothyroidism

237

1323

1.99

18.25

7.4

4.9

1.07

1.06

mmol/l

0.22

227

1215

Impotence

472

3145

1.62

18.21

11.6

7.4

1.07

1.03

mmol/l

2.68

447

2985

Open wound of wrist and hand

3378

28017

1.19

18.16

6.4

7.0

1.04

mmol/l

0.07

3179

26402

Other diseases of spinal cord

252

1437

1.95

18.15

6.3

6.2

1.03

1.04

mmol/l

0.34

234

1344

Proteinuria and renal glomerular damage; focal glomerulonephritis

23.04

18.11

27.7

6.0

1.15

1.04

mmol/l

1.17

Astigmatism

504

3396

1.59

18.02

10.0

7.1

1.09

1.10

mmol/l

0.41

470

3172

Respiratory conditions due to other external agents

192

1014

2.18

18.02

6.1

4.9

1.08

1.03

mmol/l

1.24

173

926

Follow-up care involving plastic surgery

274

1593

1.87

17.99

5.8

3.6

1.07

1.01

mmol/l

2.31

241

1438

Morphin

200

1063

2.11

17.98

4.7

4.9

1.06

1.02

mmol/l

0.83

188

971

Lactose intolerance, other/unspecified

198

1042

2.08

17.91

5.1

5.3

1.04

1.05

mmol/l

0.36

181

961

Complications of genitourinary prosthetic devices, implants and grafts

208

1120

2.07

17.89

11.1

4.7

1.07

1.03

mmol/l

0.96

196

1013

Other hearing loss

2337

18905

1.23

17.87

6.4

5.7

1.04

1.05

mmol/l

0.78

2145

17391

Dronedarone medication

228

1267

2.01

17.86

3.7

4.5

1.01

0.99

mmol/l

0.52

203

1172

Gonarthrosis, primary, with knee surgery

4790

32853

1.16

17.72

4.5

6.1

1.04

1.03

mmol/l

2.18

4445

30474

Recurrent dislocation of patella

299

1774

1.78

17.68

6.4

6.3

1.10

1.05

mmol/l

2.42

284

1661

Lyme disease, including avohilmo

1729

21217

0.79

17.64

4.4

6.2

1.02

1.04

mmol/l

2.27

1571

19848

Lyme disease

1729

21217

0.79

17.64

4.4

6.2

1.02

1.04

mmol/l

2.27

1571

19848

Psoriatic arthropathies

695

4980

1.46

17.62

5.1

6.1

1.03

1.02

mmol/l

0.27

668

4662

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

215

1180

2.04

17.56

4.1

4.2

1.02

1.04

mmol/l

0.27

204

1056

Impetigo

348

2172

1.73

17.50

9.8

7.1

1.11

mmol/l

0.18

330

2038

Non-small cell lung cancer, adenocarcinoma

463

3087

1.60

17.47

4.4

5.6

1.03

1.04

mmol/l

0.26

440

2819

Intentional self-harm by jumping from a high place

191

4.02

17.46

5.5

6.7

1.04

1.01

mmol/l

0.30

176

Reactive arthropathies, FINNGEN

486

3265

1.58

17.43

7.2

6.3

1.04

1.03

mmol/l

0.40

459

3035

Haemorrhagic disorder due to circulating anticoagulants

145

704

2.45

17.42

7.1

5.6

1.02

1.04

mmol/l

0.28

136

650

Wet age-related macular degeneration

1462

11269

1.30

17.40

5.6

5.0

1.06

1.04

mmol/l

2.47

1331

10248

Ulcerative colitis (strict definition, all Crohn cases excluded)

972

7352

1.37

17.40

5.7

6.9

1.02

1.04

mmol/l

1.55

917

6898

Alzheimer’s disease, strict definition

1506

15107

0.78

17.39

3.6

5.2

1.01

1.05

mmol/l

5.27

1336

13775

Malignant neoplasm of eye, brain and central nervous system

324

1993

1.76

17.31

4.6

6.0

1.01

1.04

mmol/l

1.22

306

1837

Systemic sclerosis, icd10

199

1073

2.09

17.26

5.9

4.9

1.04

1.03

mmol/l

0.21

181

985

Evidence of alcohol involvement determined by blood alcohol level

133

620

2.48

17.24

5.2

7.0

0.97

1.02

mmol/l

1.26

127

583

Open wound of hip and thigh

258

1497

1.88

17.22

7.4

7.0

1.05

1.04

mmol/l

0.16

240

1405

Other and unspecified nerve root and plexus disorders, also in other diseases

1480

11835

1.29

17.20

5.3

6.2

1.04

1.03

mmol/l

0.63

1375

11098

Hypertrophy of breast

1080

8295

1.35

17.19

3.8

5.2

1.04

mmol/l

0.03

998

7666

Chorioretinal inflammation

232

1311

1.96

17.17

9.8

5.4

1.04

1.03

mmol/l

0.41

218

1197

Car occupant injured in noncollision transport accident

264

1541

1.86

17.16

7.8

6.4

1.04

mmol/l

0.04

251

1440

Entropion and trichiasis of eyelid

697

5047

1.47

17.15

6.5

5.7

1.04

mmol/l

0.00

648

4664

Atrial septal defect

334

2079

1.76

17.15

9.7

8.5

1.20

1.16

mmol/l

1.32

324

1952

Congenital malformations of aortic and mitral valves

348

2198

1.73

17.11

10.7

8.0

1.11

1.09

mmol/l

0.68

342

2070

All dysplastic lesions of the vulva

303

1839

1.79

17.09

9.7

4.7

1.08

1.04

mmol/l

1.51

282

1684

Ill-defined and unknown causes of mortality

805

5968

1.43

17.09

7.7

5.8

1.06

1.04

mmol/l

1.40

751

5521

Spirochaetal infections, other/unspecified, including avohilmo

1750

21376

0.80

17.08

4.4

6.2

1.02

1.04

mmol/l

2.16

1591

19995

Sleep disorders, other/unspecified

254

1465

1.87

17.03

6.7

1.07

1.06

mmol/l

0.36

231

1373

Malignant neoplasm of ovary

330

2048

1.74

17.00

4.5

4.6

1.01

1.04

mmol/l

1.16

308

1836

Use of other anti-dementia drugs

1684

16583

0.79

16.85

2.6

5.2

1.00

1.05

mmol/l

9.56

1470

15120

Use of memantine

1684

16583

0.79

16.85

2.6

5.2

1.00

1.05

mmol/l

9.56

1470

15120

Other and unspecified rosacea

650

4651

1.47

16.84

7.9

5.8

1.04

mmol/l

0.04

617

4324

Traction detachment of retina

360

3.08

16.81

23.1

5.8

1.20

1.02

mmol/l

3.92

334

Campylobacter enteritis

223

1254

1.97

16.78

9.9

6.0

1.06

1.03

mmol/l

1.04

212

1162

Congenital malformations of great arteries

229

1295

2.02

16.77

14.1

11.2

1.29

1.26

mmol/l

0.52

224

1231

Injury of eye and orbit

975

7416

1.36

16.73

7.5

7.2

1.06

1.05

mmol/l

0.52

918

6986

Other spirochaetal diseases

1761

21444

0.80

16.68

4.4

6.2

1.02

1.04

mmol/l

2.23

1603

20060

Other chondrocalcinosis

137

665

2.48

16.66

8.2

5.5

1.05

1.04

mmol/l

0.13

130

621

Allergic urticaria

574

4021

1.50

16.64

7.0

6.2

1.07

mmol/l

0.01

536

3749

Malignant neoplasm of other endocrine glands and related structures

8.09

16.62

11.4

5.2

0.97

1.01

mmol/l

0.20

Superficial injury of forearm

709

5150

1.44

16.58

6.4

6.5

1.04

1.06

mmol/l

0.79

667

4800

Family history of malignant neoplasm

688

4962

1.44

16.57

4.5

3.8

1.04

1.02

mmol/l

0.99

640

4583

Benign paroxysmal vertigo

2245

18826

1.23

16.57

5.6

5.7

1.03

1.04

mmol/l

1.37

2073

17448

Other or unspecified common variable immunodeficiency

142

5.05

16.54

7.9

6.8

1.03

1.07

mmol/l

0.56

131

Anuria and oliguria

324

3.26

16.54

19.6

5.9

1.11

1.04

mmol/l

1.02

298

therapeutic use

267

1595

1.86

16.53

8.4

4.8

1.09

1.03

mmol/l

2.75

249

1468

Other disorders of pigmentation

359

2300

1.69

16.47

7.2

5.1

1.05

1.04

mmol/l

0.30

333

2115

Heterophoria

563

3940

1.51

16.44

7.0

6.4

1.06

1.07

mmol/l

0.45

529

3680

Hydrocephalus

596

4234

1.50

16.43

4.9

5.8

1.01

1.05

mmol/l

3.76

558

3904

Blepharochalasis

2251

18908

1.23

16.39

5.2

5.5

1.03

1.04

mmol/l

0.59

2076

17496

Supervision of normal pregnancy

732

5720

0.71

16.34

3.3

5.7

1.04

1.06

mmol/l

0.89

681

5313

Oligomenorrhoea

226

1272

1.91

16.34

6.6

5.3

1.06

1.05

mmol/l

0.20

210

1188

Lifestyle-related condition

115

520

2.63

16.32

14.2

5.7

1.13

1.04

mmol/l

2.21

109

476

Disorders of breast

3300

25064

1.18

16.31

4.4

5.0

1.04

mmol/l

0.64

3032

23031

Patent foramen ovale

215

1223

2.01

16.12

7.8

9.4

1.11

1.15

mmol/l

1.34

204

1163

Dependent personality disorder

165

855

2.18

16.11

6.7

5.4

1.07

1.04

mmol/l

0.88

149

792

Evidence of alcohol involvement determined by level of intoxication

101

432

2.76

16.11

5.5

7.5

0.99

1.05

mmol/l

1.15

407

Malignant neoplasm of brain

254

1495

1.85

16.07

4.5

6.1

1.00

1.04

mmol/l

1.43

243

1377

Other spirochaetal diseases, including avohilmo

1792

21703

0.81

16.07

4.5

6.3

1.02

1.04

mmol/l

2.08

1632

20304

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

1110

8622

1.33

16.06

5.4

5.0

1.04

mmol/l

0.12

1014

7977

Dermatopolymyositis (FG)

127

600

2.46

16.03

8.6

5.3

1.05

1.03

mmol/l

0.34

122

556

Antenatal screening

785

5935

0.72

15.98

4.4

5.7

1.05

1.06

mmol/l

0.81

737

5511

Sequelae of injuries of lower limb

641

4618

1.46

15.90

6.7

6.6

1.04

mmol/l

0.06

603

4326

Central retinal artery occlusion

206

1159

2.02

15.89

10.3

5.5

1.09

1.03

mmol/l

2.12

196

1059

Intermittent heterotropia

430

2874

1.59

15.86

8.9

7.4

1.12

1.14

mmol/l

0.65

400

2693

Other fall from one level to another

1650

13486

1.26

15.68

6.5

7.1

1.06

mmol/l

0.13

1567

12693

Isolated growth hormone deficiency

110

520

2.96

15.67

13.1

14.3

1.33

mmol/l

0.12

104

494

Noninflammatory disorders of female genital tract

2591

10959

1.21

15.67

5.6

5.0

1.07

1.06

mmol/l

0.48

2356

10086

Panhypopituitarism

162

847

2.20

15.67

6.2

6.7

0.99

1.04

mmol/l

1.68

155

788

Coxibs

2237

9782

1.23

15.61

4.0

9.3

1.03

1.06

mmol/l

5.57

2061

9152

Granulomatous disorders of skin and subcutaneous tissue

207

1163

1.97

15.58

11.9

4.9

1.10

1.05

mmol/l

1.74

198

1073

Flat foot [pes planus] (acquired)

672

4895

1.44

15.56

5.5

5.7

1.05

1.04

mmol/l

0.58

624

4528

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

390

2.84

15.55

13.0

6.2

1.08

1.06

mmol/l

0.16

357

Other keratitis

778

5800

1.40

15.49

8.8

6.3

1.06

1.04

mmol/l

1.59

743

5423

Other and unspecified syphilis

134

5.05

15.46

20.6

6.0

0.98

0.99

mmol/l

0.17

123

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

2162

18157

1.22

15.46

5.8

6.6

1.02

1.04

mmol/l

1.59

2037

17006

Benign neoplasm: Other and unspecified parts of small intestine

150

770

2.27

15.44

8.0

5.0

1.03

1.04

mmol/l

0.08

142

701

Phakomatoses, not elsewhere classified

110

500

2.60

15.42

7.8

8.2

1.05

1.09

mmol/l

0.78

104

472

Childhood allergy (age < 16)

808

4952

1.38

15.40

7.6

8.2

1.17

1.15

mmol/l

1.04

768

4646

Giant cell arteritis

354

2310

1.68

15.35

6.5

5.1

1.05

1.04

mmol/l

0.61

335

2114

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

275

1676

1.78

15.33

14.4

7.7

1.17

1.16

mmol/l

0.13

264

1577

Excessive vomiting in pregnancy

454

3077

1.54

15.32

5.0

5.1

1.03

1.05

mmol/l

0.88

419

2828

Hypothyroidism due to medicaments and other exogenous substances

114

527

2.54

15.32

8.4

5.1

1.09

1.06

mmol/l

0.48

109

487

UC patients in KELA-register (code 208), prior to 1994

333

2139

1.69

15.27

7.8

6.2

1.01

1.04

mmol/l

1.34

320

1992

Other disorders of central nervous system

112

513

2.53

15.23

6.0

6.4

1.00

1.07

mmol/l

1.75

103

471

Other prurigo

107

483

2.60

15.18

14.3

5.0

1.06

1.03

mmol/l

0.50

102

441

Specific developmental disorder of motor function

176

938

2.15

15.18

16.3

11.7

1.31

1.33

mmol/l

0.34

168

897

Other and unspecified intracranial injuries

248

1481

1.84

15.13

5.6

6.5

1.04

mmol/l

0.15

233

1374

Myopia

821

6181

1.38

15.10

8.6

6.5

1.08

1.06

mmol/l

1.67

749

5789

Perineal laceration during delivery

473

5525

0.67

15.06

2.8

5.6

1.04

1.05

mmol/l

0.69

447

5144

Hyperprolactinaemia

213

1210

1.89

15.01

7.3

5.7

1.02

1.04

mmol/l

0.63

198

1125

Benign neoplasm: Oesophagus

116

548

2.51

14.92

11.8

5.9

1.05

1.03

mmol/l

0.51

110

502

Maternal care for other conditions predominantly related to pregnancy

1084

8249

1.31

14.87

5.1

5.4

1.05

mmol/l

0.03

1020

7670

Carcinoma in situ of skin of ear and external auricular canal

163

878

2.18

14.82

12.3

5.7

1.02

1.03

mmol/l

0.12

156

814

Hypertrophic disorders of skin

379

2505

1.60

14.74

5.6

5.4

1.07

1.05

mmol/l

0.55

362

2325

Burns classified according to extent of body surface involved

440

2.69

14.70

9.9

7.8

1.02

1.06

mmol/l

0.64

416

Other diseases of gallbladder

344

2240

1.65

14.69

7.2

5.2

1.03

mmol/l

0.01

312

2057

Operations for atrial fibrillation

147

768

2.27

14.68

6.1

6.7

0.99

1.03

mmol/l

0.67

139

715

Neuroendocrine tumor and carcinoma of small intestine

127

623

2.36

14.67

6.7

4.5

1.07

1.02

mmol/l

0.84

122

560

Exposure to other and unspecified inanimate mechanical forces

555

3962

1.48

14.66

8.3

7.0

1.08

1.06

mmol/l

0.91

530

3708

Burns and corrosions of external body surface, specified by site

768

5771

1.39

14.63

6.8

7.2

1.08

1.06

mmol/l

1.25

728

5429

Persistent delusional disorders

540

3840

1.49

14.63

5.1

6.0

1.02

1.04

mmol/l

0.70

495

3568

Malignant neoplasm of breast, ER-negative, including Hilmo

1331

10010

1.28

14.56

4.4

4.5

1.04

mmol/l

0.19

1210

9012

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

143

733

2.23

14.55

5.8

4.1

1.07

1.02

mmol/l

1.07

138

657

Acute appendicitis

5137

42686

1.13

14.51

6.4

1.03

1.04

mmol/l

1.17

4821

39998

Acute lymphadenitis

394

2638

1.58

14.48

10.0

6.2

1.06

mmol/l

0.02

370

2450

Other surgical follow-up care

238

1414

1.81

14.48

8.8

4.1

1.07

1.02

mmol/l

1.88

228

1293

Salpingitis and oophoritis

1108

8748

1.31

14.45

6.0

5.0

1.04

mmol/l

0.17

1017

8060

Hypoplasia of dental enamel, prenatal

248

10.52

14.45

66.7

8.8

1.40

1.46

mmol/l

1.12

237

Perforation of tympanic membrane

711

5299

1.41

14.42

6.8

6.3

1.06

1.05

mmol/l

0.20

657

4942

Other specified and unspecified disorders of eye and adnexa

283

1769

1.73

14.41

8.4

5.7

1.05

1.03

mmol/l

0.52

262

1631

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

500

3445

1.50

14.41

10.6

7.6

1.15

mmol/l

0.16

480

3228

Disorders of orbit

323

2082

1.67

14.40

5.7

5.8

1.04

mmol/l

0.00

299

1926

Retinal haemorrhage

223

1319

1.88

14.38

13.3

5.3

1.13

1.03

mmol/l

4.74

211

1200

Parkinson's disease, strict definition, excluding more controls

880

6286

1.35

14.38

3.8

5.8

1.00

1.04

mmol/l

5.81

801

5805

Pemphigoid

242

1466

1.84

14.37

5.9

5.5

1.06

1.03

mmol/l

0.65

221

1353

Atypical facial pain

368

2440

1.61

14.35

4.3

5.7

1.02

1.04

mmol/l

0.75

333

2252

Postzoster neuralgia

152

804

2.17

14.29

8.9

4.7

1.06

1.03

mmol/l

0.52

142

734

Other disorders of penis

755

5685

1.39

14.29

8.9

7.9

1.06

mmol/l

0.05

716

5400

Autism

189

1054

1.94

14.27

5.1

8.0

1.14

1.16

mmol/l

0.56

177

993

Anogenital herpesviral [herpes simplex] infection

374

2475

1.59

14.26

8.1

5.6

1.04

mmol/l

0.01

359

2305

Disorders of optic nerve, not elsewhere classified

182

1020

2.02

14.23

9.2

5.9

1.07

1.04

mmol/l

0.87

175

946

Social disorders starting during childhood or adolecense, excluding more controls

271

3.08

14.21

10.9

7.7

1.18

1.23

mmol/l

0.67

257

Appendicitis, broad definition

5493

44337

1.13

14.19

6.4

1.03

1.04

mmol/l

1.31

5158

41529

Degenerative macular diseases

920

7143

1.35

14.13

7.6

5.2

1.07

1.03

mmol/l

2.77

846

6577

Ulcerative rectosigmoiditis

543

3881

1.47

14.12

6.8

6.6

1.01

1.04

mmol/l

1.76

515

3630

Rosacea

878

6756

1.35

14.09

8.0

5.8

1.04

mmol/l

0.19

826

6295

Other mycoses, not elsewhere classified/unspecified

191

4.00

14.00

22.8

5.8

1.07

1.04

mmol/l

0.37

179

Other and unspecified glaucoma

560

4055

1.47

13.95

7.3

5.3

1.05

1.04

mmol/l

0.28

516

3730

Spontaneous rupture of synovium and tendon

604

4414

1.44

13.93

6.5

6.2

1.04

1.03

mmol/l

0.36

565

4117

Diseases of appendix

5535

44587

1.12

13.88

6.4

1.03

1.04

mmol/l

1.47

5196

41752

Urethral stricture

447

3111

1.53

13.86

7.9

6.8

1.01

1.03

mmol/l

1.21

419

2940

Dermatopolymyositis

131

664

2.27

13.84

8.4

5.5

1.07

1.05

mmol/l

0.46

126

619

127

622

2.19

13.84

7.9

4.7

1.03

mmol/l

0.01

121

577

Enteropathic arthropathies

173

954

1.99

13.80

5.1

6.6

1.03

1.02

mmol/l

0.16

164

890

Other noninflammatory disorders of vulva and perineum

614

4488

1.42

13.79

7.0

5.0

1.06

1.04

mmol/l

0.92

577

4149

Infection due to other mycobacteria

132

669

2.23

13.77

13.0

3.8

1.06

1.03

mmol/l

0.77

123

595

Polyarthritis, unspecified

272

1702

1.73

13.77

6.9

5.9

1.04

mmol/l

0.02

257

1578

Need for immunization against other single infectious diseases

8.77

13.73

46.1

7.8

1.45

1.22

mmol/l

1.72

Secondary parkinsonism

234

1421

1.82

13.70

4.4

6.1

1.00

1.04

mmol/l

1.05

214

1318

Burns and corrosions of multiple and unspecified body regions

187

1064

1.95

13.68

7.5

1.04

1.05

mmol/l

0.22

175

1010

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

1274

10300

1.28

13.67

6.8

6.9

1.07

1.05

mmol/l

0.59

1217

9650

Lichen simplex chronicus

266

1664

1.74

13.63

9.3

5.6

1.09

1.03

mmol/l

2.40

255

1543

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

1128

9001

1.30

13.62

6.7

6.9

1.07

1.06

mmol/l

0.67

1077

8430

Other retinal artery occlusion

208

1228

1.90

13.61

7.9

5.6

1.05

1.02

mmol/l

1.01

197

1130

Use of biperiden

379

2561

1.58

13.61

4.6

6.3

1.04

1.03

mmol/l

0.20

356

2386

Other specified disorders of muscle

229

1378

1.81

13.59

6.9

6.2

1.10

1.04

mmol/l

2.30

220

1279

Other specified/unspecified soft tissue disorders

350

2322

1.61

13.58

6.0

5.2

1.04

mmol/l

0.00

330

2130

Serous carcinoma of ovary, including Hilmo

233

1408

1.80

13.57

4.5

1.02

1.04

mmol/l

0.60

218

1256

Disorders of myoneural junction and muscle in diseases classified elsewhere

343

2.87

13.53

11.8

5.1

1.05

1.04

mmol/l

0.16

310

Alzheimer disease

2097

17637

0.83

13.52

3.7

5.2

1.02

1.05

mmol/l

2.98

1850

16112

Use of antiglaucoma preparations and miotics

613

4523

1.43

13.51

8.6

5.2

1.08

1.04

mmol/l

2.74

565

4144

Hypertrichosis

139

713

2.11

13.51

5.2

5.1

1.04

1.05

mmol/l

0.30

130

653

Alzheimer disease, including avohilmo

2436

19597

0.84

13.43

3.7

5.3

1.02

1.04

mmol/l

4.42

2169

17941

Postmenopausal bleeding

1878

8196

1.23

13.41

4.3

5.0

1.04

1.05

mmol/l

0.48

1712

7511

Anomalies of dental arch relationship, including avohilmo

1306

9562

1.27

13.37

8.6

6.4

1.10

1.08

mmol/l

2.04

1209

8955

Diabetes mellitus in pregnancy

1640

8569

1.24

13.34

6.3

5.4

1.05

mmol/l

0.23

1548

7971

Acetic acid derivatives and related substances

2197

9591

1.21

13.30

4.9

9.3

1.04

1.06

mmol/l

2.51

2039

8969

Hypertrophic scar

344

2279

1.60

13.30

5.6

5.4

1.06

1.05

mmol/l

0.41

330

2116

Other injuries of upper limb, level unspecified

113

550

2.37

13.29

8.7

6.7

1.09

1.04

mmol/l

0.82

105

514

Other and/or unspecified nontoxic goitre

568

4144

1.44

13.28

4.6

5.3

1.02

1.04

mmol/l

0.57

528

3815

Crossbite

547

3646

1.46

13.27

14.1

8.0

1.19

1.16

mmol/l

1.44

514

3451

Unspecific neurodegenerative disorder

2809

22100

0.85

13.26

3.7

5.5

1.01

1.04

mmol/l

8.19

2500

20331

Wide developmental disorders

268

1678

1.71

13.24

5.2

9.8

1.18

1.22

mmol/l

1.61

252

1593

Alzheimer’s disease (Late onset)

1425

14234

0.80

13.23

3.6

5.1

1.01

1.05

mmol/l

5.50

1259

12971

Other and unspecified mononeuropathies, also in other diseases

235

1438

1.79

13.22

7.9

5.7

1.11

1.03

mmol/l

2.51

213

1326

Postprocedural disorders of nervous system

416

2860

1.52

13.22

4.7

5.8

1.04

mmol/l

0.18

390

2677

Dementia in Alzheimer disease

1022

10736

0.77

13.14

3.7

5.3

1.02

1.05

mmol/l

3.29

866

9804

Corneal scars and opacities

227

1381

1.81

13.09

11.6

5.9

1.09

1.04

mmol/l

1.88

211

1277

Pilonidal cyst

513

3671

1.45

13.07

8.5

6.8

1.06

1.03

mmol/l

1.67

485

3468

Injuries involving multiple body regions

274

1738

1.69

13.06

7.2

6.2

1.02

1.04

mmol/l

0.42

261

1616

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

118

577

2.22

13.05

6.6

5.1

1.01

1.04

mmol/l

0.76

112

535

Problems related to social environment

214

1275

1.82

13.03

5.9

5.4

1.08

1.04

mmol/l

1.35

202

1178

Rhabdomyosarcoma, including Hilmo

6.70

13.03

13.1

9.6

1.09

1.24

mmol/l

1.50

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

255

1591

1.73

13.02

6.1

6.6

1.03

1.05

mmol/l

0.38

241

1489

Ankylosing spondylitis

571

4172

1.43

13.01

6.0

7.0

1.03

1.04

mmol/l

0.31

538

3934

Personal history of certain other diseases

122

606

2.19

12.99

7.4

3.6

1.07

1.06

mmol/l

0.13

115

565

Open wound of shoulder and upper arm

160

880

2.01

12.98

7.5

6.8

1.06

1.03

mmol/l

0.62

153

825

Personal history of malignant neoplasm

561

4094

1.43

12.95

7.1

3.9

1.07

1.04

mmol/l

1.94

522

3757

Conduct disorder

158

863

2.00

12.92

6.7

8.5

1.11

1.14

mmol/l

0.68

143

819

Cervicocranial syndrome

722

5471

1.37

12.92

5.1

6.1

1.02

1.04

mmol/l

1.23

693

5086

107

516

2.38

12.87

7.3

6.1

1.05

1.02

mmol/l

0.49

475

Secondary parkinsonism+Parkinsonism in other disease

237

1468

1.78

12.86

4.3

6.0

1.00

1.04

mmol/l

1.02

217

1365

Infection due to other mycobacteria, including avohilmo

136

713

2.13

12.85

12.7

3.9

1.06

1.03

mmol/l

0.66

127

636

Seronegative juvenile rheumatoid arthritis

136

711

2.12

12.81

6.9

7.8

1.06

1.14

mmol/l

2.84

131

665

Endometriosis

2070

10157

1.21

12.80

4.6

5.0

1.04

1.05

mmol/l

1.27

1907

9339

Other sexually transmitted chlamydial diseases, including avohilmo

519

3722

1.44

12.79

8.7

6.1

1.00

1.05

mmol/l

5.62

482

3487

Other nonthrombocytopenic purpura

435

2.57

12.77

9.0

5.7

1.08

1.05

mmol/l

0.47

401

Other disorders of iris and ciliary body

227

1392

1.79

12.70

12.8

6.1

1.11

1.03

mmol/l

3.08

211

1285

Other congenital malformations of heart

377

2.81

12.69

16.7

10.6

1.29

1.23

mmol/l

0.89

352

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

129

664

2.15

12.67

6.5

6.1

1.13

1.09

mmol/l

0.62

123

619

Other otitis externa (chronic)

486

3486

1.47

12.66

7.6

6.0

1.05

mmol/l

0.09

448

3253

Alzheimer disease, excluding more controls

1294

6785

1.27

12.66

4.0

5.7

1.01

1.04

mmol/l

3.59

1149

6247

Prolonged pregnancy

438

5303

0.69

12.65

3.2

5.9

1.03

1.05

mmol/l

0.65

412

4960

Striae atrophicae

412

2.52

12.63

6.9

4.7

1.06

1.03

mmol/l

0.40

379

Dislocation, sprain and strain of joints and ligaments at neck level

962

7585

1.31

12.62

5.3

6.4

1.04

mmol/l

0.08

915

7099

Atrophic disorders of skin

1061

8477

1.29

12.61

5.8

4.8

1.03

1.04

mmol/l

0.22

989

7807

Other primary thrombocytopenia

173

3.83

12.60

6.1

6.5

1.07

mmol/l

0.01

156

Conjunctivitis (acute, non atopic), including avohilmo

8107

45022

1.10

12.58

6.5

6.4

1.04

mmol/l

0.17

7571

42092

Malignant neoplasm of anus and anal canal, including Hilmo

109

535

2.34

12.56

6.6

4.7

1.03

mmol/l

0.04

104

482

Unspecified visual impairment (binocular)

143

774

2.10

12.56

8.7

6.3

1.08

1.09

mmol/l

0.11

133

712

Other disorders of binocular movement

163

910

1.96

12.52

5.2

6.2

1.06

1.08

mmol/l

0.45

155

846

Other neurotic disorders

339

2279

1.59

12.48

4.6

5.7

1.06

1.03

mmol/l

0.96

308

2107

Bronchitis, not specified as acute or chronic

586

4333

1.41

12.46

7.8

6.3

1.05

1.03

mmol/l

0.92

541

4032

Thyrotropin deficiency

429

2.49

12.45

5.5

5.8

1.05

1.04

mmol/l

0.20

397

Unspecified/other endometriosis

496

3476

1.44

12.44

4.8

5.2

1.03

1.04

mmol/l

0.42

456

3229

Other specified/unspecified spondylopathies

203

1216

1.84

12.44

5.6

5.5

1.08

1.04

mmol/l

1.44

190

1117

Residual foreign body in soft tissue

362

2463

1.56

12.42

5.6

6.7

1.04

1.05

mmol/l

0.21

339

2313

Oxicams

1857

8854

1.22

12.40

4.5

9.2

1.03

1.05

mmol/l

3.03

1721

8292

Asthma and opportunity respiratory infection

366

2515

1.57

12.39

6.7

5.4

1.05

1.04

mmol/l

0.71

339

2314

Benign neoplasm: Liver

179

1034

1.90

12.37

6.9

5.4

1.03

1.02

mmol/l

0.11

164

962

Vasomotor and allergic rhinitis

2559

21673

1.17

12.22

5.5

6.7

1.06

mmol/l

0.15

2363

20338

Plantar fascial fibromatosis

656

4950

1.38

12.15

4.9

5.9

1.02

1.03

mmol/l

1.07

596

4616

Infective bursitis

231

1440

1.75

12.13

8.7

6.9

1.09

1.03

mmol/l

1.66

219

1348

Exfoliative dermatitis

102

497

2.39

12.13

8.9

6.3

1.07

1.04

mmol/l

0.51

457

Wilms' tumor, including Hilmo

276

3.05

12.09

13.2

6.6

1.19

1.10

mmol/l

1.12

252

Acute drug-induced interstitial lung disorder

363

2.73

12.09

6.9

4.9

1.10

1.04

mmol/l

0.70

332

Malignant neoplasm of breast, HER-negative

1213

9478

1.26

12.04

4.4

1.04

mmol/l

0.13

1102

8526

Chromosomal abnormalities, not elsewhere classified

192

1147

1.87

12.00

7.2

10.8

1.18

1.23

mmol/l

1.27

184

1090

LSIL lesion of the vulva

192

1139

1.83

11.95

9.5

4.6

1.07

1.04

mmol/l

0.91

181

1035

Benign neoplasm: Liver/bile ducts

196

1172

1.82

11.95

7.4

5.6

1.03

mmol/l

0.11

180

1086

Anoxic brain damage

124

651

2.18

11.94

6.8

6.5

1.09

1.04

mmol/l

1.08

116

604

Impingement syndrome of shoulder

1661

13970

1.22

11.93

5.9

6.2

1.04

1.03

mmol/l

1.07

1556

13095

Other diseases of peritoneum

320

2151

1.59

11.90

6.7

5.1

1.06

1.03

mmol/l

0.77

306

1979

Motor disorders

176

1036

1.96

11.90

16.3

12.6

1.31

1.33

mmol/l

0.41

168

995

Ectropion of eyelid

332

2255

1.58

11.84

7.0

5.4

1.05

1.04

mmol/l

0.18

301

2073

Malignant neoplasm of nasal cavity and sinuses, including Hilmo

413

2.49

11.83

3.9

4.6

0.97

1.01

mmol/l

0.72

371

Sequelae of injuries of upper limb

662

5030

1.37

11.81

6.5

6.7

1.04

mmol/l

0.03

625

4707

Hirsutism in women

118

600

2.13

11.80

4.6

5.3

1.03

1.05

mmol/l

0.39

109

550

Optic atrophy

155

879

1.99

11.74

7.0

6.3

1.01

1.08

mmol/l

1.97

146

821

Temporal arteritis

298

1991

1.63

11.71

6.6

5.0

1.06

1.04

mmol/l

0.49

280

1818

Juvenile rheumatoid arthirtis

144

787

1.98

11.71

7.5

6.6

1.04

1.05

mmol/l

0.23

138

730

Hereditary hypogammaglobulinemia

131

4.08

11.65

12.6

8.9

1.10

1.11

mmol/l

0.04

120

Non-neuropathic heredofamilial amyloidosis

8.45

11.59

13.3

4.8

1.18

1.08

mmol/l

0.76

Brachial plexus disorders

557

4127

1.40

11.58

4.0

6.0

1.01

1.03

mmol/l

1.15

535

3857

Guillain-Barre syndrome

137

750

2.06

11.58

7.3

6.1

1.02

1.03

mmol/l

0.17

129

700

Superficial injury of shoulder and upper arm

834

6547

1.32

11.57

5.8

6.5

1.04

mmol/l

0.16

782

6114

131

698

2.04

11.57

12.2

5.6

1.17

1.18

mmol/l

0.21

124

650

Meralgia paraesthetica

254

1635

1.68

11.55

4.4

6.3

1.03

mmol/l

0.02

242

1516

Behavioural disorders

157

888

1.92

11.55

6.8

8.7

1.11

1.14

mmol/l

0.70

142

837

Other and unspecified epidermal thickening

206

1262

1.78

11.54

15.0

5.6

1.09

1.05

mmol/l

1.50

199

1166

Other proliferative retinopathy

186

3.41

11.48

23.5

6.6

1.19

1.03

mmol/l

2.22

171

Other and unspecified haemorrhagic conditions

131

708

2.08

11.44

9.8

6.0

1.08

1.06

mmol/l

0.37

125

657

Other and unspecified mental retardation

181

1086

1.91

11.38

7.5

11.6

1.23

1.27

mmol/l

0.91

174

1034

Synovial cyst of popliteal space [Baker]

522

3857

1.42

11.34

5.4

5.9

1.03

mmol/l

0.00

481

3579

Hyphaema and other vascular disorders of iris and ciliary body

174

1028

1.88

11.32

14.8

5.6

1.13

1.02

mmol/l

4.86

164

948

Hypermetropia

535

3970

1.41

11.29

10.2

6.9

1.09

1.11

mmol/l

0.57

496

3704

Other specified and unspecified retinal disorders

278

1841

1.63

11.26

11.7

5.6

1.05

1.03

mmol/l

0.63

263

1697

Sixth [abducent] nerve palsy

267

1756

1.65

11.24

6.4

6.2

1.05

1.04

mmol/l

0.18

248

1629

Dislocation, sprain and strain of joints and ligaments of thorax

254

1643

1.66

11.23

6.0

6.3

1.02

1.04

mmol/l

0.49

245

1524

Communicating hydrocephalus

177

1055

1.86

11.22

5.5

6.3

1.00

1.07

mmol/l

2.57

170

974

Immunodeficiency associated with other major defects

139

4.38

11.17

11.4

8.7

1.17

mmol/l

0.02

131

Other and unspecified acne

105

526

2.21

11.17

18.1

6.5

1.09

1.07

mmol/l

0.20

100

500

Delivery, wide proxy

1779

11122

0.83

11.16

4.2

5.3

1.05

1.06

mmol/l

0.82

1623

10120

Blindness, monocular

432

2.43

11.14

12.3

5.1

1.08

1.05

mmol/l

0.45

395

Cutaneous lupus erythematosus

184

1107

1.82

11.12

6.2

4.7

1.04

1.03

mmol/l

0.09

178

1011

Artificial joint re-operation

533

3982

1.42

11.11

6.3

5.6

1.08

1.04

mmol/l

3.02

498

3668

Other erythematous conditions

273

1805

1.63

11.10

7.7

5.7

1.05

mmol/l

0.16

258

1663

Other inflammation of eyelid, including avohilmo

3116

27570

1.15

11.10

5.7

6.1

1.04

1.05

mmol/l

0.65

2875

25808

Acquired pure red cell aplasia [erythroblastopenia]

186

3.46

11.05

12.8

5.7

1.09

mmol/l

0.02

169

Malignant neoplasm, without specification of site

237

1514

1.68

11.03

5.5

4.5

1.04

1.03

mmol/l

0.20

215

1370

Congenital malformations of pulmonary and tricuspid valves

428

2.54

11.02

18.3

11.8

1.30

1.27

mmol/l

0.50

401

Other disorders of cornea

687

5307

1.35

10.98

7.1

6.1

1.04

mmol/l

0.00

626

4940

Achalasia of cardia

145

820

1.97

10.97

4.7

6.0

1.03

mmol/l

0.08

137

747

Bruxism

131

713

2.01

10.96

7.6

5.6

1.03

mmol/l

0.03

118

665

Other specified/unspecified inflammatory spondylopathies

284

1884

1.59

10.91

5.1

6.3

1.04

mmol/l

0.01

265

1772

Inguinal hernia

4511

27047

1.12

10.88

7.5

6.7

1.03

1.04

mmol/l

1.46

4268

25340

Malignant neoplasm of cervix uteri, including Hilmo

159

918

1.87

10.87

7.1

4.2

1.04

1.03

mmol/l

0.10

150

831

Other salmonella infections

255

1664

1.64

10.86

7.9

5.1

1.05

1.03

mmol/l

0.42

236

1530

Other/unspecified crystal arthropathies

330

2.75

10.86

10.7

4.9

1.05

1.03

mmol/l

0.17

301

Meningitis

342

2371

1.53

10.83

6.7

6.2

1.01

1.04

mmol/l

0.91

328

2209

Dermatographic urticaria

423

3038

1.46

10.80

5.2

5.6

1.02

1.04

mmol/l

0.98

401

2832

Abscess of external ear

108

557

2.17

10.78

8.9

6.2

1.06

1.05

mmol/l

0.19

102

522

Malignant neoplasm of other and unspecified female genital organs

126

687

2.06

10.75

3.8

3.7

1.04

1.03

mmol/l

0.12

118

612

Uterine polyps

1829

9079

1.20

10.74

4.9

5.1

1.03

1.05

mmol/l

2.52

1655

8349

Schizotypal disorder

157

908

1.88

10.73

3.4

6.9

1.04

1.02

mmol/l

0.35

145

855

Chondropathies

992

8018

1.28

10.72

6.2

6.5

1.03

1.04

mmol/l

0.53

921

7504

Panniculitis affecting regions of neck and back

249

1619

1.64

10.70

6.8

6.3

1.03

1.04

mmol/l

0.19

237

1507

Thyroiditis

462

3378

1.43

10.69

4.9

5.7

1.03

1.04

mmol/l

0.29

434

3116

Other infective otitis externa

428

3097

1.46

10.67

7.9

6.1

1.04

mmol/l

0.19

390

2893

Hypogonadotropic hypogonadism

218

1380

1.70

10.62

6.4

8.2

1.00

1.02

mmol/l

0.50

210

1316

Bicuspidal aortic valve syndrome

278

1863

1.60

10.62

8.0

7.5

1.08

1.06

mmol/l

0.50

272

1757

Other disorders of the genitourinary system

890

7136

1.30

10.59

6.2

5.2

1.04

mmol/l

0.19

816

6554

Polycystic ovarian syndrome, broad definition

503

3705

1.39

10.59

4.1

5.1

1.06

1.05

mmol/l

0.87

476

3434

Bullous pemphigoid

187

1152

1.80

10.58

5.7

5.2

1.05

1.03

mmol/l

0.37

169

1066

Acute appendicitis, no complications

3846

34340

1.13

10.54

6.3

6.6

1.03

1.04

mmol/l

0.81

3618

32274

Maternal care related to the fetus and amniotic cavity and possible delivery problems

1940

13261

0.84

10.52

4.3

5.6

1.04

1.05

mmol/l

0.85

1823

12305

Gestational [pregnancy-induced] hypertension

1327

11009

1.23

10.52

5.1

4.9

1.05

1.04

mmol/l

1.52

1272

10191

Third [oculomotor] nerve palsy

158

932

1.90

10.51

11.1

6.0

1.09

1.04

mmol/l

1.28

152

861

Giant cell arteritis with polymyalgia rheumatica

298

2039

1.58

10.50

6.6

5.1

1.06

1.04

mmol/l

0.51

280

1864

Anogenital herpesviral [herpes simplex] infection, including avohilmo

609

4633

1.35

10.48

6.7

5.6

1.03

1.04

mmol/l

0.28

581

4314

Scar conditions and fibrosis of skin

277

1852

1.59

10.47

7.5

5.2

1.05

mmol/l

0.21

261

1713

Glucosamine medication

3649

26119

1.14

10.45

4.2

5.6

1.03

1.04

mmol/l

0.60

3312

24051

Blindness or visual impairment, binocular

221

3.11

10.43

13.3

5.9

1.09

1.07

mmol/l

0.15

195

Disorder of the sleep-wake schedule

140

793

1.94

10.42

6.2

7.9

1.11

mmol/l

0.05

130

743

CR(E)ST syndrome

124

680

2.05

10.42

5.7

4.8

1.02

1.04

mmol/l

0.29

115

622

Other drug-induced secondary parkinsonism

466

2.33

10.40

3.8

5.9

0.99

1.02

mmol/l

0.59

435

Optic atrophy, wide definition

157

927

1.89

10.37

7.0

6.4

1.02

1.08

mmol/l

1.71

148

867

Benign neoplasm: Skin of trunk

311

2142

1.55

10.33

10.0

5.9

1.06

1.04

mmol/l

0.71

296

1982

Monoplegia

128

712

2.02

10.31

8.5

5.3

1.03

mmol/l

0.05

117

659

Autism spe

179

1084

1.77

10.28

4.9

9.0

1.13

1.16

mmol/l

0.62

169

1018

Myocardial infarction, unclassifiable

1697

12936

1.20

10.28

8.6

5.6

1.10

1.04

mmol/l

13.53

1572

11869

Benign neoplasm of major salivary glands

687

5362

1.34

10.27

6.0

6.1

1.02

1.04

mmol/l

0.73

634

4989

Carcinoma in situ of other and unspecified digestive organs

346

2443

1.52

10.27

7.9

6.2

1.02

1.03

mmol/l

0.50

329

2273

Eustachian salpingitis and obstruction

467

3433

1.41

10.25

7.2

6.8

1.04

mmol/l

0.23

440

3241

Congenital malformations of the musculoskeletal system, not elsewhere classified

111

587

2.09

10.23

6.5

1.13

1.10

mmol/l

0.39

106

548

Trigeminal neuralgia

399

2872

1.46

10.21

4.6

5.4

1.05

1.03

mmol/l

0.80

366

2651

Atrial septal defect, secundum type

243

1602

1.65

10.14

9.3

9.4

1.22

1.19

mmol/l

0.68

235

1519

Fistulae involving female genital tract

123

676

2.01

10.13

6.7

4.6

1.00

1.04

mmol/l

1.21

118

635

Pyoderma

149

869

1.89

10.12

9.8

6.2

1.06

1.05

mmol/l

0.25

141

804

Other and unspecified erythematous conditions

248

1641

1.63

10.12

7.6

5.7

1.05

mmol/l

0.15

234

1509

Polyp of the female genital tract

1917

9298

1.19

10.11

4.8

5.0

1.03

1.05

mmol/l

1.28

1755

8541

Carcinoma in situ of skin, other sites/unspecified

146

857

1.94

10.09

14.6

5.1

1.04

1.03

mmol/l

0.15

140

789

Other and unspecified disorders of pigmentation

277

2.68

10.04

7.7

5.5

1.11

1.07

mmol/l

0.42

255

Motor neuron disease (with DMD)

146

845

1.88

10.03

4.3

6.0

1.03

1.07

mmol/l

0.98

135

788

Other and unspecified nail disorders

179

1101

1.77

9.96

10.7

5.5

1.12

1.03

mmol/l

2.17

167

1027

Alzheimer’s disease (Early onset)

147

2457

0.57

9.95

4.6

5.1

1.03

1.05

mmol/l

0.42

132

2235

Disorders of iron metabolism

115

621

2.04

9.94

10.3

5.5

1.03

1.01

mmol/l

0.48

106

584

Other abnormal immunological findings in serum

155

918

1.85

9.92

6.7

6.4

1.08

1.07

mmol/l

0.08

147

856

Asthma mixed form (mode), excluding more controls

280

1886

1.55

9.89

6.3

4.2

1.09

1.03

mmol/l

2.48

259

1731

Malignant neoplasm of vulva, including Hilmo

106

563

2.11

9.81

4.6

3.4

1.03

1.04

mmol/l

0.16

497

Fenamates

1098

6134

1.25

9.78

4.2

9.4

1.02

1.06

mmol/l

3.58

992

5735

Other noninflammatory disorders of uterus, except cervix

1448

8138

1.22

9.77

4.7

5.0

1.05

mmol/l

0.00

1313

7460

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

271

1839

1.58

9.76

8.9

5.3

1.07

1.03

mmol/l

1.31

254

1696

197

1253

1.73

9.75

6.7

5.8

1.11

1.04

mmol/l

2.37

179

1151

Injury of nerves and spinal cord at neck level

176

1089

1.77

9.68

5.2

6.8

1.01

1.03

mmol/l

0.32

170

1012

Other congenital malformations of circulatory system

196

1245

1.71

9.62

5.3

6.2

1.04

mmol/l

0.04

181

1157

Traumatic ischaemia of muscle

112

611

2.06

9.60

9.1

6.3

1.14

1.03

mmol/l

2.52

102

572

Radial styloid tenosynovitis [de Quervain]

347

2458

1.47

9.60

5.9

5.7

1.05

1.04

mmol/l

0.20

326

2279

Vulvovaginal ulceration/inflammation in other diseases

379

2725

1.44

9.53

6.9

5.1

1.05

mmol/l

0.15

356

2518

Other noninflammatory disorders of vagina

494

3712

1.38

9.52

7.1

5.0

1.03

1.04

mmol/l

0.61

451

3430

Malignant neoplasm of lip, including Hilmo

456

2.22

9.52

7.7

4.9

1.05

1.02

mmol/l

0.41

413

Hypersomnia

109

590

2.06

9.50

4.9

6.2

1.04

1.03

mmol/l

0.05

102

544

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

455

3375

1.40

9.45

5.4

6.4

1.03

mmol/l

0.12

433

3152

Macular pucker

1198

10037

1.23

9.43

7.0

5.5

1.06

1.03

mmol/l

3.52

1096

9314

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

138

803

1.88

9.42

5.5

5.1

1.03

mmol/l

0.13

130

734

Benign neoplasm: salivary glands, exclude unknown (D119)

616

4803

1.34

9.36

5.7

6.1

1.02

1.03

mmol/l

0.64

566

4469

Medical abortion

4136

20239

1.12

9.33

4.8

4.9

1.04

1.05

mmol/l

0.77

3840

18564

Other specified/unspecified dorsopathies

237

1575

1.60

9.31

5.1

5.8

1.05

1.04

mmol/l

0.22

219

1463

Malignant neoplasm of other and ill-defined sites, including Hilmo

121

680

1.96

9.30

6.4

4.2

1.09

1.02

mmol/l

1.27

116

617

Other specified/unspecified disorders of bone/cartilage

192

1220

1.69

9.30

6.8

6.0

1.05

1.03

mmol/l

0.29

178

1141

Ganglion

1324

11154

1.21

9.28

5.2

5.8

1.03

mmol/l

0.18

1229

10386

Malignant neoplasm of rectosigmoid junction, including Hilmo

207

1341

1.66

9.27

6.0

5.1

1.08

1.03

mmol/l

1.72

195

1225

Retinal detachment with retinal break

926

7572

1.27

9.24

9.1

5.9

1.05

1.03

mmol/l

1.75

871

7067

Other and unspecified injuries of ankle and foot

285

1966

1.53

9.23

7.5

6.2

1.05

1.06

mmol/l

0.48

269

1829

Other and unspecified injuries of shoulder and upper arm

230

1524

1.61

9.21

6.8

6.4

1.04

mmol/l

0.12

217

1419

Disorders of globe

194

1242

1.69

9.20

9.5

5.2

1.08

1.03

mmol/l

1.01

183

1139

Leiomyoma of uterus

4145

21060

1.12

9.10

4.9

1.03

1.04

mmol/l

1.98

3780

19359

Contusion of ankle

274

1882

1.54

9.10

8.0

6.3

1.06

mmol/l

0.14

255

1757

Otalgia

586

4550

1.34

9.09

6.5

6.8

1.06

1.08

mmol/l

1.44

553

4238

Iridocyclitis in diseases classified elsewhere

149

898

1.82

9.06

7.2

6.5

1.02

1.04

mmol/l

0.41

143

827

Premature rupture of membranes

731

6540

0.78

9.04

4.0

5.7

1.04

mmol/l

0.41

688

6095

Cerebral palsy

128

739

1.91

9.04

11.5

8.7

1.13

1.17

mmol/l

0.61

123

703

Crowding of teeth, including avohilmo

578

3688

1.34

9.04

13.1

7.3

1.21

1.16

mmol/l

3.56

544

3473

Frostbite

473

2.17

9.04

7.5

6.6

1.08

1.02

mmol/l

1.30

446

Other/unspecified reactive arthropathies

428

3183

1.41

9.03

7.3

6.5

1.05

1.04

mmol/l

0.36

403

2973

Mixed connective tissue disease

131

762

1.89

9.01

6.7

5.4

1.03

1.04

mmol/l

0.28

123

701

Respiratory tuberculosis, confirmed, including avohilmo

146

876

1.82

8.99

7.1

5.7

1.06

1.03

mmol/l

0.37

137

800

Postpartum haemorrhage

926

9341

0.80

8.98

4.2

5.7

1.04

1.05

mmol/l

0.39

864

8698

Secondary malignant neoplasm of other and unspecified sites

142

848

1.85

8.98

3.9

4.6

1.00

1.03

mmol/l

0.56

134

770

Complications of labour and delivery

3180

19721

0.88

8.98

4.6

5.3

1.04

mmol/l

0.03

2926

18203

Cluster headache, strict, including avohilmo

306

2150

1.49

8.97

4.7

6.4

1.02

1.04

mmol/l

0.43

287

2021

Foreign body in alimentary tract

391

2877

1.43

8.96

5.6

6.8

1.05

1.06

mmol/l

0.43

371

2677

Localized skin eruption due to drugs and medicaments

503

2.13

8.94

5.7

5.9

1.03

1.04

mmol/l

0.24

468

Presbycusis

1118

9227

1.23

8.90

5.4

5.2

1.03

1.05

mmol/l

1.37

1005

8386

Acute hepatitis B

189

3.06

8.90

7.5

6.8

0.99

1.01

mmol/l

0.25

171

Tooth eruption problems

824

6417

1.27

8.89

12.9

6.8

1.13

1.11

mmol/l

1.48

777

6014

Primary coxarthrosis, bilateral

2211

19487

1.16

8.88

5.0

5.8

1.04

1.03

mmol/l

0.76

2042

17990

Progressive vascular leukoencephalopathy

308

2186

1.50

8.88

4.8

4.7

1.01

1.05

mmol/l

1.90

276

2008

Erythema multiforme

171

1073

1.73

8.84

8.5

6.2

1.06

1.05

mmol/l

0.32

160

991

Benign neoplasm of middle ear and respiratory system

551

4267

1.35

8.83

5.7

6.3

1.06

1.03

mmol/l

1.21

514

3989

Laparoscopic right hemicolectomy

443

3343

1.41

8.82

4.6

5.9

1.02

1.03

mmol/l

0.23

409

3105

Hallux rigidus

930

7636

1.25

8.82

3.9

5.6

1.03

mmol/l

0.04

852

7058

Chronic iridocyclitis

339

2442

1.46

8.80

6.2

6.0

1.04

mmol/l

0.07

318

2263

Erythema nodosum

203

1324

1.64

8.80

8.8

5.0

1.04

1.03

mmol/l

0.28

190

1228

Mild mental retardation

198

1289

1.66

8.79

10.7

8.6

1.18

1.14

mmol/l

1.09

190

1216

Chondrocostal junction syndrome [Tietze]

258

1769

1.55

8.78

5.0

5.4

1.04

1.03

mmol/l

0.07

237

1632

Arthropathic psoriasis

740

5935

1.29

8.77

5.2

6.6

1.02

1.04

mmol/l

0.73

712

5566

Spinal instabilities

192

1237

1.66

8.76

4.6

6.4

1.03

1.02

mmol/l

0.08

180

1160

Malignant neoplasm of vulva

409

2.25

8.75

4.9

3.5

1.04

mmol/l

0.06

359

Lagophthalmos

110

618

2.01

8.74

8.7

5.0

1.07

1.04

mmol/l

0.52

104

564

Outcome of delivery

537

4287

0.75

8.68

3.5

5.7

1.03

1.05

mmol/l

1.30

498

3977

Respiratory tuberculosis, confirmed

142

854

1.82

8.68

7.0

5.7

1.06

1.03

mmol/l

0.38

133

780

Other injuries of lower limb, level unspecified

439

2.20

8.67

9.6

6.3

1.14

1.05

mmol/l

1.48

404

Palmar fascial fibromatosis [Dupuytren]

1111

9302

1.23

8.67

6.3

6.1

1.04

1.03

mmol/l

0.28

1034

8675

406

2991

1.39

8.66

5.1

1.03

1.04

mmol/l

0.49

377

2800

Other salmonella infections, including avohilmo

281

1960

1.51

8.64

7.6

5.2

1.04

mmol/l

0.16

262

1810

Intentional self-harm by smoke, fire and flames

4.78

8.59

4.0

9.2

0.98

1.03

mmol/l

0.54

Sequelae of intentional self-harm, assault and events of undetermined intent

265

2.57

8.57

6.2

7.9

1.00

1.06

mmol/l

0.82

244

Use of rivastigmine

873

10571

0.80

8.55

3.3

5.1

1.00

1.05

mmol/l

8.44

775

9635

Pleural plaque

704

5650

1.30

8.53

5.1

6.0

1.04

1.03

mmol/l

0.12

642

5257

Sacrococcygeal disorders, not elsewhere classified

195

1265

1.63

8.51

3.8

6.0

1.03

1.04

mmol/l

0.41

186

1185

Habit and impulse disorders

112

630

1.93

8.50

3.3

7.4

1.06

1.04

mmol/l

0.26

106

595

Erectile dysfunction

598

4718

1.33

8.50

11.0

7.2

1.05

1.04

mmol/l

0.50

561

4459

Pituitary-dependent Cushing's disease

136

3.53

8.46

3.5

7.0

0.95

1.04

mmol/l

1.08

124

Contact with sharp glass

240

1630

1.55

8.42

6.8

7.1

1.03

1.05

mmol/l

0.31

234

1537

Other secondary gonarthrosis

381

2824

1.42

8.40

6.1

6.6

1.06

1.03

mmol/l

0.79

368

2630

Biomechanical lesions, not elsewhere classified

362

2662

1.44

8.38

5.5

5.7

1.03

mmol/l

0.17

337

2464

Myasthenia gravis

136

820

1.83

8.38

4.3

6.2

1.02

mmol/l

0.04

128

757

Malignant neoplasm of heart, mediastinum and pleura

105

587

1.99

8.34

6.3

5.6

1.05

1.04

mmol/l

0.16

530

Generalized epilepsy

275

1926

1.51

8.32

5.8

7.5

1.11

1.09

mmol/l

0.32

256

1809

Pustulosis palmaris et plantaris

286

2022

1.50

8.30

4.8

5.9

1.03

mmol/l

0.00

264

1871

Benign neoplasm: Parotid gland

550

4298

1.34

8.29

5.5

6.1

1.02

1.04

mmol/l

0.57

504

4000

Failure of sterile precautions during surgical operation

144

3.43

8.26

6.2

6.5

1.06

1.03

mmol/l

0.21

136

Deviated nasal septum

2327

20619

1.15

8.25

5.8

7.1

1.02

1.03

mmol/l

1.93

2170

19453

Acute hepatitis B, including avohilmo

196

2.91

8.25

7.5

6.7

0.99

1.01

mmol/l

0.23

178

Other secondary coxarthrosis

244

1680

1.55

8.25

6.6

5.8

1.04

1.03

mmol/l

0.22

228

1553

Caries of enamel

7340

44785

1.08

8.23

7.8

6.2

1.04

mmol/l

0.17

6910

41927

Other and unspecified hydrocephalus

146

901

1.78

8.20

5.8

5.7

1.00

1.07

mmol/l

2.53

136

830

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

499

3842

1.35

8.19

8.3

4.7

1.08

1.03

mmol/l

3.31

473

3539

Pustular psoriasis

315

2271

1.46

8.18

4.8

6.0

1.04

mmol/l

0.04

290

2096

Glaucoma suspect

2724

24413

1.14

8.15

6.6

5.7

1.04

mmol/l

0.21

2534

22582

Impacted cerumen

849

6980

1.26

8.15

6.9

6.2

1.06

1.05

mmol/l

0.03

735

6506

Examination and encounter for administrative purposes

540

4207

1.33

8.15

7.0

5.3

1.02

mmol/l

0.16

514

3931

Spinal osteochondrosis

432

2.13

8.14

4.9

6.1

1.02

1.04

mmol/l

0.30

404

Female infertility, associated with anovulation

336

2425

1.42

8.12

4.1

5.2

1.05

mmol/l

0.00

320

2268

375

2762

1.40

8.11

6.1

4.7

1.06

1.04

mmol/l

0.55

352

2479

Nontoxic single thyroid nodule

464

3549

1.36

8.10

5.4

1.03

1.04

mmol/l

0.29

423

3279

Cluster headache, wide,, including avohilmo

319

2301

1.45

8.10

4.6

6.4

1.02

1.04

mmol/l

0.43

299

2159

Osteomyelitis of vertebra

164

3.24

8.08

12.1

5.4

1.08

mmol/l

0.05

151

Congenital malformations of the nervous system

166

1057

1.70

8.08

10.6

8.7

1.16

mmol/l

0.11

156

1004

Acute alcohol intoxication ICD-9

231

1578

1.56

8.07

6.2

6.9

1.02

1.04

mmol/l

0.35

220

1463

Congenital deformities of feet, including avohilmo

253

1754

1.52

8.07

8.1

6.8

1.07

1.08

mmol/l

0.18

245

1647

Melanocytic naevi of lower limb, including hip

298

2132

1.47

8.07

10.5

6.1

1.06

1.04

mmol/l

0.56

281

1978

Acanthosis nigricans

121

3.46

8.04

10.9

4.4

1.04

1.00

mmol/l

0.41

115

Drug-induced Cushing's syndrome

6.26

8.04

4.3

7.6

0.98

1.05

mmol/l

0.50

Viral meningitis, including avohilmo

230

1566

1.55

8.03

7.0

6.5

1.04

mmol/l

0.05

219

1459

Family history of other conditions

516

1.99

8.01

11.3

3.6

1.09

1.07

mmol/l

0.26

479

Respiratory tuberculosis, bacteriologically and histologically confirmed

144

889

1.76

7.98

6.9

5.6

1.06

1.03

mmol/l

0.38

135

808

Vascular syndromes of brain in cerebrovascular disorders

335

2458

1.45

7.98

6.7

5.8

1.04

mmol/l

0.06

312

2292

Other/unspecified disorders of vestibular function

307

2222

1.47

7.92

5.2

5.6

1.04

mmol/l

0.00

283

2047

Rheumatic fever incl heart disease

216

1462

1.57

7.90

10.6

5.4

1.08

1.04

mmol/l

1.31

196

1335

Bitten or struck by other mammals

702

5660

1.28

7.86

7.3

6.3

1.06

1.05

mmol/l

0.39

652

5296

HSIL lesion of the vulva

125

747

1.83

7.85

10.2

4.1

1.07

1.04

mmol/l

0.61

115

677

Viral agents as the cause of diseases classified to other chapters

164

1051

1.69

7.84

11.1

7.2

1.07

1.06

mmol/l

0.18

157

990

Viral agents as the cause of diseases classified to other chapters, including avohilmo

183

1201

1.64

7.83

10.3

7.2

1.07

1.06

mmol/l

0.13

173

1130

Other and unspecified diseases of spleen

196

2.89

7.81

12.2

5.7

0.99

1.01

mmol/l

0.23

179

Superficial injuries involving multiple body regions

180

1175

1.63

7.78

7.5

6.0

1.03

1.04

mmol/l

0.15

171

1094

Ulcerative proctitis

381

2847

1.39

7.77

5.9

6.3

1.02

1.04

mmol/l

0.70

360

2656

Effects of foreign body entering through natural orifice

1658

14452

1.17

7.76

6.9

7.3

1.03

1.05

mmol/l

1.85

1575

13657

Memory loss

664

5358

1.29

7.72

4.5

5.7

1.00

1.04

mmol/l

4.12

587

4973

Sacroiliitis, not elsewhere classified

252

1755

1.49

7.66

4.7

6.3

1.04

mmol/l

0.03

232

1651

Exposure to excessive natural cold

488

2.04

7.58

9.1

6.3

1.06

1.02

mmol/l

0.47

452

Shoulder region

115

681

1.86

7.56

6.5

6.2

1.05

mmol/l

0.03

110

634

Severe visual impairment, binocular

236

2.60

7.55

20.0

5.9

1.09

1.07

mmol/l

0.16

213

Melanocytic naevi of upper limb, including shoulder

166

1074

1.66

7.54

11.3

5.9

1.08

1.04

mmol/l

1.07

161

993

Other lack of coordination

134

828

1.78

7.53

5.5

6.8

1.03

1.05

mmol/l

0.43

127

766

Congenital malformations of the respiratory system

154

990

1.72

7.50

13.1

8.6

1.16

1.18

mmol/l

0.15

144

931

Coxarthrosis, primary, with hip surgery

3666

31069

1.11

7.49

5.1

5.8

1.05

1.03

mmol/l

2.09

3393

28720

Chronic Coagulation defects

157

1003

1.68

7.49

9.1

6.4

1.06

1.07

mmol/l

0.20

147

927

Benign neoplasm: Rectosigmoid junction

309

2266

1.45

7.48

7.0

5.8

1.04

1.03

mmol/l

0.20

294

2098

115

3.41

7.45

22.2

6.5

1.13

1.02

mmol/l

1.39

105

Amblyopia ex anopsia

298

2167

1.45

7.44

10.1

7.7

1.15

1.13

mmol/l

0.70

275

2029

Additional codes for the location of defect, injury or illness

399

3032

1.38

7.43

7.5

6.3

1.05

mmol/l

0.03

381

2821

Drug-induced tremor

312

2.36

7.39

6.0

6.2

1.08

1.05

mmol/l

0.44

286

Dislocation, sprain and strain of joints and ligaments of knee

4192

34794

1.10

7.37

5.3

6.4

1.03

1.04

mmol/l

0.47

3925

32651

Tuberculosis, IBD comorbidity

479

3731

1.33

7.37

6.9

5.0

1.06

1.04

mmol/l

1.12

447

3425

Dislocation of lens

125

762

1.80

7.37

8.8

5.1

1.03

1.02

mmol/l

0.22

115

694

Raynaud syndrome

551

4362

1.31

7.36

3.6

6.0

1.03

1.04

mmol/l

0.44

516

4068

Single delivery by caesarean section

725

5084

0.80

7.31

5.0

6.8

1.05

1.06

mmol/l

0.50

682

4741

Disorders of eyelid in diseases classified elsewhere

221

1528

1.53

7.30

8.8

5.5

1.05

mmol/l

0.10

208

1400

Obstructive hydrocephalus

119

720

1.82

7.26

5.4

7.1

1.00

1.09

mmol/l

2.66

111

667

Other complications of labour and delivery, not elsewhere classified

311

3755

0.72

7.26

3.2

5.5

1.03

1.05

mmol/l

1.46

288

3505

Nystagmus and other irregular eye movements

114

682

1.84

7.26

9.9

8.2

1.09

1.12

mmol/l

0.35

106

643

Allergic contact dermatitis

801

6605

1.24

7.25

6.1

5.5

1.05

1.04

mmol/l

0.45

724

6124

Other benign neoplasms of connective and other soft tissue

639

5160

1.28

7.24

5.3

6.2

1.01

1.04

mmol/l

2.45

584

4806

Exposure to smoke, fire and flames

176

1166

1.62

7.23

5.4

7.2

1.02

1.04

mmol/l

0.54

168

1090

Pulmonary eosinophilia, not elsewhere classified

526

1.97

7.22

7.8

5.0

1.03

mmol/l

0.05

480

Otorrhagia

379

2.22

7.21

13.2

6.8

1.14

1.11

mmol/l

0.32

349

Aphakia

109

640

1.84

7.19

9.7

5.4

1.11

1.02

mmol/l

2.35

102

589

Senility

383

2.07

7.15

2.8

4.3

1.04

1.07

mmol/l

0.32

350

Combined immunodeficiencies

477

2.02

7.14

10.4

5.0

1.04

1.06

mmol/l

0.26

436

Contusion of other and unspecified parts of foot

331

2454

1.40

7.13

7.3

6.6

1.08

1.07

mmol/l

0.29

312

2295

Paranoid personality disorder

121

735

1.77

7.10

5.2

6.2

1.00

1.04

mmol/l

0.90

110

690

Social disorders starting during childhood or adolescence

371

2.17

7.09

10.9

9.2

1.18

1.21

mmol/l

0.30

356

Chronic diseases of tonsils and adenoids

5676

33266

1.09

7.08

6.3

6.7

1.05

mmol/l

0.58

5319

31216

Crushed, pushed or stepped on by crowd or human stampede

448

3469

1.33

7.07

6.1

7.3

1.07

1.06

mmol/l

0.03

420

3258

Arthropod-borne viral fevers and viral haemorrhagic fevers

616

4974

1.28

7.04

7.1

6.7

1.09

1.04

mmol/l

3.50

592

4671

Vertical strabismus

237

1675

1.50

7.01

5.2

5.8

1.05

mmol/l

0.09

220

1563

Acute appendicitis, with complications

1291

11142

1.18

7.00

6.8

6.5

1.03

1.04

mmol/l

0.71

1203

10451

Viral meningitis

214

1479

1.52

6.98

7.0

6.3

1.04

1.03

mmol/l

0.13

205

1378

Benign neoplasm of brain and other parts of central nervous system

436

3386

1.34

6.97

5.6

6.2

1.03

1.04

mmol/l

0.75

400

3157

Ankylosing spondylitis, ICD10

542

4314

1.30

6.96

5.9

6.8

1.03

mmol/l

0.21

511

4055

Recurrent dislocation and subluxation of joint

378

2863

1.36

6.95

5.6

6.3

1.02

1.03

mmol/l

0.48

361

2678

Congenital malformations of the respiratory system, including avohilmo

162

1071

1.65

6.94

12.6

8.2

1.16

1.17

mmol/l

0.13

151

1006

Benign neoplasm: Skin of other and unspecified parts of face

710

5828

1.26

6.94

8.6

5.8

1.04

mmol/l

0.01

648

5408

Follicular adenocarcinoma of thyroid gland, including Hilmo

415

2.06

6.91

4.1

4.8

1.07

1.03

mmol/l

0.63

369

Sequelae of infectious and parasitic diseases, including avohilmo

474

3715

1.32

6.90

7.7

5.8

1.05

1.03

mmol/l

0.80

432

3458

Benign neoplasm: Tongue

198

1361

1.56

6.88

7.3

5.8

1.03

mmol/l

0.08

188

1259

Other and unspecified iridocyclitis

318

2365

1.41

6.87

6.6

6.1

1.04

mmol/l

0.10

305

2195

Contusion of toe(s) without damage to nail

174

1159

1.59

6.86

7.2

6.1

1.08

1.06

mmol/l

0.57

160

1089

Autonomic disorders

172

1147

1.60

6.86

7.0

5.9

1.05

1.04

mmol/l

0.13

162

1062

Sudden idiopathic hearing loss

696

5712

1.26

6.86

7.8

6.3

1.05

1.04

mmol/l

0.15

647

5325

Congenital malformations of trachea and bronchus

494

2.00

6.85

10.4

6.8

1.10

1.12

mmol/l

0.19

455

Other and unspecified trigeminal disorders

113

684

1.80

6.82

4.5

4.7

1.01

1.04

mmol/l

0.55

105

626

Other/unspecified enthesopathies, not elsewhere classified

544

4342

1.29

6.82

6.2

5.9

1.07

1.04

mmol/l

1.98

507

4051

Motor neuron disease ALS

128

797

1.72

6.80

3.4

5.7

0.99

1.05

mmol/l

1.83

117

741

Other contact dermatitis

492

3879

1.31

6.79

7.5

5.6

1.04

mmol/l

0.17

461

3605

Alzheimer’s disease (Atypical or mixed), excluding more controls

639

3865

1.27

6.76

3.7

5.1

1.02

1.06

mmol/l

2.64

546

3518

Toxic colitis

153

2.99

6.73

9.6

6.8

1.03

1.05

mmol/l

0.14

138

Psoriatic arthropathies, ICD10

668

5466

1.26

6.72

5.1

6.5

1.03

mmol/l

0.26

646

5115

Other bullous disorders

196

1351

1.55

6.71

7.5

5.9

1.05

mmol/l

0.04

189

1258

Sequelae of infectious and parasitic diseases

461

3614

1.32

6.71

7.8

5.9

1.05

1.03

mmol/l

0.85

420

3364

Vascular dementia

739

5892

1.25

6.69

4.2

5.1

1.02

1.05

mmol/l

2.52

654

5372

Dislocation, sprain and strain of joint and ligaments of hip

270

1970

1.45

6.68

6.9

5.7

1.04

mmol/l

0.08

252

1816

Dislocation, sprain and strain of joints and ligaments of head

251

1801

1.46

6.67

6.6

6.9

1.07

1.08

mmol/l

0.30

233

1678

Causalgia

111

672

1.79

6.66

7.1

5.9

1.09

1.03

mmol/l

2.05

100

621

206

1407

1.56

6.61

18.3

12.3

1.40

1.33

mmol/l

2.34

200

1341

Disorders of lacrimal system and orbit in diseases classified elsewhere

166

1108

1.60

6.60

4.6

4.9

1.07

1.04

mmol/l

0.61

150

1025

Male infertility

255

1834

1.44

6.60

13.8

8.2

1.04

1.02

mmol/l

0.40

243

1758

Disorders of porphyrin and bilirubin metabolism

428

1.99

6.56

9.3

6.3

1.08

1.06

mmol/l

0.31

399

Etanercept

402

3109

1.34

6.53

5.1

6.6

1.04

1.05

mmol/l

0.45

390

2916

Nontoxic diffuse goitre

204

1421

1.52

6.52

4.5

4.9

1.02

1.05

mmol/l

0.81

184

1301

Procedures for purposes other than remedying health state

146

948

1.63

6.48

6.4

3.3

1.06

1.02

mmol/l

0.95

132

855

LSIL lesion of the cervix uteri, vagina or vulva

728

6014

1.24

6.45

7.1

4.9

1.04

mmol/l

0.23

673

5575

Obstructed labour due to malposition and malpresentation of fetus

806

8929

0.82

6.45

4.3

5.8

1.03

1.04

mmol/l

0.84

748

8325

Compression of brain

5.76

6.44

9.8

6.9

1.02

1.06

mmol/l

0.17

Graves ophthalmopathy, strict

148

971

1.63

6.40

4.9

5.1

1.06

1.04

mmol/l

0.42

133

892

Nonspecific lymphadenitis

350

2663

1.36

6.39

6.1

6.2

1.06

1.04

mmol/l

0.82

326

2469

Contact with sharp object, undetermined intent

163

1091

1.59

6.37

5.8

7.3

1.03

1.04

mmol/l

0.10

156

1028

228

1568

1.50

6.35

18.0

11.8

1.39

1.32

mmol/l

2.50

222

1497

Psoriasis (vulgaris), strict definition

227

1621

1.48

6.33

4.8

6.7

1.05

1.02

mmol/l

0.63

217

1515

Acute epiglottitis

104

628

1.79

6.31

7.9

6.3

1.04

mmol/l

0.03

590

Other and unspecified nonscarring hair loss

292

2.20

6.29

6.6

5.4

1.03

1.05

mmol/l

0.20

264

Febrile neutrophilic dermatosis [Sweet]

4.69

6.29

8.4

3.4

1.13

1.01

mmol/l

0.54

Autoimmune thyroiditis

116

719

1.72

6.29

4.8

5.6

1.04

1.05

mmol/l

0.27

109

666

Benign neoplasm: Skin of ear and external auricular canal

276

2043

1.42

6.28

6.3

5.6

1.03

mmol/l

0.03

244

1886

Abscess of mediastinum

3.84

6.28

16.5

6.0

1.18

1.10

mmol/l

0.37

ILD medications: pirfenidone

538

1.91

6.28

9.2

4.6

1.05

1.02

mmol/l

0.33

500

Other facial nerve disorders

192

1333

1.53

6.27

4.3

5.4

1.02

1.03

mmol/l

0.23

175

1230

Other nonscarring hair loss

405

1.99

6.27

8.4

5.4

1.03

1.05

mmol/l

0.20

371

Malignant neoplasm of lip

336

2.13

6.26

7.7

5.0

1.06

1.03

mmol/l

0.45

308

Accidental poisoning by and exposure to alcohol

117

728

1.72

6.26

8.0

6.7

1.05

mmol/l

0.02

112

686

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

3692

32550

1.10

6.24

5.3

5.9

1.05

mmol/l

0.12

3404

30302

Pregnancy, childbirth and the puerperium

1639

9694

0.87

6.20

4.2

5.1

1.05

1.06

mmol/l

1.60

1489

8785

Asthma mixed form (mode)

280

2067

1.40

6.16

6.3

4.5

1.09

1.04

mmol/l

1.98

259

1904

Contact with heat and hot substances

352

2703

1.36

6.12

8.2

7.3

1.07

mmol/l

0.18

333

2533

Benign neoplasm: Skin of eyelid, including canthus

1057

9097

1.19

6.12

6.2

5.8

1.04

mmol/l

0.04

971

8438

Tuberculosis, wide, including avohilmo

497

3985

1.29

6.12

7.1

5.4

1.06

1.04

mmol/l

1.05

465

3659

Hypertrophy of tongue papillae

100

605

1.80

6.11

9.0

5.5

1.06

1.03

mmol/l

0.43

567

Other and specified injuries of hip and thigh

165

1121

1.57

6.09

7.5

5.5

1.06

1.04

mmol/l

0.33

149

1028

Dystonia

351

2699

1.36

6.06

4.1

6.1

1.04

mmol/l

0.08

323

2508

Allergic rhinitis

1909

16832

1.13

6.06

5.5

6.8

1.08

1.07

mmol/l

0.53

1776

15798

Other demyelinating diseases of the central nervous system

207

1462

1.48

6.04

6.6

6.0

1.02

1.04

mmol/l

0.46

193

1374

Disorder of external ear, unspecified

230

1665

1.46

6.00

8.1

6.1

1.06

1.03

mmol/l

1.16

223

1560

Graves ophthalmopathy

163

1108

1.57

5.98

4.7

5.0

1.07

1.04

mmol/l

0.66

147

1022

Adenomyosis (Endometriosis of uterus)

810

6809

1.22

5.98

4.3

5.0

1.03

1.04

mmol/l

0.50

752

6271

Osteochondrodysplasia with defects of growth of tubular bones and spine

3.81

5.98

8.0

8.1

1.18

1.23

mmol/l

0.54

Other psoriatic arthropathies

643

5311

1.25

5.95

5.1

6.5

1.03

1.04

mmol/l

0.28

622

4971

Other melanin hyperpigmentation

161

1096

1.58

5.94

7.7

4.5

1.03

mmol/l

0.14

151

1004

Other bursitis of hip

150

1005

1.60

5.93

5.0

4.5

1.01

1.04

mmol/l

0.80

137

922

Respiratory and cardiovascular disorders specific to the perinatal period

232

1521

1.49

5.93

15.6

12.2

1.37

1.33

mmol/l

1.02

223

1454

Tuberculosis, wide

489

3930

1.29

5.91

7.0

5.5

1.06

1.04

mmol/l

1.02

457

3609

Other congenital malformations of skin

260

1923

1.42

5.90

7.2

6.9

1.06

1.09

mmol/l

0.86

249

1789

Other superficial mycoses, including avohilmo

628

5169

1.24

5.89

6.3

6.4

1.04

1.05

mmol/l

0.20

573

4852

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

214

1531

1.46

5.87

5.1

6.2

1.04

mmol/l

0.08

195

1427

Optic neuritis

233

1690

1.44

5.85

4.9

5.8

1.04

1.03

mmol/l

0.09

212

1577

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1879

16812

1.13

5.85

5.7

6.8

1.05

1.04

mmol/l

0.17

1768

15806

Viral haemorrhagic fevers, not elsewhere classified/unspecified

499

4026

1.28

5.84

6.8

6.7

1.10

1.03

mmol/l

4.13

479

3780

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

242

2.20

5.84

6.9

4.8

1.11

1.06

mmol/l

0.61

219

Tic and related disorders

525

1.82

5.83

7.9

7.8

1.14

1.21

mmol/l

1.16

493

Vascular dementia (mixed)

162

1112

1.57

5.80

3.7

5.3

1.00

1.06

mmol/l

1.39

151

1040

Other lesions of median nerve

191

1350

1.50

5.77

7.3

4.9

1.11

1.04

mmol/l

2.03

174

1219

Sequelae of other and unspecified infectious and parasitic diseases

311

2365

1.36

5.76

8.5

6.5

1.05

1.03

mmol/l

0.79

285

2219

Vascular dementia (undefined)

300

2249

1.37

5.76

3.8

5.0

1.02

1.06

mmol/l

1.60

256

2042

Perioral dermatitis

137

902

1.60

5.74

9.3

5.0

1.06

1.05

mmol/l

0.25

124

832

Atypical mycobacterium lung infection

549

1.82

5.72

10.8

5.2

1.04

1.06

mmol/l

0.30

498

Other specified/unspecified hearing loss

624

5167

1.25

5.70

6.8

6.1

1.04

1.05

mmol/l

0.63

587

4790

Demyelinating diseases of the central nervous system

464

3713

1.28

5.70

5.2

6.0

1.01

1.03

mmol/l

1.54

426

3468

Ascorbic acid deficiency

6.27

5.62

26.8

7.4

1.27

1.16

mmol/l

0.65

Miliary tuberculosis

3.76

5.62

6.9

7.2

0.95

1.11

mmol/l

2.03

Scleritis and episcleritis

367

2866

1.33

5.60

8.2

5.7

1.05

1.04

mmol/l

0.31

350

2669

Malignant neoplasm of rectosigmoid junction

118

761

1.67

5.60

5.6

4.8

1.07

1.03

mmol/l

0.77

113

688

Femoral hernia

300

2288

1.37

5.60

5.7

5.5

1.04

mmol/l

0.13

279

2112

Burn and corrosion of trunk

203

1457

1.47

5.60

5.4

7.1

1.05

mmol/l

0.01

193

1367

Achilles tendinitis

660

5496

1.23

5.59

7.3

6.8

1.03

mmol/l

0.29

619

5167

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

135

900

1.62

5.56

7.0

5.4

1.05

1.04

mmol/l

0.26

124

824

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

312

2387

1.36

5.56

8.5

6.5

1.05

1.03

mmol/l

0.69

286

2241

Pedestrian injured in transport accident

441

3527

1.29

5.55

6.1

6.2

1.05

1.04

mmol/l

0.18

415

3270

Disorders in reading

118

762

1.66

5.54

18.6

9.1

1.15

1.20

mmol/l

1.01

113

718

Injury of nerves at lower leg level

439

1.90

5.54

6.0

1.02

1.04

mmol/l

0.32

413

Intestinal helminthiases, other/unspecified, including avohilmo

137

2.93

5.54

5.0

4.8

0.96

1.05

mmol/l

1.32

126

Congenital deformities of hip

126

824

1.63

5.53

9.3

8.8

1.18

1.21

mmol/l

0.53

119

767

All dysplastic lesions of the vagina

161

1107

1.53

5.53

8.3

4.6

1.05

mmol/l

0.01

149

1006

Other acute disseminated demyelination

349

2.00

5.53

7.0

5.8

1.04

1.02

mmol/l

0.23

325

Tetralogy of Fallot, a congenital heart defect.

231

2.45

5.52

8.8

11.5

1.36

1.26

mmol/l

1.12

221

Gluteal tendinitis

273

2054

1.38

5.51

5.0

5.9

1.02

1.04

mmol/l

0.47

251

1899

Exposure to other and unspecified animate mechanical forces

193

1373

1.47

5.50

9.0

7.0

1.08

1.07

mmol/l

0.18

178

1286

Allergic conjunctivitis

3864

34483

1.09

5.47

5.3

6.1

1.05

mmol/l

0.00

3564

32134

Arthropathy in ulcerative colitis

538

1.79

5.47

4.4

6.4

1.04

1.03

mmol/l

0.08

507

Amoebiasis, including avohilmo

338

2.03

5.46

8.7

5.9

1.10

1.09

mmol/l

0.14

312

Long labour

923

9117

0.85

5.45

4.0

5.6

1.04

mmol/l

0.36

873

8474

Benign neoplasm: Tonsil

580

1.78

5.44

6.2

5.6

1.01

1.03

mmol/l

0.19

540

Von Willebrand disease

485

1.83

5.41

6.6

5.3

1.05

1.06

mmol/l

0.12

452

Embedded teeth, including avohilmo

471

3793

1.27

5.41

11.5

6.5

1.09

1.07

mmol/l

0.95

443

3548

Pervasive developmental disorders excl. Autism + Asperger

120

778

1.67

5.41

4.9

11.0

1.24

1.31

mmol/l

1.51

112

746

Mixed conductive and sensorineural hearing loss

851

7283

1.20

5.38

6.4

6.1

1.03

1.05

mmol/l

0.91

786

6748

Pigmented purpuric dermatosis

474

1.86

5.38

6.4

5.1

1.08

1.03

mmol/l

0.67

438

Inflammatory disorders of breast

329

2541

1.33

5.37

5.7

4.9

1.05

mmol/l

0.01

305

2340

Marfan's syndrome

215

2.35

5.36

6.4

6.7

1.02

1.04

mmol/l

0.19

196

Convergent concomitant strabismus

334

2591

1.33

5.36

7.6

6.7

1.08

mmol/l

0.00

314

2427

Labour and delivery complicated by fetal stress [distress]

832

6368

0.84

5.35

3.9

5.6

1.03

1.05

mmol/l

1.13

782

5943

Congenital deformities of hip, including avohilmo

138

927

1.58

5.35

8.7

8.5

1.17

1.20

mmol/l

0.51

128

865

Suggestive for eosinophilic asthma

594

4927

1.24

5.34

5.6

6.4

1.03

mmol/l

0.14

561

4603

Hordeolum and other deep inflammation of eyelid

384

3039

1.31

5.32

8.0

6.3

1.05

1.06

mmol/l

0.28

362

2839

Need for immunization against single bacterial diseases

198

2.70

5.27

25.3

12.0

1.20

1.34

mmol/l

1.54

190

Endometriosis of pelvic peritoneum

857

6653

1.19

5.25

4.0

5.2

1.03

1.04

mmol/l

1.20

796

6173

Benign neoplasm: Spinal cord

101

639

1.71

5.25

5.1

6.3

1.04

1.02

mmol/l

0.26

602

Onycholysis

286

2.12

5.24

11.7

5.7

1.06

1.08

mmol/l

0.13

263

Other and unspecified injuries of thorax

124

820

1.61

5.24

7.5

6.2

1.00

1.04

mmol/l

1.09

117

756

Burn and corrosion of shoulder and upper limb, except wrist and hand

147

1009

1.55

5.21

7.4

7.2

1.08

1.05

mmol/l

0.67

139

942

Deep bite

747

5556

1.21

5.19

10.5

7.2

1.15

1.12

mmol/l

2.13

689

5223

Sweet's syndrome

4.04

5.19

8.4

4.8

1.13

1.01

mmol/l

0.51

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

267

2030

1.38

5.15

5.3

6.2

1.04

1.03

mmol/l

0.22

247

1887

Carcinoma in situ of other and unspecified genital organs

129

864

1.59

5.15

7.8

4.1

1.05

1.03

mmol/l

0.34

118

777

Lateral epicondylitis

790

6730

1.20

5.15

4.2

6.3

1.02

1.03

mmol/l

0.65

730

6314

Pseudomembranous colitis

323

2.02

5.13

11.6

5.6

1.07

1.04

mmol/l

0.43

294

Tongue abnormality

409

3284

1.29

5.13

6.7

5.8

1.01

1.04

mmol/l

1.67

382

3024

Carcinoma in situ of colon

213

1573

1.44

5.11

8.3

6.1

1.02

1.03

mmol/l

0.20

201

1459

L02BX Other hormone antagonists and related agents

432

3504

1.29

5.11

5.0

7.1

1.03

mmol/l

0.05

410

3314

Benign neoplasm of bone and articular cartilage

503

4120

1.26

5.10

5.8

6.4

1.04

mmol/l

0.20

481

3848

Excessive earwax

4952

42121

1.08

5.10

6.1

6.3

1.03

1.04

mmol/l

2.89

4588

39311

Congenital aortic valve stenosis

265

2.23

5.08

11.6

11.3

1.28

1.23

mmol/l

0.59

256

Rheumatic valve diseases

152

1055

1.53

5.07

9.5

5.2

1.07

1.04

mmol/l

0.84

132

955

Lichen planus

865

7451

1.19

5.05

5.7

5.9

1.02

1.04

mmol/l

1.25

812

6916

Granuloma annulare

101

644

1.68

5.03

6.7

4.9

1.10

1.05

mmol/l

0.88

589

Mild or no visual impairment, binocular

200

2.34

5.03

6.5

5.7

0.99

1.12

mmol/l

1.84

184

Other sideroblastic anaemias

141

2.64

5.02

10.7

4.5

1.16

1.06

mmol/l

0.54

132

Other retinal disorders in diseases classified elsewhere

3.26

5.00

20.8

7.5

1.23

1.06

mmol/l

1.01

Dermatitis herpetiformis

122

815

1.61

5.00

5.7

6.1

1.02

1.04

mmol/l

0.45

117

759

Neuroendocrine tumor and carcinoma of lung

349

1.97

4.99

3.5

5.0

1.00

1.05

mmol/l

1.01

317

Other/unspecified soft tissue disorders related to use, overuse and pressure

187

1349

1.45

4.99

5.0

5.8

1.04

mmol/l

0.07

173

1259

Disorders of endocrine glands in diseases classified elsewhere

3.45

4.98

51.8

7.1

1.27

1.17

mmol/l

0.76

Mental and behavioural disorders due to use of volatile solvents

3.05

4.96

5.5

6.3

0.91

0.97

mmol/l

0.65

Acute nasopharyngitis (common cold)

695

5829

1.21

4.96

8.8

7.2

1.04

mmol/l

0.16

671

5537

Tonsillectomy and adenotomy

3497

22539

1.09

4.95

6.6

7.0

1.06

mmol/l

0.01

3312

21215

Pyogenic granuloma

121

807

1.60

4.94

7.7

5.5

1.08

1.04

mmol/l

0.84

114

753

Nocardiosis

5.66

4.94

21.7

4.7

1.05

1.07

mmol/l

0.11

Nocardiosis, including avohilmo

5.66

4.94

21.7

4.7

1.05

1.07

mmol/l

0.11

Herpesviral keratitis and keratoconjunctivitis

285

2199

1.35

4.93

8.4

5.7

1.05

1.03

mmol/l

0.62

265

2038

Schizoid personality disorder

113

743

1.62

4.93

3.7

6.9

1.04

1.03

mmol/l

0.19

103

701

Caught, crushed, jammed or pinched in or between objects

332

2608

1.32

4.93

5.6

7.5

1.03

1.05

mmol/l

1.21

310

2452

Dentofacial anomalies [including malocclusion]

4825

35403

1.07

4.92

6.2

6.3

1.04

1.05

mmol/l

0.32

4468

33173

Non-small cell lung cancer, adenocarcinoma, helper endpoint

463

3790

1.27

4.91

4.4

5.8

1.03

1.04

mmol/l

0.30

440

3520

Carcinoma in situ of other and unspecified sites

293

2279

1.35

4.91

6.5

6.7

1.04

1.03

mmol/l

0.17

276

2128

Malignant neoplasm of eye and adnexa, including Hilmo

106

689

1.65

4.89

7.5

5.5

1.12

1.04

mmol/l

1.46

626

Calcification and ossification of muscle

100

3.03

4.87

9.0

5.0

1.08

1.07

mmol/l

0.05

Divergent concomitant strabismus

449

3655

1.26

4.86

5.6

6.2

1.07

1.05

mmol/l

0.40

422

3413

Haemophilus septicemia

3.26

4.86

22.0

6.4

1.16

1.06

mmol/l

0.67

Malignant neoplasm of other and unspecified major salivary glands, including Hilmo

323

1.99

4.85

5.1

5.0

0.98

1.02

mmol/l

0.59

288

Malignant neoplasm of accessory sinuses

3.08

4.79

4.1

4.9

0.98

1.03

mmol/l

0.33

Universal erythroderma, KELA reimbursement

639

1.67

4.77

6.7

5.6

1.06

1.02

mmol/l

0.75

596

Osteomalacia

339

1.95

4.76

8.2

5.2

1.01

1.03

mmol/l

0.18

313

Eclampsia

3.29

4.73

10.1

4.8

1.08

1.06

mmol/l

0.18

Degenerative diseases of the nervous system

2519

19698

0.91

4.72

3.9

5.4

1.02

1.04

mmol/l

4.83

2245

18077

Benign neoplasm: Skin, unspecified

258

1978

1.36

4.69

10.6

5.8

1.04

1.03

mmol/l

0.12

242

1835

Localized scleroderma [morphea]

633

1.66

4.67

6.6

4.0

1.03

1.04

mmol/l

0.13

578

Other superficial mycoses

144

1005

1.51

4.66

13.2

6.6

1.07

1.03

mmol/l

0.95

137

952

Other and unspecified injuries of abdomen, lower back and pelvis

100

649

1.64

4.62

6.6

5.6

1.00

1.03

mmol/l

0.63

605

Multiple delivery

315

3979

0.77

4.61

4.5

6.5

1.03

1.05

mmol/l

0.87

297

3711

Other acquired deformities of musculoskeletal system and connective tissue

281

2185

1.34

4.59

5.7

6.3

1.03

mmol/l

0.05

265

2035

Fasciculation

510

1.74

4.59

4.9

6.4

1.03

1.04

mmol/l

0.06

479

Postpartum hemorraghe, all women as controls

926

10374

0.86

4.58

4.2

5.3

1.04

mmol/l

0.37

864

9666

Burn and corrosion of ankle and foot

100

653

1.65

4.58

10.5

6.4

1.14

1.03

mmol/l

2.69

612

Other and unspecified injuries of wrist and hand

244

1860

1.36

4.58

7.0

6.7

1.08

1.06

mmol/l

0.65

224

1734

Other congenital malformations of skin, including avohilmo

482

3980

1.24

4.56

5.8

6.6

1.04

1.07

mmol/l

1.65

456

3725

Sequelae of other accidents

109

726

1.60

4.53

3.6

5.8

1.06

1.03

mmol/l

0.50

104

680

Alcoholic myopathy

4.51

4.52

4.5

4.9

0.98

0.99

mmol/l

0.02

Other deformities of toe(s)

226

1713

1.38

4.46

4.8

5.6

1.05

1.04

mmol/l

0.12

203

1574

Disorders of synovium and tendon in diseases classified elsewhere

143

1008

1.50

4.46

9.3

6.6

1.07

1.04

mmol/l

0.60

135

939

Ebstein's anomaly

3.45

4.45

22.0

10.9

1.18

1.23

mmol/l

0.29

Congenital malformations of genital organs

498

4108

1.23

4.39

7.7

6.7

1.12

1.10

mmol/l

0.75

458

3833

Injury of muscle and tendon at forearm level

116

788

1.56

4.36

6.5

7.2

1.03

mmol/l

0.04

111

750

Other endophthalmitis

233

2.13

4.35

14.9

5.1

1.03

1.04

mmol/l

0.11

210

Early lumbar disc prolapse, operated

464

3825

1.24

4.33

6.3

7.4

1.04

1.03

mmol/l

0.28

439

3634

Injury of nerves at wrist and hand level

226

1720

1.37

4.32

5.4

7.2

1.06

1.03

mmol/l

0.90

216

1618

Intentional self-harm by other and unspecified firearm discharge

3.49

4.30

5.4

6.8

0.97

1.02

mmol/l

0.35

Benign neoplasm of ovary

1031

9097

1.15

4.29

4.9

4.8

1.05

1.04

mmol/l

0.53

953

8320

Intussusception

136

956

1.50

4.29

5.0

5.3

1.05

1.04

mmol/l

0.16

129

882

Personality and behavioural disorders due to brain disease, damage and dysfunction

104

696

1.60

4.26

5.0

6.6

1.05

1.04

mmol/l

0.06

652

Severe combined immunodeficiency [SCID] with low T- and B-cell numbers

7.72

4.25

16.2

3.9

1.00

0.99

mmol/l

0.05

Other disorders of breast

773

6686

1.18

4.24

4.8

5.0

1.04

mmol/l

0.12

700

6164

Tuberculosis

403

3300

1.26

4.24

6.4

5.4

1.07

1.04

mmol/l

1.16

367

3021

Aortic stenosis

113

3.19

4.23

15.1

12.1

1.33

1.29

mmol/l

0.20

108

Other articular cartilage disorders

151

1086

1.46

4.21

6.2

6.1

1.06

1.03

mmol/l

0.41

143

1004

Acute otitis externa, noninfective

112

763

1.56

4.20

9.2

5.6

1.09

1.04

mmol/l

1.03

104

708

False labour

1179

8243

0.88

4.20

3.3

5.9

1.04

1.05

mmol/l

1.20

1089

7697

Androgenic alopecia

344

1.85

4.19

4.0

4.3

1.07

1.04

mmol/l

0.32

310

LSIL lesion of the vagina

600

1.63

4.19

8.7

4.5

1.03

1.04

mmol/l

0.08

542

Pleural plaque without asbestos

264

2072

1.34

4.19

5.9

5.7

1.04

1.03

mmol/l

0.06

238

1929

Pedestrian injured in collision with car, pick-up truck or van

155

1121

1.45

4.17

6.5

5.8

1.03

mmol/l

0.15

140

1042

Other disorders of male genital organs

249

1932

1.34

4.15

8.5

7.9

1.05

1.04

mmol/l

0.08

234

1833

Other specified/unspecified deforming dorsopathies

106

714

1.57

4.14

6.2

5.6

1.05

1.02

mmol/l

0.46

664

Chronic suppurative otitis media

414

3407

1.25

4.12

7.2

6.1

1.08

1.06

mmol/l

0.47

387

3162

All dysplastic lesions of the cervix uteri, vagina or vulva

1489

13090

1.12

4.12

6.7

5.0

1.04

mmol/l

0.18

1381

12170

Other peripheral vertigo

599

5104

1.20

4.12

4.0

5.9

1.03

1.04

mmol/l

0.38

549

4730

Injury of muscle and tendon at hip and thigh level

636

5442

1.20

4.09

6.5

6.6

1.06

1.04

mmol/l

1.25

595

5115

Myositis ossificans

109

2.68

4.07

5.9

6.4

1.01

1.06

mmol/l

0.34

Calcific tendinitis of shoulder

339

2736

1.28

4.05

5.9

6.0

1.05

1.03

mmol/l

0.67

313

2550

Congenital malformations of eye, ear, face and neck

379

3095

1.26

4.05

9.7

7.4

1.13

1.10

mmol/l

0.89

359

2901

Pollen allergy

1061

9264

1.14

4.05

5.5

7.4

1.10

1.09

mmol/l

0.56

980

8702

Pedal cyclist injured in transport accident

1418

12783

1.12

4.05

6.0

6.7

1.04

1.05

mmol/l

0.44

1325

12000

Peritonsillar abscess

1215

10852

1.13

4.05

6.4

6.9

1.04

mmol/l

0.24

1162

10232

Hyperkinetic disorders (excl. ADHD)

141

996

1.48

4.05

9.6

10.0

1.20

1.24

mmol/l

0.77

133

951

Benign neoplasm: Skin of lower limb, including hip

179

1334

1.41

4.04

9.9

5.6

1.04

mmol/l

0.01

169

1236

Carcinoma in situ of rectum

100

676

1.61

4.04

7.0

6.4

1.03

1.02

mmol/l

0.13

629

Other hereditary haemolytic anaemias

284

1.97

4.02

5.4

6.2

1.05

1.09

mmol/l

0.42

262

Coarctation of the aorta

606

1.65

4.00

13.7

9.5

1.21

1.18

mmol/l

0.24

575

Oral lichen planus

179

1338

1.41

4.00

5.6

5.2

1.01

1.03

mmol/l

0.69

167

1236

Q fever, including avohilmo

7.58

4.00

10.2

15.2

1.04

1.00

mmol/l

—

Oral lichen planus and hypothyroidism or thyroxine medication

126

889

1.51

3.99

4.0

4.5

0.98

1.04

mmol/l

2.12

117

810

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

378

3101

1.26

3.98

4.8

5.4

1.01

1.04

mmol/l

1.53

346

2852

Juvenile osteochondrosis

180

1341

1.39

3.98

9.0

6.8

1.05

1.07

mmol/l

0.45

173

1257

Benign neoplasm: other/unspecified salivary gland

175

1305

1.41

3.97

6.6

5.5

1.01

1.03

mmol/l

0.52

166

1203

Mesothelioma, including Hilmo

579

1.63

3.95

5.4

5.6

1.05

1.03

mmol/l

0.21

522

Carcinoma in situ, bladder

267

2116

1.32

3.95

6.5

6.7

1.04

1.03

mmol/l

0.14

253

1979

Premenstrual syndrome

424

1.70

3.92

4.7

5.9

1.03

1.04

mmol/l

0.18

396

Femoral hernia, unilateral

186

1404

1.39

3.90

5.8

5.2

1.03

mmol/l

0.05

173

1296

Inguinal of femoral hernia, unilateral

186

1404

1.39

3.90

5.8

5.2

1.03

mmol/l

0.05

173

1296

Inguinal hernia, unilateral

186

1404

1.39

3.90

5.8

5.2

1.03

mmol/l

0.05

173

1296

Cysts of oral region, not elsewhere classified

366

2996

1.26

3.90

9.1

6.6

1.05

1.04

mmol/l

0.33

337

2800

Habitual aborter

541

1.61

3.89

5.0

5.6

1.07

1.04

mmol/l

0.36

513

Melanocytic naevi of other and unspecified parts of face

347

2824

1.27

3.88

6.5

5.7

1.06

1.04

mmol/l

0.44

326

2621

Pedal cyclist injured in other and unspecified transport accidents

696

6026

1.18

3.85

6.2

6.7

1.03

1.05

mmol/l

0.68

649

5635

Chronic conjunctivitis

195

1483

1.37

3.85

7.5

6.0

1.07

1.06

mmol/l

0.09

186

1378

Bacterial meningitis

211

1622

1.36

3.85

6.2

6.3

1.01

1.03

mmol/l

0.46

200

1508

Conductive hearing loss, unspecified

520

4407

1.21

3.81

7.1

6.5

1.03

1.05

mmol/l

1.25

482

4112

Gestational diabetes (for exclusion)

1726

10798

1.11

3.81

4.9

5.4

1.04

1.05

mmol/l

0.22

1630

10051

Abnormal findings in bronchial washings nasal secretions pleural fluid sputum throat scrapings

133

2.48

3.81

9.9

5.6

1.05

1.03

mmol/l

0.14

118

Atypical virus infections of central nervous system

402

1.76

3.81

5.3

5.8

1.01

1.02

mmol/l

0.12

373

Immunodeficiency with short-limbed stature

8.28

3.79

19.7

2.9

1.12

1.00

mmol/l

—

Lesion of plantar nerve

376

3098

1.25

3.79

4.1

5.4

1.02

1.03

mmol/l

0.46

347

2840

Sequelae of hyperalimentation

3.17

3.77

6.2

6.9

1.16

1.03

mmol/l

0.95

Varus deformity, not elsewhere classified

481

1.68

3.77

5.1

6.2

1.06

1.05

mmol/l

0.04

440

Rickettsioses, including avohilmo

2.85

3.76

8.8

6.9

1.04

1.01

mmol/l

0.32

Episcleritis

301

2420

1.28

3.76

8.4

5.8

1.04

mmol/l

0.20

287

2261

Other, unspecified and serous retinal detachments

211

1631

1.35

3.74

9.0

6.0

1.06

1.03

mmol/l

1.11

200

1504

Urethritis and urethral syndrome

130

930

1.46

3.74

8.3

4.9

1.01

1.04

mmol/l

0.64

120

861

Medullary carcinoma of thyroid gland, including Hilmo

2.99

3.73

5.2

4.2

1.06

1.03

mmol/l

0.18

Burns and corrosions confined to eye and internal organs

158

1169

1.41

3.72

5.8

6.9

1.05

1.02

mmol/l

0.66

148

1103

Benign neoplasm: Brain, supratentorial

102

701

1.55

3.71

6.5

6.1

1.06

1.04

mmol/l

0.22

650

Lesion of sciatic nerve

284

2278

1.29

3.71

4.4

5.1

1.04

mmol/l

0.09

266

2088

Follicular adenocarcinoma of thyroid gland

268

1.93

3.71

4.0

5.2

1.08

1.05

mmol/l

0.40

237

Benign neoplasm: Spinal meninges

493

1.67

3.70

5.1

4.8

1.07

1.03

mmol/l

0.83

452

Other disorders of Eustachian tube

191

1457

1.37

3.70

7.8

5.5

1.03

mmol/l

0.02

181

1348

Other and unspecified corneal deformities and disorders

202

1553

1.35

3.69

7.0

5.8

1.05

1.03

mmol/l

0.43

181

1436

Separation of retinal layers (serosa)

259

2055

1.31

3.69

13.2

6.3

1.07

1.02

mmol/l

1.53

247

1906

Other inflammation of vagina/vulva

184

1391

1.36

3.66

4.7

5.1

1.04

mmol/l

0.06

165

1279

Benign neoplasm: Other specified/unspecified intrathoracic organs (+ respiratory system NOS of Icd-9)

102

2.66

3.66

5.7

8.0

1.08

1.05

mmol/l

0.19

Dementia in other diseases classified elsewhere

318

2589

1.27

3.66

4.5

5.7

0.99

1.04

mmol/l

3.51

274

2412

Digeorge syndrome

5.28

3.64

12.3

14.8

1.33

1.40

mmol/l

0.35

Enterohaemorrhagic Escherichia coli infection

3.02

3.62

13.9

6.1

1.06

mmol/l

0.00

Corneal degeneration

117

831

1.50

3.62

7.5

5.1

1.01

1.03

mmol/l

0.43

107

754

Other corneal oedema

418

1.73

3.61

6.9

5.0

1.05

1.04

mmol/l

0.22

379

Inflammatory diseases of prostate (prostatitis)

852

7525

1.15

3.60

6.5

7.1

1.02

1.03

mmol/l

0.25

805

7129

Use of galantamine

409

4877

0.82

3.60

3.1

4.9

0.98

1.05

mmol/l

6.07

369

4443

Primary open-angle glaucoma, strict

1939

17830

1.10

3.58

5.3

5.5

1.03

1.04

mmol/l

1.01

1798

16372

Exophthalmic conditions

472

1.67

3.58

6.8

5.3

1.00

1.04

mmol/l

0.54

430

Burn and corrosion of wrist and hand

229

1796

1.32

3.58

5.2

7.1

1.10

1.06

mmol/l

0.76

218

1691

Atypical virus infections of central nervous system, including avohilmo

409

1.72

3.57

5.3

5.8

1.01

1.02

mmol/l

0.09

380

Other and unspecified acute skin changes due to ultraviolet radiation

164

1233

1.40

3.57

7.4

5.4

1.03

mmol/l

0.01

156

1135

Other acute skin changes due to ultraviolet radiation

215

1676

1.33

3.57

6.5

5.4

1.02

1.03

mmol/l

0.21

205

1552

Contact with hot air and gases

279

1.89

3.56

8.4

6.1

1.05

1.03

mmol/l

0.18

260

Other conjunctival vascular disorders and cysts

154

1149

1.41

3.54

7.0

5.2

1.05

1.03

mmol/l

0.24

145

1065

Other acantholytic disorders

153

2.37

3.53

5.2

6.6

1.03

1.05

mmol/l

0.11

143

Drug-induced nonautoimmune haemolytic anaemia

7.44

3.53

7.9

3.6

0.92

0.95

mmol/l

—

Vestibular neuronitis

564

4850

1.19

3.52

5.2

6.3

1.04

mmol/l

0.19

511

4519

Onychogryphosis

104

2.60

3.51

17.7

4.4

1.10

1.03

mmol/l

0.58

Simple and mucopurulent chronic bronchitis

263

2103

1.29

3.51

8.0

6.2

1.11

1.06

mmol/l

1.31

248

1943

Benign neoplasm of other and unspecified sites

208

1620

1.34

3.50

4.5

5.8

1.03

mmol/l

0.04

195

1500

Adult-onset Still disease

157

2.21

3.50

6.8

4.3

1.07

1.04

mmol/l

0.25

143

Orthopaedic devices associated with adverse incidents

131

958

1.46

3.49

5.8

5.2

1.06

1.03

mmol/l

0.39

120

881

Other protozoal intestinal diseases, including avohilmo

123

882

1.45

3.49

6.7

5.6

1.05

1.06

mmol/l

0.02

116

822

Other congenital malformations of peripheral vascular system

612

1.56

3.47

8.6

7.7

1.10

mmol/l

0.04

573

Injury of muscle and tendon at lower leg level

953

8497

1.14

3.44

7.9

6.9

1.05

1.03

mmol/l

1.28

897

8019

Benign neoplasm: Skin of upper limb, including shoulder

131

957

1.44

3.44

10.2

5.4

1.05

1.03

mmol/l

0.29

125

880

Other and unspecified myoneural disorders

159

2.21

3.43

2.7

6.9

1.04

1.03

mmol/l

0.05

144

Other specified and unspecified disorders of eyelid

690

1.53

3.42

5.3

5.5

1.03

1.04

mmol/l

0.06

634

Vertigo of central origin

110

782

1.49

3.41

3.8

4.9

1.03

1.04

mmol/l

0.14

706

Other specified and unspecified disorders of lens

424

1.69

3.39

4.0

4.7

1.01

1.06

mmol/l

0.96

379

Ankylosing spondylitis, strict definition

232

1834

1.30

3.38

4.4

7.1

1.03

mmol/l

0.06

218

1736

Motorcycle rider injured in noncollision transport accidents

170

1291

1.36

3.37

5.7

7.4

1.04

mmol/l

0.10

164

1222

Open bite

306

2497

1.26

3.36

12.8

7.6

1.14

mmol/l

0.05

288

2353

Kaposi sarcoma, including Hilmo

3.13

3.36

13.2

5.5

0.92

1.09

mmol/l

1.42

Respiratory tuberculosis

342

2828

1.25

3.36

6.6

5.4

1.07

1.03

mmol/l

1.45

313

2591

Fourth [trochlear] nerve palsy

147

1099

1.41

3.36

6.9

5.8

1.05

1.03

mmol/l

0.41

136

1016

Prepatellar bursitis

283

2296

1.27

3.35

8.3

7.2

1.05

1.03

mmol/l

0.42

271

2164

Atopic conjunctivitis

262

2105

1.28

3.34

7.4

6.2

1.08

1.07

mmol/l

0.29

243

1967

Respiratory tuberculosis, confirmed and not-confirmed

342

2830

1.24

3.34

6.6

5.4

1.07

1.03

mmol/l

1.44

313

2592

Infectious mononucleosis, including avohilmo

400

3345

1.22

3.34

6.7

6.2

1.06

mmol/l

0.08

379

3137

Infectious mononucleosis

400

3345

1.22

3.34

6.7

6.2

1.06

mmol/l

0.08

379

3137

Postpartum hemorraghe, parous women as controls

926

8700

0.88

3.33

4.2

4.9

1.04

mmol/l

0.03

864

8120

Injury of muscle and tendon at wrist and hand level

841

7459

1.15

3.33

6.1

7.1

1.05

1.03

mmol/l

0.67

795

7040

Adrenomedullary hyperfunction

134

2.34

3.32

7.0

6.2

1.06

mmol/l

0.05

124

Chronic mastoiditis

166

1266

1.37

3.31

5.4

5.8

1.02

1.03

mmol/l

0.27

148

1168

Alzheimer’s disease (Late onset), excluding more controls

998

5790

1.14

3.30

3.6

5.5

1.01

1.05

mmol/l

5.80

895

5303

Benign neoplasm: Larynx

203

1591

1.33

3.29

6.0

6.4

1.06

1.04

mmol/l

0.39

189

1479

Triptan medication for migraine, min. 3 purchases

3404

23934

1.07

3.27

4.5

6.1

1.03

1.04

mmol/l

3.88

3160

22353

Other bursitis of elbow

421

1.67

3.23

9.3

6.2

1.04

1.03

mmol/l

0.08

397

Superficial injury of neck

113

811

1.45

3.23

4.1

7.0

1.01

1.05

mmol/l

1.02

107

762

Haemangioma, any site

526

4533

1.19

3.21

5.6

6.4

1.01

1.05

mmol/l

3.90

492

4222

Maternal care for known or suspected malpresentation of fetus

650

5317

0.86

3.21

4.5

5.9

1.05

1.04

mmol/l

0.29

616

4976

Other vitreous opacities

270

2194

1.27

3.20

6.2

5.6

1.03

1.04

mmol/l

0.12

245

2027

Benign neoplasm of eye and adnexa

678

5954

1.16

3.20

6.6

6.1

1.05

1.04

mmol/l

0.48

618

5540

Guttate psoriasis

581

1.54

3.20

6.4

5.5

1.08

1.03

mmol/l

0.85

543

Malignant neoplasm of retroperitoneum and peritoneum

335

1.75

3.19

5.0

3.8

1.11

1.01

mmol/l

1.36

300

Other osteochondropathies

397

3345

1.22

3.17

6.7

6.8

1.04

mmol/l

0.02

377

3136

Haemangioma and lymphangioma, any site

560

4855

1.18

3.16

5.8

6.5

1.02

1.06

mmol/l

2.48

522

4517

Subacute thyroiditis

200

1569

1.32

3.15

4.8

5.4

1.02

1.04

mmol/l

0.38

188

1456

Female genital prolapse

1752

8958

1.10

3.12

3.9

5.0

1.03

1.05

mmol/l

1.55

1589

8221

Other and unspecified disorders of globe

2.70

3.09

6.2

7.2

1.12

1.09

mmol/l

0.11

Anomalies of pupillary function

125

922

1.42

3.08

5.2

6.1

1.07

1.06

mmol/l

0.04

118

864

Chronic suppurative otitis media, including avohilmo

490

4219

1.19

3.05

7.3

6.7

1.08

1.07

mmol/l

0.19

457

3928

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

630

1.51

3.04

6.0

5.0

1.05

1.03

mmol/l

0.22

588

Abscess of Bartholin gland

132

981

1.39

3.03

6.0

4.7

1.02

1.04

mmol/l

0.52

124

902

Rickettsioses

2.83

3.03

9.4

7.3

1.06

1.05

mmol/l

0.10

Congenital absence, atresia and stenosis of large intestine

109

2.72

3.02

30.9

7.7

1.35

mmol/l

0.02

102

Cryptococcosis

6.89

3.01

6.5

4.1

0.96

0.99

mmol/l

—

Cryptococcosis, including avohilmo

6.89

3.01

6.5

4.1

0.96

0.99

mmol/l

—

Mandibular retrognathia AND surgery (BSSO)

987

0.65

2.99

2.9

6.1

1.02

1.03

mmol/l

0.18

924

LeFortI or BSSO operation

118

1595

0.72

2.98

4.0

6.1

1.01

1.03

mmol/l

0.56

107

1500

Ulcer of vagina/vulva

154

1177

1.36

2.97

5.3

4.9

1.06

1.05

mmol/l

0.16

143

1073

LSIL lesion of the cervix uteri

523

4523

1.17

2.96

6.5

4.9

1.04

mmol/l

0.08

486

4199

Helminthiases, including avohilmo

236

1904

1.28

2.96

7.7

7.1

1.08

1.10

mmol/l

0.28

227

1786

Nephropathy induced by unspecified drug, medicament or biological substance

5.41

2.95

8.7

4.0

1.13

1.05

mmol/l

—

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

145

1101

1.36

2.91

7.5

5.3

1.06

1.05

mmol/l

0.25

135

1023

Sequelae of malnutrition and other nutritional deficiencies

2.56

2.91

14.9

5.1

1.14

1.03

mmol/l

0.68

Accidental poisoning by and exposure to pesticides

107

2.41

2.89

7.2

6.7

1.07

1.04

mmol/l

0.24

Inguinal or femoral hernia, bilateral

735

6542

1.15

2.87

7.7

6.8

1.02

1.04

mmol/l

1.05

690

6154

Other congenital malformations of digestive system

100

2.43

2.86

9.8

7.3

1.08

1.06

mmol/l

0.14

Alopecia areata

151

1159

1.35

2.85

7.4

6.1

1.07

1.06

mmol/l

0.27

146

1073

Benign neoplasm: Anus and anal canal

179

1410

1.32

2.84

6.5

5.7

1.05

1.04

mmol/l

0.33

163

1305

Generalized epilepsy, mode (most common among epilepsy diagnosis)

176

1380

1.32

2.84

5.8

7.3

1.10

1.09

mmol/l

0.16

162

1298

Rheumatic fever with heart involvement

223

1.89

2.84

17.7

5.3

1.09

1.04

mmol/l

0.62

208

Impacted teeth

991

7667

1.12

2.83

9.9

6.6

1.11

1.08

mmol/l

2.53

939

7178

Allergic colitis

157

1216

1.35

2.82

12.9

9.4

1.20

1.25

mmol/l

1.45

148

1150

L02BG Aromatase inhibitors

1915

17602

1.09

2.82

3.5

4.9

1.04

mmol/l

0.16

1765

16096

Haemorrhage in early pregnancy

1415

12621

1.10

2.82

4.6

5.1

1.04

mmol/l

0.13

1323

11684

Periodontal disease, other/unspecified

160

1242

1.34

2.80

6.6

5.2

1.02

1.04

mmol/l

0.82

155

1144

Tinnitus

1552

14338

1.10

2.79

5.4

6.2

1.01

1.04

mmol/l

3.79

1416

13419

Non-small cell lung cancer, squamous

273

2250

1.24

2.79

4.7

5.4

0.98

1.04

mmol/l

2.66

258

2041

Unspecified parasitic disease, including avohilmo

356

1.66

2.77

10.6

6.4

1.08

1.04

mmol/l

0.55

330

Fetal alcohol syndrome (dysmorphic)

4.44

2.75

4.9

9.0

1.15

1.21

mmol/l

—

Intestinal helminthiases, other/unspecified

5.98

2.75

5.6

9.1

0.91

1.02

mmol/l

—

Ménière disease

584

5138

1.16

2.75

4.3

5.8

1.01

1.04

mmol/l

2.23

540

4760

Sexual dysfunction

109

803

1.42

2.74

10.7

7.7

1.06

1.02

mmol/l

0.84

101

765

Drug-induced hypopituitarism

3.39

2.74

21.6

11.6

0.98

1.13

mmol/l

1.22

Parapsoriasis

118

882

1.40

2.74

4.5

5.9

1.00

1.04

mmol/l

1.28

106

821

Embedded and impacted teeth

1387

10331

1.10

2.72

10.3

6.7

1.10

1.07

mmol/l

2.75

1315

9707

Golimumab

187

1484

1.30

2.72

2.5

7.0

1.02

1.04

mmol/l

0.46

179

1389

Mesothelioma

455

1.58

2.72

5.3

5.2

1.06

1.02

mmol/l

0.38

413

Contact with nonpowered hand tool

249

2044

1.25

2.72

6.2

7.4

1.05

1.03

mmol/l

0.47

231

1934

Arteriovenous malformation of cerebral vessels

496

1.55

2.72

5.3

6.2

1.05

1.04

mmol/l

0.07

468

Lordosis

109

2.30

2.72

9.1

6.7

1.16

1.07

mmol/l

0.51

100

Carcinoma in situ of oral cavity and pharynx

2.67

2.71

4.4

6.7

0.92

1.03

mmol/l

1.53

Lichen planus, including avohilmo

1228

11256

1.11

2.69

5.2

6.0

1.01

1.04

mmol/l

3.67

1148

10480

Mental and behavioural disorders associated with the puerperium

315

1.66

2.69

6.9

6.0

1.11

1.03

mmol/l

1.21

286

Viral conjunctivitis, including avohilmo

214

1728

1.27

2.69

9.2

5.6

1.05

mmol/l

0.02

200

1596

Bursitis of shoulder

151

1171

1.34

2.69

4.2

5.7

1.05

1.04

mmol/l

0.35

145

1082

L02BB Anti-androgens

648

5756

1.15

2.67

4.7

6.7

1.03

1.04

mmol/l

0.40

603

5382

Severe combined immunodeficiency [SCID] with reticular dysgenesis

124

2.20

2.67

19.4

7.7

1.11

1.06

mmol/l

0.36

116

Dermatitis due to ingested food

230

1794

1.26

2.66

7.7

10.2

1.22

1.26

mmol/l

1.10

217

1697

Foreign body in respiratory tract

310

2605

1.22

2.66

6.1

6.5

1.03

1.07

mmol/l

1.81

290

2419

Inguinal hernia, bilateral

719

6426

1.14

2.65

7.6

6.8

1.02

1.04

mmol/l

1.03

677

6050

Seropositive rheumatoid arthritis, strict definition

924

8364

1.12

2.65

4.4

5.8

1.03

1.04

mmol/l

0.08

877

7768

Dysplasia of cervi uteri

1212

7783

1.10

2.64

6.4

5.1

1.05

1.04

mmol/l

0.14

1122

7207

Alzheimer’s disease (Early onset), excluding more controls

145

1763

0.76

2.64

4.7

5.1

1.03

1.06

mmol/l

0.64

131

1607

Fall on and from ladder

489

4267

1.17

2.64

6.1

7.2

1.03

mmol/l

0.04

462

4018

Reduction defects of unspecified limb, including avohilmo

2.93

2.64

5.1

4.8

1.07

1.03

mmol/l

0.21

Sunburn

2.63

7.4

3.5

1.05

1.00

mmol/l

0.71

Other congenital musculoskeletal deformities, including avohilmo

138

2.08

2.63

11.4

10.9

1.18

1.17

mmol/l

0.03

124

Encephalocele

3.18

2.60

9.3

2.8

1.02

1.03

mmol/l

0.02

Maternal care for known or suspected fetal abnormality and damage

554

5344

0.87

2.60

4.3

5.9

1.03

1.04

mmol/l

0.95

517

5012

Glaucoma-related operations

380

3262

1.20

2.59

5.1

5.4

1.05

1.04

mmol/l

0.63

359

3001

Endometriosis ASRM stages 1,2

883

7971

1.12

2.59

4.1

5.1

1.03

1.04

mmol/l

0.67

820

7378

Pedal cyclist injured in noncollision transport accidents

681

6068

1.14

2.58

6.1

6.7

1.04

1.05

mmol/l

0.41

641

5693

Other specified and unspecified strabismus

534

1.50

2.57

7.3

6.1

1.16

1.09

mmol/l

0.92

496

Beningn neoplasm: Meninges, unspecified

100

739

1.42

2.55

4.2

4.9

1.00

1.04

mmol/l

0.74

670

Benign neoplasm: Connective and other soft tissue of head, face and neck

729

1.42

2.55

4.3

5.7

0.98

1.03

mmol/l

1.66

680

Other maternal disorders predominantly related to pregnancy

3181

18839

1.06

2.54

5.3

5.2

1.04

mmol/l

0.18

2968

17391

Lichen ruber planus, wide definition including periferal and oral lichen planus

1459

13509

1.09

2.53

5.0

5.9

1.01

1.04

mmol/l

3.81

1364

12581

Other infective spondylopathies

2.41

2.53

5.3

4.9

1.15

1.07

mmol/l

0.25

Hand

222

1.81

2.53

11.8

5.9

1.02

1.03

mmol/l

0.10

206

Macular cyst

214

1750

1.27

2.53

9.3

5.6

1.06

1.02

mmol/l

1.10

199

1612

Contraceptive management

2213

16483

0.93

2.53

6.4

7.0

1.03

1.04

mmol/l

0.39

2073

15508

Ethmoidectomy

757

6797

1.13

2.53

5.1

6.6

1.03

mmol/l

0.29

714

6380

Contact with other hot fluids

183

1466

1.29

2.52

6.3

7.7

1.10

1.07

mmol/l

0.60

169

1377

Perichondritis of external ear

110

826

1.40

2.52

5.4

1.04

1.03

mmol/l

0.11

105

756

Squamous cell neoplasms and carcinoma of cervix

228

1.77

2.52

13.3

4.2

1.03

1.04

mmol/l

0.06

201

Congenital absence, atresia and stenosis of small intestine

2.82

2.52

27.1

6.4

1.33

1.40

mmol/l

0.44

Post-traumatic hydrocephalus, unspecified

120

2.19

2.52

10.8

6.3

0.97

1.06

mmol/l

0.75

110

Abnormal reflex

215

1.83

2.52

7.2

5.8

1.07

1.03

mmol/l

0.50

198

Malignant otitis externa

2.60

2.51

17.9

3.4

1.15

1.02

mmol/l

0.51

Mononeuritis multiplex

120

2.17

2.50

7.0

5.0

1.03

mmol/l

0.04

114

Abnormal findings on diagnostic imaging of breast

638

1.45

2.50

5.1

3.8

1.03

mmol/l

0.06

571

Disorders of other and unspecified cranial nerves

239

1.78

2.50

7.9

5.9

1.02

1.04

mmol/l

0.13

215

Hyperchylomicronaemia

2.57

2.49

29.8

2.4

1.16

1.01

mmol/l

0.88

Bilateral sagittal split ramus osteotomy operation

1308

0.72

2.48

3.5

5.9

1.01

1.03

mmol/l

0.47

1228

Unspecified parasitic disease

350

1.63

2.48

10.9

6.4

1.08

1.04

mmol/l

0.51

325

Pathological resorption of teeth

221

1812

1.26

2.48

8.4

6.5

1.04

mmol/l

0.02

203

1694

Congenital ichthyosis

135

2.09

2.47

13.6

6.6

1.16

1.11

mmol/l

0.31

126

Suppurative otitis media, unspecified

141

1096

1.33

2.46

8.7

5.6

1.12

1.08

mmol/l

0.96

134

1013

Primary open-angle glaucoma

2341

21218

1.07

2.46

5.3

5.5

1.04

mmol/l

0.07

2156

19478

Infections of genitourinary tract in pregnancy

456

3972

1.17

2.44

5.5

5.2

1.07

1.04

mmol/l

1.21

420

3644

Female infertility, cervical, vaginal, other or unspecified origin

1340

7889

1.09

2.43

4.2

5.2

1.05

mmol/l

0.08

1262

7328

Poor fetal growth

489

4275

1.16

2.43

7.1

5.1

1.05

1.04

mmol/l

0.59

451

3998

Kwashiorkor

2.65

2.42

7.3

5.2

1.09

1.06

mmol/l

0.17

Other puerperal infections

305

2572

1.20

2.42

3.4

5.0

1.02

1.04

mmol/l

0.78

287

2385

Pedestrian injured in other and unspecified transport accidents

541

1.48

2.42

7.4

5.4

1.10

1.04

mmol/l

0.83

492

Inflammatory disease of cervix uteri

345

2952

1.20

2.41

3.8

4.8

1.02

1.04

mmol/l

0.57

310

2689

Laparoscopic left hemicolectomy

117

896

1.37

2.40

4.7

6.3

1.04

1.03

mmol/l

0.08

109

838

Benign lipomatous neoplasm

1933

18121

1.08

2.39

6.0

6.2

1.04

mmol/l

0.28

1793

16914

Deficiency of vitamin E

8.69

2.39

5.6

9.7

0.95

0.89

mmol/l

—

Benign neoplasm: Long bones of lower limb

181

1459

1.28

2.38

6.8

6.3

1.04

1.03

mmol/l

0.02

172

1364

Foreign body or object entering through skin

352

3020

1.19

2.37

6.8

7.0

1.03

1.04

mmol/l

0.16

341

2829

Distal bite

247

2043

1.23

2.37

14.0

8.4

1.20

1.19

mmol/l

0.26

232

1940

Hyperfunction of pituitary gland, other and/or unspecified

2.71

2.37

11.7

4.5

1.03

1.01

mmol/l

0.18

Congenital malformation of optic disc

2.61

2.37

29.5

11.7

1.32

1.27

mmol/l

0.22

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

682

1.43

2.36

11.6

4.9

1.05

1.03

mmol/l

0.25

622

Muscle strain

186

1504

1.27

2.36

8.3

6.4

1.08

1.04

mmol/l

0.90

175

1410

Other specific arthropathies, wide

121

930

1.35

2.34

5.2

5.4

1.06

1.02

mmol/l

1.03

116

844

Assault by other and unspecified firearm discharge

2.59

2.34

10.3

8.1

1.11

1.00

mmol/l

0.83

Injury of blood vessels at forearm level

145

2.00

2.33

12.2

8.7

1.14

1.04

mmol/l

0.79

139

Fibrosarcoma, including Hilmo

355

1.59

2.32

5.4

1.04

1.05

mmol/l

0.13

329

Q fever

5.30

2.32

11.0

15.3

1.05

1.02

mmol/l

—

Other obstructed labour

370

3192

1.18

2.30

4.3

5.2

1.03

1.04

mmol/l

0.04

339

2953

HSIL lesion of the cervix uteri, vagina or vulva

944

8610

1.11

2.28

6.8

5.1

1.04

mmol/l

0.23

880

7997

Postinflammatory hyperpigmentation

2.63

2.28

13.2

4.0

1.19

1.04

mmol/l

0.88

FESS (DNB20)

723

6518

1.13

2.28

4.9

6.6

1.03

mmol/l

0.24

682

6123

Benign neoplasm: Peripheral nerves and autonomic nervous system

100

754

1.39

2.27

3.8

5.8

1.03

1.02

mmol/l

0.12

695

Contusion of toe(s) with damage to nail

497

1.48

2.26

10.4

6.6

1.11

1.05

mmol/l

0.93

466

Effects of other external causes

151

1198

1.30

2.26

5.5

7.5

1.03

1.05

mmol/l

0.39

141

1129

Other and unspecified disorders of vitreous body

2995

27854

1.06

2.25

5.7

1.03

mmol/l

0.32

2747

25899

Female infertility

1452

8066

1.09

2.24

4.4

5.2

1.05

mmol/l

0.19

1365

7490

Foreign body entering into or through eye or natural orifice

475

4185

1.16

2.24

7.1

7.2

1.03

1.05

mmol/l

0.74

447

3932

Sexual assault by bodily force

2.37

2.24

3.3

3.9

1.09

1.03

mmol/l

0.31

Medial epicondylitis

208

1713

1.25

2.24

5.5

6.6

1.00

1.04

mmol/l

1.19

198

1602

Lichen sclerosus et atrophicus

669

6015

1.13

2.23

4.6

4.8

1.02

1.03

mmol/l

0.92

623

5502

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

247

2067

1.22

2.23

4.9

6.0

1.03

mmol/l

0.06

232

1939

Vascular dementia (subcortical)

244

2048

1.23

2.23

4.5

5.2

1.03

1.05

mmol/l

0.55

222

1894

Macular hole

382

3325

1.18

2.23

6.0

5.6

1.02

1.03

mmol/l

0.40

352

3058

Inflammation of lacrimal passages (acute and unspecified)

108

825

1.36

2.23

8.5

5.0

1.04

mmol/l

0.04

101

747

Fractures involving multiple body regions

2.24

2.22

6.5

1.06

1.03

mmol/l

0.23

Benign neoplasm: Lower jaw bone

185

1.83

2.21

5.6

6.3

1.03

1.07

mmol/l

0.36

171

Systemic atrophies primarily affecting the central nervous system

268

2269

1.22

2.21

6.0

6.3

1.04

1.05

mmol/l

0.20

252

2099

Normotensive glaucoma

578

5168

1.14

2.21

5.6

5.4

1.03

1.04

mmol/l

0.27

536

4761

Isolated patent ductus arteriosus

669

1.43

2.20

13.4

12.4

1.32

1.34

mmol/l

0.23

639

Profound mental retardation

2.59

2.19

5.1

8.8

1.16

1.20

mmol/l

0.23

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

272

1.67

2.18

5.7

5.0

1.05

1.01

mmol/l

0.43

246

Nezelof syndrome

163

1.88

2.17

3.2

5.6

0.96

1.05

mmol/l

1.40

146

Stenosis and insufficiency of lacrimal passages

575

5140

1.14

2.16

5.6

1.03

1.05

mmol/l

0.65

539

4749

Transient acantholytic dermatosis [Grover]

114

2.18

2.16

2.0

7.1

0.99

1.05

mmol/l

0.42

108

Chronic inflammatory disorders of orbit

112

2.10

2.16

8.4

5.3

1.00

0.99

mmol/l

0.05

107

Anti-inflammatory and antirheumatic products, non-steroids

2209

10464

1.07

2.15

5.7

9.6

1.05

1.08

mmol/l

3.52

2055

9809

Unspecified lump in breast

884

8078

1.11

2.14

4.8

4.9

1.04

mmol/l

0.16

805

7425

Murder, homicide, or other assault by rifle, shotgun and larger firearm discharge

3.36

2.13

35.0

16.6

0.98

1.05

mmol/l

—

Endometriosis of ovary

902

7761

1.11

2.12

5.0

5.2

1.02

1.04

mmol/l

1.72

822

7178

Other and unspecified mononeuropathies of lower limb

162

1311

1.28

2.12

4.8

5.1

1.03

mmol/l

0.10

145

1202

Other congenital musculoskeletal deformities

120

2.02

2.10

12.7

11.6

1.20

1.19

mmol/l

0.01

109

Kernicterus

6.63

2.08

1.8

7.2

0.84

1.00

mmol/l

—

Need for immunization against certain single viral diseases

2.62

2.08

7.8

10.6

1.09

1.06

mmol/l

0.13

Other noninflammatory disorders of cervix uteri

278

2372

1.20

2.07

5.3

5.0

1.07

1.04

mmol/l

1.35

260

2181

Melanoma in situ

297

2555

1.20

2.06

8.0

5.6

1.02

1.03

mmol/l

0.50

279

2363

Precocious puberty

212

1.73

2.06

19.4

9.3

1.24

1.23

mmol/l

0.04

201

Thoracic root disorders

2.40

2.06

5.5

6.5

1.21

1.00

mmol/l

0.91

Haemorrhagic and haematological disorders of fetus and newborn

173

1364

1.28

2.05

16.0

13.0

1.36

1.35

mmol/l

0.27

168

1304

Other specified and unspecified disorders of iris and ciliary body

166

1.84

2.05

6.0

5.5

1.00

1.07

mmol/l

0.78

156

Mental and behavioural disorders due to hallucinogens

204

1.73

2.05

4.6

6.1

1.07

1.01

mmol/l

0.44

190

Oral leukoplakia, including avohilmo

169

1381

1.27

2.05

6.6

6.2

1.04

1.03

mmol/l

0.37

155

1281

Other hypertrichosis

121

1.99

2.04

8.3

5.7

1.00

1.07

mmol/l

0.47

107

Operations 1 for CAVS

161

1.90

2.03

20.0

10.9

1.20

1.17

mmol/l

0.24

151

Postpartum haemorrhage due to retained placenta

394

4498

0.87

2.03

3.5

4.7

1.03

1.04

mmol/l

0.81

370

4200

Benign neoplasm: Connective and other soft tissue, unspecified

509

1.44

2.02

5.3

1.02

1.04

mmol/l

0.17

473

Short Achilles tendon (acquired)

150

1209

1.28

2.02

5.6

5.3

1.13

1.04

mmol/l

3.51

145

1114

Keratoconus

136

1085

1.29

2.01

8.6

6.5

1.05

1.03

mmol/l

0.23

129

1025

Congenital malformations of ovaries, fallopian tubes and broad ligaments

243

2051

1.21

2.01

5.4

5.1

1.05

mmol/l

0.23

219

1894

Other specified transport accidents

253

1.64

2.00

6.6

6.9

1.10

1.08

mmol/l

0.22

233

Benign neoplasm: Nasopharynx

419

1.50

1.99

4.8

5.0

1.00

1.04

mmol/l

0.53

391

Other appendicitis

471

4183

1.14

1.99

7.3

6.5

1.03

1.04

mmol/l

0.23

446

3908

Carcinoma in situ of other/unspecified male genital organs

4.82

1.98

5.8

11.3

0.91

1.00

mmol/l

—

Unspecified abortion

240

2029

1.21

1.98

6.5

5.3

1.02

1.04

mmol/l

0.71

222

1869

Allergic contact dermatitis due to drugs in contact with skin

125

991

1.31

1.97

7.8

5.1

1.11

1.03

mmol/l

2.00

116

913

Any dementia, excluding more controls

2708

17691

1.06

1.97

4.1

5.6

1.02

1.04

mmol/l

3.29

2434

16305

Cutaneous autosensitization

2.97

1.97

2.3

7.8

0.98

1.06

mmol/l

—

Torsion of testis

101

777

1.34

1.97

8.9

8.7

1.04

1.10

mmol/l

1.00

742

Contact with other sharp object(s)

359

3133

1.16

1.97

6.8

7.3

1.06

1.05

mmol/l

0.23

336

2942

Liposarcoma

303

1.58

1.96

6.9

5.1

1.08

1.01

mmol/l

1.07

273

Complications associated with artificial fertilization

465

1.43

1.96

2.7

5.8

1.00

1.04

mmol/l

0.73

436

Vascular dementia (other)

380

1.52

1.94

2.9

4.9

1.02

1.07

mmol/l

0.42

355

Abnormal findings in secretions and smears from cervix uteri vagina vulva

2768

19387

1.06

1.93

6.1

5.0

1.04

mmol/l

0.29

2597

17895

Mental and behavioural disorders of puerperium, not classified elsewhere

343

1.51

1.93

6.9

5.0

1.11

1.04

mmol/l

1.00

313

Primary angle-closure glaucoma

275

2368

1.19

1.90

7.9

5.4

1.06

1.03

mmol/l

0.79

252

2164

Dissection of cerebral arteries, nonruptured

322

1.55

1.90

8.7

5.1

1.01

1.02

mmol/l

0.06

300

Vitiligo

489

1.43

1.89

7.8

5.4

1.06

1.04

mmol/l

0.30

458

Burn and corrosion of hip and lower limb, except ankle and foot

132

1059

1.29

1.89

6.7

1.04

mmol/l

0.04

123

997

Maternal care for cervical incompetence

192

1601

1.23

1.88

4.3

4.8

1.04

1.05

mmol/l

0.28

187

1465

Granulosa cell carcinoma of ovary

147

1.83

1.88

5.2

4.2

1.06

mmol/l

0.01

131

Tic and related disorders

682

1.36

1.86

7.9

9.9

1.14

1.19

mmol/l

0.76

641

Melanocytic naevi of scalp and neck

133

1071

1.28

1.85

10.0

5.8

1.07

1.05

mmol/l

0.59

125

998

Single ventricle heart

107

2.17

1.84

26.6

15.5

1.35

1.31

mmol/l

0.22

Non-allergic asthma

523

4699

1.13

1.83

6.5

7.1

1.07

mmol/l

0.06

502

4384

Pseudopolyposis of colon

127

1.91

1.81

4.8

6.0

0.99

mmol/l

0.00

115

Other and unspecified disorders of refraction

3.09

1.81

3.7

10.0

1.05

1.04

mmol/l

—

Benign neoplasm: Other and unspecified parts of mouth

197

1658

1.22

1.80

6.9

5.7

1.04

1.03

mmol/l

0.20

184

1537

Pleural plaque with presence of asbestos

494

4442

1.14

1.80

5.1

6.7

1.04

mmol/l

0.01

451

4157

Traumatic secondary and recurrent haemorrhage

2.24

1.77

8.9

3.8

1.02

1.01

mmol/l

0.02

Fatigue fracture of vertebra

297

1.58

1.77

4.3

7.4

1.09

1.16

mmol/l

0.92

277

Other chromosome abnormalities, not elsewhere classified

360

1.55

1.75

6.3

12.3

1.29

1.34

mmol/l

0.62

340

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

129

1043

1.30

1.75

12.1

14.4

1.45

1.36

mmol/l

1.93

123

996

Abnormal findings in peritoneal fluid saliva

167

1.76

1.74

8.8

5.7

0.97

1.04

mmol/l

0.74

150

Hirsprung

2.42

1.74

27.1

10.1

1.12

1.33

mmol/l

1.78

Complications of the puerperium, not elsewhere classified

165

1364

1.23

1.74

3.9

5.2

1.04

1.05

mmol/l

0.30

154

1271

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

137

1119

1.26

1.72

6.8

5.7

1.01

1.03

mmol/l

0.37

125

1029

Contact with blunt object, undetermined intent

255

1.58

1.71

8.9

6.8

1.03

mmol/l

0.03

238

Pemphigus vulgaris

100

2.04

1.71

11.6

4.3

0.99

1.05

mmol/l

0.44

Benign neoplasm: Other/unspecified site

719

1.33

1.69

5.4

5.7

1.02

1.04

mmol/l

0.19

669

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

268

2317

1.17

1.68

4.3

4.9

1.05

1.04

mmol/l

0.35

257

2150

Exposure to controlled fire, not in building or structure

130

1.85

1.68

4.5

7.3

0.99

1.01

mmol/l

0.16

125

Scissor bite

182

1518

1.22

1.67

11.6

9.8

1.23

1.21

mmol/l

0.38

170

1447

Mandibular prognathia

765

1.32

1.66

8.2

8.6

1.07

1.12

mmol/l

0.93

724

Other bursal cyst

740

1.32

1.64

8.0

5.4

1.06

1.04

mmol/l

0.25

683

Benign neoplasm of thyroid gland

185

1564

1.21

1.63

5.4

4.8

1.03

mmol/l

0.03

173

1442

Melanoma of uvea

479

1.41

1.63

7.2

5.7

1.14

1.04

mmol/l

1.31

445

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

251

1.57

1.62

9.2

7.3

1.04

1.00

mmol/l

0.38

242

Respiratory distress of newborn

145

1125

1.27

1.61

14.8

13.2

1.39

1.37

mmol/l

0.29

140

1071

Hereditary ataxia

619

1.35

1.61

9.1

6.9

1.09

1.06

mmol/l

0.39

577

Benign lipomatous neoplasm of other sites/unspecified

522

4736

1.12

1.60

5.7

6.0

1.06

1.04

mmol/l

0.66

483

4392

Maternal care for known or suspected disproportion

179

1507

1.21

1.59

4.4

5.8

1.07

1.03

mmol/l

1.46

168

1423

Subclinical iodine-deficiency hypothyroidism

2.27

1.59

4.4

4.1

1.07

1.03

mmol/l

0.25

Drug-induced autoimmune haemolytic anaemia

2.44

1.58

18.7

4.1

1.19

1.02

mmol/l

0.67

Moyamoya

2.76

1.58

17.2

7.5

1.12

1.02

mmol/l

—

Benign neoplasm: Skin of lip

603

1.35

1.58

8.0

5.2

1.00

1.04

mmol/l

0.79

559

Loose body in joint

131

1075

1.25

1.58

4.7

6.5

1.00

1.03

mmol/l

0.45

122

996

Telogen effluvium

2.08

1.57

15.9

5.6

1.04

1.07

mmol/l

0.14

Disorders of puberty, other/unspecified

197

1.65

1.56

10.5

8.9

1.17

1.24

mmol/l

1.02

184

Sequelae of tuberculosis

105

843

1.28

1.55

6.8

4.7

1.07

1.04

mmol/l

0.52

758

Sequelae of tuberculosis, including avohilmo

108

870

1.28

1.55

6.8

4.6

1.08

1.04

mmol/l

0.64

781

Benign neoplasm: Cranial nerves

174

1473

1.22

1.55

4.9

5.5

1.01

1.03

mmol/l

0.56

159

1361

Use of levodopa decarbox-comt-inhibitor

150

1787

0.82

1.54

3.4

5.8

1.00

1.03

mmol/l

1.10

138

1657

Use of selegiline

212

2458

0.84

1.54

3.3

5.9

1.00

1.04

mmol/l

1.19

190

2279

Hereditary corneal dystrophies

213

1834

1.19

1.54

6.0

5.2

1.01

1.03

mmol/l

0.45

189

1678

Granuloma faciale [eosinophilic granuloma of skin]

3.63

1.51

5.6

6.3

1.17

1.07

mmol/l

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

192

2243

0.84

1.51

3.5

5.4

1.01

1.04

mmol/l

1.45

181

2058

Medicines for HER+ breast cancer

2283

20324

1.05

1.51

3.6

5.0

1.04

mmol/l

0.26

2108

18606

Complications following abortion and ectopic and molar pregnancy

190

1623

1.20

1.51

4.4

4.9

1.03

1.04

mmol/l

0.14

173

1492

Disorders of acoustic nerve

165

1394

1.22

1.51

4.9

5.4

1.01

1.04

mmol/l

0.56

150

1298

Certain zoonotic bacterial diseases, including avohilmo

171

1448

1.21

1.50

7.2

5.8

1.05

1.04

mmol/l

0.17

161

1338

Propionic acid derivatives

2181

10459

1.05

1.48

5.3

9.6

1.05

1.08

mmol/l

3.51

2030

9804

Disturbances of smell and taste

236

2052

1.17

1.48

5.0

5.9

1.01

1.04

mmol/l

1.16

216

1909

Congenital malformations of breast

509

1.35

1.48

3.6

5.3

1.01

1.06

mmol/l

0.80

472

Other deformity of hallux (acquired)

340

1.45

1.48

4.2

5.4

1.05

mmol/l

0.01

306

Benign neoplasm: Choroid

406

3658

1.13

1.47

6.3

5.9

1.04

mmol/l

0.02

361

3393

Viral conjunctivitis

111

903

1.26

1.46

11.2

5.5

1.08

1.04

mmol/l

0.72

105

843

Transient retinal artery occlusion

1.93

1.45

9.2

5.9

1.08

1.06

mmol/l

0.10

Idiopathic urticaria

113

922

1.26

1.45

5.7

5.6

1.06

1.04

mmol/l

0.51

106

861

Other benign neoplasms of uterus

300

2661

1.15

1.43

3.8

4.2

1.03

1.05

mmol/l

0.31

263

2397

Sequelae of poliomyelitis, including avohilmo

412

1.40

1.42

5.2

4.7

1.02

1.03

mmol/l

0.05

383

Other specified/unspecified disorders of middle ear and mastoid

106

1.86

1.41

4.9

6.1

1.06

1.07

mmol/l

0.11

Generalized epilepsy, strict definition

124

1026

1.24

1.41

5.6

7.7

1.16

1.12

mmol/l

0.55

119

964

Carcinoma in situ of prostate

253

1.54

1.40

6.9

7.0

0.97

1.03

mmol/l

0.71

246

Complications predominantly related to the puerperium

1261

11894

1.07

1.40

4.1

5.2

1.02

1.04

mmol/l

2.08

1191

11037

Female infertility, tubal origin

219

1900

1.17

1.39

6.1

5.5

1.03

1.04

mmol/l

0.40

207

1782

Other benign neoplasm of uterus: Corpus uteri

353

1.43

1.39

6.0

4.4

1.04

1.05

mmol/l

0.14

313

Benign neoplasm: Lip

123

1021

1.24

1.38

4.9

5.6

0.97

1.02

mmol/l

1.33

106

940

Sleepwalking [somnambulism]

114

1.79

1.38

5.3

5.7

1.12

1.10

mmol/l

0.10

104

Bullous keratopathy

406

1.40

1.38

4.8

4.7

1.04

1.05

mmol/l

0.07

369

Unspecified maternal hypertension

326

1.42

1.36

3.3

5.2

1.01

1.04

mmol/l

0.36

296

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

3726

27971

1.04

1.36

6.3

5.7

1.04

mmol/l

0.01

3490

26003

Peripheral retinal degeneration

174

1492

1.19

1.35

6.0

5.3

1.00

1.02

mmol/l

0.37

162

1376

Contracture of joint

546

1.33

1.35

5.9

5.4

1.07

1.02

mmol/l

0.84

500

Congenital malformations of breast, including avohilmo

553

1.31

1.34

3.6

5.3

1.02

1.06

mmol/l

0.62

513

Glaucoma in diseases classified elsewhere

3.41

1.33

34.6

4.3

1.22

1.00

mmol/l

—

Otosclerosis

361

4003

0.89

1.33

5.9

6.1

1.01

1.04

mmol/l

1.37

343

3714

Other degenerative diseases of the basal ganglia

124

1038

1.24

1.33

3.9

6.0

1.00

1.03

mmol/l

0.57

119

965

Pregnancy with abortive outcome

4064

20491

1.04

1.32

4.9

1.04

1.05

mmol/l

0.50

3742

18783

Benign neoplasm: Skin of scalp and neck

146

1238

1.21

1.30

9.9

6.5

1.04

mmol/l

0.07

133

1151

Dementia due to Parkinsons disease, excluding more controls

131

1100

1.22

1.30

2.5

5.5

0.97

1.05

mmol/l

3.85

119

1026

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

792

7392

1.08

1.29

5.8

6.3

1.04

1.03

mmol/l

0.20

730

6903

Vasomotor rhinitis (mode)

414

3762

1.12

1.29

5.9

6.0

1.03

1.04

mmol/l

0.27

370

3505

Blepharospasm

419

1.37

1.29

4.9

4.7

0.97

1.03

mmol/l

1.14

380

Nasal polyp

1202

11371

1.07

1.28

5.5

6.7

1.02

1.03

mmol/l

0.59

1134

10676

Thromboangiitis obliterans

141

1.67

1.27

7.8

6.1

1.03

mmol/l

0.00

130

Benign neoplasm: Lymph nodes

118

1.76

1.26

4.3

4.1

1.04

1.01

mmol/l

0.19

108

Spasmodic torticollis

172

1483

1.19

1.26

3.7

5.4

1.03

1.04

mmol/l

0.05

160

1372

Postpartum care and examination

522

3573

0.91

1.26

5.7

5.5

1.07

1.05

mmol/l

1.22

480

3306

Hyperalimentation, other specified

2.41

1.25

2.1

3.8

0.98

1.10

mmol/l

—

Chondrosarcoma

126

1.71

1.25

2.4

6.6

0.98

1.07

mmol/l

0.85

117

Myasthenia gravis, drug-induced

2.08

1.25

4.6

5.7

0.96

1.03

mmol/l

0.36

MS-disease / Multiple Sclerosis

339

3051

1.12

1.25

4.1

6.0

1.00

1.03

mmol/l

1.79

307

2851

Other or unspecified paralytic strabismus

274

1.45

1.24

5.1

4.7

0.99

1.04

mmol/l

0.91

249

Peroneal tendinitis

713

1.27

1.24

6.6

5.6

1.04

1.03

mmol/l

0.15

671

Preterm labour and delivery

1304

12365

1.06

1.24

5.8

5.4

1.04

mmol/l

0.21

1208

11460

Edwards' syndrome and Patau's syndrome

2.33

1.24

11.9

8.1

0.91

1.13

mmol/l

—

Malignant neoplasm of eye and adnexa

343

1.40

1.24

6.6

5.8

1.10

1.06

mmol/l

0.29

314

Pedestrian injured in collision with pedal cycle

168

1448

1.18

1.24

4.3

6.3

1.05

1.04

mmol/l

0.18

161

1343

Presbyopia

430

3925

1.11

1.22

5.8

6.3

1.02

1.03

mmol/l

0.46

397

3681

Congenital mitral valve regurgitation

113

1.82

1.22

21.9

11.8

1.19

1.27

mmol/l

0.49

105

Other haemoglobinopathies

104

1.81

1.22

6.3

5.5

1.04

1.01

mmol/l

0.21

Idiopathic progressive neuropathy

1.99

1.22

2.1

6.4

1.15

1.06

mmol/l

0.66

Other benign neoplasm of uterus: Other parts/unspecified

230

2035

1.15

1.20

3.1

3.9

1.04

mmol/l

0.18

201

1821

Family history of certain disabilities and chronic diseases leading to disablement

211

1849

1.16

1.20

7.1

3.7

1.03

mmol/l

0.02

201

1718

Traumatic amputation of forearm

2.61

1.19

30.1

4.4

1.01

1.03

mmol/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

355

3211

1.12

1.19

5.2

4.8

1.04

mmol/l

0.19

335

2980

Postpolio syndrome

1.86

1.18

5.6

5.7

1.02

1.07

mmol/l

0.27

Early lumbar disc prolapse operation

478

4387

1.10

1.18

6.2

7.1

1.03

mmol/l

0.17

453

4156

Other disorders affecting eyelid function

452

1.34

1.18

4.9

5.2

1.05

mmol/l

0.01

415

Disorders of vagus nerve

2.20

1.17

29.8

8.7

1.13

1.03

mmol/l

—

Transient global amnesia

496

5375

0.91

1.17

5.0

5.8

1.01

1.04

mmol/l

1.95

463

5003

Retinal breaks without detachment

1002

9464

1.07

1.17

6.7

5.7

1.03

mmol/l

0.02

917

8828

Carcinoma in situ of breast, other/unspecified

613

1.28

1.16

3.1

4.0

1.06

1.05

mmol/l

0.09

549

Acquired stenosis of external ear canal

498

1.32

1.16

6.9

6.7

0.98

1.04

mmol/l

0.86

463

Kissing spine

1.88

1.15

4.2

5.8

1.07

1.02

mmol/l

0.24

Labour and delivery complicated by umbilical cord complications

214

1885

1.15

3.6

5.2

1.04

mmol/l

0.01

200

1750

Dislocation, sprain and strain of joints and ligaments of elbow

344

3119

1.12

1.14

7.0

6.7

1.07

mmol/l

0.07

321

2905

conjunctival degenerations and deposits

124

1053

1.21

1.14

7.5

5.2

1.01

1.03

mmol/l

0.28

119

963

Epiphora

133

1137

1.20

1.13

5.4

5.1

1.07

1.04

mmol/l

0.39

126

1040

Congenital malformations of posterior segment of eye

273

1.44

1.12

16.9

9.4

1.17

1.18

mmol/l

0.07

257

Unspecified chronic bronchitis

196

1722

1.16

1.12

9.4

5.5

1.03

mmol/l

0.08

182

1584

Abnormalities of forces of labour

384

4208

0.90

1.12

4.8

5.6

1.06

1.04

mmol/l

0.86

364

3934

Congenital myopathies

1.83

1.12

3.2

7.6

1.14

1.08

mmol/l

0.43

Disorders of hypoglossal nerve

1.98

1.11

6.3

3.0

1.04

0.99

mmol/l

0.36

Meningococcal infection

254

1.43

1.11

8.3

4.1

1.07

1.04

mmol/l

0.27

232

Noonan syndrome

2.03

1.10

14.3

15.2

1.29

mmol/l

0.01

Degenerative macular diseases, drug-induced

147

1.60

1.10

5.0

6.4

1.04

1.05

mmol/l

0.08

135

Intrahepatic Cholestasis of Pregnancy (ICP)

268

2401

1.13

1.09

4.3

5.3

1.05

mmol/l

0.17

257

2230

Triptan medication for migraine, single purchase ok

4977

32852

1.03

1.09

4.8

6.6

1.03

1.05

mmol/l

5.30

4621

30774

Migraine, single triptan purchase ok & required. ICD-code if available is included

4977

32852

1.03

1.09

4.8

6.6

1.03

1.05

mmol/l

5.30

4621

30774

Complications of anaesthesia during the puerperium

106

1.69

1.09

3.7

5.0

1.06

1.01

mmol/l

0.49

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

249

2229

1.14

1.08

4.9

6.1

1.02

1.03

mmol/l

0.19

229

2064

Other bursitis, not elsewhere classified

413

1.33

1.08

4.1

6.2

1.04

mmol/l

0.02

387

All dysplastic lesions of the cervix uteri

1193

11160

1.06

1.07

6.6

5.1

1.04

mmol/l

0.07

1114

10383

Assault by drugs, medicaments and biological substances

1.99

1.07

2.8

7.3

1.04

1.02

mmol/l

0.07

Carcinoma in situ of cervix uteri

417

3827

1.10

1.06

6.8

4.9

1.07

1.04

mmol/l

1.34

385

3545

Other conditions originating in the perinatal period

2.05

1.05

39.6

15.9

1.31

1.37

mmol/l

0.30

HSIL lesion of the cervix uteri

797

7496

1.07

1.05

6.5

5.1

1.04

mmol/l

0.01

745

6973

Dyshidrosis [pompholyx]

629

1.25

1.05

6.6

5.5

1.03

1.04

mmol/l

0.17

580

Injury of nerves at hip and thigh level

191

1.51

1.04

5.0

5.7

1.06

1.08

mmol/l

0.22

173

Maternal care for known or suspected abnormality of pelvic organs

1067

7595

0.94

1.04

4.2

5.7

1.04

mmol/l

0.07

1019

7079

Unspecified contact dermatitis due to drugs in contact with skin

2.17

1.04

5.9

3.7

1.28

1.01

mmol/l

—

Small cell lung cancer, including Hilmo

129

1107

1.19

1.03

4.0

4.5

1.07

1.02

mmol/l

0.61

121

992

Small cell lung cancer

129

1107

1.19

1.03

4.0

4.5

1.07

1.02

mmol/l

0.61

121

992

Epidermolysis bullosa

1.97

1.03

20.2

14.8

1.11

1.22

mmol/l

0.70

Alzheimer’s disease (Atypical or mixed)

683

7179

0.93

1.03

3.6

4.9

1.03

1.05

mmol/l

1.25

580

6558

Benign neoplasm: Short bones of upper limb

668

1.25

1.03

6.0

5.9

1.04

mmol/l

0.02

630

Meningococcal infection, including avohilmo

258

1.40

1.03

8.3

4.1

1.07

1.04

mmol/l

0.27

234

Anisometropia and aniseikonia

184

1626

1.15

1.01

8.5

6.2

1.12

1.08

mmol/l

1.04

171

1499

Use of amantadine

725

1.23

1.00

3.6

5.0

1.02

1.03

mmol/l

0.05

657

Polyhydramnios

181

1595

1.15

0.99

7.1

5.8

1.04

mmol/l

0.05

168

1490

Impacted maxillary canine

510

1.29

0.99

15.9

9.7

1.24

1.23

mmol/l

0.17

482

Deformity of finger(s)

279

1.39

0.98

5.4

1.05

1.01

mmol/l

0.34

255

Congenital malformations of larynx

222

1.48

0.98

19.5

11.4

1.28

1.36

mmol/l

0.49

209

Other and unspecified degenerative diseases of nervous system

170

1502

1.16

0.96

4.3

5.6

1.01

1.05

mmol/l

0.88

157

1388

Benign neoplasm: Liver/bile ducts (ICD-9)

2.13

0.96

11.6

3.9

1.16

1.08

mmol/l

—

Benign neoplasm of breast

631

5921

1.07

0.95

4.6

4.8

1.05

1.04

mmol/l

0.42

565

5414

Aggressive periodontitis

128

1110

1.18

0.95

7.6

6.2

1.08

1.03

mmol/l

1.12

119

1026

Tooth agenesis EXCLUDE clefts and syndromes

203

1809

1.14

0.95

13.6

7.9

1.18

1.16

mmol/l

0.47

193

1719

Other changes in lacrimal passages

1.94

0.94

5.8

6.0

1.19

1.11

mmol/l

—

Failed induction of labour

222

1989

1.13

0.94

4.4

5.7

1.06

1.04

mmol/l

0.36

213

1852

Malignant neoplasm of vagina, including Hilmo

136

1.56

0.93

12.2

2.6

1.01

1.03

mmol/l

0.08

112

Spinal enthesopathy

143

1246

1.16

0.93

5.0

4.7

1.04

1.05

mmol/l

0.14

133

1111

Congenital ovarian cysts

174

1539

1.14

0.93

5.4

4.9

1.06

1.05

mmol/l

0.27

158

1424

Other and unspecified heterotropia

137

1.56

0.92

9.0

8.5

1.02

1.09

mmol/l

0.59

126

Cervical polyps

518

4836

1.08

0.92

4.7

5.3

1.03

1.04

mmol/l

0.22

484

4473

Discharge of firework

2.18

0.91

12.2

5.5

1.19

1.02

mmol/l

—

Impacted maxillary molar

242

2183

1.12

0.91

11.2

6.4

1.10

1.07

mmol/l

1.17

226

2032

Benign neoplasm: Brain, unspecified

239

1.39

0.90

6.7

6.1

1.06

1.04

mmol/l

0.21

218

Other congenital malformations of face and neck

140

1225

1.16

0.90

7.2

6.7

1.08

1.06

mmol/l

0.38

129

1148

Dementia, including avohilmo

3598

23915

1.03

0.89

4.2

5.8

1.02

1.04

mmol/l

6.42

3265

22099

Rheumatic heart disease, other

1.78

0.88

3.9

3.1

1.03

mmol/l

0.00

Convulsions of newborn

2.04

0.88

9.0

12.3

1.35

1.45

mmol/l

—

Cicatricial pemphigoid

106

1.64

0.87

3.5

4.5

1.03

1.08

mmol/l

0.28

Motorcycle rider injured in other and unspecified transport accidents

286

2613

1.11

0.87

7.4

7.7

1.05

1.04

mmol/l

0.19

275

2481

Placenta praevia

140

1594

0.87

4.9

5.7

1.06

1.04

mmol/l

0.39

132

1489

Diffuse (eosinophilic) fasciitis

1.84

0.87

2.8

7.8

1.05

1.06

mmol/l

0.01

Other parasitologically confirmed or unspecified malaria

1.64

0.85

9.1

1.05

1.03

mmol/l

0.15

Lower leg

295

1.34

0.85

8.1

6.4

1.08

1.04

mmol/l

0.43

260

Use of dimethyl fumarate

247

0.67

0.83

1.9

5.6

0.98

1.01

mmol/l

0.30

226

Torsion of ovary, ovarian pedicle and fallopian tube

785

1.19

0.83

3.9

5.1

1.05

1.04

mmol/l

0.10

733

Other disorders of amniotic fluid and membranes

502

5174

0.93

0.82

3.9

5.9

1.03

1.04

mmol/l

0.54

480

4835

Selective deficiency of immunoglobulin M [IgM]

2.46

0.81

13.0

12.8

1.27

1.10

mmol/l

—

Bicipital tendinitis

264

2415

1.11

0.81

7.1

6.5

1.01

1.03

mmol/l

0.96

250

2269

Dengue fever [classical dengue]

1.77

0.81

8.5

7.9

1.00

1.05

mmol/l

0.29

Vertiginous syndromes in diseases classified elsewhere

2.36

0.80

1.4

4.9

0.98

1.02

mmol/l

—

Disorders of muscle in diseases classified elsewhere

1.84

0.79

8.7

3.7

1.13

1.10

mmol/l

—

Other menopausal disorders

1435

8307

0.96

0.79

4.4

5.2

1.01

1.04

mmol/l

4.45

1298

7679

Prolapse and hernia of ovary and fallopian tube

205

1838

1.12

0.79

3.7

3.9

1.02

1.05

mmol/l

0.69

182

1653

Pregnancy examination and test

622

4085

0.94

0.78

4.2

5.6

1.04

1.06

mmol/l

0.84

582

3784

Multiple system atrophy (rare forms of Parkinsonism)

134

1.51

0.78

4.5

5.7

0.96

1.06

mmol/l

1.26

126

Hereditary angioödema type 1

1.98

0.78

3.4

7.7

1.04

1.07

mmol/l

—

Benign neoplasm: Bone and articular cartilage, unspecified

308

1.31

0.77

3.1

5.5

1.04

1.01

mmol/l

0.38

283

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

192

1739

1.12

0.75

5.5

6.6

1.06

mmol/l

0.05

179

1622

Malignant neoplasm of other and ill-defined sites

127

1.49

0.73

4.2

1.14

1.05

mmol/l

0.41

110

Other disorders of skin and subcutaneous tissue related to radiation

1.70

0.71

6.8

4.2

1.11

1.03

mmol/l

0.40

Melanocytic naevi of ear and external auricular canal

241

1.33

0.71

4.4

5.3

1.05

1.08

mmol/l

0.12

219

Chalazion

642

6100

1.06

0.70

6.2

6.4

1.03

1.04

mmol/l

0.70

601

5688

Interstitial cystitis (chronic), drug-induced

137

1.46

0.70

2.8

4.0

1.04

1.09

mmol/l

0.45

119

Retinoschisis and retinal cysts

137

1226

1.14

0.70

8.1

5.8

1.02

mmol/l

0.02

131

1121

Benign neoplasm: Conjunctiva

177

1605

1.12

0.70

6.7

5.8

1.06

1.04

mmol/l

0.49

168

1488

Overjet

159

1428

1.13

0.69

15.7

10.0

1.23

mmol/l

0.04

149

1349

Other injuries involving multiple body regions, not elsewhere classified

1.67

0.67

7.6

9.1

1.06

1.07

mmol/l

0.04

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

433

1.23

0.67

11.4

9.1

1.18

1.15

mmol/l

0.26

405

Benign neoplasm: Vulva

105

927

1.15

0.66

7.0

4.5

1.07

1.04

mmol/l

0.40

841

Degeneration of iris and ciliary body

1.84

0.66

15.6

4.3

1.19

1.01

mmol/l

—

Certain zoonotic bacterial diseases

871

1.16

0.66

7.1

5.6

1.04

1.03

mmol/l

0.15

808

Varicose veins of other sites

348

3255

1.08

0.66

6.3

6.7

1.03

mmol/l

0.07

312

3042

Solar urticaria

1.75

0.66

1.6

8.7

0.98

1.06

mmol/l

—

Other cestode infections

152

0.63

0.66

3.8

4.2

0.96

1.03

mmol/l

—

137

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

355

3320

1.08

0.66

5.2

1.04

mmol/l

0.07

335

3074

Knuckle pads

1.62

0.65

16.8

4.5

1.07

1.03

mmol/l

0.19

Personal history of allergy to analgesic agent

256

0.72

0.65

2.8

5.6

1.10

1.04

mmol/l

0.66

236

Mandibular retrognathia

288

3087

0.92

0.65

9.5

7.3

1.10

mmol/l

0.13

267

2905

Benign neoplasm: Scapula and long bones of upper limb

417

1.23

0.64

4.7

6.3

1.00

1.05

mmol/l

0.73

389

Dementia due to Parkinson's disease

131

1455

0.89

0.64

2.5

5.4

0.97

1.03

mmol/l

2.47

119

1351

Congenital retinoschisis

114

0.58

0.64

4.7

7.7

0.87

1.09

mmol/l

—

106

Abrasion of teeth

2278

22219

1.03

0.63

6.1

6.0

1.03

mmol/l

0.13

2131

20761

Flatback syndrome

1.62

0.63

1.9

4.5

1.14

1.10

mmol/l

—

Meningitis, viral

175

1.36

0.62

13.7

7.0

1.08

1.06

mmol/l

0.14

156

Relapsing fevers

1.52

0.62

8.2

7.9

1.05

1.17

mmol/l

0.71

Acquired atrophy of ovary and fallopian tube

106

1.48

0.62

2.3

5.0

1.01

1.04

mmol/l

0.19

Diving or jumping into water causing injury other than drowning or submersion

211

1.33

0.61

2.9

8.5

1.05

1.03

mmol/l

0.15

200

Adhesive middle ear disease

679

1.17

0.61

3.8

6.1

1.04

1.05

mmol/l

0.09

626

Congenital malformations of nose

1.62

0.61

15.5

9.8

1.12

1.11

mmol/l

0.03

Ectopic pregnancy

837

8041

1.05

0.60

4.6

5.1

1.03

1.04

mmol/l

0.24

772

7445

Congenital absence of the vagina

1.78

0.60

11.2

10.6

1.29

1.09

mmol/l

—

Carcinoma in situ of uteri, other/unspecified

229

0.72

0.59

4.4

1.05

1.07

mmol/l

0.14

202

Glaucoma secondary to drugs

133

1.41

0.59

9.8

5.6

1.06

1.05

mmol/l

0.10

125

Cholesteatoma of middle ear

290

2712

1.08

0.59

5.8

5.7

1.04

mmol/l

0.15

270

2504

Other protozoal diseases, not elsewhere classified/unspecified, including avohilmo

1.74

0.59

2.8

9.9

1.02

1.03

mmol/l

—

Sleep terrors [night terrors]

1.54

0.58

8.3

8.9

1.06

1.15

mmol/l

0.94

Any dementia

2918

20587

0.98

0.58

4.1

5.5

1.02

1.04

mmol/l

3.79

2618

18933

Type 1 diabetes, wide definition, subgroup 2

612

0.84

0.57

20.6

6.0

1.19

1.06

mmol/l

1.82

557

Chromomycosis and phaeomycotic abscess, including avohilmo

169

1.35

0.57

8.7

6.2

1.00

1.06

mmol/l

0.45

153

Oral lichen planus, including avohilmo , including avohilmo

395

3737

1.07

0.56

4.0

5.9

1.00

1.04

mmol/l

2.84

368

3459

Pedestrian injured in collision with two- or three-wheeled motor vehicle

152

1.37

0.56

9.0

5.5

1.06

1.05

mmol/l

0.04

140

Erosion and ectropion of cervix uteri

146

1331

1.11

0.55

4.6

5.0

1.07

1.04

mmol/l

0.62

134

1225

Benign neoplasm: Vertebral column

109

1.45

0.55

5.4

9.6

1.10

1.06

mmol/l

0.27

104

Benign neoplasm: Urethra

1.62

0.55

9.4

5.2

0.97

1.03

mmol/l

—

Disorders of multiple cranial nerves

1.60

0.55

4.5

10.8

1.14

1.06

mmol/l

—

Supervision of high-risk pregnancy

890

5552

0.96

0.54

3.9

5.7

1.04

1.05

mmol/l

0.48

832

5161

Dengue fever [classical dengue], including avohilmo

1.54

0.54

8.5

9.1

1.00

1.06

mmol/l

0.42

Mumps

123

1114

1.12

0.53

6.5

6.1

1.04

1.02

mmol/l

0.48

116

1040

Lymphocyte function antigen-1 [LFA-1] defect

1.70

0.53

6.4

7.2

1.03

1.13

mmol/l

—

Other parasitologically confirmed or unspecified malaria, including avohilmo

127

1.40

0.53

8.2

7.9

1.02

mmol/l

0.03

119

Mumps, including avohilmo

126

1144

1.12

0.53

7.2

6.2

1.04

1.02

mmol/l

0.42

119

1068

Toxic effect of pesticides

1.65

0.52

3.7

5.3

1.06

1.03

mmol/l

—

Cyst of Bartholin Gland

165

1517

1.10

0.52

2.5

4.8

1.03

1.04

mmol/l

0.37

149

1396

Postmenopausal atrophic vaginitis

1472

8242

0.97

0.51

4.6

5.1

1.03

1.05

mmol/l

0.98

1341

7577

Pityriasis lichenoides chronica

200

1.30

0.51

3.1

6.0

1.04

1.05

mmol/l

0.06

184

Malignant neoplasm of trachea, including Hilmo

1.56

0.50

10.3

6.2

0.86

1.02

mmol/l

—

Female pelvic inflammatory disorders in diseases classified elsewhere

1.44

0.50

4.8

4.3

0.95

1.02

mmol/l

0.51

Puerperal sepsis

631

6061

1.05

0.50

4.6

5.2

1.02

1.04

mmol/l

1.40

597

5596

Alopecia universalis

120

1.39

0.50

8.8

10.0

1.14

1.13

mmol/l

0.09

111

Other and unspecified disease of Bartholin gland

138

1264

1.11

0.49

4.7

4.6

1.06

1.04

mmol/l

0.21

125

1158

Other infestations

112

1.41

0.48

3.5

7.8

1.09

1.04

mmol/l

0.25

107

Torticollis

684

1.14

0.48

8.7

6.8

1.06

1.08

mmol/l

0.13

636

Traumatic amputation of wrist and hand

234

2196

1.08

0.47

5.6

7.6

1.05

1.03

mmol/l

0.61

228

2078

Cyst of iris, ciliary body and anterior chamber

1.50

0.47

2.0

3.7

1.08

1.10

mmol/l

0.09

Congenital malformations of nose, including avohilmo

1.43

0.46

13.3

9.6

1.09

mmol/l

0.00

Congenital nasolacrimal duct obstruction or stenosis

248

1.25

0.46

11.1

11.4

1.31

mmol/l

0.04

234

Trisomy 21 (Down syndrome) due to meiotic nondisjunction

132

1.37

0.45

3.6

11.6

1.25

1.32

mmol/l

0.38

121

Benign neoplasm: Mesothelial tissue of pleura

0.00

0.45

0.0

1.9

—

0.96

—

Flexion deformity

1.45

0.44

2.6

3.3

1.02

mmol/l

—

Crushing injury of shoulder and upper arm

0.00

0.44

0.0

12.2

—

1.01

—

Abnormal spermatozoa

757

7820

0.96

0.44

6.1

7.4

1.01

1.03

mmol/l

1.13

699

7400

Congenital absence, occlusion, or narrowing of the ear canal

103

0.64

0.43

4.9

10.4

0.98

1.13

mmol/l

—

Other assisted single delivery

647

0.87

0.43

3.6

6.6

1.00

1.04

mmol/l

0.88

615

Feeding problems of newborn

355

1.20

0.43

12.8

13.6

1.35

1.36

mmol/l

0.07

340

Ovarian dysfunction: androgen excess

1.38

0.42

4.5

5.7

1.02

1.03

mmol/l

—

Respiratory tuberculosis, not confirmed

220

2070

1.07

0.42

6.0

5.4

1.07

1.04

mmol/l

0.73

200

1899

Congenital glaucoma

1.43

0.42

10.6

9.2

0.98

1.21

mmol/l

—

Sequelae of injuries involving multiple and unspecified body regions

1.46

0.41

2.5

5.4

1.07

1.05

mmol/l

—

Other congenital malformations of eye

1.46

0.40

9.3

9.4

1.01

1.24

mmol/l

1.11

Relapsing polychondritis

1.38

0.40

3.1

4.8

0.99

1.02

mmol/l

0.13

Heberden's nodes [with arthropathy]

402

1.17

0.40

4.1

4.6

0.99

1.06

mmol/l

0.97

363

Chorioretinal scars

161

1.28

0.40

16.6

5.5

1.08

1.04

mmol/l

0.26

151

Other abnormal products of conception

1390

9333

0.97

0.39

4.9

5.5

1.04

mmol/l

0.37

1290

8675

Use of interferon beta-1a

790

1.11

0.39

5.2

6.4

1.00

1.04

mmol/l

0.77

743

Urticaria due to cold and heat

308

1.19

0.39

4.8

5.4

1.05

1.07

mmol/l

0.15

284

Obstructed labour due to maternal pelvic abnormality

717

7398

0.97

0.39

5.0

5.2

1.05

1.04

mmol/l

0.51

658

6841

Major anomalies of jaw size

131

1214

1.09

0.39

5.9

7.3

1.06

1.07

mmol/l

0.14

118

1145

Foreign body on external eye

822

7985

1.03

0.39

7.2

7.6

1.03

mmol/l

0.18

785

7597

Malignant neoplasm of vagina

1.41

0.38

12.8

2.4

1.05

1.04

mmol/l

0.08

Mucocutaneous lymph node syndrome [Kawasaki]

124

0.69

0.38

9.9

10.8

1.13

1.19

mmol/l

—

116

Contact with lifting and transmission devices, not elsewhere classified

870

1.11

0.38

4.3

7.3

0.97

1.02

mmol/l

1.28

821

Benign neoplasm of other and unspecified female genital organs

213

2011

1.07

0.38

5.3

4.7

1.06

1.04

mmol/l

0.42

193

1837

Retained placenta and membranes, without haemorrhage

535

5545

0.96

0.38

4.5

5.2

1.06

1.04

mmol/l

1.01

491

5132

Other sudden death, cause unknown

0.63

0.38

20.6

7.3

1.17

1.05

mmol/l

—

Relapsing fevers, including avohilmo

117

1.33

0.38

7.7

7.6

1.05

1.14

mmol/l

0.55

109

Rheumatic fever without mention of heart involvement

144

1.29

0.38

7.6

6.2

1.10

1.04

mmol/l

0.57

131

Calcaneal spur

574

1.13

0.38

2.9

4.8

0.98

1.04

mmol/l

1.20

534

Diaper [napkin] dermatitis

100

1.38

0.37

27.3

14.4

1.14

1.30

mmol/l

1.21

Lumbosacral root disorders, not elsewhere classified

556

1.13

0.37

3.8

5.3

1.06

1.03

mmol/l

0.23

509

Deep endometriosis

410

4267

0.96

0.37

4.4

4.8

1.03

1.04

mmol/l

0.60

370

3917

Disorder of visual pathways, unspecified

128

1.33

0.36

5.3

11.6

1.04

1.23

mmol/l

2.05

121

Burn and corrosion confined to eye and adnexa

106

978

1.09

0.36

5.2

6.8

1.07

1.03

mmol/l

0.75

925

Unspecified dementia

690

6379

0.97

0.36

4.0

5.1

1.04

1.06

mmol/l

0.76

608

5792

Benign mammary dysplasia

762

7407

1.03

0.36

4.3

4.7

1.03

1.04

mmol/l

0.98

699

6771

Injury of muscle and tendon at ankle and foot level

120

1114

1.09

0.35

5.2

6.1

1.02

1.03

mmol/l

0.24

114

1040

Other cestode infections, including avohilmo

166

0.76

0.35

8.0

4.1

1.04

1.03

mmol/l

0.01

147

Burn and corrosion of head and neck

105

970

1.09

0.35

6.5

7.2

1.01

1.04

mmol/l

0.50

909

Complications specific to multiple gestation

136

1.28

0.35

1.6

6.2

0.98

1.04

mmol/l

0.47

123

Undefined dementia

700

6649

0.97

0.35

4.0

4.8

1.04

1.05

mmol/l

0.49

616

5990

Melanoma in situ of trunk

827

1.10

0.35

5.5

6.2

1.02

1.03

mmol/l

0.07

765

Phlebitis and thrombophlebitis of other deep vessels of lower extremities, drug-induced

137

1.28

0.34

12.4

5.2

0.97

1.05

mmol/l

0.56

130

Abnormalities of ear ossicles

1.38

0.34

2.9

6.7

1.21

1.04

mmol/l

0.83

Ovarian dysfunction: estrogen excess

1.43

0.33

1.7

4.0

1.16

1.08

mmol/l

—

Benign leiomyoma with endometriosis

847

8260

1.03

0.33

4.9

4.8

1.03

1.04

mmol/l

0.59

776

7565

195

0.78

0.33

10.0

14.1

1.40

1.36

mmol/l

0.19

186

Respiratory tuberculosis, not confirmed, including avohilmo

220

2093

1.06

0.32

6.0

5.4

1.07

1.04

mmol/l

0.72

200

1919

Erysipeloid, including avohilmo

175

1.23

0.32

8.7

5.0

0.99

1.04

mmol/l

0.35

155

Dysplastic lesion of the vulva of unknown severity

1.36

0.30

2.3

3.5

1.06

1.14

mmol/l

—

ICD 8 haemorrhage (epidural, subarachnoid, subduralis)

161

0.79

0.29

4.3

6.1

0.94

1.03

mmol/l

0.54

154

Cleft lip

122

1.26

0.28

10.5

10.4

1.18

1.14

mmol/l

0.34

111

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

361

3488

1.04

0.28

6.0

6.5

1.04

1.03

mmol/l

0.12

339

3264

Congenital nasolacrimal duct obstruction or stenosis, including avohilmo

301

1.16

0.27

10.5

11.6

1.31

mmol/l

0.01

285

Polypectomy (DHB20)

341

3529

0.96

0.27

6.0

6.9

1.03

mmol/l

0.03

333

3312

Pneumoconiosis due to asbestos and other mineral fibres

118

1111

1.07

0.27

6.5

6.1

1.02

1.04

mmol/l

0.29

110

1033

Other fusion of spine

1.25

0.27

2.0

3.5

1.01

1.06

mmol/l

—

Discharge from other and unspecified firearms

148

0.79

0.26

4.7

6.3

0.98

1.02

mmol/l

0.28

142

Toxic effect of metals

1.43

0.25

17.6

8.4

1.13

1.02

mmol/l

—

Congenital malformations of uterus and cervix

647

1.09

0.25

8.0

5.4

1.06

1.05

mmol/l

0.11

596

Injury of muscle and tendon at shoulder and upper arm level

2417

23886

1.01

0.25

5.9

6.7

1.03

mmol/l

0.02

2284

22438

Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours

115

1.26

0.25

2.7

7.5

1.16

1.03

mmol/l

0.60

108

General- and plastic-surgery devices associated with adverse incidents

115

1.25

0.25

3.0

4.7

1.03

mmol/l

0.01

103

Hereditary spherocytosis

115

1.25

0.25

3.6

7.8

1.09

1.17

mmol/l

0.54

104

Balanced rearrangements and structural markers, not elsewhere classified

143

1.21

0.24

6.0

7.7

1.08

1.11

mmol/l

0.23

134

Parkinson's disease, including avohilmo

1021

10030

1.02

0.24

3.8

5.9

1.00

1.04

mmol/l

5.84

934

9300

Perioral dermatitis, drug-induced

1.32

0.24

5.6

2.0

0.86

1.03

mmol/l

—

Intentional self-harm by drowning and submersion

0.72

0.24

9.4

3.8

0.98

1.00

mmol/l

—

Congenital malformations of ear causing impairment of hearing

178

0.82

0.23

21.1

7.7

1.11

1.10

mmol/l

0.05

165

Benign neoplasm: Urinary organ, other/unspecified

116

1.24

0.23

8.4

3.9

1.05

1.01

mmol/l

0.14

103

Bilateral

0.00

0.23

0.0

5.6

—

1.02

—

Bradycardia, unspecified, drug-induced

124

0.79

0.23

1.8

5.7

0.94

1.03

mmol/l

—

114

Left side

209

0.84

0.23

7.1

6.6

1.07

1.03

mmol/l

0.26

195

Anthrax

0.00

0.23

0.0

4.5

—

0.92

—

Anthrax, including avohilmo

0.00

0.22

0.0

4.3

—

0.94

—

Imperforate hymen

1.21

0.22

1.8

3.6

1.11

1.06

mmol/l

—

Benign neoplasm of male genital organs

116

1102

1.06

0.22

7.6

7.5

1.06

1.02

mmol/l

0.79

107

1047

Endometriosis diagnosis and infertility diagnosis occurring together

429

4180

1.03

0.21

4.3

5.2

1.04

mmol/l

0.00

405

3880

Malignant neoplasm of meninges, including Hilmo

155

1.19

0.21

7.6

4.5

0.88

1.02

mmol/l

1.23

140

Spontaneous abortion

2401

16237

0.99

0.20

5.1

1.04

mmol/l

0.07

2223

14976

Glaucoma, exfoliation

676

6636

1.02

0.19

4.3

5.0

1.06

1.04

mmol/l

0.80

609

6062

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

439

4291

1.03

0.19

6.4

6.0

1.03

1.04

mmol/l

0.20

409

3984

Dislocations, sprains and strains involving multiple body regions

1.24

0.19

14.1

5.9

1.06

1.08

mmol/l

—

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

532

1.08

0.19

5.3

6.5

1.12

1.05

mmol/l

0.90

496

Maternal care for other known or suspected fetal problems

968

6164

0.98

0.18

4.9

5.8

1.05

mmol/l

0.01

898

5761

Calcium deposit in bursa

1.25

0.18

12.1

6.1

1.18

1.08

mmol/l

—

Family history of other specific disorders

504

1.08

0.17

7.2

3.6

1.03

1.05

mmol/l

0.17

463

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

150

1444

1.04

0.17

5.8

5.4

1.08

1.04

mmol/l

0.83

134

1331

Spermatocele

442

4328

1.02

0.17

7.1

7.2

1.02

1.03

mmol/l

0.51

417

4086

Photocontact dermatitis [berloque dermatitis]

1.17

0.17

1.9

6.8

1.15

1.08

mmol/l

—

Benign neoplasm: Cornea

0.76

0.17

19.2

6.4

1.43

1.03

mmol/l

—

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

672

1.06

0.16

5.6

6.9

1.00

1.01

mmol/l

0.09

639

Use of ropinirole

199

1931

1.04

0.16

3.2

6.1

1.02

1.03

mmol/l

0.18

183

1793

Familial erythrocytosis

197

1.13

0.16

4.9

6.2

1.03

1.05

mmol/l

0.22

186

Pterygium

154

1594

0.96

0.16

5.3

5.8

1.00

1.03

mmol/l

0.64

139

1488

Other specified disorders of external ear

209

2030

1.03

0.16

6.9

1.08

1.04

mmol/l

0.93

191

1915

Microtia (small ears)

0.79

0.15

14.1

13.0

1.25

1.18

mmol/l

—

Persons encountering health services in circumstances related to reproduction

3661

24689

0.99

0.15

7.4

7.2

1.06

mmol/l

0.55

3446

23228

Other and unspecified disorders of lacrimal system

1.11

0.15

9.6

3.4

1.13

1.04

mmol/l

—

Sequelae of inflammatory diseases of the central nervous system

131

1.17

0.15

11.3

5.5

0.94

1.00

mmol/l

0.48

121

Inhalation of gastric contents

112

1.18

0.15

8.3

6.5

1.10

1.04

mmol/l

0.35

104

Small cell lung cancer, helper endpoint

129

1336

0.96

0.14

4.0

5.6

1.07

1.04

mmol/l

0.35

121

1227

Antepartum haemorrhage, not elsewhere classified

311

3176

0.98

0.13

4.4

5.8

1.05

1.04

mmol/l

0.15

282

2975

L02BA Anti-estrogens

890

8798

1.01

0.13

3.6

5.0

1.02

1.04

mmol/l

1.39

830

8078

Use of rasagiline

140

1358

1.04

0.13

2.5

6.1

0.98

1.04

mmol/l

1.86

122

1253

Congenital retinoschisis

137

0.86

0.13

4.9

7.5

0.96

1.09

mmol/l

1.01

129

Enterobiasis, including avohilmo

914

1.04

0.12

6.3

8.3

1.20

1.15

mmol/l

0.70

861

Other diseases of appendix

532

1.06

0.12

9.1

5.5

0.99

1.04

mmol/l

1.00

494

Other/unspecified postprocedural disorders of ear and mastoid process

143

1.14

0.12

7.5

4.5

1.06

1.07

mmol/l

0.06

132

Postpartum haemorrhage due to anatomy

318

3242

0.98

0.12

4.0

4.7

1.04

mmol/l

0.02

292

3028

Mucinous and mucinous cystic tumor

182

1.11

0.11

7.0

3.0

0.96

1.02

mmol/l

0.52

153

Parkinson's disease, strict definition

881

8900

0.99

0.11

3.8

5.9

1.00

1.04

mmol/l

5.30

801

8251

Other disorders following mastoidectomy

198

0.90

0.11

5.2

4.6

1.15

1.05

mmol/l

1.70

181

Multiple gestation

348

3540

0.98

0.11

4.2

5.8

1.03

1.04

mmol/l

0.13

337

3317

Struck by thrown, projected or falling objec

261

2559

1.02

0.11

7.0

7.3

1.05

mmol/l

0.17

248

2407

Female infertility, uterine origin

125

1.13

0.10

5.7

6.0

1.06

1.02

mmol/l

0.42

117

Lichen planopilaris

145

1.12

0.10

4.9

4.2

0.96

1.05

mmol/l

0.77

129

Asymmetry of jaw

564

0.95

0.09

4.4

6.7

1.11

1.07

mmol/l

0.49

527

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

543

0.95

0.09

2.9

9.3

1.17

1.16

mmol/l

0.10

509

Other disorders of prostate

186

1823

1.02

0.09

8.2

7.0

1.04

1.03

mmol/l

0.11

179

1718

Parkinson's disease

969

9614

1.01

0.09

3.9

6.0

1.00

1.04

mmol/l

5.46

884

8917

Huntington disease

1.06

0.09

9.2

7.5

1.01

1.02

mmol/l

—

Tularaemia, including avohilmo

897

0.97

0.09

7.2

6.0

1.06

1.04

mmol/l

0.41

835

Carcinoma in situ of bronchus and lung

0.78

0.09

1.0

7.7

0.90

1.04

mmol/l

—

Non-small cell lung cancer, squamous, helper endpoint

273

2772

0.98

0.08

4.7

5.8

0.98

1.03

mmol/l

2.30

258

2557

Inflammation of lacrimal passages (chronic)

746

1.04

0.08

4.9

1.09

1.04

mmol/l

1.01

672

Injury of muscle and tendon at neck level

0.83

0.08

4.3

9.2

1.03

mmol/l

—

Desensitization to allergens

212

2156

0.98

0.08

4.1

7.5

1.08

mmol/l

0.20

190

2031

Contact with hypodermic needle

166

1.09

0.08

4.1

7.5

0.96

1.03

mmol/l

0.51

150

Other helminthiases, including avohilmo

108

1.13

0.07

5.2

6.0

1.01

1.06

mmol/l

0.37

100

Food allergy

108

1.12

0.07

4.8

8.5

1.08

1.10

mmol/l

0.14

Chondromalacia

129

1263

1.02

0.07

5.4

6.4

1.01

1.03

mmol/l

0.33

114

1177

Type 1 diabetes, strict definition, subgroup 2

118

1.12

0.07

16.9

11.2

1.16

1.24

mmol/l

0.52

111

Normal-pressure hydrocephalus

278

2745

1.01

0.07

3.8

5.4

1.03

1.04

mmol/l

0.23

253

2530

Use of levodopa decarboxylase inhibitor

886

8802

1.01

0.07

4.2

5.9

1.00

1.04

mmol/l

4.21

805

8154

Hydatidiform mole

487

0.96

0.06

4.4

5.2

1.03

1.05

mmol/l

0.25

445

Dementia

3283

22371

1.00

0.06

4.1

5.7

1.02

1.04

mmol/l

7.71

2968

20646

Circumscribed brain atrophy

109

1110

0.98

0.05

4.1

5.8

0.98

1.04

mmol/l

2.03

1028

Carcinoma in situ of breast, intraductal

433

4363

0.99

0.05

4.2

5.0

1.04

mmol/l

0.05

395

3997

Fetus and newborn affected by noxious influences transmitted via placenta or breast milk

131

1.11

0.04

20.0

15.5

1.47

1.43

mmol/l

0.18

126

Spirochaetal infections, other/unspecified

502

4989

1.01

0.04

5.5

6.5

1.02

1.04

mmol/l

0.79

463

4663

Endometriosis of rectovaginal septum and vagina

352

3547

0.99

0.04

4.5

4.9

1.03

1.04

mmol/l

0.33

316

3274

Endometriosis ASRM stages 3,4

1139

11431

1.00

0.04

5.0

4.7

1.03

1.04

mmol/l

0.80

1037

10537

Medical treatment for female infertility

816

8117

1.00

0.04

4.4

5.3

1.04

mmol/l

0.00

766

7583

Vascular dementia (multiple infarctions)

596

1.02

0.04

6.0

5.1

1.04

1.07

mmol/l

0.41

558

Rubella [German measles]

158

1596

0.99

0.03

9.9

7.8

1.02

1.01

mmol/l

0.24

152

1542

Choroidal detachment

108

0.92

0.03

7.9

5.1

1.26

1.04

mmol/l

—

100

Contact with machinery

612

6096

1.00

0.03

6.8

7.5

1.03

mmol/l

0.02

589

5781

Pedal cyclist injured in collision with motor vehicle

139

1404

0.99

0.03

3.1

6.2

1.00

1.04

mmol/l

0.60

125

1308

Twin gestation

340

3414

1.00

0.02

4.2

5.8

1.03

1.04

mmol/l

0.14

330

3197

Mesial bite

422

1.02

0.01

11.0

8.9

1.19

1.15

mmol/l

0.31

396

Rubella [German measles], including avohilmo

159

1600

0.99

0.01

9.8

7.8

1.02

1.01

mmol/l

0.25

153

1546

Right side

267

0.97

0.01

3.8

5.9

1.02

1.04

mmol/l

0.20

253

Unattended death

456

0.98

0.00

5.5

6.0

1.05

1.04

mmol/l

0.09

425

Premature separation of placenta [abruptio placentae]

804

1.01

0.00

4.1

6.1

1.03

1.05

mmol/l

0.25

746

Toxic effect of contact with venomous animals

207

2064

1.00

0.00

5.6

6.7

1.03

1.06

mmol/l

1.01

194

1924

Other obstetric trauma

186

1864

1.00

0.00

4.6

5.4

1.04

mmol/l

0.11

171

1737

Upper arm

108

1.02

0.00

6.5

6.9

1.03

1.09

mmol/l

0.48

100

Abnormal findings on antenatal screening of mother

258

2576

1.00

0.00

3.5

5.3

1.04

1.05

mmol/l

0.10

245

2391

Craniosynostosis EXCLUDE syndromes

122

0.98

0.00

6.3

14.1

1.37

1.38

mmol/l

0.03

117

Congenital malformations of lung

152

0.98

0.00

9.9

9.0

1.32

1.24

mmol/l

0.31

141

Benign neoplasm: Respiratory system, unspecified

107

1.03

0.00

9.5

3.8

1.23

1.02

mmol/l

0.82

Contact with other specified venomous animals

307

1.01

0.00

3.8

6.8

1.02

1.05

mmol/l

0.26

286

Acute myringitis

314

0.99

0.00

14.6

6.7

1.05

1.11

mmol/l

0.63

296

Other specified/unspecified diseases of inner ear

225

0.98

0.00

3.0

6.2

1.02

1.09

mmol/l

0.35

205

Indeterminate sex and pseudohermaphroditism

0.88

0.00

4.4

5.7

0.92

1.06

mmol/l

—

Occupational exposure to risk-factors

171

1710

1.00

-0.00

5.7

7.0

1.02

1.03

mmol/l

0.23

155

1606

Neonatal aspiration syndromes

1.00

-0.00

3.3

11.9

1.21

1.32

mmol/l

—

Disorders of vitreous body and globe in diseases classified elsewhere

0.00

-0.00

0.0

4.6

—

1.05

—

Gastric ulcer - Acute with haemorrhage, drug-induced

0.91

-0.00

22.4

6.3

1.11

1.06

mmol/l

—

Progressive osseous muscle inflammation

1.03

-0.00

7.9

5.9

1.06

1.00

mmol/l

—

Other inherited muscular atrophy

1.01

-0.00

6.2

1.20

1.09

mmol/l

—

Acne tropica

0.00

-0.00

0.0

4.1

—

1.02

—

Use of metixene

0.00

-0.00

0.0

3.1

—

1.17

—

Acute disseminated encephalitis/encephalomyelitis

0.97

-0.00

7.9

7.2

1.11

mmol/l

—

Erysipeloid

1.00

-0.00

14.3

5.8

0.87

1.05

mmol/l

—

Complications of anaesthesia during pregnancy

0.96

-0.00

6.0

6.8

1.08

1.04

mmol/l

—

Intentional self-harm by hanging, strangulation and suffocation

290

1.00

-0.00

3.2

7.1

1.04

1.01

mmol/l

0.19

272

Lipomatosis, not elsewhere classified, drug-induced

0.00

-0.00

0.0

10.0

—

1.02

—

Miliaria, unspecified

0.00

-0.00

0.0

3.0

—

0.76

—

Alopecia mucinosa, drug-induced

0.00

-0.00

0.0

10.0

—

0.99

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Phosphate [Moles/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS